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Abstract 
 
Patterns of Antimicrobial Resistant E. coli and Genetic Interplay Between Livestock, Humans 
and Their Shared Environment in a High-Density Livestock-Human Population in Western Kenya 
 
Steven A Kemp 
 
Antimicrobial resistance (AMR) is a global One Health issue. There has been a significant increase 
in the rates of AMR infections in both humans and veterinary medicine. The dynamics of AMR in 
developing countries are poorly understood, especially in community settings, due to a 
paucity of data on AMR prevalence and the drivers of resistance. Previous studies in sub-
Saharan Africa indicated a high prevalence of multi-drug resistance (MDR) amongst 
Enterobacteriaceae such as E. coli in both humans and livestock. In western Kenya, there is 
significant overlap between humans, livestock, and their shared environments, due to the high 
density of smallholder farmers. This increases the risk of bacterial transmission via direct or 
close contact between humans and animals, or indirectly via the shared environment. The 
aims of this study were to determine the knowledge, attitudes and practices (KAP) amongst 
antimicrobial users and providers; to estimate the prevalence of carriage and identify risk 
factors for AMR E. coli including to the highest priority critically important antimicrobials 
(HPCIAs) amongst humans, livestock and the environment in an area of high-density 
smallholder farms in western Kenya and; finally, to explore AMR E. coli faecal carriage amongst 
livestock slaughterhouse workers. 
 
Three studies were conducted; a cross-sectional KAP study of 147 antimicrobial users and 
prescribers understanding of AMR across Busia county; a cross-sectional study (farm) study 
collecting and characterising faecal E. coli from farmers, livestock and their shared environments, 
and finally examination and characterisation of faecal AMR E. coli amongst slaughterhouse 
workers. During the KAP and farm studies a structured questionnaire was used as a framework 
to interview all participants. During the farm study, E. coli isolates were isolated from farmers 
and livestock faeces, and from living environments and water sources on 70 farms across Busia. 
The slaughterhouse study was a retrospective study which collected faecal E. coli from workers 
in 142 slaughterhouses across western Kenya. All E. coli isolates were subjected to antimicrobial 
susceptibility testing using the disk-diffusion method and a subset were characterised by Whole 
Genome Sequencing (WGS). Non-sequenced isolates with an ESBL phenotype were subjected to 
PCR to determine ESBL resistance genes. Mixed effect logistic regression models were utilised to 
assess risk factors for carriage of AMR E. coli using questionnaire-derived data from the farm 
study.  
 
The KAP study indicated that antimicrobials are accessed via agrovet shops, with a large 
proportion (~40%) being sold without a prescription. Concerning knowledge of antimicrobials; 
less than half of agrovets had sufficient training regarding livestock health and disease, and a 
registered pharmacist was often not present to dispense veterinary antimicrobials. Detailed 
information regarding dosage, withdrawal periods and the risks of AMR were not routinely 
provided by agrovets or animal healthcare assistants (AHAs) to farmers at point-of-sale. The most 
commonly sold/purchased antimicrobials were broad-spectrum oxytetracyclines and penicillin-
streptomycin. Due to a lack of diagnostic facilities, broad-spectrum antimicrobials were often 
used empirically. There was good record keeping of antimicrobials sold by agrovets, but few 
records kept by farmers or AHAs who treated animals. Withdrawal periods were acknowledged 
by 80% of farmers, but only 28% had a good understanding and strictly adhered to them. A high 
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proportion of agrovets (69.2%), AHAs (39.7%) and farmers (29.0%) had never heard of AMR or 
‘resistance’ before. 
 
Faecal carriage of AMR E. coli on smallholder farms was high amongst sampled humans, livestock, 
and environment, with 95.3% of samples being resistant to at least one class of antimicrobial. 
Resistance to tetracycline (89.2%), trimethoprim (71.0%) and sulfonamides (69.4%) most 
prevalent. There was a high prevalence of MDR isolates (53.9%), with sheep and goats having the 
largest proportion compared to other animals. There was a moderate prevalence of ESBL-E. coli 
(14.8%) with two ESBL hotspots were identified in Nambale and Butula sub-counties. Molecular 
characterisation of E. coli isolates indicated a high diversity of E. coli with several similar strains 
found across animal, human and livestock populations between farms, confirmed by a large 
number of multi-locus sequence types (MLST) common to all groups. The most prevalent STs 
were identified in all three groups. Four distinct clonal groups with common ancestors were 
identified, all associated with carriage of blaCTX-M ESBL resistance genes. There was suggestion of 
clonal spread, as each member of the groups had similarities between serogroups, plasmids 
carried and resistance and virulence determinants, however directionality could not be 
determined. Two major risk factors were associated with increased risk of AMR - antimicrobial 
use (AMU) and animal vaccination.  
 
There was a high proportion of faecal AMR E. coli amongst slaughterhouse workers (95.1%). 
There was a lower proportion of MDR (45.5%) and ESBL-E. coli (9.6%) compared to that found in 
farmers, livestock, and the farm environment. The largest proportion of ESBL-E. coli was found 
amongst mixed ruminant slaughterhouse workers. The most common resistance phenotypes 
were to tetracycline (86.2%), trimethoprim (59.3%) and sulfonamides (57.4%). A similarly wide 
diversity of E. coli was found amongst slaughterhouse workers, confirmed by numerous STs. Five 
isolates were identified as forming a clonal group of ST131 primarily amongst pig-only 
slaughterhouse workers. These were associated with serogroup O25:H4, the human pandemic 
clone and ESBL producer. Two other large clonal groups were associated with carriage of ESBL 
resistance genes, ST617 (blaCTX-M) and ST361 (blaSHV), also carrying ESBL resistance genes.  
 
These findings indicate that there are gaps in the knowledge of antimicrobial users and 
prescribers and prescribing of broad-spectrum drugs. There is a high prevalence of circulating 
AMR E. coli amongst humans, livestock, and the environment as well as a moderate prevalence 
of ESBL-E.coli associated with blaCTX-M-15 in all groups. This is important as there was little 
documented use of HPCIAs to provide selection pressure. There was overlap evident between 
humans, livestock, and the environment, as well as in slaughterhouse workers in rural settings. It 
is important to consider both direct and indirect transmission pathways of bacteria between 
humans, livestock, and the environment, using an integrated One Health approach to protect 
food safety and reduce the transmission of AMR bacteria. There is urgent need for surveillance 
systems to collect AMU and AMR data which will allow for targeted interventions and further 
identify reservoirs of resistance genes amongst different populations. 
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1.1 Introduction 
The development of antimicrobials is one of the most important medical breakthroughs in the 
history of modern medicine. Their use has significantly helped to reduce the morbidity and 
mortality associated with bacterial infections (Andersson and Hughes, 2010). Early 
antimicrobials including penicillins and tetracyclines were based on naturally occurring 
compounds, produced by environmental microorganisms (Fleming, 1932; Martinez, 2008). 
Since then, several synthetic and semi-synthetic antimicrobials have been developed. In 1935, 
Domagk discovered and produced the first commercially available antibacterial drug, 
sulfonamidochrysoïdine (Prontosil, Bayer, Germany) (Domagk, 1935b). This was the first 
antimicrobial belonging to the sulfonamides.  
 
During the “Golden age of antibiotics” (1950-1960s) more than 50% of the  antimicrobials 
commonly used today were discovered, including macrolides, cephalosporins, quinolones, and 
aminoglycosides (Davies, 2006). The global use of antimicrobials is constantly rising and is 
primarily driven by increased consumption in LMICs; latest estimates suggest that human 
antimicrobial consumption, expressed in defined daily doses (DDD), increased 65% from 21.1 
billion DDDs in 2000, to 34.8 billion DDD in 2015 (Klein et al., 2018). In food-producing animals, 
in 2010, there was an estimated 63,151 tons of antimicrobials used per annum, with projections 
suggesting this will rise to over 105,596 tons by 2030 (Van Boeckel et al., 2015).   
 
Antimicrobial resistance (AMR) has existed for many thousands of years, being a natural product 
of bacteria (D'Costa et al., 2011) but the widespread use of antimicrobials in human and animal 
medicine has led to more rapid development. Over the last 80 years, evidence has shown there 
is a direct correlation between the antimicrobial use (AMU) and AMR (Steinke and Davey, 2001; 
Goossens et al., 2005). With the introduction of new semi-synthetic antimicrobials, for use in 
human and veterinary medicine, resistance has been detected shortly afterwards (Figure 1.1). 
 
Antimicrobial overuse occurs in all involved sectors – human, animal and agriculture - and this 
is the main driver for the spread of resistant bacteria and resistance determinants within and 
between these sectors and around the globe (O’Neill, 2016; Klein et al., 2018). Wherever 
antimicrobials are used, there is also concurrent development of reservoirs of AMR. This 
happens within the human population in hospitals and community settings, in animals and farm 
and aquaculture environments, but also in water, soil, wildlife, and many other ecological 
niches, as a result of pollution by sewage, pharmaceutical industry waste, and manure runoff 
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from farms (Marti et al., 2014; Huijbers et al., 2015). There is evidence to show that bacteria 
and the genes they carry can intersperse easily within and between humans, animals, and the 
environment (Woolhouse et al., 2015). The bacterial adaption to selection pressures within any 
one sector, is reflected in other sectors and actions taken to contain AMR do have an effect in 
other sectors (O’Neill, 2015). AMR is an inherently ecological problem which can be 
characterised by complex interactions involving diverse microbial populations affecting the 
health of humans, animals, and the environment. As such, it makes sense to address the issue 
of AMR by using a coordinated, multisectoral approach, such as the ‘One Health’ approach, 
discussed in Section 1.7. 
 
Figure 1.1 Development and emergence of resistance timeline for major classes of antimicrobials. (Adapted 
from https://mega.online/en/articles/antibiotic-armageddon). 
 
 
The emergence of AMR is a global concern for human and animal health; interaction at the 
human-animal-environmental interface can lead to the spread of AMR genes. In order to 
combat this issue effectively, intersectoral approaches which share the cost and responsibility 
evenly between environmental, human and veterinary health professionals is required, which 
laid out in the “One Health” paradigm (Fisman and Laupland, 2010). 
 
1.2 AMR 
AMR is a “global emergency” with long-reaching social, economic, and political burdens. It is the 
most serious public health threat of the 21st century (World Health Organization, 2012; Davies, 
2013). AMR is currently estimated to cause 700,000 deaths per year, worldwide (O’Neill, 2016). 
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Due to the increasing amounts of antimicrobial use in human and animal medicine, AMR is 
developing at a rate which is faster than available control methods. By 2050, annual deaths from 
AMR-bacterial infections are estimated to reach 10 million, if action is not taken to tackle the 
issue (O’Neill, 2016). AMR is a multifactorial issue arising from the interplay between humans, 
their immediate environment and pathogens (Shears, 2001; Okeke et al., 2007). AMR bacteria 
arising in any of these sectors may spread between themselves, across species and borders. 
Addressing the issue will require a multisectoral, or One Health approach. To help facilitate this, 
the WHO has included AMR as one of the top ten threats to global health in 2019 (WHO, 2019a). 
 
1.2.1 Current state of AMR 
The state of AMR has changed rapidly over the last 15 years. In the past, major pathogens of 
concern included Gram-positive bacteria which circulated in hospitals - methicillin-resistant 
Staphylococcus aureus (MRSA), penicillin-resistant pneumococcus (PRP) and vancomycin-
resistant enterococci (VRE). The clinical management for both PRP and MRSA revolved around 
better infection control and containment in hospitals, until MRSA began to spread amongst 
communities  (Smith et al., 2016). More recently, research has shifted focus to AMR in Gram-
negative pathogens — particularly in MDR and extensively drug-resistant (XDR) 
Enterobacteriaceae. The emergence and rapid spread of AMR genes means that some infections 
are now completely resistant to all currently available antimicrobials.  
 
A recent example of dangerous resistance genes is the New Delhi metallo-beta-lactamase 1 
(NDM-1) which encodes an enzyme that confers resistance to a wide range of antimicrobials – 
this emerged in India and spread to the UK due to medical tourism (Yong et al., 2009). The NDM-
1 gene has since been detected in (most commonly, but not exclusively) E. coli in surface and 
tap water in India and in the environment in Bangladesh (Islam et al., 2017; Khan et al., 2017), 
indicating the potential for NDM-1 being of environmental origin. The gene has also been 
identified in Arctic soil, indicating that the gene is spread in the faeces of migratory birds 
(McCann et al., 2019). Another example is the mobilised colistin resistance-1 (MCR-1) gene, 
which is a plasmid-borne gene conferring resistance to colistin – an antimicrobial of last resort; 
this gene was originally identified in Chinese pigs (Liu et al., 2016), but has now spread to 
humans and other animals in many countries (Wang et al., 2018).  
 
The majority of antimicrobial classes are used in both human and veterinary medicine, though 
some are reserved exclusively for humans (e.g. isoniazid, for tuberculosis treatments) and some 
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are reserved exclusively for animal use (e.g. flavophospholipols and ionophores, due to  toxicity 
to humans) (Van Boeckel et al., 2015; EMA, 2018). In human medicine, antimicrobials are 
predominantly used to treat clinical infections in individual patients, but there are also other 
prophylactic uses such as post-surgery. In Niger, an LMIC with very high risk of mortality, 
ciprofloxacin prophylaxis was shown to reduce the attack rate during a meningococcal group C 
epidemic (Coldiron et al., 2018) and twice-annually dose of azithromycin was found to reduce 
infant mortality (age <5) by 18% compared to control villages (Keenan et al., 2018). In veterinary 
medicine, there are differences between food-producing animals, and companion animals. 
Companion animals such as dogs, cats, horses etc. have similar antimicrobial use patterns to 
humans i.e. the majority of antimicrobials are to treat clinical infections (Sykes, 2013). In food 
animals, when a proportion of animals in a group are clinically infected and require antimicrobial 
treatment, medications may be administered in feed or water to an entire group. These 
methods of mixed treatment and prophylaxis for animals that are not infected; is defined as 
inappropriate use of antimicrobials in animals (Van Boeckel et al., 2017).  
 
A particularly controversial use of antimicrobials in food-producing animals are the long-term, 
low-dose antimicrobials administered for growth promotion. This practice has been shown to 
enhance selection for AMR as the antimicrobials are administered to entire groups of animals 
for prolonged periods of time, often at subtherapeutic doses (FAO, 2016). This enriches the 
environment for AMR, thus selecting for and spreading AMR bacteria within and between 
groups of animals, as well as to humans through food or other environmental pathways. The 
imprudent use of antimicrobials is primarily for economic reasons – to allow animals to grow 
faster, but it is clear that use of antimicrobials for growth promotion exacerbates AMR to 
antimicrobials that are particularly important in both human and animal health (FAO, 2016; 
Carrique-Mas and Rushton, 2017; Coyne et al., 2019).  
 
AMR is not a new phenomenon; numerous antimicrobials are based on naturally-occurring 
substances and so, the origin of resistance genes commonly found in clinical settings, likely 
originated in non-clinical settings (Alonso et al., 2001; D'Costa et al., 2011). Microorganisms 
which are most adapted to survival in environments that are heavily polluted with antimicrobial 
compounds (including heavy metal ions, and naturally-ocurring antimicrobials and antifungals) 
possess an excess of genes which confer protection to these stressors, including toxin transport 
genes (NarK) nitrate/nitrite antiporters and Cd2+/Zn2+/Co2+ efflux components (CzcABC, CzcD) 
(Hemme et al., 2010). It has been known for some time now that bacteria can acquire AMR from 
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other bacteria, via mobile genetic elements such as integrons, transposons and plasmids, as well 
as other integrative and conjugative elements (ICEs) (Boyd et al., 2009; Wozniak and Waldor, 
2009). Gene exchange is a universal property of bacteria and when a bacterium is exposed to 
environmental stressors or antimicrobials, there is a selective pressure placed upon it (Gillings 
and Stokes, 2012). Bacteria faced with antimicrobial selection pressures, can enhance their 
fitness by acquiring and expressing resistance genes and then share those genes with other 
bacteria. Thus, any antimicrobial use and subsequent overuse, are important drivers of the 
resistance phenomenon; the other main drivers are factors such as poor sanitation and high 
population densities which promote the spread of resistant bacteria and their genes locally and 
globally (Holmes et al., 2016). This sharing enriches the environment for AMR, and will in turn, 
increase the opportunity for the sharing of other resistance genes between bacteria. This all 
contributes to the development of multi-drug resistance, posing increased risk to human health 
(Kümmerer, 2009; Pawlowski et al., 2016). It is not only antimicrobials which can select for AMR 
microorganisms; various pollutants, including agricultural, biomedical, and industrial run-off can 
also place selective pressures, enriching the environment for AMR. For example, the highest 
concentration of waste antimicrobials found in the environment, are in areas close to hospital 
effluent (Verlicchi et al., 2015) and soils treated with manure or used for livestock (Kay et al., 
2004).  
 
Antibiotics are explicitly designed to kill or prevent the growth of bacterial populations, but the 
effects depend on the antimicrobial mode of action and the bacterium. Where there is 
inappropriate or sub-optimal use of antimicrobials, depending on the size of the population and 
the antimicrobial, bacteria may undergo one of several changes: develop resistance to 
antimicrobials by placing a selective pressure for de novo resistance mutations to occur (Ashbolt 
et al., 2013) and increase the rate of adaptive evolution, producing genetic or phenotypic 
variability (Oz et al., 2014).  
 
1.3 General AMR Mechanisms 
Antimicrobial action is bacteriostatic (slow bacterial growth and reproduction) or bactericidal 
(kill bacteria). Their action is dependent on their mechanisms of action, and concentrations at 
which they are administered (Pankey and Sabath, 2004). Antimicrobials targets specifically 
disrupt bacterial cell machinery to prevent growth and kill them; these inhibit the synthesis of 
bacterial cell walls (β-lactams and bacitracin), proteins (chloramphenicol, macrolides, 
aminoglycosides, tetracyclines), cell membranes (polymyxins), nucleic acid  (quinolones and 
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rifampicin) and inhibit folic acid metabolism (sulfonamides, trimethoprim) (Hooper, 2001; 
Samaha-Kfoury and Araj, 2003). 
 
Antimicrobial resistance can be an intrinsic or an acquired property of a microorganism. Intrinsic 
resistance is the innate ability of a bacterial species to resist the mechanism of action of an 
antimicrobial due to inherent properties; this allows tolerance to either an antimicrobial, or an 
entire antimicrobial class (Munita and Arias, 2016). Acquired resistance occurs when a 
bacterium resists the mechanisms of action of an antimicrobial to which it was previously 
sensitive. This may have developed over time due to a specific selective pressure, requiring the 
microorganism to develop a counter-mechanism (Wright, 2005).  
 
The ‘antibiotic resistome’, coined by Gerald Wright, refers to the collection of all 
the antimicrobial resistance genes and their precursors in both pathogenic and non-
pathogenic bacteria. This is comprised of resistance genes not only found in pathogenic and 
non-pathogenic bacteria, but also resistance genes embedded in bacterial chromosomes, as 
well as precursor genes which can encode proteins that have some bacteriostatic or bactericidal  
effects (Wright, 2007). Antibiotics are indeed ancient and are thought to have been around for 
hundreds of millions of years (Bhullar et al., 2012), existing naturally. The sheer number of 
resistance genes in the resistome is a testament to the continuous evolution of molecules in 
both natural environments and microbial genomes. It is important to realise that whilst AMU is 
a key driver of AMR, both structural biology and protein biochemistry has shown that AMR 
initially evolved from precursors with other functions; i.e. in response to cytotoxic antimicrobial 
agents placing selective pressures on bacteria (Wright, 2007).  
 
Bacterial AMR is mediated by several mechanisms. A diagram collating these methods is shown 
here (Figure 1.2), but such methods include:  
 
1) Reducing antimicrobial molecule entry to a cell, and efflux of any accumulated 
antimicrobials.  
2) Alteration of the antimicrobial target via mutations in binding elements.  
3) Bypassing the pathway being inhibited. 
4) Obtaining an alternative gene that the antimicrobial cannot bind to. 
5) Chemical modifications or destruction of the antimicrobial molecule.  
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Many antimicrobials have intracellular targets, requiring them to gain entry through the cell 
membranes to have effect. To prevent entry, bacteria can alter the permeability of their 
membranes, preventing influx of antimicrobial molecules. This is more important for Gram-
negative bacteria than for Gram-positive bacteria; the highly hydrophobic lipid bilayer is what 
aminoglycosides, macrolides, fusidic acid and various peptides diffuse through (Nikaido, 2003). 
Other antimicrobials such as β-lactams, tetracyclines and fluoroquinolones cannot pass through 
the outer membrane and must enter through diffusion-channels (porins) (Pages et al., 2008). In 
addition to limiting influx, bacterial efflux systems actively remove antimicrobial molecules from 
their cells. Many classes of efflux pumps have been defined; they are often substrate specific, 
but can also have broader substrate specificity, such as those found in MDR bacteria which can 
efflux fluoroquinolones, β-lactams, carbapenems and polymyxins (Delmar et al., 2014). 
 
 
 
Some bacteria produce proteins which block binding to the antimicrobial target; many of these 
are encoded on the bacterial chromosome, but clinically relevant variants appear to be carried 
on mobile genetic elements (MGEs). Using MGEs, AMR can be spread between related and non-
related species. One of the most common method of sharing genes is via horizontal gene 
Figure 1.2 An overview of bacterial AMR mechanisms, indicating the mechanisms of antimicrobial actions 
and resistance to them. Adapted from (Wright, 2010). 
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transfer (HGT). HGT happens in three main ways which involve genetic recombination: 
transformation (naked DNA is assimilated), transduction (bacteriophages transfer genes) and 
conjugation (bacterial ‘sexual’ mating) (Manson et al., 2010). Of particular relevance are 
plasmids and transposons, which are important in the spread of AMR to clinically-relevant 
bacteria (Hayes, 2001). 
 
Antimicrobial target site changes can be made in several ways. Target site changes primarily 
affect tetracyclines, fluoroquinolones, fusidic acid, macrolides and lincosamides (Connell et al., 
2003; Lambert, 2005; Golkar et al., 2018). A well-defined example of the target site mechanism 
is described in tetracyclines; proteins belonging to the GTPase superfamily act as homologues 
of elongation factors – these interact with the ribosome to dislodge tetracycline from its binding 
site and then prevent re-binding (Donhofer et al., 2012). The target site can be modified in three 
different ways:  
 
1. Mutations of the target site itself, such as those found in resistance to quinolones, 
prevents transcription by interfering with RNA polymerase pathways – by blocking the 
nascent RNA pathways, and can work synergistically with efflux-pumps (Kim et al., 
2012). Mutational changes also confer oxazolidine resistance; interaction with bacterial 
ribosomes interferes with aminoacyl-tRNA placement, resulting in inhibition of protein 
synthesis (Mendes et al., 2014). 
2. Production of new antimicrobial molecule targets; these are mechanistically similar to 
the original targets but binding of antimicrobial molecules to them has no effect. An 
example of this is seen in methicillin- and vancomycin-resistance S. aureus (M/VRSA) 
which has modified peptidoglycan structures (Szweda et al., 2012).  
3. Over-production of antimicrobial target sites e.g. dihydrofolate reductase – this means 
that higher antimicrobial or inhibitor concentrations are required to bind to targets to 
enact the bacteriostatic activity. This mechanism works primarily on trimethoprim, but 
also on  sulfamethoxazole, and thus, trimethoprim-sulfamethoxazole (Eliopoulos and 
Huovinen, 2001).     
  
Bacterial ribosomes are one of the major targets of antimicrobials, namely the 50S and 30S 
subunits. Antimicrobials targeting the 30S subunit inhibit protein synthesis by preventing 
binding of tRNAs or by moving tRNAs via translocation (Mehta and Champney, 2002). 
Antimicrobials targeting the 50S subunit inhibit protein synthesis by preventing the binding of 
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aminoacylated-tRNAs or preventing nascent polypeptide chains travelling through the 
ribosomal tunnel (Lambert, 2012). Another AMR mechanism is the modification of the 
antimicrobial molecule, to prevent binding to these sites. (Wilson, 2014). Examples of these are 
aminoglycoside-modifying enzymes (AMEs) - acetyltransferases (ACC), adenyltransferases 
(ANT) and phosphotransferases (APH) (Ramirez and Tolmasky, 2010), and the chloramphenicol 
acetyltransferases (CATs), which modify chloramphenicol molecules (Schwarz et al., 2004). 
Another modification-type resistance mechanism is antimicrobial molecule destruction – e.g.  
β-lactamases hydrolyse the amide-ring in β-lactam antibiotics, which deactivates the molecule’s 
properties (Abraham and Chain, 1940; Bush et al., 1995).   
 
Resistance to a wide range of antimicrobial classes in human and veterinary medicine has been 
reported to all of our antimicrobials (Mathew et al., 1999; van den Bogaard and Stobberingh, 
2000; van den Bogaard et al., 2001).  A plethora of genes which encode for resistance against 
antimicrobials have been identified in E. coli; this makes it an ideal model organism for studying 
AMR, due to ubiquitous presence in the human microbiome. Benefits of using E. coli as a sentinel 
for this study are described in section 1.4. A discussion of major resistance genes within E. coli 
are described here.  
 
1.3.1  β-Lactam Action & Resistance 
β-lactam antibiotics include penicillin derivatives, cephalosporins, monobactams and 
carbapenems. β-lactams are bactericidal, and their mode of action targets the final stage of cell 
wall synthesis, transpeptidation. β-lactams have a high affinity for penicillin-binding proteins 
(PBPs) responsible for manufacturing peptidoglycan which makes up the cell wall by forming 
cross-links. In the presence of β-lactams, peptidoglycan cross-links cannot form, leaving the cell 
wall unable to withstand changes in osmotic pressure, leading to cell lysis (Tomasz, 1979).   
 
β-lactamase enzymes confer resistance to β-lactams by hydrolysing the β-lactam central ring – 
inactivating the molecule. Penicillinase was the first β-lactamase to be discovered; it was 
isolated from E. coli even before the clinical introduction of penicillin (Abraham and Chain, 
1940). By the end of 2009, approximately 890 unique β-lactamase protein sequences had been 
identified (Bush and Jacoby, 2010). There are currently two β-lactamase classification models, 
and these are broadly based on either the primary structure or the functional properties of the 
enzyme. Molecular classifications split them into classes A, B, C and D, based on the amino acid 
motifs (Ambler, 1980) where each class except for B hydrolyse the β-lactam ring via an active 
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site serine. Class B β-lactamases are metalloenzymes e.g. New Delhi metallo-β-lactamase 1 
(NDM-1), and they utilise at least one active site zinc in ring hydrolysis. The other classification 
model introduces functional grouping: group 1 (class C) cephalosporinases; group 2 (classes A 
and D) broad-and extended-spectrum β-lactamases and serine carbapenemases; and group 3 
metallo-β-lactamases (Bush et al., 1995). The most commonly occurring plasmid-mediated β-
lactamase types are TEM, which confer resistance to ampicillin (Datta and Kontomichalou, 
1965); SHV (which can also be found on the chromosome) confers resistance to broad-spectrum 
penicillins (Livermore, 1995); OXA (almost always plasmid-mediated) which confer resistance to 
penicillins (some newer OXA can also confer resistance to cephalosporins and carbapenems 
(Evans and Amyes, 2014)); and CTX-M, which preferentially hydrolyses cefotaxime (Gazouli et 
al., 1998). These three enzymes make up much of the β-lactam resistance encountered in E. coli. 
These β-lactamases are encoded for by bla genes which can be found on chromosomal cassettes 
and plasmids (Matthew, 1979).   
 
In addition to blaTEM and blaSHV, E. coli has AmpC genes which encode for AmpC β-lactamases. 
These enzymes belong to subclass 1 and are cephalosporinases (Jacoby, 2009). AmpC genes are 
also chromosomally or plasmid-mediated; they are expressed at higher levels when on plasmids, 
due to promotors on the mobile elements (Schmidtke and Hanson, 2006).  
 
CTX-M β-lactamases are commonly isolated from enterobacteriales such as E. coli and other 
enterobacteriales such as Klebsiella spp. (Canton et al., 2012). More than 100 variants of blaCTX-
M have been sequenced - they are frequently reported in the literature to be increasing in 
frequency around the world. The rate of spread of CTX-M enzymes points to a global pandemic 
as they have supplanted both TEM- and SHV-derived extended-spectrum β-lactamases (ESBLs, 
see section 1.4.2.1) and carry intrinsic resistance to 3rd and 4th generation cephalosporins 
(Woerther et al., 2013). 
 
The 3rd-5th generation cephalosporins are antimicrobials which are on the list of highest priority 
critically important antimicrobials to human health (HPCIAs). Use of cephalosporins is known to 
provide selective pressures for the development of β-lactamase-producing Salmonella spp. and 
E. coli in animals (ur Rahman et al., 2018). Furthermore, the growing incidence of human disease 
due to AMR Salmonella and E. coli (World Health Organisation, 2017) requires that 
cephalosporins are only used as a drug of last resort, to preserve their efficacy for human health. 
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1.3.1.1 Extended-Spectrum-β-Lactamases 
ESBLs are a group of enzymes, first discovered in 1979, which effectively hydrolyse β-lactam 
antibiotics with oxyimino side chains (Sanders and Sanders, 1979). They confer resistance to all 
aminopenicillins, variably to third-generation cephalosporins (cefotaxime, ceftriaxone 
ceftazidime), and the monobactam, aztreonam. ESBLs do not mediate resistance to 
cephamycins (e.g. cefoxitin) or carbapenems (Bonnet, 2004) and the majority remain 
susceptible to β-lactam inhibitors including clavulanate and tazobactam. There have been 
newer reports of amoxicillin-clavulanate-resistant Enterobacteriaceae however, in a new 
blaTEM variant (Di Conza et al., 2014). Despite much discussion, there are no official consensus 
on a universal definition for ESBLs; they are simply transmissible β-lactamases with expanded 
activity against oxyimino cephalosporins, which can be inhibited by clavulanic acid, tazobactam 
or sulbactam, and are encoded for by genes which can be horizontally transferred between 
bacteria (Paterson and Bonomo, 2005).  
 
CTX-M enzymes originated through mobilization of chromosomal blaKLUA genes 
from Kluyvera spp., which conferred resistance to 3rd generation cephalosporins (Humeniuk et 
al., 2002). These genes were then incorporate into mobile genetic elements (Cantón, 2008) and 
they have increased in prevalence, worldwide since 2000. They have now been reported around 
the world it is now widely considered that CTX-M enzymes have nearly displaced other ESBLs 
enzymes in the Enterobacteriaceae, including TEM, SHV and OXA ESBL variants (Coque et al., 
2008a; Woerther et al., 2013; Giani et al., 2017). CTX-M enzymes are divided into clusters based 
on their amino acid sequences, these are currently CTX-M-1, -2, -3, -8, -14, -25, -45 and -64. As 
of 2018, within those clusters, there are 172 defined CTX-M enzymes, 223 TEM and 193 SHV 
types, though not all have an ESBL phenotype (https://externalwebapps.lahey.org/studies/). 
CTX-M-14 and CTX-M-15 are the most dominant and clinically relevant enzymes and they have 
been associated with both hospital- and community-acquired infections, as well as increasingly 
in animal and environmental sources (Hawkey and Jones, 2009; Bevan et al., 2017). Besides 
these major classes of β-lactamases, there are a number of other, less common β-lactamases: 
PER (Bauernfeind et al., 1996), GES (Poirel et al., 2000), VEB (Poirel et al., 1999) and SFO-1 
(Matsumoto and Inoue, 1999), which all act in a similar method, but have varying activities 
against penicillins and extended-spectrum cephalosporins, as well as different rates of inhibition 
by clavulanic acid. 
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ESBLs are commonly associated with MDR bacteria, as resistance to fluoroquinolones, 
aminoglycosides, and trimethoprim-sulfamethoxazole can also be carried on the same MGEs 
(Emery and Weymouth, 1997). Of important note is CTX-M producing- E. coli; since 2005, E. coli 
producing the CTX-M enzyme has emerged worldwide as a primary cause of community-
acquired urinary tract infections and bacteraemia. As such, CTX-M is regarded as being 
pandemic amongst E. coli  causing extra-intestinal infections (Canton and Coque, 2006). A single 
clone of MDR, CTX-M-15-producing E. coli (ST131) has been identified in humans and animals in 
many countries around the world (Rogers et al., 2010; Pitout and DeVinney, 2017). This clone is 
usually associated with serogroup O25, carries a large number of virulence genes, harbours MDR 
IncFII plasmids and are almost always resistant to fluoroquinolones (Johnson et al., 2008; 
Literacka et al., 2009). Isolates belonging to ST131, are also associated with other β-lactamases, 
but also ciprofloxacin-resistant E. coli that do not carry ESBL genes (Johnson et al., 2009; Oteo 
et al., 2009). Furthermore, ST131 isolates are pathogenic owing to the large number of 
infections they cause in hospital and community settings. 
 
1.3.2 Tetracycline Action & Resistance 
Tetracyclines are broad-spectrum, bacteriostatic antibiotics with efficacy against a wide range 
of Gram-positive and Gram-negative bacteria, as well as protozoal parasites. They have been 
used extensively in human and veterinary medicine for prophylaxis, growth promotion and 
therapeutically. The first tetracycline, chlortetracycline, was discovered in 1948 and was 
isolated from Streptomyces aurofaciens (Duggar, 1948). Second-generation tetracyclines are 
semisynthetic analogues, developed in the 1960s e.g. doxycycline and minocycline; they have 
superior stability and pharmacological activity (Stephens et al., 1963). Tetracyclines remain 
important for both human and veterinary medicine, though increasing rates of AMR have 
drastically limited their effectiveness.  
 
More than fifty tetracycline resistance genes have been described in the literature and these 
confer resistance in three main ways: efflux (tetM), ribosomal protection (tetA) and less 
commonly, enzymatic inactivation (tetX). The primary mechanism of resistance is via increased 
efflux of the tetracycline molecule from the cell, which is mediated by a family of Tet proteins 
which are found on the cytoplasmic surface of the cell membrane; twelve transmembrane 
helices force the tetracycline molecules out of the membrane by exchanging the molecule for a 
proton across a concentration gradient (Yamaguchi et al., 1990). There are seven different 
groups of efflux pump, which are sorted according to their amino acid sequences; all except one 
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tetracycline efflux pump belong to group 1, and they share almost 75% protein homology 
(Thaker et al., 2010). Group 1 efflux proteins can be found on transposons within large plasmids 
and are associated with other antimicrobial and heavy metal resistances (Chopra and Roberts, 
2001). Another resistance mechanism involves ribosomal protection proteins - cytoplasmic 
proteins Tet(O) and Tet(M) – which bind to the ribosome, blocking binding of tetracycline 
molecules, as well as unbinding bound tetracycline from the ribosome (Connell et al., 2003). A 
final mechanism of tetracycline-resistance is antimicrobial inactivation. Tet(X) is a flavoprotein 
monooxygenase which hydroxylates tetracycline molecules, causing it to lose affinity for 
bacterial ribosomes, leading to non-enzymatic decomposition of molecules (Volkers et al., 
2011).  
 
In human medicine, tetracyclines are still routinely used for the prophylaxis of malaria in many 
places including the UK, USA and Europe (most commonly doxycycline) caused by Plasmodium 
falciparum, as well as for treatment of Chlamydia species (tetracycline, though this is being 
phased out, in favour of azithromycin) rickettsia and spirochetes (doxycycline) (Gaillard et al., 
2015; Quinn and Gaydos, 2015; Rahi et al., 2015). 
 
1.3.3 Quinolone Action & Resistance 
Quinolones are synthetic, broad-spectrum, bactericidal antimicrobials – the first of which was  
Nalidixic acid (Lesher et al., 1962). Quinolones mechanistic action works on the cleavage of 
bacterial DNA-enzyme complexes associated with DNA gyrase and DNA topoisomerase IV. As 
double-stranded bacterial DNA is cleaved, bacterial DNA synthesis (replication and 
transcription) fails, which rapidly causes cell death (Hooper, 1998, 1999). After the introduction 
of first-generation quinolones such as nalidixic acid in 1962, subsequent second-, third- and 
fourth-generation fluoroquinolones have been developed by structurally modifying them e.g. 
adding a fluorine atom to the central quinolone ring; these fluoroquinolones have improved 
Gram-negative and anaerobic coverage (Ambrose et al., 1997). To date, ciprofloxacin is one of 
the most widely used fluoroquinolones in human medicine and to a lesser degree, veterinary 
husbandry (enrofloxacin is the most common). 
 
Chromosomal resistance to quinolones is dependent on the bacteria; in Gram-negative bacteria 
mutations in the genes encoding DNA gyrase enzymes are more common (Zhao et al., 1997). 
Single amino acid substitutions in the ‘quinolone resistance determining region (QRDR)’ are 
enough to cause resistance to quinolones (Yoshida et al., 1990). In E. coli, Ser(83)Trp and 
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Ser(83)Leu substitutions, and mutations in Asp(87) within gyrA are the most commonly 
observed. These result in reduced binding of quinolones to gyrase-DNA complexes (Willmott et 
al., 1994; Aldred et al., 2014). Point mutations in gyrB or parC can also lead to enhanced levels 
of resistance to fluoroquinolones (Barnard and Maxwell, 2001).  
 
Another mode of resistance to quinolones in E. coli pertains to membrane porins, OmpA, OmpC 
and OmpF; these porins control access of quinolones into cells – reduced expression of OmpF 
leads to reduced uptake of the antimicrobial molecule (Hirai et al., 1986). On the chromosome, 
the same loci which regulates porin expression also regulates efflux pumps. Any mutations at 
these loci (MarRAB and SoxRS) will reduce quinolone concentrations within the cell by reducing 
permeability of the membrane, but also by actively pumping out quinolone molecules from the 
cell via overexpression of pumps (Alekshun and Levy, 1997). These resistance mechanisms can 
only be vertically transferred to progeny; they are not transmissible to other species of bacteria, 
however, there are instances of plasmid-mediated quinolone resistance (PMQR) being 
described in the literature. 
 
PMQR was first described in 1998 as conferring low-level, transferable resistance to quinolones 
and fluoroquinolones (Martinez-Martinez et al., 1998). The qnr (quinolone resistance) gene and 
subsequent QNR proteins inhibit quinolone binding to DNA gyrase- and DNA topoisomerase-
complexes (Tran and Jacoby, 2002). Of relevance to E. coli, plasmids carrying qnrA (and other 
qnr genes), qnrB and qnrS have been identified globally and have been associated with ESBL 
genes (on the same integron) (Poirel et al., 2006). These genes have been shown to only confer 
low-level resistance, but they may also increase the mutation prevention concentration (Gebru 
et al., 2011; Hooper and Jacoby, 2015).   
 
Another plasmid-mediated mode of resistance is a type of enzyme inactivation, mediated by the 
aminoglycoside acetyltransferase, aac(6’)-Ib-cr. This can modify ciprofloxacin and reduces its 
activity by acetylation of the piperazinyl ring (Robicsek et al., 2006). This confers low-level 
resistance to some fluoroquinolones, but not to certain quinolones, which lack an amino-
nitrogen on the piperazinyl ring, such as nalidixic acid. This AAC works synergistically with qnrA 
but has also been shown to confer low-level resistance in its absence too (Robicsek et al., 2006). 
Plasmid-mediated quinolone and aminoglycoside resistance genes are often reported to be co-
associated with genes encoding for β-lactamases, most predominantly blaCTX-M-15. These have 
been associated with the pandemic E. coli ST131 clone (Karisik et al., 2006; Jiang et al., 2008).  
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Finally, a PM efflux pump, qepA, has been identified on plasmid pHPA in E. coli; it preferentially 
targets ciprofloxacin and norfloxacin, but not hydrophobic quinolones such as nalidixic acid 
(Yamane et al., 2007). The prevalence of qepA - and its described variant, qepA2 - resistance 
genes are estimated to be no more than ~1% in human clinical E. coli isolates, globally (Yamane 
et al., 2008). Other efflux pumps have been described in E. coli; AcrAB-TolC and OqxAB (Li et al., 
2000; Hansen et al., 2007) are multi-drug efflux pumps which efflux chloramphenicol and 
trimethoprim molecules, as well as quinolones (Hansen et al., 2007; Sørensen et al., 2003). 
 
Fluoroquinolones are another class of antimicrobials considered to be on HPCIA list. Use of 
quinolones is known to put selective pressure for the development of quinolone-resistant 
Salmonella spp. and E. coli in animals. Furthermore, the growing incidence of human disease 
due to AMR Salmonella and E. coli requires that fluoroquinolones are only used as a drug of last 
resort, to preserve their efficacy for human health (World Health Organisation, 2017). 
 
1.3.4 Sulfonamide Action & Resistance 
Sulfonamides or sulfa-drugs are a class of synthetic, broad-spectrum, bacteriostatic 
antimicrobials. They have been largely replaced by more narrow-spectrum antimicrobials but 
are still used in treatment of urinary tract infections, or in combination (potentiated) with other 
diaminopyrimidines, such as trimethoprim. The first sulfonamide, Prontosil, was created from 
an azo dye and was found to have activity against streptococcal infections – it was later found 
to be a prodrug. It was actually the  metabolite, sulphanilamide, that was the active agent 
(Domagk, 1935a). Since then, numerous other sulfa-drugs including sulfathiazole, sulfadiazine 
and sulfamethoxazole have been developed and are commonly used today (Spink and Hansen, 
1940; Schwartz, 1949). 
 
Sulfonamide mode of action targets DNA metabolism by inhibiting folic acid synthesis. 
Sulfonamides competitively inhibit para-aminobenzoic acid (PABA), which prevents dihydrofolic 
acid synthesis (Woods, 1940; Swedberg et al., 1979), starving bacterial cells of thymidine and 
uridine which are necessary for DNA replication and transcription. By potentiating with 
trimethoprim, the combination also inhibits dihydrofolate reductase (Roland et al., 1979). This 
combination sequentially inhibits two enzymes along one biosynthetic route – allowing for the 
effective dosage to be reduced. Co-treatment with trimethoprim also combats the rapid 
emergence of resistance to sole sulfonamides, which began in the 1970s. 
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In E. coli, sulfonamide resistance is chromosomal or plasmid-mediated. The primary mechanism 
for sulfonamide resistance is mutations in the dihydropteroate synthase (DHPS) gene, folP. As 
sulfonamides are analogues of PABA, substitutions of Phe(28) on folP reduces the affinity of 
sulfa-drugs to bind to the active site of DHPS which prevents the production of dihydropteroic 
acid. However, it also reduces the affinity of PABA itself, albeit to a lesser degree (Sköld, 2000).  
 
Plasmid-mediated resistance to sulfonamides is via dissemination of variant genes which 
encode for AMR DHPS enzymes (Swedberg and Skold, 1983). Originally only two genes, sul1 and 
sul2, were thought to confer resistance to sulfonamides – they were found in equal proportions 
amongst sulfonamide-resistant E. coli and other bacterial species due to their ability to transfer 
horizontally across class 1 integrons  (Radstrom et al., 1991). Despite sul1 being the dominant 
resistance gene, more recently prevalence of sul2 has increased amongst clinically-relevant 
isolates of E. coli in Denmark and the UK (Kerrn et al., 2002). Both sul1 and sul2 share 57% 
homology and their origins are yet unknown (Radstrom and Swedberg, 1988). In 2003, a third 
gene encoding sulfonamide-resistant DHPS was discovered in E. coli amongst pathogenic strains 
amongst pigs in Switzerland, sul3 (Perreten and Boerlin, 2003). As recently as 2017, a fourth 
mobile sulfonamide gene, sul4, and is described as having potential impact on both humans and 
animals (Razavi et al., 2017). 
 
1.3.5 Trimethoprim Action & Resistance 
Trimethoprim is a broad-spectrum, bacteriostatic, synthetic antimicrobial which targets folic 
acid synthesis. It was first used in 1962 as a treatment for UTIs. It competitively inhibits 
dihydrofolate reductase (DHFR), which is the enzyme required to reduce dihydrofolic acid to 
tetrahydrofolic acid, which is a precursor of thymidine. Interference with this pathway 
ultimately inhibits DNA synthesis.  
 
Resistance mechanisms against trimethoprim include provision of alternative metabolic 
pathways, changes in the DHFR enzymes and active efflux (Flensburg and Skold, 1987; 
Eliopoulos and Huovinen, 2001). There are a number of DHFR enzymes, which are categorised 
according to their amino acid sequences, and these are encoded for by dfr genes carried on 
plasmids and transposons (Blahna et al., 2006). Resistance can also be chromosomally encoded 
with two such mechanisms described in the literature, relating to the dfr gene. Less common is 
the overexpression of the DHFR enzyme which confers high-level resistance to trimethoprim, 
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though numerous mutational events are required to achieve this (Huovinen, 1987). More 
commonly, mutations which decrease the amount of available thymidylate synthetase 
precipitate, leading to underproduction of exogenous thymine, effectively making the DHFR 
enzyme redundant. This means that any binding of trimethoprim is irrelevant, as a lack of 
thymidine means there is a lack of dihydropteroic acid (the stage before dihydrofolic acid is 
produced). This mechanism only confers low-level resistance (Huovinen et al., 1995). The most 
prevalent trimethoprim resistance mechanism in E. coli is the acquisition of trimethoprim-
insensitive DHFR variant resulting in high-level trimethoprim resistance (de Crecy-Lagard, 2014). 
 
1.4 Escherichia coli 
E. coli is a rod-shaped, Gram-negative member of the Enterobacteriaceae family. It is a gut 
commensal of warm-blooded mammals, including humans. Various strains of E. coli colonise the 
gut of infants shortly after birth and are mostly non-pathogenic (except in immunocompromised 
persons); they are one of the most highly adapted and successful facultative anaerobes of the 
human gut microflora (Sweeney et al., 1996). E. coli is a ubiquitous bacterium which has 
frequent exposure to a variety of antimicrobials in the gastrointestinal (GI) tract, aimed at 
treating other pathogens. E. coli is thought to act as a reservoir for AMR genes which may 
transfer resistance to other zoonotic or commensal organisms (Aarestrup, 2015); as such it 
would be a good indicator of resistance. E. coli is also the most comprehensively studied 
bacterium due to the relative ease of genetic manipulation and controlled growth in laboratory 
settings. They are relatively easy to isolate and investigate, and have been the subject of 
numerous studies which have highlighted the issue of increasing prevalence of drug-resistant 
commensal E. coli from healthy adults and children in many different countries (Osterblad et al., 
2000; Nys et al., 2004; Pallecchi et al., 2007). They are also a major contaminant of carcasses 
during slaughtering of animals (Stopforth et al., 2006; Kabiru et al., 2015). For these reasons, E. 
coli was chosen as a sentinel organism in this study.  
 
E. coli can be broadly split into commensal and pathogenic strains, though this is not always 
easy to do, and depends on numerous factors such as the occupying niche, and whether 
virulence genes are being expressed or not. Despite E. coli being the predominant non-
pathogenic facultative bacterium in the GI tract, some strains have developed the ability to 
cause infections by acquiring  virulence genes (Nataro and Kaper, 1998). The most successful 
virulence factors (encoding adhesins and toxins) combine to produce specific pathotypes of E. 
coli and infection with these can result in three general clinical syndromes: sepsis or meningitis, 
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urinary tract infections (UTIs) and enteric or diarrhoeal disease (Kaper et al., 2004). With 
advances in whole genome sequencing (WGS), it is apparent that these pathotypes are not as 
distinct as once thought and there has been some question as to whether pathotypes are still 
relevant. Whilst useful in tracking disease outbreaks or single-person diagnoses, pathotyping 
may be imprecise due to the continuously evolving nature of E. coli. This was the case with the 
German outbreak of E. coli O104:H4 in 2011 – it was originally assumed that the outbreak had 
been caused by an enterohemorrhagic strain. In fact, the outbreak was due to an 
enteroaggregative strain which had acquired Shiga toxin production genes (Buchholz et al., 
2011). 
 
There are several distinct diarrheagenic strains of E. coli which cause clinical syndromes 
including diarrhoeal disease, urinary tract infections and sepsis/meningitis. Intestinal 
pathogenic E. coli have been classically divided into 6 categories: enteropathogenic (EPEC), 
enterohaemorrhagic (EHEC), enterotoxigenic (ETEC), enteroaggregative (EAEC), enteroinvasive 
(EIEC) and diffusely adherent E. coli (DAEC) (Nataro and Kaper, 1998). UTIs result from 
extraintestinal E. coli (ExPEC), known as uropathogenic E. coli (UPEC) (Lloyd et al., 2009) and 
sepsis/meningitis are caused by meningitis-associated E. coli (MNEC) (Russo and Johnson, 2000). 
Some of these classifications have further evolved, as our understanding of E. coli virulence 
factors has increased and with the increasing use of whole genome sequencing. For examples, 
some factors which do not neatly fit into one of these seven classifications have now been 
moved to subclasses e.g. DAEC which expresses the aidA adhesin gene is now a member of the 
atypical EPEC (aEPEC), and enteropathogenic EPEC has now been reclassified into typical (tEPEC) 
and atypical (aEPEC) (Croxen et al., 2013). 
 
Pathotypes are identified according to the specific combination of virulence factors they carry. 
There are numerous different virulence determinants attributed to pathogenic E. coli, including 
adhesins, invasins, motility/chemotaxis assistance, toxins, antiphagocytic surface properties, 
defences against bactericidal or immune responses and genetic attributes. Adhesins are a group 
of proteins which are involved in the attachment of bacteria to non-biological (plastic and steel) 
and biological (intestinal wall) surfaces (Klemm and Schembri, 2000). Usually these proteins 
form distinct structures, called fimbriae which allow E. coli to attach to mannose receptors, 
resist shear force and obtain nutrients. Invasins allow invasive pathotypes of E. coli to invade 
and multiply within cells e.g. EIEC replication inside epithelial cells. Various toxins are produced 
by E. coli – these have effects on several eukaryotic processes. Common toxins include heat-
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labile enterotoxin (LT), heat-stable enterotoxin a (STa) and heat-stable enterotoxin b (STb) 
(Sears and Kaper, 1996), Shiga toxin (Stx) (Kaper and O'Brien, 1998) and cytolethal distending 
toxin (CDT) (De Rycke and Oswald, 2001). Siderophores are high-affinity iron-chelating 
compounds which allow bacteria to acquire iron from their immediate environment (even 
where iron concentrations are low) for various microbial systems. Enterobactin is an example 
of a siderophore found in Gram-Negative bacteria such as E. coli (Harris et al., 1979). Some 
pathogenic E. coli have K antigens, which are capsular polysaccharides that decrease binding of 
antibodies to the bacteria, and reduce the ability of phagocytes to recognise and engulf the 
bacterial cells (Van Dijk et al., 1979). Combinations of these virulence factors pertain to a specific 
pathotypes (Table 1.1). 
 
 
              Chapter One    Introduction & Literature Review 
 
Table 1.1 Characteristics and associated virulence factors for the main six pathotypes of diarrhoeal-associated E. coli. 
Pathotype Presents as/associated with Characteristics 
Major Virulence Factors 
(Genes) 
Virulence Functions References 
DAEC 
Urinary Tract Infection 
 
Pregnancy Complications 
 
Diarrhoea in children <5 years old. 
Adheres to HEp-2 cell 
monolayers 
  
Adhesins (Afa/Dr) 
afaE-I, afaE-III, daaE, draE, 
draE2 
Adhesins 
§ Bind to decay-accelerating factor (DAF) which 
protects cells from complement damage. 
§ Has cytopathic activity; develops long extensions 
which constrict adherent bacteria. 
§ Activates signal transduction cascades including 
activation of PI-3 kinase. 
(Guignot et al., 2000; Nowicki et 
al., 2001; Servin, 2005) 
ETEC Rapid onset of watery diarrhoea.  
Produce heat-labile (LT) and 
heat-stable (ST) enterotoxins. 
Can express both or just one or 
the other. 
 
Produce more than one 
colonising factor which help 
with attachment to intestinal 
mucosal surfaces. 
Adhesins 
cfaB, cooA, cs3, cssA, etpA, 
etpB 
 
Toxins 
eltA-B, estIa  
Adhesins 
§ Adhesive fimbriae – binds to oligosaccharide 
components of glycolipids and glycoproteins 
§ EtpA – interacts with flagellin (tips of flagella) and 
tethers EtpA adhesins which anchor bacteria to cell 
surfaces 
 
Toxins 
§ Heat-labile – activates adenylate cyclase, resulting in 
ion secretion 
§ Heat-stable – STa activates guanylate cyclase, 
resulting in ion secretion. STb increased intracellular 
calcium, resulting in ion secretion. 
(Nataro and Kaper, 1998; Kaper et 
al., 2004; Roy et al., 2009) 
EIEC 
Diarrhoea 
 
Shigellosis/bacillary dysentery 
 
Haemolytic Uremic Syndrome 
EIEC is an intracellular pathogen 
 
Has almost identical virulence 
factors to Shigella spp. 
 
Dysentery caused by EIEC is 
indistinguishable from that 
caused by Shigella. 
 
Contains large plasmids which 
are functionally interchangeable 
with S. flexneri 
  
Actin-based motility 
icsA/virG 
 
Endotoxin 
gtrA-B, gtrII 
 
Iron uptake 
iucaA-D, iutA 
 
Protease 
pic 
 
Toxin 
set1A-B, senB, stxA-B 
 
Pathogenicity islands 
SHI-1-3, SRL 
Actin-based motility 
IcsA (VirG) – intracellular movement using actin tails 
 
Endotoxin 
LPS – resist host defences and for intracellular spread. 
 
Iron uptake 
Aerobactin – siderophore which facilitates iron uptake 
for intracellular growth. 
 
Protease 
Pic - protease and mucinase 
 
Toxins 
§ ShET1/2 – involved in early diarrhoeal phase 
§ Shiga Toxin – responsible for complications such as 
haemorrhagic colitis and haemolytic uremic 
syndrome. 
 
Pathogenicity islands 
 
(Nataro and Kaper, 1998; Vargas 
et al., 1999; Vokes et al., 1999; Al-
Hasani et al., 2001; Morona et al., 
2003; Cossart and Sansonetti, 
2004; Bergan et al., 2012) 
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Carries ShET1 and autotransporters SigA and Pic. 
 
EAEC 
Traveller’s diarrhoea 
 
Haemolytic Uremic Syndrome 
 
Persistent diarrhoea 
No secretion of heat-labile or 
heat-stable toxins. 
 
Adheres to the surface of HEp-2 
cells in an aggregative pattern 
 
Mainly heterogenous, but many 
harbour virulence plasmids  
Adherence 
AAFs 
aafA-D, agg3A-D, aggA-D, 
R 
 
Dispersin 
aap, aatA-D, P 
 
Toxins 
astA, pet, pic, set1A 
AAFs 
Belongs to Dr adhesin family 
 
Most EAC harbour plasmids which encode AAF/I or 
AAF/II and/or EAST1 and Pet toxins 
 
Dispersin 
Promotes dispersal of EAEC on intestinal mucosa to 
establish new infections and facilitate colonisation. 
 
Toxins 
§ EAST1 – Activates guanylate cyclase resulting in ion 
secretion 
§ Pet – Serine protease cleaves cytoskeletal proteins 
resulting in epithelial cell rounding 
§ Pic – protease and mucinase 
§ ShET1 – Involved in ion secretion 
(Bernier et al., 2002; Sheikh et al., 
2002; Kaper et al., 2004) 
(Fasano et al., 1995; Henderson et 
al., 1999; Dutta et al., 2002; 
Menard and Dubreuil, 2002) 
 
 
EPEC Diarrhoea in children <5 years old. 
Creates an attaching and 
effacing lesion on intestinal 
epithelium. 
 
Does not produce Shiga toxin. 
 
Carries a large virulence plasmid 
which allows production of 
bundle-forming pili with a 
characteristic pattern called 
localised adherence. 
Adherence 
bfpA-L,P, eae, lifA/efa1, 
paa 
 
Protease 
espC 
 
Regulation 
ler 
 
Toxin 
cdtA-C, east1 
 
Pathogenicity islands 
EspC island 
LEE 
Adherence 
§ BFP – localised adherence via pili. 
§ Intimin – as EHEC. 
§ Lymphostatin/LifA – expresses various 
lymphokines and inhibits lymphocyte 
proliferation 
§ Paa – as EHEC. 
 
Protease 
EspC – serine protease 
 
Regulation 
Ler – as EHEC 
 
Toxin 
§ Cytolethal Distending Toxin – disrupts chromatin 
which leads to growth arrest and cell death. 
§ EAST1 - Activates guanylate cyclase resulting in ion 
secretion. 
 
Pathogenicity islands 
§ EspC – contains espC and orf3 virulence loci. 
§ LEE – as EHEC 
(Bieber et al., 1998; Sperandio et 
al., 2000; Menard and Dubreuil, 
2002; Badea et al., 2003; Navarro-
García et al., 2004) (Schmidt, 
2010) 
EHEC Watery diarrhoea, haemorrhagic 
colitis, HUS 
Has a pathogenicity island for 
enterocyte effacement (LEE) 
 
Produces Shiga toxins 
Adherence 
yagV,ecpE, yagW/ecpD, 
efa1, eae, paa, toxB 
 
Adherence 
§ ECP – pilus adherence factor crucial for virulence in 
O157 strains. Also carried in commensal strains. 
(Badea et al., 2003; Batisson et al., 
2003; Rendón et al., 2007; Leo et 
al., 2015) 
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Iron uptake 
chuA, chuS, chuU, chuW 
 
Protease 
espP, stcE 
 
Regulation 
ler 
 
Toxin 
hlyA-D 
stx1A/B, stx2A/B 
 
Pathogenicity island 
LEE 
§ Efa-1/LifA – main adhesin in non-O157 strains. 
Inhibits lymphocyte activation 
§ Intimin – facilitates intracellular changes – 
reorganises cytoskeletal proteins and polymerises 
actin. 
§ Paa – involved in initial bacterial adhering. 
§ ToxB – affects the production of virulence factor 
secretion 
 
Iron uptake 
Chu – excretion of cytotoxins which gain access to 
intracellular heme reservoir. Facilitates usage of iron 
from heme. 
 
Protease 
§ EspP – serine protease; cleaves coagulation factor V 
§ StcE – cleaves C1 esterase inhibitor, required for 
complement initiation. 
 
Regulation 
Ler – required for pathogenicity island activation 
(activates LEE2, LEE3, tir and orf19 promoters) 
 
Toxin 
Haemolysin -broadly cytotoxic to different types of 
blood cell. Stimulates release of IL-1β and TNF. 
 
Stx – responsible for haemolytic uremic syndrome. 
(Torres and Payne, 1997) 
 
(Lathem et al., 2004) 
 
(Sperandio et al., 2000) 
 
(Sandvig, 2001; Schindel et al., 
2001) 
 
(Schmidt, 2010) 
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1.5 Epidemiology of AMR in Africa 
1.5.1 Defining the Issue of Increasing AMR 
The 2014 WHO global report on surveillance of AMR and the O’Neill report (tackling drug-
resistant infections globally) have described significant gaps in country-wide surveillance 
systems and a lack of standardised methods for capturing AMR data and sharing it (WHO, 2014; 
O’Neill, 2016). In particular, the WHO report highlighted the fact that Africa and South-East Asia 
are two major regions in which there are no rigorous country-wide surveillance systems in place 
for AMR (WHO, 2014).  
 
The lack of quantitative data on AMR, particularly in the Africa region, is problematic. As there 
is no readily available national (or even regional, in many cases) datasets, guidelines will have 
to be based on sporadic reports from all over the countries in the region, or from trend-data 
(which can be equally sporadic) from neighbouring countries. These data may not accurately 
reflect the epidemiology of disease and AMR in the area in which the guidelines are issued, and 
so there can be reliance on empirical therapies such as broad-spectrum antimicrobials, which 
can have an exacerbating effect of increasing AMR (Saleh et al., 2015).  Furthermore, there is a 
significant gap in public health capacities, particularly in more rural areas. There are too few 
government-regulated physicians and veterinary staff to cover large areas, and a severe lack of 
diagnostic facilities in which to perform AMR testing (Mboya-Okeyo et al., 2009). Diagnostic 
services are needed to assess and confirm the resistance patterns of bacteria, so that 
appropriate antimicrobials can be used, thus reducing the selection for AMR. In the absence of 
systematic screening programmes, conducted by quality-assured microbiological laboratories 
(Exner et al., 2017), antimicrobials tend to be repeatedly used in the same patterns.  
 
Despite limitations in diagnostic capabilities, there are other socioeconomic factors at play – 
access to antimicrobials, costs of those drugs and questionable quality of drugs. There is a lack 
of regulation regarding the sale of antimicrobials in many developing countries; antimicrobials 
can be purchased without a prescription and they are dispensed by either street vendors or 
unlicensed stockists (retail pharmacies), and may be administered by untrained persons (Barker 
et al., 2017; Erku et al., 2017). These drug vendors sell medications for human and animal 
consumption often without requesting a prescription (Zawahir et al., 2019). In addition to this, 
there may also be gaps in vendor’s knowledge of diseases and they may resort to blind 
recommendation of multiple and broad-spectrum antimicrobials to ensure a positive treatment 
outcome. Unlicensed pharmacies can be seen as a more attractive option than (sparse) 
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government-owned facilities, as they can have shorter waiting times, do not charge consultation 
fees and may be willing to negotiate treatment options and prices, to better fit with the 
purchaser’s financial ability. These types of pharmacies, which cater to both human and 
veterinary needs, especially in rural Africa, have become the new primary level of care (Kwena 
et al., 2008; Mukonzo et al., 2013; Zawahir et al., 2019).  
 
There are several issues with unlicensed retail pharmacies. High ambient temperatures and 
humidity can quickly degrade the quality of antimicrobials during storage (Okeke and Lamikanra, 
2001; Risha et al., 2002). Degraded antimicrobials may contain less than the stated dose 
(Lallemand et al., 2016), which means that the intended recipient (human or animal), may 
receive less than the optimal dose of the drug. Sub-therapeutic dosing can select for AMR 
bacteria. There is also a problem of counterfeit drugs, in which the drug may contain little or no 
active substance of the antimicrobial or the wrong substance. The influx of counterfeit and sub-
standard antimicrobials into the pharmaceutical markets in some regions is a major problem 
(Ozawa et al., 2018) as these preparations of reduced potency also result in pathogens being 
exposed to sub-therapeutic concentrations of the drug. Studies have observed that the highest 
prevalence of poor-quality medicines was observed in African countries, where 18.7% of 
antimicrobials were substandard or falsified (there were more substandard antimalarials 
(19.1%) than antimicrobials (12.4%)) (Ozawa et al., 2018). These findings were in agreement 
with the report produced by the WHO regarding falsified medical products (Tabernero et al., 
2014; WHO, 2017b).  
 
Antimicrobial misuse is another large factor contributing to the increase in AMR. Particularly 
relevant for African settings, is the diagnosis and treatment of malaria; as there is improved 
diagnosis for malaria, global transmission is slowly declining, however it has also highlighted the 
lack of testing available for other infectious diseases. In these cases, patients who tested 
negative for malaria, were still given a course of antimicrobials (Sandlund et al., 2013; Hopkins 
et al., 2017). There are clinical treatment algorithms in place, as well as guidelines published by 
the WHO, which have sought to optimise antimicrobial prescriptions in resource-limited 
settings, but there is still an unmeasured overuse of antimicrobials (Vasan et al., 2014; Gera et 
al., 2016; Chem et al., 2018). Healthcare providers should play an essential role in the treatment 
and prevention of diseases, but in informal settings, prescription of antimicrobials (or lack 
thereof) are frequently inappropriate; they can be for an inappropriate antimicrobial, the wrong 
dose, or an antimicrobial may not be necessary (Ayukekbong et al., 2017). Healthcare 
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professionals, and those people working in retail pharmacies, may be restricted by poor 
dissemination of research information. As access to current information on AMR patterns within 
the country is challenging (and not always available) the same antimicrobials are routinely 
recommended to purchasers. As there is little capacity to perform AMR testing, and patients do 
not necessarily have the money, or wish to pay for these tests, there is an over-reliance on 
broad-spectrum antibiotics such as tetracyclines and penicillins. Long-term, inappropriate use 
of broad-spectrum antimicrobials can contribute to the development of resistance; a selective 
pressure is placed not only on the disease-causing bacterium, but also on commensal bacteria 
(such as E. coli) (Hansen et al., 2017). 
 
Finally, non-human use of antimicrobials can contribute to the development of AMR. As 
discussed, in African settings, a high proportion of people engage in mixed crop-animal farming. 
Antimicrobials have historically been used for prophylaxis and treatment of animals, as well as 
for growth promotion. Antimicrobials are also used directly and indirectly in crop farming – 
directly sprayed onto crops to prevent disease and treat disease, or indirectly, through 
antimicrobial residues found in animal manure in a host of low and middle-income countries 
(LMICs), which are used to fertilise fields (Tasho and Cho, 2016; Collignon and McEwen, 2019). 
In Kenya, particularly high levels of antimicrobial drug residues were detected in meat intended 
for consumption (Mitema et al., 2001a), though this could be due to AMU or lack of information 
surrounding withdrawal periods.  
 
Overuse of antimicrobials can be attributed to their ease of access. In the absence of 
government-controlled veterinary services, veterinary paraprofessionals (animal healthcare 
assistants, AHAs) may travel to farms and treat animals. There are strict laws regarding the 
delivery of antimicrobials and these are regulated by three different laws in Kenya – the Animal 
diseases Act, the Veterinary Surgeons and Veterinary Para-professionals Act and the Pharmacy 
Poisons act (Global Antibiotic Resistance Partnership, 2011; National Council for Law Reporting, 
2012b). Theoretically, AHAs must be registered with the Kenya Veterinary Board to practice as 
a paraprofessional. However, in rural areas, there is extremely limited access to veterinary 
services from registered veterinary surgeons. This means that there is reliance on private 
veterinary paraprofessionals who may dispense antimicrobials inappropriately. Animal owners 
may freely access drugs without prescription from retail pharmacies (or Agrovet shops, which 
stock agricultural products and antimicrobials for animals) and treat their animals, or get para-
professionals to do it (Global Antibiotic Resistance Partnership, 2011). Kenyan law also states 
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that “A person shall be qualified for registration as a veterinary paraprofessional if the person 
is a citizen of Kenya and has successfully completed a post-secondary school training course in 
animal health science lasting two years or more at an institution approved by the Board and has 
a certificate, diploma or degree and has served an internship of not less than twelve months 
under supervision of a registered veterinary surgeon” (National Council for Law Reporting, 
2011). As there is insufficient capacity to fully regulate private veterinary paraprofessionals, it is 
unclear if their training is up to date or not. 
 
As previously discussed, there is some link between AMR bacteria and their spread between 
animals, humans, and the environment. In rural African areas, three major dissemination 
pathways of AMR bacteria are possible. Firstly, close contact with animals is frequent, as animals 
are usually free to graze around farms, and humans’ domiciles are often near chicken coops, 
cattle huts, and sheep pens. Human sewage is perhaps also an issue – many farms do not have 
toilets inside the main house, rather dug latrine pits are more common. These are not treated 
with chemicals, and are simply filled in when they are full, and a new one dug nearby (WSP, 
2004). Antimicrobial residues in faeces can leach into the surrounding soil and into water 
sources; contaminated water may then be drunk or crops may take up residues through the soil 
(Tasho and Cho, 2016). Animals treated with veterinary antimicrobials may also defecate and 
urinate in the vicinity of human dwellings, further allowing the spread of residues (Figure 1.3). 
There may also be some issues with use of expired antimicrobials – socioeconomic reasons may 
prevent an antimicrobial user to continue using antimicrobials from a previous treatment, 
instead of disposing and purchasing a new batch. Furthermore, there can be contamination of 
the environment with the disposal of unused antimicrobials. 
 
Whilst it is currently unknown what the magnitude of AMU in food-producing animals is to 
human AMR, the extremely close contact between humans and their animals warrants further 
investigation into dissemination and transmission pathways between these groups.  
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1.5.2 General Trends of Prevalence of AMR in Sub-Saharan African Countries 
A number of studies conducted over the last 30 years have investigated the prevalence of AMR 
in the Enterobacteriaceae in African countries. These studies have all highlighted the increasing 
prevalence of AMR Gram-negative bacteria, including E. coli, in a host of community and clinical 
settings, as well as in food-producing animals in Africa. These studies show that there is an 
increasing prevalence of AMR bacteria, and high-level resistance to commonly used 
antimicrobials such as oxytetracycline, aminopenicillins, sulfonamides and phenicols 
(Laxminarayan et al., 2013; Leopold et al., 2014; Van Boeckel et al., 2014; Tadesse et al., 2017; 
Founou et al., 2018). In human populations, the need for these antimicrobials is driven by the 
endemicity of diarrhoeal disease, respiratory tract infections, malaria and HIV/AIDs in sub-
Saharan African countries (WHO, 2018), as well as the increase burden of zoonotic diseases such 
as brucellosis, leptospirosis and Q fever (Cleaveland et al., 2017). As the incidence of these 
diseases increases, there is increased demand for antimicrobials for prophylaxis and therapeutic 
treatment of humans, but also to treat the animals which spread these diseases. 
Figure 1.3 Possible routes of transmission of AMR bacteria between humans, animals and their shared 
environments. Dashed lines are presumed routes. Adapted from (Walsh, 2018). 
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There is a paucity of AMR data in many African countries, at the time of writing, 23 out of 54 
countries did not have any robust, published, AMR studies. There have been several systematic 
reviews and meta-analyses of AMR in the African continent during the last 10 years – each of 
these has attempted to collate data from published studies which detail AMR in various bacteria 
such as E. coli, S. aureus, S. typhi etc. Most of these studies focus on human, clinical infections, 
though there are also sporadic studies conducted in community settings and in food-producing 
animals too. The most recent systematic review of human-derived AMR in Africa assessed 144 
studies across the continent to form an insight into AMR in the African context. Tadesse et al 
were able to calculate the prevalence of AMR, median resistance and inter-quartile ranges for 
a number of bacterial species, and they used these to calculate a standardised measure of 
overall resistance in human populations from the data (Tadesse et al., 2017). Three other 
systematic reviews were also examined, regarding AMR E. coli in humans, however these were 
limited to smaller parts of Africa i.e. Eastern Africa only, Western Africa only and these only 
encompassed a far smaller number of studies (14). 
 
A limitation in this collation of AMR across African countries is that their comparison was made 
from different patient groups, and across different countries. This approach gives an overview 
of resistance across Africa, but this may also have normalised peaks of resistance to specific 
antimicrobials, in different countries reducing the ability to detect country specific outbreaks. It 
is arguable that due to the large number of E. coli isolates tested, there is sufficient resolution 
to deduce general trends. Similarly, not all studies included in this analysis utilised the same 
laboratory methodologies, however, the majority of studies used the disk diffusion method 
(81.9%) and CLSI guidelines (72.9%). As such, the variation in AMR methodology on the validity 
of the final results was suggested to be minimal. This data is shown here, however, individual 
studies are examined in more detail in Sections 1.5.2.1 – 1.5.2.3. 
 
Data pertaining to human AMR E. coli has been extracted from Tadesse et al (2007) systematic 
review of AMR in human participants, in clinical and community settings, and is presented here 
(Table 1.2). The highest prevalence of AMR in human-derived E. coli was to macrolides, 
penicillins, tetracyclines, β-lactams and potentiated sulfonamides. Alongside this data, the 
review highlighted that a third of African countries had no publicly published data and that there 
is a need for standardisation of microbiological identification of bacteria and testing 
methodologies of AMR, in order to allow for national and international surveillance of AMR. 
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Table 1.2 Collated prevalence of AMR E. coli from a systematic review of AMR in human participants, in 
clinical and community settings. Antimicrobials are sorted in descending order of prevalence, according to 
their class. Extracted from (Tadesse et al., 2017). 
 
Antimicrobials Antimicrobial class # of Isolates Median Prevalence (%) IQR 
Tobramycin Aminoglycoside 677 32 (12.3–43.2) 
Gentamicin Aminoglycoside 8282 29.8 (8.4–45.3) 
Amikacin Aminoglycoside 5422 0.2 (0–24.5) 
Meropenem Carbapenem 3402 0 (0–5.7) 
Cefalotin Cephalosporin 515 56.9 (23.5–63.5) 
Ceftriaxone Cephalosporin 2800 31.5 (6.9–47.7) 
Cefuroxime Cephalosporin 3925 30 (19.7–51.2) 
Cefotaxime Cephalosporin 5173 26.8 (8.3–64.5) 
Cefepime Cephalosporin 957 21.8 (5.8–42.5) 
Ceftazidime Cephalosporin 2773 19.5 (10.0–55.8) 
Cefoxitin Cephalosporin 535 8.3 (2.9–44.1) 
Nalidixic Acid Quinolone 2960 36 (12.7–53.8) 
Ofloxacin Fluoroquinolone 1294 30.4 (9.8–47.9) 
Norfloxacin Fluoroquinolone 876 25.6 (15.0–46.3) 
Ciprofloxacin Fluoroquinolone 7877 23.2 (7.7–35.6) 
Levofloxacin Fluoroquinolone 751 19.2 (8.7–47.6) 
Erythromycin Macrolide 675 81.6 (29.9–86.5) 
Nitrofurantoin Nitrofuran 5087 14 (4.5–25.1) 
Amoxicillin Penicillin 5500 88.1 (81.4–92.6) 
Ampicillin Penicillin 2951 86.7 (69.2–96.7) 
Penicillin Penicillin 43 62 (52.9–90.6) 
Amoxicillin/Clavulanic Acid 
Penicillin + β-
lactam 
6764 43.5 (30.8–61.9) 
Chloramphenicol Phenicol 2963 40.9 (11.3–58.0) 
Trimethoprim/Sulphamethoxazole 
Potentiated 
Sulphonamide 
7493 80.7 (69.8–85.6) 
Tetracycline Tetracycline 2896 76.2 (72.6–87.9) 
Doxycycline Tetracycline 302 54.5 (12.8–72.3) 
Oxacillin β-lactam 411 91.5 (22.2–98.5) 
Piperacillin β-lactam 132 58.4 (35.1–95.0) 
Imipenem β-lactam 1613 0.2 (0–5.5) 
Piperacillin/Tazobactam 
β-lactam + β-
lactamase inhibitor 
235 21 (11.1–30.6) 
 
 
A similar analysis was performed to gauge the general trends of AMR E.coli associated with food-
producing animals, across Africa. Another systematic review of AMR in food animals in Africa 
was conducted by Founou et al; 6 studies specifically examining AMR from a mixture of healthy, 
sick, or dead food-producing animals and animal products. Data pertaining to E. coli in food-
producing animals was extracted here (Table 1.3). A high prevalence of AMR was found in 
Animal-origin E. coli, especially to ampicillin and tetracyclines. A more variable prevalence of 
resistance to potentiated sulfonamides and phenicols was also noted.
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Table 1.3 Collated prevalence of AMR E. coli from 6 studies of AMR E. coli in food-producing animals (cattle, pigs and poultry) from a mixture of farms and slaughterhouses.  
Colour-coding indicates high prevalence (red) to low prevalence (green). Adapted from (Founou et al., 2018). Blank space indicates no data present. 
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Calculated Overall 
Resistance* 
54.8 42.6 51.2 13.1 0 14.3 12.5 2.1 8.4 2.9 19.2 10.0 3.0 43.6 24.3 6.5 21.9 
 
Each row represents a different study, data is for AMR in food-producing animals only. Missing data was not reported. *Calculated Overall Resistance: proportion of isolates 
resistant to each antimicrobial, divided by the total number of isolates collected across all studies. MDR isolates: resistant to 3 or more classes of antimicrobial. All resistance 
figures are percentages.
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As with the human derived E. coli dataset (Table 1.2), this collation of food-producing animal E. 
coli has its own limitations. There was no data on antimicrobial consumption included in the 
studies due to lack of availability. There was no correlation between resistance to specific 
antimicrobials, particularly those regarded as HPCIAs, and resistance or virulence genes, as 
these were not published. This is reflective of the limited laboratory capacity in Africa. The 
included studies were similar in the origin of animals (similar sized farms/slaughterhouses), 
farming and slaughterhouse practices and study design. Despite this, there were 3 different 
AMR guidelines used (CLSI/EUCAST/NCCLS), so studies should not necessarily be deemed as fully 
comparable. However, this gives a broad overview of AMR trends in food-producing animals 
across Africa. 
 
1.5.2.1 Detailed Prevalence of AMR E. coli in hospital and community settings  
Most studies relating to AMR in Africa are either clinical or community based. The incidence of 
both hospital-acquired and community-acquired infections are hard to gauge as there are 
inconsistencies in reporting methods and the panels of antimicrobials tested. Furthermore, 
studies are often limited to small geographic areas. Various reports suggest a decrease in the 
incidence of hospital-acquired infection due to the improvement being made in infection and 
prevention controls, though AMR still remains prevalent (Wangai et al., 2017). However, 
numerous other studies show that many healthcare facilities have ineffective plans in place 
(Mugomeri, 2018; Oji et al., 2018). In community-acquired infection literature, it is common to 
see an increasing number of AMR infections. This is mainly due to use of broad-spectrum 
antimicrobials as empirical therapies, unregulated access to antimicrobials, self-medication etc. 
(Al-Kubaisi et al., 2018). 
 
In sub-Saharan Africa, diarrhoeal diseases are one of the most common causes of hospitalisation 
and death, particularly in children (GBD 2016 Diarrhoeal Disease Collaborators, 2018). ETEC is 
the predominant cause of travel-associated diarrhoea and in cases of children under the age of 
five, in developing countries. ETEC is typically associated with acute and chronic diarrhoea. 
Persistent diarrhoea results in a high proportion of deaths by nutritional deficit (Levine and 
Edelman, 1984; Okeke et al., 2000; Okeke, 2009). In 2013, the Global Enteric Multicentre Study 
published a contrasting report indicating that EPEC, not ETEC, was one of the most commonly 
isolated E. coli, associated with moderate-to-severe, infant diarrheal disease in sub-Saharan 
Africa and South Asia (Kotloff et al., 2013). Diarrhoeagenic E. coli has a disproportionately larger 
impact in LMICs due to high population densities, lack of infrastructure and slower responses to 
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disease outbreaks, a high proportion of people with compromised immunity due to 
comorbidities such as HIV/AIDS or parasitic diseases, and lifestyles in which daily life depends 
on animals. Diarrhoea persisting in patients is routinely treated with azithromycin, doxycycline, 
trimethoprim-sulfamethoxazole and fluoroquinolones (Paredes-Paredes et al., 2011; Taylor et 
al., 2017). Whilst there is a case for treating moderate-to severe diarrhoea with antimicrobials, 
in most cases antimicrobial therapy is not suggested, because the illness is usually self-limiting. 
Antimicrobial therapy may lead to adverse events, and unnecessary treatments exacerbate 
AMR development (Zollner-Schwetz and Krause, 2015).  
 
A study from Guinea-Bissau screened 408 children under the age of 5 years presenting with 
fever or tachycardia to paediatric emergency wards, for faecal carriage of ESBL-producing E. coli. 
Susceptibility to cefotaxime, ceftazidime, gentamicin, tobramycin, tigecycline and amoxicillin-
clavulanic acid was tested with the VITEK2 system and susceptibility to trimethoprim-
sulfamethoxazole, piperacillin-tazobactam, ciprofloxacin and meropenem was tested with the 
antibiotic disc diffusion method, using EUCAST guidelines. In the study, 32.6% of participants 
carried at least one ESBL-producing E. coli (47.7%) or K. pneumoniae (52.3%) (Isendahl et al., 
2012). The predominant β-lactamase gene family was blaCTX-M (96.4% in E. coli). Three isolates 
were determined to belong to the pandemic clone ST131. Quinolone resistance was reported in 
81.9% E. coli isolates, as well as 43.4% resistance to aminoglycosides, and 94.0% resistance to 
trimethoprim-sulfamethoxazole, however no carbapenem resistance was found. (Isendahl et 
al., 2012). A similar study in Cameroon examined ESBL-producing Enterobacteriaceae from 358 
faecal samples of outpatients and healthy volunteers, E. coli represented the most common 
species associated with ESBL production (78.4%). The majority of ESBL-producers carried blaCTX-
M-15 (98.0%) and resistance was common to gentamicin (61.0%), ciprofloxacin (75.6%), 
nitrofurantoin (34.1%) and trimethoprim/sulfamethoxazole (97.5%) (Lonchel et al., 2012). In 
Benin, the prevalence of ESBL-E. coli in nosocomial infections was determined and found in 
35.5% isolates. There was a high prevalence of resistance to amoxicillin (92.8%), ampicillin 
(94%), trimethoprim-sulfamethoxazole (85.7%), ceftriaxone (58.3%) and gentamicin (54.8%) 
(Anago et al., 2015). In Tanzania, a study examining the carriage of E. coli in stool samples (and 
milk from animals) from three different cultural groups indicated a high prevalence of ampicillin 
(68.4%), tetracycline (52.5%), trimethoprim (54.2%), sulfamethoxazole (57.5%) and 
streptomycin (40.6%) resistance (Caudell et al., 2018) This study did not look for ESBL-E. coli 
however.  
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In Ethiopia, a study examining UTIs showed that of 228 cultured urine samples, only a small 
percentage were significant bacteriuria cases (9.2%). Of these, E. coli was isolated in a third of 
cases; resistance to a number of antimicrobials was described, including ampicillin (100.0%), 
amoxicillin (100.0%), clindamycin (28.6%), ciprofloxacin (14.3%), tetracycline (28.6%) and 
trimethoprim/sulfamethoxazole (28.6%) (Beyene and Tsegaye, 2011). In another UTI study in 
Rwanda, examining resistance in E. coli in community- and hospital-acquired UTIs, showed high 
prevalence of resistance to various antimicrobials including: amoxicillin (93.0%), nitrofurantoin 
(28.1%), nalidixic acid (61.3%), amoxicillin/clavulanic acid (63.1%), gentamicin (41.5%) and 
trimethoprim/sulfamethoxazole (80.0%) (Muvunyi et al., 2011). 
 
Few studies have investigated the socioeconomic costs of AMR. In Tanzania, a cohort study 
examining the risk of fatality after admission to hospital (of children between the ages of 0-7) 
with systemic infections, revealed that AMR was a major risk factor in patients with septicaemia 
(Blomberg et al., 2007). In Uganda, patients with ESBL-producing Enterobacteriaceae and MRSA 
were more at risk of death than those without, in cases of surgical site infections (Seni et al., 
2013). Numerous studies in high-income countries (HICs) have highlighted that patients with 
AMR-associated infections have higher rates of mortality, require longer hospital stays and have 
higher overall healthcare costs when compared to patients with antimicrobial-susceptible 
infections (Mauldin et al., 2010; Neidell et al., 2012); it is likely to be the same in LMICs.  
 
A Kenyan survey of more than 900 E. coli isolates, isolated from urine, blood and diarrheal 
clinical cases over an 18-year period showed high rates of resistance to β-lactam antimicrobials; 
27.0% of isolates were ESBL-producing, and 57.5% of those ESBLs showed resistance to 
aztreonam, ceftazidime and other cephalosporins (Kiiru et al., 2012). The report suggests that 
AMU correlates to the AMR resistance phenotypes being reported such as ampicillin, 
trimethoprim/sulfamethoxazole, streptomycin, and amoxicillin/clavulanic acid. This report also 
indicates moderate resistance to third-generation cephalosporins and fluoroquinolones (Kiiru 
et al., 2012).  
 
The overall prevalence of AMR E. coli appears to fluctuate between different parts of Africa. It 
is particularly important that policy makers have accurate data on hospital-acquired infections, 
in order to better implement infection control policies, reducing the need for antimicrobial 
therapies. In many LMICs there are few auditing systems, and so rates of AMR are never truly 
known, even by healthcare staff. For community-acquired infections, most studies suggest a 
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general increase in AMR infections. The highest proportion of resistance is to oral antimicrobials, 
which can be acquired without prescription from retail pharmacies or community hospitals 
(Kalungia et al., 2016; Mboya et al., 2018).   
 
1.5.2.2 Detailed Prevalence of AMR E. coli in animal settings 
Smallholder farms are the most common type of farming in sub-Saharan Africa. The World Bank 
estimates that approximately 70% of people engage in some degree of farming in Kenya (and in 
other sub-Saharan African countries), and the majority of them live around or below the poverty 
line (Mondiale, 2008; Wiggins et al., 2010). Traditionally, farming encompasses keeping animals 
including indigenous east African Zebu cattle, sheep and goats in the low-rainfall, semi-arid and 
arid parts of the country, though in more recent years there has been a major shift towards 
smaller holdings and marketed milk production using imported (or exotic) cattle in mixed, crop-
livestock systems. The production system in these areas includes mainly dairy cattle, other 
livestock (mostly poultry, sheep, and goats), cash crops (e.g., coffee, tea, horticulture) and 
subsistence crops (e.g., maize, vegetables). Various studies have investigated the prevalence of 
AMR E. coli in food-producing animals, though there are far fewer studies than in human cases, 
in Africa. Studies which analyse E. coli also appear to be far fewer than in other enteric bacteria 
such as Salmonella spp. and Campylobacter spp. in animals.  
 
In a stratified random sample of Zambian dairy cattle on 104 different small, medium, and 
commercial-sized dairy farms, faecal E. coli was analysed for AMR. Diarrhoea in the cattle was 
the most common reason for treating with antimicrobials (mean number of cases was 54.1%); 
the estimated prevalence of resistance across the different farming systems (376 isolates) was 
found to be surprisingly low in almost all of the antimicrobials tested - tetracycline (10.6%), 
ampicillin (6.0%), sulfamethoxazole/trimethoprim (4.5%), cefpodoxime (1.9%), gentamicin 
(0.9%) and ciprofloxacin (0%) (Mainda et al., 2015). Mainda et al suggest that there was a higher 
prevalence of AMR E. coli from dairy cattle in commercial-sized farms, compared with medium- 
and small-scale farms, however there was no statistically significant difference. The differences 
they reported in prevalence of AMR E. coli from different sized farms could be attributed to 
differences in testing methodology, however the study does not explain those differences. Of 
note was a significant association between exotic breeds (imported Friesian and Jersey breeds) 
and a higher rate of isolation of AMR E. coli compared to local breeds (Zebu). Future work could 
be undertaken in order to assess if local breeds are more inherently resistant to specific 
diseases, and therefore require fewer antimicrobials to maintain their health. 
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In a Ghanaian study, 210 stool samples were collected from farm animals, including goats, 
sheep, pigs and poultry and E. coli isolated. There was a high prevalence of resistance of AMR 
E. coli in 8 of the 9 tested antimicrobials: cefuroxime (97.7%), ampicillin (95.7%), tetracycline 
(91.6%), chloramphenicol (80.9%), gentamicin (75.0%), co-trimoxazole (68.3%) and amikacin 
(60.8%). Of these isolates, 97.7% were MDR (resistant to 3 or more classes of antimicrobial, 
according to disc-diffusion test). There was no reported resistance to cefotaxime in E. coli from 
any of the animals in the study. There was correlation between the high prevalence of resistance 
of all animal isolates, and the high rates of antimicrobial usage in animal husbandry in Ghana 
(Donkor et al., 2012). The antimicrobials commonly used in Ghanaian animal husbandry 
practices correlated with AMR in animal E. coli isolates, especially in tetracycline and penicillins. 
These antimicrobials have been described in other studies as being widely available on the 
market, which suggests that they have been used extensively in veterinary and human medicine 
(Newman et al., 2011).  
 
AMR is also an issue for aquaculture – several classes of antimicrobials are commonly used in 
large quantities in the fish industry, particularly in LMICs, where they are not regulated. This has 
resulted in a number of African aquaculture products containing high antimicrobial residues - 
this is not only a public health issue, but also an economic one, as exports may decrease or 
products may become devalued due to AMR (Okocha et al., 2018). An example of this is 
oxytetracycline residues detected in African catfish, in Nigeria. The study showed that the 
majority (95%) of questioned fish farmers frequently administered antimicrobials (in feed and 
water) to their fish without veterinary prescription, and did not observe withdrawal periods 
(Olatoye and Basiru, 2013) 
 
There are many studies which have looked specifically for ESBL, plasmid-mediated AmpC 
(pAmpC) and carbapenemase-producing E. coli in farm animals in various African countries; 
detection is often associated with MDR and infections caused by pAmpC-producing 
Enterobacteriaceae have high therapy failure and mortality rates (Rensing et al., 2019).  Whilst 
surveillance of ESBL-E. coli is important, very few of these studies report the resistance profiles 
to individual antimicrobials (Alonso et al., 2017). The potential for inter-host spread of AMR and 
MDR clones through close contact with animals or ingestion of contaminated products is a 
public health risk. Over the last 10 years, there has been a large increase in the prevalence of 
resistance to HPCIAs, including to fluoroquinolones and third/fourth generation cephalosporins 
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amongst commensal E. coli in healthy livestock species. In most cases, resistance to both 
antimicrobial families are co-selected and disseminated not only by clonal spread but possibly 
also to via HGT, or via plasmids carrying qnr or aac(6)Ib-cr and bla genes (especially, of the CTX-
M group). Furthermore, carbapenem- and colistin-resistant E. coli strains are also emerging 
among husbandry animals in Africa, which demonstrates the urgent need of a better control of 
the usage of veterinary drugs and the implementation of effective surveillance programmes to 
stop the dissemination of MDR and ESBL- E. coli strains (Mitgang et al., 2018).  
 
One such example of a study incorporating examination of ESBLs, alongside resistance 
phenotypes is a Tunisian study of 136 faecal samples collected from healthy poultry across 36 
different farms; these were tested for AMR using the disc and double-discs diffusion methods 
according to CLSI guidelines. There was a moderately high prevalence of ESBL-E. coli according 
to double-disc diffusion test approximately 30%. Sixty-seven CTX-resistant E. coli isolates 
(including duplicates from 57 of the faecal samples) had MDR phenotypes, including to 
tetracycline (94%), nalidixic acid (89.5%), norfloxacin (71.6%), trimethoprim–sulfamethoxazole 
(73.1%), gentamicin (6.0%) and amikacin (6.0%). All the isolates were susceptible to imipenem. 
Only one isolate carried blaCTX-M-1 and blaCMY-2 genes; blaTEM-1 was detected in 26 isolates (38.8%). 
QnrS1 was detected in 2 blaCTX-M-1 producing E. coli and QnrB5 in one blaCMY-2 isolate and the 
aac(6ʹ)-Ib-cr gene in 2 blaCTX-M-15 and one blaCTX-M-1 producing isolates (Mnif et al., 2012). This 
study highlights the importance of investigating not only resistance phenotypes, but also to dig 
deeper in the genomes of isolated E. coli in order to assess patterns of spread between animals, 
humans and their environments, by understanding the resistance and virulence genes carried 
on plasmids. 
  
There is some evidence suggesting the transmission of AMR bacteria and genes between 
animals, humans, and the environment, though there is difficulty in determining precisely if 
there has been transmission or not. A recent systematic review examining the evidence of 
transmission of bacteria between humans and animals was conducted by Muloi et al; showed 
that 8 studies (18%) suggested evidence of transmission of AMR from food animals to humans, 
25 studies (56%) suggested transmission between animals and humans with no specific 
direction, and 12 studies (26%) indicated there was no proof of transmission. As many of these 
studies have relied on MLST and the presence of similar bacteria in hosts, it is becoming more 
prudent to make use of high-resolution whole genome data analysis with systematic 
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longitudinal, epidemiological evidence to fully demonstrate AMR transmission between food 
animals and humans (Muloi et al., 2018). 
 
1.5.2.3 Detailed Prevalence of AMR in African environments 
There have been extremely few African studies examining the presence of antimicrobial 
residues and AMR in the environment. As a large proportion of the African population live in 
rural areas with restricted access to clean drinking water and sub-optimal sanitation, there is a 
significantly increased risk of transmission of diseases. It is a good idea to investigate 
environmental isolates, alongside human and animals in order to assess factors which facilitate 
the exchange of AMR genes between environmental microbiota and human and animals’ 
commensals and pathogens.  
 
A recent study in South Africa examined the prevalence of AMR and potentially pathogenic E. 
coli from treated wastewater (Adefisoye and Okoh, 2016). In this study, 223 E. coli isolates were 
tested using disc diffusion tests, according to CLSI guidelines - there was high prevalence of AMR 
E. coli, with resistance to ampicillin (55.6%), cephalexin (51.1%), nalidixic acid (31.4%), 
tetracycline (60.1%) and chloramphenicol (22.9%). There was also a moderately high prevalence 
of MDR isolates (32.7%). Additionally, associated resistance genes were detected using PCR - 
strA (88.2%), aadA (52.9%), cat I (15%), cmlA1 (4.6%), bla TEM (56.4%), tet(A) (30.4%), tet(B) 
(28.4%), tet(C) (42.2%), tet(D) (50%), tet(K) (11.8%), and tet(M) (68.6%).  
 
Existing studies have highlighted hotspots for environmental contamination (such as effluent 
from hospitals) (Harris et al., 2014; Huijbers et al., 2015); however, very few studies have 
attempted to integrate all three components of the One Health spectrum to understand the 
dynamics of transmission.  
 
1.6 Kenya’s Current Policy on AMR  
Since this study began in 2015, Kenya has implemented a national action plan (NAP) to tackle 
the growing crisis of AMR. In 2009, the Global Antibiotic Resistance Partnership (GARP) Kenya 
was established – this group was tasked with undertaking a situational analysis of both 
antimicrobial use and resistance in Kenya in August 2011 (Global Antibiotic Resistance 
Partnership, 2011). Findings of the situational analysis led to Kenya hosting its first AMR 
awareness week in November 2013. Events were held to highlight issues surrounding 
antimicrobial use and resistance. The following month, a regional antimicrobial stewardship 
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workshop was held, in December 2013. The outcome of the workshop provided 
recommendations to the National Infection Prevention and Control Committee at the Ministry 
of Health in Kenya. All findings of the situational analysis completed in 2011 were disseminated 
to health managers in 45 counties in Kenya. In March 2014 it was decided that the threat of 
AMR should be a focal point for discussion and mitigation. The Infection Prevention and Control 
Unit formed the National strategic plan, with two strategic objectives specific for AMR: a) 
establish a national AMR surveillance system, and b) appointment of a National Antimicrobial 
Stewardship Advisory Committee (Wesangula et al., 2016). In June 2017, the National Policy on 
Prevention and Containment of Antimicrobial Resistance was published (Government of Kenya, 
2017).  
 
The plan sets out a number of objectives which it hopes to achieve, these are: 
1) Improve the awareness and understanding of AMR by implementing effective 
surveillance systems and commit to research, communication, education, and training. 
2) Improve the knowledge base and gaps in evidence on AMR via surveillance and 
research. 
3) Reduce infections associated with AMR-bacteria by improving sanitation, hygiene and 
infection prevention and control measures. 
4) Optimise the use of antimicrobials in animal, human and plant health. 
5) Support sustainable investment, targeted towards Kenyan needs, and increase 
investment in medicines, diagnostic tools, vaccines, and other necessary interventions. 
 
The National Policy on Prevention and Containment of Antimicrobial Resistance should be a 
good start to unifying AMR issues and numerous challenges and action points are discussed 
(Government of Kenya, 2017); these action points are summarised in (Table 1.4)  
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Table 1.4 Summary of issues and action points in the Kenya National Policy on Prevention and Containment 
of Antimicrobial Resistance (Government of Kenya, 2017). 
 
Objective Issue Action 
Increase 
understanding 
of AMR by 
implementing 
effective 
surveillance 
systems 
General population has a high risk of 
exposure to AMR bacteria, particularly at 
human-animal-environmental interface. 
Raise awareness across all sectors by 
targeting human, animal, and 
agricultural practices as well as 
consumers and school children. To be 
done via public communication 
campaigns. 
Strengthen 
knowledge base 
and evidence of 
AMR 
Lack of integrated surveillance systems 
as well as poor diagnostic and laboratory 
capacity. 
Develop and support a national, 
integrated action plan to combat AMR. 
Enforce compulsory reporting of AMU 
and AMR so that a national database 
can be maintained. Also increase the 
capacity of laboratories to assist with 
reporting. 
Reduce AMR by 
adopting 
preventative 
measures 
A broad range of antimicrobials used in 
livestock production systems, leading to 
high prevalence of AMR. 
Core infectious disease control 
practices to be implemented, including 
better biosecurity, hand hygiene, food 
and water safety and promotion of 
vaccination programmes instead of 
prophylactic AMU. 
Optimising the 
use of 
antimicrobials 
in human, 
animal, and 
human health 
Antimicrobials are used in all aspects of 
human, veterinary, and environmental 
life, including for aquaculture and crop-
production systems, for non-therapeutic 
uses. There is frequent over-prescription 
in hospitals and unregulated access to 
antimicrobials in non-hospital settings. 
Set up a clear antimicrobial supply 
chain to reduce the number of illegal 
outlets providing antimicrobials. Also 
enforce legislation on the prudent use 
of antimicrobials and ensure that 
county governments guarantee access 
to essential antimicrobials at all levels. 
Regulation of 
monitoring 
antimicrobials 
Various laws exist to govern 
antimicrobial use in Kenya, including the 
Kenya National Drugs Policy and the 
National Livestock Policy. There is weak 
enforcement due to lack of funding and 
capacity to monitor compliance. 
Restructure laws governing AMU and 
better enforce importing and 
manufacture of human and veterinary 
antimicrobials to reduce counterfeits 
and illegally imported antimicrobials. 
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1.7 The One Health Paradigm as a Solution 
One Health has been defined by the One Health commission as “the collaborative effort of 
multiple health science professions, together with their related disciplines and institutions—
working locally, nationally, and globally—to attain optimal health for people, domestic animals, 
wildlife, plants, and our environment” (One Health, 2018). The One Health approach (Figure 1.4) 
is designed to aid in designing and implementing various programmes, policies, legislations, and 
ongoing research where multiple sectors work together to achieve better public health 
outcomes.  
 
Specific areas in which a One Health approach is particularly relevant are in food safety, control 
of zoonoses and combatting AMR. The One Health concept recognises that humans and animals 
are mutually dependent on one another, and they have a shared environment, as well 
significant overlap in the microbes which infect both (Zinsstag et al., 2012); indeed as many as 
75% of human infectious diseases that have emerged or re-emerged in recent decades are 
zoonotic in origin (Cutler et al., 2010). Efforts directed by individual sectors cannot prevent or 
eliminate issues such as AMR and spread of zoonoses when there is crossover with other 
sectors. A good example of this is prevention of rabies in humans; only by targeting the animal 
source of the rabies virus (i.e. vaccinating dogs) can humans become protected. Similarly, 
information on circulating influenza strains in animals are important for the selection of human 
vaccines for potential influenza pandemics. Finally, AMR bacteria can be transmitted between 
humans and animals via direct contact or through contaminated food. In order to prevent 
ongoing transmission of AMR bacteria, a well-coordinated multifactorial approach is therefore 
required.  
 
AMR has highlighted the importance of a ‘One Health’ approach and has shifted the 
responsibility of tackling it cross multiple sectors, namely across human health, animal health, 
agriculture, and environmental platforms. To effectively detected and respond to AMR, zoonotic 
outbreaks and food safety issues, epidemiological and laboratory data needs to be shared across 
sectors.  
 
Epidemiological, microbiological and social science research is needed at population levels 
across the One Health spectrum in order to fill the large gaps in knowledge of AMR in low-
resource settings like Africa (Rousham et al., 2018). This calls for a robust surveillance system 
for monitoring environmental contamination with antimicrobial residues and emergence of 
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AMR. For any surveillance system to be effective, especially in the context of AMR, it needs to 
be truly ‘One Health’ in its approach. Until now, a full country-wide level of integration has not 
occurred in any part of Africa; all data from multiple sectors are generally considered separately; 
Africa is well-positioned to benefit from an integrated approach (Kamani et al., 2015). The 
Global AMR Surveillance System (GLASS) was launched by the WHO and is a good first step at 
having an international surveillance system for reporting AMR and identifying global health 
security threats. This calls for a certain level of capacity building and standardisation of the 
coordinating labs; it is expected that smaller countries can benefit greatly from the 
improvement in lab capacity. It is hoped that this surveillance platform will grow and move 
slowly into the agriculture and environment sectors too (Seale et al., 2017; World Health 
Organization, 2017). 
 
 
Surveillance studies such as the Zoonoses in Livestock in Africa study (ZooLiNK) (Falzon et al., 
2019), from which this thesis stems are a good start in filling in gaps in AMR data in western 
Kenya. Studies such as these can aid policymakers by educating them about the prevalence and 
Comparative  
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Figure 1.4 Venn diagram the relationship between human, animal and environmental sectors in the One Health 
paradigm. (Adapted from University of Alaska Fairbanks https://www.uaf.edu/onehealth/). 
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risks of AMR. These policies can then be filtered down to antimicrobial users and providers, 
through communication campaigns (Pehrsson et al., 2016). In LMICs, adopting a One Health 
approach may be a better solution for tackling AMR, by drawing together different bodies and 
standardising reporting across all sectors. In this way, a targeted approach to tackling AMR, in 
the vein of the Kenyan NAP (Fleming Fund, 2019) can be achieved.  
 
1.8 Aims of this study 
This study is part of a larger surveillance study being conducted in three western counties of 
Kenya called ZooLiNK. The study aims to help Kenya develop an effective surveillance system, 
dedicated to zoonotic infectious diseases, and fill in the many gaps in the carriage of AMR E. coli 
in humans, animals, and their environments. This will be achieved using a One Health approach, 
by facilitating cross-disciplinary partnerships between veterinarians, physicians, ecologists, 
economists, and public health professionals.  
 
The work in this thesis will first determine the general understanding of antimicrobials by users 
(farmers and animal healthcare workers) and providers (animal healthcare workers and retail 
pharmacies) using questionnaires-guided interviews, giving a basis of the most prudent 
audience to target in surveillance plans. Following that, E. coli isolates from farmers, farm 
animals and their environment will be characterised to investigate the potential for sharing of 
E. coli strains, mobile genetic elements and resistance and virulence genes between those 
groups.  To achieve these aims, antimicrobials users and providers were recruited across Busia 
county (Chapter 3) and then cross-sectional sampling of farms was undertaken (Chapter 4). 
Finally, a retrospectively collected cohort of E. coli from slaughterhouse workers was collected, 
to examine the carriage of AMR E. coli in the faeces of slaughterhouse workers (Chapter 5). 
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2.1 Literature Review Strategy 
A systematic literature search was carried out using multiple electronic databases (PubMed, 
Web of Science and Scopus), for research articles published in peer-reviewed journals. No 
geographical, language or date restrictions were used. A combination of keywords was used to 
find search results, and these included antibiotic resistan* (encompassing resistant and 
resistance), drug resistan*, antimicrobial resistan*, Escherichia coli, E. coli, Enterobacteriaceae, 
human, livestock, food-producing animal*, food animal*, pig, poultry, cattle, sheep, goats. Grey 
literature including reports (GLASS report (WHO), Kenyan Government (annual reports) and the 
Centre for Disease Dynamics, Economics & Policy Global Antibiotic Resistance Partnership 
(CCDEP-GARP) and conference proceedings (poster or oral presentations) was also searched 
using the same keywords. Articles and grey literature were excluded if they were written in a 
non-English language or if there was no reference to E. coli (the bacterium of interest) within 
the abstract or text body. Article searches were performed by considering both the article titles 
and abstracts. Data extraction from articles and grey literature was performed by one author 
(SK) only. 
 
2.2 Ethics Statement 
Before data and sample collections, ethical approval was sought from ILRI-IREC (International 
Livestock Research Institute - Institutional Ethical Research Committee), which is accredited by 
the National Commission for Science, Technology, and Innovations (NACOSTI) in Kenya. 
Approval was also sought concurrently, from the University of Liverpool Veterinary Research 
Ethics Committee (VREC). Permission to engage with farmers and antimicrobial providers was 
given by the District Veterinary Officer of Busia county, and then also by each of the seven sub-
county veterinary officers. Informed consent was obtained from all participants, both verbally 
and written (or with a thumbprint in cases of potential illiteracy). The aims of the study as well 
as participants rights to withdraw were fully explained in both English and Kiswahili; each 
participant was given enough time to ask questions regarding the study, before giving consent. 
To ensure good ongoing links with the district veterinary services, copies of questionnaires were 
provided, and regular contact was made with the sub-county veterinary officers for the duration 
of the studies. 
 
2.3 Study Site 
The study population was a mixed crop-livestock farming community in Busia County, western 
Kenya (0.434° N, 34.242° E) which supports one of the highest human and animal population 
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densities in Eastern Africa (Figure 2.1). The area is broadly representative of other communities 
spanning the Victoria Lake Basin in Kenya, Uganda, and Tanzania. The study area covered 
approximately 1630km2, in a 45km radius from Busia town, where the ILRI/BUSIA lab is based. 
There is a high density of human (1.4 million people) (OpenData, http://www.opendata.go.ke), 
cattle (340,000) and domestic pig populations (55,000) in this region (Divisional Livestock 
Production Office data). Busia county also has a high proportion of smallholder farms; up to 90% 
of people are thought to engage in crop-livestock farming.  
 
2.3.1 KAP Study 
Taking into account the anticipated time it would take to recruit and interview participants, it 
was advised by Jane Poole at the International Livestock Research Institute (informed by 
previous KAP studies that had been conducted in Kenya),  that approximately 70 farms were an 
appropriate target for the proposed timeframe of 8 weeks of fieldwork. Busia County is divided 
into seven sub-counties, and so random sampling of farmers was stratified by sub-county to to 
adhere to logtical consideration of sharing vehicular access. Maps of Busia were generated in 
QGIS v3.2 (QGIS Dev Team, www.qgis.org/en/site) and overlaid with 1km2 grids. Farms were 
randomly selected with a random number generator, which corresponded to each grid number. 
The centre of each grid was input into Google Maps (Google 2017, California, USA) and using 
the satellite navigation feature, we travelled to the physical location indicated. The nearest farm 
to the co-ordinates was then selected for recruitment. Where there was no farm at, or close to 
the co-ordinates, a repeat randomly generated point (constrained to the grid), with new co-
ordinates was generated. Where these points were closer than 500m to a previously recruited 
farm, a new random point was generated at grid level. This constraint was designed to capture 
farms from different urban and peri-urban locations within each sub-county, as opposed to 
presumably highly similar farming neighbours. Once we arrived at the farm, GPS of the actual 
farm or agrovet were captured using a mobile phone and stored in a secure database for direct 
follow-up in future studies. 
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Agrovet shops and AHAs was recruited systematically, with assistance from the sub-county 
veterinary officer from each sub-county. These officers accompanied all visits and were able to 
assist in directing us to all agrovet shops in each sub-county. The most senior person (or only 
person present) in each agrovet shop was interviewed, except for shops which were closed on 
more than two occasions during repeat visits. A comprehensive list of all known AHAs was 
collected from sub-county district officers; all AHAs were recruited by phone and all agreed to 
participate – once recruited, we travelled to a convenient location for the AHA and gave the 
interview at the roadside.   
 
Busia 
Figure 2.1 Location of field site in relation to Kenya. The field laboratory (green star) is located 
in Busia township, within Busia county. (0.434° N, 34.242° E) 
. 
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2.3.2 Farm Study 
A second cross-sectional study was designed, to collect faecal E. coli from livestock, farmers, 
and the environment. The GPS coordinates captured from farms during the KAP study were used 
to locate, approach and attempted to recruit the same 70 farms to the cross-sectional study, 
however, 27 farmers declined to participate. Therefore, 27 new farms were recruited using the 
same random method as for the KAP study.   
 
2.4 Data Collection 
2.4.1 KAP Study 
A detailed questionnaire was designed, and all participants were interviewed orally using that 
framework. Different groups of respondents were given a relevant mixture of open and closed 
questions, and these were used to ascertain participants’ education, access to veterinary 
antimicrobials, prescribing patterns and knowledge of ABR and withdrawal periods. 
Questionnaires were designed in Adobe® Acrobat® Pro DC (Adobe, San Jose, United States) and 
coded electronically using AppSheet® (AppSheet c/o Solvebot Inc., Seattle, Washington). 
Participants were interviewed in English or Kiswahili by bilingual Kenyan research members, 
being asked each of the questions in the questionnaire. All answers were given verbally by the 
participant and these were recorded as verbatim transcribed text into the coded questionnaire 
on a mobile phone or tablet, by the interviewer.  
 
2.4.2 Farm Study 
Prior to bacterial sampling, the farm study collected additional questionnaire data. Some of the 
questions had crossover from the KAP study; such questions included knowledge of AMR and 
withdrawal periods, the incidence of disease during the prior 3 and 12 months (to the 
questionnaire) amongst animals, and purchase of antimicrobials. An additional subset of 
questions was asked to gather data regarding slaughter practices, use of personal protection 
equipment, human illness, and hygiene practices. This was conducted in the same way as in the 
KAP study i.e. participants were interviewed in English or Kiswahili by research members using 
the questionnaire as a framework.  
 
2.5 Microbiological Methods 
Various samples were collected during the farm study, including livestock and human faeces, 
water from the main water sources on farms and environmental boot swabs of living areas on 
farms. A retrospective study examining slaughterhouse workers also collected faecal samples, 
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but in a different way. All samples were immediately processed at the Busia/ILRI lab and then 
shipped to Liverpool University where they were purified and subjected to further 
characterisation. Collection of these samples and isolation and purification of E. coli are detailed 
in the respective chapters. Once purified, isolates were subjected to antimicrobial susceptibility 
testing and further characterisation. 
 
2.5.1 Antimicrobial Susceptibility Testing 
Antimicrobial susceptibility testing was performed on all isolates using the disc diffusion method 
detailed by the European Committee on Antimicrobial Susceptibility Testing (EUCAST, 2017). 
Following overnight incubation, several colonies were selected from the NA plate and 
homogenised by vortex in 3ml of sterile distilled water to achieve a 0.5 McFarland standard. The 
suspension was inoculated onto a Müeller Hinton Agar plate (MHA) using a sterile cotton swab 
and rotary plate, to obtain a confluent lawn. For the standard antimicrobial sensitivity panel, 
seven antimicrobial discs were applied to each plate using a disc dispenser: ampicillin 10µg, 
chloramphenicol 30µg, ciprofloxacin 5µg, gentamicin 10µg, sulfathiazole 1000µg, tetracycline 
30µg and trimethoprim 5µg. For ESBL confirmation, the combination double-disc diffusion 
method was used (M'Zali et al., 2000). Three pairs of antibiotic discs containing ceftazidime 
(30μg), cefotaxime (30μg) and cefpodoxime (30μg) with and without clavulanic acid (10μg) were 
applied to inoculated MHA plates. All plates were then incubated aerobically overnight at 37°C. 
Following incubation all plates were photographed using a laboratory camera mounted to a 
pedestal (to ensure photos were taken at fixed height) and downloaded to a computer. Zones 
of inhibition were measured using the Fiji distro of ImageJ2 (Schindelin et al., 2012) and 
transferred to a spreadsheet. Isolates of the standard antimicrobial panel were considered to 
be resistant if their size in mm was less the published breakpoint; suspected ESBL isolates were 
confirmed as being an ESBL if the zone of inhibition for the cephalosporin with the clavulanic 
acid disc was at least 5mm greater than the zone of its counterpart without clavulanic acid. 
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Zones of inhibition for all antimicrobials except for sulfathiazole and tetracycline were 
categorised as resistant or sensitive according to EUCAST human clinical breakpoints (EUCAST, 
2017). Tetracycline was interpreted according to BSAC human clinical breakpoints (BSAC, 2015). 
There are no published breakpoints for sulfathiazole and so a tentative epidemiological cut-off 
value (TECOFF) was estimated using the distribution of zones of inhibition. After all susceptibility 
testing has been completed and zones of inhibition measured, a histogram was constructed 
indicating their frequency (mm). A bimodal distribution was observed (Figure 2.2) – the left 
cluster of peaks indicate antimicrobial-resistant bacteria and the right cluster of peaks indicate 
susceptible bacteria. The TECOFF was set between the peaks representing the largest 
proportion of isolates within the two populations (Morrissey et al., 2014); for susceptible 
isolates this value is 32mm and for the resistant isolates, this was 6mm. As such, isolates with 
zones of inhibition of <19mm were considered to be resistant, and those ≥19mm were 
‘susceptible’.  
 
All culture media was sourced from Lab M Ltd, Bury, UK; antimicrobial discs were obtained from 
MAST Group Ltd., Bootle, UK; and cefotaxime and ceftazidime powder were sourced from 
Sigma-Aldrich Company Ltd., Gillingham, UK. 
 
Figure 2.2 Bimodal distribution of zones of inhibition for the antimicrobial sulfathiazole, measured using the PC 
method. A total of 3763 E. coli isolates from pigs, poultry, sheep, goats, cattle, humans and the environment were 
used to determine the bimodal distribution. 
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2.5.1.1 Use of software to measure zones of inhibition 
Typically zones of inhibition are measured with a ruler. An alternative method using a camera 
and a computer to measure these zones was trialled, alongside the ruler method. 2078 zones of 
inhibition were measured traditionally with a ruler and simultaneously photographed, using a 
pedestal mounted camera to ensure consistency in height from each plate. Concordance 
between the ruler measurement and the Fiji measurement was determined using a Bland-
Altman test (Bland and Altman, 1986).  Measurements of both ruler and computer were input 
into a spreadsheet, named RULER and PC. The difference between the two was calculated by 
using “PC” – “RULER”. The mean of the two measurements was calculated using (“PC” + 
“RULER”) / 2. A one-sample T-Test was run to determine how close to 0, the mean is. In this 
case, the mean (difference) was found to be -0.2862mm. i.e. the pc method underestimated the 
average zone of inhibition size by 0.29mm. The PC method was found to be 98.6% sensitive and 
specific (Table 2.1). In total, the PC method showed only two discrepancies, one false-positive 
and one false-negative. 
 
Table 2.1 Concordance between the use of a ruler and computer software to measure zones of inhibition 
following a disk-diffusion test. Results indicate a subset of resistant isolates (n=608) detected using both 
methods.   
  Antimicrobials Tested 
  CIP CHLOR GENT TET SULFA AMP TRIM Total 
Method Used 
PC 1 12 0 149* 164 116 166** 608 
RULER 1 12 0 150 164 116 165 608 
 Concordance 100.0% 100.0% N/A 99.3% 100.0% 100.0% 98.8% 99.8% 
*Isolate was resistant but measured as sensitive. **Isolate was sensitive but measured as resistant. 
 
2.5.2 Isolate Storage 
Isolates destined for long-term storage at -80⁰C, were inoculated into Microbank™ cryovials 
(Pro-Lab Diagnostics U.K, Cheshire UK) as previously detailed. Briefly, colonies from a pure 
isolate culture were inoculated into the cryopreservative fluid to achieve a turbidity of 
approximately 4 McFarland standard and inverted numerous times to ensure binding of the 
organisms to Microbank™ beads. Excess cryopreservative was then removed using a sterile 
pipette. Isolates were recovered by removing a single bead from the cryovial using sterile 
forceps and inoculation of the bead onto nutrient agar for aerobic incubation at 37⁰C for 18-24 
hours. 
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2.5.3 Polymerase Chain Reaction (PCR) 
All isolates that were morphologically consistent with E. coli (shiny, metallic-green colonies on 
eosin-methylene blue agar) were confirmed by detection of the uidA gene (McDaniels et al., 
1996). PCR assays were also used to assess the carriage of β-lactamase resistance genes (blaSHV, 
blaTEM, blaOXA and blaCTX-M), to the grouping of isolates carrying a blaCTX-M resistance gene, and 
also to identify isolates belonging to the O25b-ST131 clade (Clermont et al., 2009). The 
procedure for each of these assays follows a similar pattern, beginning with DNA extraction. 
 
2.5.3.1 DNA Extraction   
Cell lysates were prepared by inoculating several purified E. coli colonies from a NA plate into 
1ml of sterile distilled water (to an opaque turbidity) in 1.5ml Eppendorf tubes. Suspensions 
were thoroughly homogenised by vortex and boiled at 100°C for 10-15 minutes in a heat block. 
DNA lysates were stored at 4°C for short-term working and then transferred to a -20°C freezer 
for long-term storage. 
 
2.5.3.2 PCR Substrates and Primers 
All PCR assays were made up in 25µl volumes and utilised 5x FIREPol® 12.5mMCl2 Master Mix 
Ready to Load (Solis Biodyne, Tartu, Estonia), comprising 1U FIREPol® DNA polymerase, 80mM 
Tris-HCl, 20mM (NH4)2SO4, 0.02% w/v Tween-20, 2.5mM MgCl2 and 200μM of each dNTP per 
reaction plus blue and yellow dye. Reactions testing for the presence of uidA and extended-
spectrum beta-lactamase (ESBL) resistance genes were undertaken in reaction volumes of 25μl 
constituting 4μl of master mix, 5ρmol of each primer and 1μl of DNA lysate with the addition of 
sterile molecular grade water (Sigma-Aldrich, Dorset, UK) to make up the reaction required 
reaction volume. PCR assays for the detection of E. coli O25b-ST131 were undertaken in 
reactions containing 4μl of master mix, 10ρmol of each primer, 3μl of DNA lysate and sterile 
molecular grade water making up a reaction volume of 25μl. A lysate of a bacterial isolate known 
to carry the gene of interest and sterile molecular grade water were included as a positive and 
negative control in each PCR run.  
 
All primers were synthesised by Eurofins MWG Operon (Ebersberg, Germany) and PCR reactions 
were undertaken using ABI 2720 Thermal Cyclers (Applied Biosystems, California, USA). Target 
genes, amplicon sizes and various conditions for all PCR assays carried out can be seen in (Table 
2.2). 
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Table 2.2 Gene targets, primers and conditions for each PCR assay used to confirm and characterise E. coli. 
Gene Target Primer DNA Sequence 5’à3’ 
Amplicon 
size (bp) 
Annealing 
(°C) 
Reference 
uidA 
uidAF CCAAAAGCCAGACAGAGT 
623 58 
(McDaniels et 
al., 1996) uidAR GCACAGCACATCAAAGAG 
blaTEM 
TEMF CATTTCCGTGTCGCCCTTATTC 
800 
60 
Multiplex 
 
(Dallenne et 
al., 2010) 
TEMR CGTTCATCCATAGTTGCCTGAC 
blaSHV 
SHVF AGCCGCTTGAGCAAATTAAAC 
713 
SHVR ATCCCGCAGATAAATCACCAC 
blaOXA 
OXAF GGCACCAGATTCAACTTICAAG 
564 
OXAR GCACCCAAGTTICCTGTAAGTG 
blaCTX-M 
CTX-MU1 ATGTGCAGYACCAGTAARGTKATGGC 
593 58 
(Boyd et al., 
2004) CT-MU2 TGGGTRAARTARGTSACCAGAAYCAGCGG 
blaCTX-M 
Group 1 
CTX-MGrp1F CCCATGGTTAAAAAATCACTGC 
876 55 
(Carattoli et 
al., 2008) CTX-MGrp1R CAGCGCCTTTTGCCGTCTAAG 
blaCTX-M 
Group 2 
CTX-MGrp2F ATGATGACTCAGAGCATTCGC 
876 55 
(Hopkins et al., 
2006) CTX-MGrp2R TGAGAAACCGTGGGTTACGAT 
blaCTX-M 
Group 9 
CTX-MGrp9F ATGGTGACAAAGAGAGTGCAAC 
893 55 
(Batchelor et 
al., 2005) CTX-MGrp9R TTACAGCCCTTCGGCGATG 
ST131 trpa 
trpAF GCTACGAATCTCTGTTTGCC 
427 60 
(Clermont et 
al., 2009) 
trpAR GCAACGCGGCCTGGCGGAAG 
ST131 pabB 
pabBF TCCAGCAGGTGCTGGATCGT 
347 65 
pabR GCGAAATTTTTCGCCGTACTGT 
F = Forward primer, R = Reverse Primer 
 
2.5.3.3 Visualisation of PCR Products 
All amplified PCR products were visualised by gel electrophoresis, on peq-GREEN (Peqlab, 
Fareham, UK) stained 2.0% agarose medium (150ml) or large (250ml) gels, produced using Hi-
pure EEO agarose (Biogene, Cambridge, UK) in 1 x Tris-acetate-EDTA (TAE) buffer (Sigma-
Aldrich). 10µl of 100bp DNA ladder (Solis Biodyne, Tartu, Estonia) was added to the first well of 
each gel and for all reactions, 8µl of products was loaded into each well following the DNA 
ladder. All gels were run in electrophoresis tanks containing 1xTAE Buffer. To obtain maximum 
differentiation of DNA bands, all gels were run at 100V for 60 mins (medium gel, 150ml) and 90 
minutes (large gel, 250ml). PCR products were visualised under an ultraviolet transilluminator 
using the UVItec gel documentation system (UVItec, Cambridge, UK). Gel images were printed 
for analysis and saved using UVIProMV (UVItec, Cambridge, UK).  
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2.6 Whole Genome Sequencing  
A subset of E. coli isolates from the farm study (Chapter 4) and the slaughterhouse study 
(Chapter 5) were selected for whole genome sequencing. Selection of isolates and the method 
by which isolates were sequenced were different for both studies and are detailed in the 
respective chapters.   
 
WGS services were provided by two different groups. For the farm study, all isolates were 
sequenced by the Liverpool Centre for Genomic Research (CGR). For the slaughterhouse study, 
all isolates were sequenced by MicrobesNG, a BBSRC-funded collaboration between the 
University of Birmingham and the University of Sheffield. The exact methods used for DNA 
extraction, library preparation and sequencing are detailed in the respective chapters. 
 
2.6.1 WGS Workflow 
A standard workflow was designed to analyse both sets of WGS results. Illumina pair-end reads 
(forwards and backwards) were first downloaded each from the CGR and MicrobesNG servers. 
FastQ files were assessed for quality using FastQC v0.11.7 (Andrews, 2010). Poor quality reads 
(score <20) and any detected primers or adapters were removed using Trimmomatic v0.36 
(Bolger et al., 2014). Forward and reverse reads were then mapped to a reference E. coli genome 
(E. coli K12 MG1655; NCBI Reference Sequence: NC_000913.3 (Blattner et al., 1997), using the 
Burrow-Wheeler Alignment (bwa mem v0.7.17) (Li, 2013). Once BAM files had been made, a 
further QC step to check the mean mapping quality scores and coverage in relation to the 
reference genome was performed with QualiMap2 (Okonechnikov et al., 2015). In any instance 
where there was poor coverage across the genome (<10x) after mapping, genomes would be 
excluded from further analysis. Any reads which did not map to the reference genome were 
assembled de novo into contigs, using  SPADES v3.12.0 (Bankevich et al., 2012). Speciation 
analysis of those contigs was then performed using Kraken v2.0.7 (Wood and Salzberg, 2014) 
and an in-house database downloaded from NCBI sequence read archive 
(https://www.ncbi.nlm.nih.gov/sra/).  Non-E. coli contigs were excluded from further analysis.   
 
2.6.2 Analysis of Sequencing results 
A brief comparison of methods was made regarding resistance and virulence gene data. Up to 
date resistance and virulence sequences from several different databases were downloaded, 
and the frequency of detection of common resistance and virulence genes was assessed. 
Databases were manually compiled on 18th October 2018 and used to screen mapped reads. 
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Databases screened included ResFinder (Zankari et al., 2012), CARD (McArthur et al., 2013), 
NCBI Antibacterial Resistance Reference gene database (NCBI A Accession: PRJNA313047, ID: 
313047), EcOH (Ingle et al., 2015), PlasmidFinder (Carattoli et al., 2014) and VDFB (Chen et al., 
2016). 
 
Initial analysis was performed with the most up to date version of the ResFinder database 
(generated on 9th October 2018). To date, there have been several updates to the ResFinder 
programme and database; resistance genes such as blaCARB and blaFRI genes, updates to the 
fusidic acid database, the addition of mcr-9.1 to the colistin database and various qnr mutations 
have been added to the quinolone database. These changes have not largely altered the results 
presentd in this thesis. 
 
All reads were blasted against the up to date ResFinder (Zankari et al., 2012) and VirulenceFinder 
(Joensen et al., 2014) databases (18th October 2018) to assess carriage of acquired resistance 
and virulence genes. In each case, a 90% threshold for identification was set and a minimum 
query length of 60% was utilised. Where no resistance or virulence genes were detected, this 
was re-checked using a lower threshold for identity of 75% for identification. 
 
To identify plasmids carried by isolates, the PlasmidFinder tool for Enterobacteriaceae was used 
(Carattoli et al., 2014) using an identity threshold of 95% and minimum coverage of 60%. Where 
no plasmids were detected, this was re-checked using a lower threshold for identity of 75% for 
identification. 
 
In silico serotyping of isolates was undertaken using SerotypeFinder v2.0 (Joensen et al., 2015) 
in order to assess the O and H serogroups of each isolate using a 85% identity threshold and 
query length of 60%. 
 
Multilocus sequence typing (MLST) was determined using a custom batch script (Seemann T, 
mlst GitHub https://github.com/tseemann/mlst) which blasts assemblies or consensus fasta 
files against the E. coli #1 schema (https://pubmlst.org/escherichia/) (Jolley and Maiden, 2014). 
From this a sequence type (ST) was assigned according to the adk, fumC, gyrB, icd, mdh, purA 
and recA loci. For any detected ST131 isolates, fim typing was undertaken using a custom script 
to blast genomes for fimA and fimH genes (Totsika et al., 2011). Literature was then searched 
to match the fimtype to known ST131 isolates.   
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In silico phylogenetic typing (phylotyping) of all sequences was performed using the tool 
Clermont Typing (Beghain et al., 2018), which assigns a Clermont phylogenetic type (A, B1, B2, 
C, D, E, F and Cryptic Clade I) to each sequence. As of 2019, the Clement phylotyping tool also 
identifies the new phylogroup, G (Clermont et al., 2019).  
 
Finally, maximum-likelihood phylogenetic trees were constructed by using concatenated single 
nucleotide polymorphisms (SNPs) of all sequences. SNPs were called against the E. coli K12 
Reference genome (U00096.3) using Samtools mpileup (Li et al., 2009) (minimum coverage, 1x; 
minimum number of reads, 2; minimum variant frequency 0.2; minimum SNP quality, 30; 
minimum read mapping quality, 25) and VarScan (Koboldt et al., 2009) to produce VCF files. 
Non-variable positions were extracted from the VCFs using a custom Perl script to produce 
pseudosequences of concatenated SNPs of the same length. Phylogenetic trees were 
constructed using IQ-Tree (Nguyen et al., 2015), using 1000 bootstrap replicates and the GTR 
model. Maximum-likelihood trees were rooted using the E. coli K12 Reference genome 
(U00096.3). Tree topology was checked using Figtree v1.4.4 (Rambaut, 2012) and then 
annotated using the interactive tree of life (iTOL) v5.0 (Letunic and Bork, 2016).  
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3.1 Introduction 
AMR is a growing, global problem. AMR is a multifactorial issue, exacerbated by inappropriate 
dispensing and use of antimicrobials, varying quality of antimicrobials (Padget et al., 2016), 
disproportionately higher mortality impact (in LMICs) than in HICs, lacking access to healthcare 
facilities (Bebell and Muiru, 2014), few available resources for enacting and enforcing national 
action plans, and a lack of targeted infrastructure to combat AMR bacterial transmission 
(Jasovsky et al., 2016). There are complex interactions between factors, but it is likely that 
unregulated access to a wide variety of human and veterinary antimicrobials plays a key role in 
the exacerbation of developing AMR in sub-Saharan Africa. Whilst there has been evidence to 
suggest that animals can act as reservoirs of AMR bacteria, the complex epidemiology of AMR 
and the degree of the contribution of veterinary antimicrobials use on human AMR are still being 
investigated (Muloi et al., 2018). 
 
Agriculture is one of the key contributors to Kenya’s economy, representing 27.3% of its GDP 
and employing more than 70% of Kenya’s rural population (Food and Agriculture Organization, 
2014). More than three-quarters of Kenyans own and maintain small-holder, mixed crop-
livestock farms with traditional livestock, such as pigs, poultry, sheep, goats and cattle. These 
traditional, low-input systems often have challenges with biosecurity, which can result in a 
higher incidence of disease amongst animals – this can lead to the increased need to treat 
animals (Grace, 2015). One of the challenges of rapidly growing populations is the increased 
demand for animal products, and this requires a shift in agricultural practices. In many sub-
Saharan African countries, there is an ongoing shift to commercialisation and intensification of 
farming, from subsistence farming (Chen et al., 2018). Similarly, intensification of livestock 
production can also be associated with the increased use of antimicrobials to maintain animal 
health; there is evidence to suggest that AMR and MDR bacteria is more prevalent in larger, 
intensified farms, though it is still unclear if this is due to more antimicrobial use (AMU) or 
differences in management practices (Ström et al., 2017). Also, with the increased demand for 
meat, there has been a rise in diarrhoeal and food-related illnesses, linked to contamination in 
the value chain (Alarcon et al., 2017a; Carron et al., 2018) providing a vehicle for the 
transmission of foodborne enteric pathogens such as E. coli and Salmonella spp. (Okeke, 2009; 
Kotloff et al., 2013).  
 
The sale of veterinary antimicrobials is covered by the Pharmacy and Poisons Act in Kenya 
(National Council for Law Reporting, 2012a) and is now the responsibility of the Kenyan 
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Veterinary Medicines Directive. To legally sell antimicrobials (for human and animal use), the 
law requires the presence of a registered pharmacist. This is infrequently adhered to as farmers 
can purchase any veterinary antimicrobial at informal, or unlicensed agrovet shops or retail 
pharmacies without a prescription, even though these are required by law (Esimone et al., 2007; 
National Council for Law Reporting, 2012a; Luseba and Rwambo, 2015; Kalungia et al., 2016). 
Furthermore, 78% of veterinary medicine outlets were found to be operated by unqualified 
persons (Kenya Veterinary Association, 2016). To operate legally, the premises owner must 
possess a valid license from the local veterinary office and have a qualified pharmacist present, 
though many do not – due to finite resources, ensuring that correct licensing is in place can be 
challenging (Luseba and Rwambo, 2015). As such, unregulated access to antimicrobials, and 
AMU in farming settings risks contributing to the development of AMR.  
 
There is a paucity of data on the true prevalence of AMR in Kenya, as there are limited laboratory 
capacity and no rigorous, systematic, national surveillance systems for zoonotic-related diseases 
in place. To successfully manage the issue of ABR, the Global Antimicrobial Resistance 
Partnership was tasked, in 2011, to conduct a situational analysis to identify gaps in available 
data, by identifying groups working on resistance issues and support their research (Global 
Antibiotic Resistance Partnership, 2011). As of June 2017, a National Action Plan on Prevention 
and Containment of Antimicrobial Resistance in Kenya was designed (Government of Kenya, 
2017). This aims to improve awareness and understanding of AMR by committing to a national 
surveillance programme and improve community knowledge of AMU and the consequences of 
AMR.  This will be implemented by the Fleming Fund from 2019 onwards (Fleming Fund, 2019). 
A particularly important gap to fill would be the current understanding of the consequences of 
using HPCIAs in animal therapies. The WHO and European Medicine Agency (EMA) list 3rd-5th 
generation cephalosporins, fluoroquinolones, and polymyxins as HPCIAs for human health. This 
list (updated most recently in 2018) is intended for public health and animal health authorities, 
practising physicians and veterinarians and stakeholders involved in managing antimicrobial 
resistance, to ensure that all antimicrobials, especially these HPCIAs, are used prudently both in 
human and veterinary medicine (OIE, 2017; WHO, 2019b).  
 
Relatively few studies have examined the attitudes, knowledge and practices relating to 
antimicrobial use or considered the disease burden and elevated need for antimicrobial 
therapies when investigating ABR in Kenya. The present study is the first to determine the access 
to, and understanding of AMU and AMR, as well as the practices surrounding AMU in western 
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Kenya. The focus was on both antimicrobial providers and users in an area of extremely high 
density of both humans and animals (Fèvre et al., 2017), chosen as to examine the relationship 
between human and animal AMU and AMR.  
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3.2 Materials & Methods 
3.2.1 Study Area and Population 
The study population was a mixed crop-livestock farming community in Busia County, western 
Kenya (0.434° N, 34.242° E) which supports one of the highest human and animal population 
densities in Eastern Africa. This area is broadly representative of other communities spanning 
the Victoria Lake Basin in Kenya, Uganda, and Tanzania. The study area has a cattle population 
of around 340,000 and a domestic pig population of around 55,000 (Divisional Livestock 
Production Office data). Busia county has a high proportion of smallholder farms, with an 
estimated 90% of people engaging in some degree of crop-livestock farming.  
 
Three main groups were identified as being antimicrobial users or prescribers: animal 
healthcare workers (AHAs) and veterinary surgeons, smallholder farmers, and agrovet shop 
workers and owners. The inclusion criteria were defined as “drug stockist shops (agrovets), 
smallholder farmers who keep livestock (including pigs, poultry, cattle, sheep and goats) for the 
intent of sale or consumption of the animals or any animal products, veterinary practitioners 
and private and public/government-employed AHAs”. Exclusion criteria included “Children 
under 16 years of age, those that do not speak either English or Kiswahili and farmers who no 
longer own any animals.  
 
3.2.2 Study Design 
It was anticipated (according to advice from Jane Poole at ILRI) that approximately 70 farmers 
could be recruited in the proposed 8-week fieldwork timeframe. As Busia county is divided into 
seven sub-counties, random sampling of farmers was stratified by sub-county to adhere to 
logistical consideration of vehicular access, and time required by veterinary officers to 
accompany us during the study. To randomly select each farm, each sub-county was divided 
into 1km2 grids using QGIS v.3.2 (QGIS Dev Team, www.qgis.org/en/site) and numbered 
sequentially. A random number generator was used to indicate a grid number – when a grid was 
selected, a random point within the grid was generated within QGIS v3.2 and the co-ordinates 
of this point input into Google Maps (Google 2017, California, USA). In the field, using Google 
Maps satellite navigation feature, we travelled to the physical location indicated. The nearest 
farm to the co-ordinates was selected for recruitment. In instances where there was no farm at 
the co-ordinates, a repeat randomly generated point, with new co-ordinates was generated. 
Where these points were closer than 500m, a new random point was generated. 
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Systematic interviewing of agrovet shops and AHAs was conducted with assistance from the 
sub-county veterinary officer, from each sub-county. They accompanied all visits and they were 
able to direct us to all agrovet shops in each sub-county. The most senior person (or only person) 
in each agrovet shop was interviewed in each sub-county, except for shops that were closed on 
more than two occasions during repeat visits. A comprehensive list of all known AHAs was 
collected from sub-county district officers; all AHAs were recruited by phone and all agreed to 
participate – once recruited, we travelled to a convenient location for the AHA and gave the 
interview at the roadside.   
 
3.2.3 Questionnaire Design and Implementation 
A detailed questionnaire was designed, and all participants were interviewed orally using that 
framework. Different groups of respondents were given a different mixture of open and closed 
questions, and these were used to ascertain participants’ education, access to veterinary 
antimicrobials, prescribing patterns and knowledge of ABR and withdrawal periods. 
Questionnaires were designed in Adobe® Acrobat® Pro DC (Adobe, San Jose, United States) and 
coded electronically using AppSheet® (AppSheet c/o Solvebot Inc., Seattle, Washington). 
Participants were interviewed in English or Kiswahili by bilingual Kenyan research members, 
being asked each of the questions in the questionnaire. All answers were given verbally by the 
participant and these were recorded as verbatim transcribed text into the coded questionnaire 
on a mobile phone or tablet, by the interviewer.  
 
The questionnaire comprised of four sections each relevant to the aforementioned groups of 
people (Appendix I, Figure I-iii). Questions were designed to determine participant’s education, 
access to veterinary antimicrobials, prescribing patterns of antimicrobials and knowledge of 
antimicrobial resistance and withdrawal periods. Questions specifically asked of farmers 
focused around access to veterinary antimicrobials, basic information on animals kept (date of 
acquisition, vaccination status etc.), which diseases they frequently treat and their 
understanding of antimicrobial resistance and withdrawal periods for animal products including 
meat, milk, and eggs. Questions asked to AHAs/agrovets/veterinarians focused more on access 
to antimicrobials, sales/prescription patterns and responsible use of antimicrobials. 
Furthermore, data on the use of some of HPCIAs according to the EMA list (EMA, 2015), 
including fluoroquinolones, 3rd-5th generation cephalosporins and polymyxins were collected.  
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The exact geolocations of each farm and agrovet shop were recorded using the AppSheet 
Geocapture feature and corroborated with Google Maps. Location data of all farms and agrovet 
shops was then transferred to QGIS v3.2 (QGIS Dev Team, www.qgis.org/en/site) to produce 
additional maps. 
 
3.2.4 Pilot Testing of Questionnaire 
Pilot testing of the questionnaire with different respondents allowed the specific terminology 
to be better targeted towards Kenyan customs/culture e.g. in questions including the word 
‘vaccination’, distinguishing information had to be included, as some Kenyan people confused 
vaccinations with injectable antimicrobials. Further alterations were made to the wording of 
some questions according to revisions suggested by Dr Salome Bukachi (University of Nairobi, 
co-PI of ZooLiNK project), to ensure that Kenyans clearly understood all questions. 
 
The initial version of the questionnaire was piloted on field team staff at IRLI, Nairobi (two 
clinical officers,  and two veterinarians). Minor modifications in wording were made according 
to their comments e.g. to ‘stay in a place’ means ‘to live in a place’ to Kenyans. Following minor 
modifications, the questionnaire was again piloted on a sub-country veterinary officer visiting 
ILRI, prior to being taken to the field. The first time the questionnaire was used on a farmer and 
a member of agrovet staff was also considered to be pilots to ensure the smooth operation of 
the coded questionnaire. After this testing period, the questionnaire was considered to be fit 
for purpose and was used unadjusted, for the remainder of the study. 
 
3.2.5 Ethical Approval and Permissions 
Ethical approval was sought locally from ILRI, Nairobi and the University of Liverpool Veterinary 
Science Research Ethics Committee before dissemination of the questionnaire. Before 
beginning any work in Busia county, state permission was sought from the Acting County 
Director of Veterinary Services and it was also necessary to approach and gain the permission 
of each sub-county Veterinary Officer (SCVO). Whilst travelling through each sub-county, it was 
requested that we travel alongside the relevant SCVO to farms and agrovet shops, so that 
participants understood that we had the appropriate permission to conduct our work. In cases 
where the SCVO was unable to travel with us, a representative of the office was brought along. 
In cases where this was not possible, we contacted the village elder and sought permission to 
conduct our study. 
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3.2.6 Data Analysis 
Answers were stored within the AppSheet application until an internet connection was 
available. Data were then uploaded to a secure server in XLS format for later analysis. Data were 
imported from the XLS file into Microsoft Excel 2016 (Microsoft Corporation, Redmond, USA) 
and some descriptive analysis (e.g. frequency tables of participant demographics), was 
conducted using SPSS Statistics 25.0 (IBM SPSS Statistics for Windows Version 25.0, (New York: 
IBM Corp). Multiple-choice questions with responses on 5-point Likert scales were condensed 
down to a 3-point Likert; “Never” and “Rarely” were condensed into “Never or Rarely” and 
“Sometimes” and “Often” were condensed into “Sometimes and Often” following piloting of 
the questionnaire, to ensure each category had enough data to compare.  
 
Open-ended questions were analysed on a question-per-question basis using a thematic 
approach (Nowell et al., 2017). Briefly, text responses were read twice to ascertain a general 
comprehension of the responses. A large number of themes were identified and input into an 
Excel spreadsheet. Once all responses had been categorised, similar themes were condensed 
together. To ensure reproducibility, these themes were cross-checked by Dr Gina Pinchbeck 
(University of Liverpool). All data was then imported into SPSS Statistics 25.0 (IBM SPSS Statistics 
Version 25.0, New York: IBM Corp). 
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3.3 Results 
3.3.1 Participant Demographics 
In total, 70 farmers, staff at 49 agrovet shops, 27 AHAs and 1 veterinarian surgeon were 
recruited. For the purpose of analysis, the (only) veterinarian surgeon located in this study was 
included in the AHA dataset. The majority of farmers and AHAs were male, though agrovet staff 
(agrovets) were as likely to be male or female (Table 3.1). The primary age bracket for all groups 
was 25-44. The main/most senior person in each agrovet shop was interviewed and the majority 
of these identified themselves as an agrovet assistant or the owner of the shop. AHAs had 
several titles and other jobs, including livestock officers, animal health technicians or laboratory 
staff. Most participants had been working in their current position for longer than 3 years. 
 
Table 3.1 Demographics of interviewed agrovet staff, AHAs and farmers. 
Demographic Factors 
Agrovet Staff 
(n=49) 
AHAs (n=28) Farmers (n=70) 
n % n % n % 
Gender Male 25 51.0 27 96.4 48 68.6 Female 24 49.0 1 3.6 22 31.4 
Age 
18-24 8 16.3 - - 2 2.9 
25-44 35 71.4 20 71.4 40 57.1 
45-64 5 10.2 6 21.4 17 24.3 
65+ 1 2.0 2 7.1 11 15.7 
Position 
Animal Healthcare Worker 1 2.0 14 50.0 - - 
Artificial Insemination Technician - - 1 3.6 - - 
Sub-country Veterinary Officer - - 3 10.7 - - 
Agrovet Assistant 39 79.6 1 3.6 - - 
Laboratory Staff / Vet Technician 1 2.0 3 10.7 - - 
Livestock Officer - - 5 17.6 - - 
Veterinarian - - 1 3.6 - - 
Manager 1 2.0 - - - - 
Owner 9 18.4 - - - - 
Length of time at job 
<1 Year 14 28.6 1 3.6 - - 
1-2 Years 4 8.2 - - - - 
>3 Years 31 63.3 27 96.4 - - 
 
Most farmers kept a similar group of core animals including cattle (dairy and beef production 
systems), poultry, goats, pigs, and sheep on their farms. A small minority of farmers also kept 
one or more ‘other’ animals including ducks, turkeys, rabbits, and donkeys (Figure 3.1). The 
average number of cattle kept by farmers was 6 animals, compared to 21 poultry. Only four 
farms reported keeping ‘other’ animals, including doves (n=5), donkeys (n=3) and rabbits (n=4).  
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3.3.2 Qualifications & Training of antimicrobial providers 
All agrovets and AHAs, and 40% of farmers had completed at least secondary education (Table 
3.2). Of the AHAs, almost all had attained a college diploma and received specific training in 
livestock health and disease, and the majority had also received specific training to dispense 
antimicrobials for animal use. Conversely, less than half of agrovets had a college diploma or 
formal training in livestock health and disease, and more than half did not have training to 
dispense veterinary antimicrobials. Whereas AHAs obtained most of their training from formal 
courses (college diploma/certificate or university), agrovets were more likely to receive either 
no training or informal (on-the-job) training. Almost a third of agrovets participated in short 
courses provided by pharmaceutical companies when they delivered antimicrobials to the 
agrovet shop, though they were only educated regarding the specific antimicrobial being 
supplied (Table 3.3).   
 
Species of Animal
Nu
m
be
r o
f A
ni
m
al
s
0
20
40
60
80
100
120
Poultry Pigs Sheep/Goats Cattle Other
Figure 3.1 The average number of each species of animal, kept by farmers on 70 smallholder farms across 
Busia County, Western Kenya. Tails indicate range, dots indicate outliers, crosses indicate median and 
lines within the boxes indicates the mean.  
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Table 3.2 The highest level of education achieved by agrovet workers, AHAs and farmers. 
Education 
Agrovets (n=49) AHAs (n=28) Farmers (n=70) 
n % n % n % 
No Formal Education - - - - 4 5.7 
Primary Education - - - - 24 34.3 
Secondary Education 27 55.1 3 10.7 33 47.1 
College 
(certificate/diploma) 20 40.8 23 82.1 7 10 
University 2 4.1 2 7.1 2 2.9 
 
 
Table 3.3 Specific training undertaken or received, by antimicrobial providers. 
 
3.3.3 Access to Antimicrobials 
All antimicrobials were purchased directly by farmers or by AHAs (who then used their own 
supply to treat animals) at agrovet shops, which highlights the key role these facilities play in 
supplying antimicrobials. Antimicrobial stock and vaccines were always purchased by local 
agrovets shops from two larger wholesale agrovet shops within Busia county, who in turn 
obtained antimicrobials directly from manufacturers/distributors. Specific agrovet shops were 
chosen by farmers for several reasons including the “close distance to [their] farms”, ability to 
“get drugs on credit” and for “wide selection” and “good stock availability”.  Most AHAs (92.9%) 
and agrovet staff (85.7%) reported that there were no restrictions on the quantity or classes of 
antimicrobials which could be purchased. Farmers also did not report any restrictions when 
purchasing antimicrobials from agrovet shops, even without a prescription. The majority of 
farmers first sought the advice of a veterinarian or AHA before deciding to purchase 
antimicrobials (78.6%) though. More than half of farmers (54.3%) never requested specific 
Question Responses 
Agrovets 
(n=49) 
AHAs (n=28) 
Number % Number % 
Have you had specific training in Livestock Health 
and/or Diseases? 
Yes 26 53.1 28 100 
No 23 46.9 - - 
Have you ever received training or are you still 
training to dispense antimicrobials for animal 
use? 
Yes 21 42.9 23 82.1 
No 28 57.1 5 17.9 
Nature of Training 
Professional 
Qualification 8 16.3 26 92.9 
Pharmaceutical 
company 15 30.6 - - 
None/Informal 
Training 22 44.9 2 7.1 
Cannot Remember 3 6.1 - - 
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antimicrobials without first discussing with an agrovet or AHA. A small minority of farmers 
(12.9%) purchased antimicrobials without first obtaining advice from an agrovet or a 
prescription from an AHA. Farmers who purchased antimicrobials without consultation did so 
“using [their] own knowledge” or “already had a prescription from a veterinary officer from a 
previous consultation”. A small proportion of farmers also used antimicrobials previously 
prescribed or purchased, “[having antimicrobials leftover] from previous use”.  
 
3.3.4 Information provided at point-of-sale 
Agrovets and AHAs indicated that they provided various information to farmers when they 
purchased antimicrobials. When presenting at an agrovet shop or when deciding which 
antimicrobial to prescribe, the most commonly offered information offered by both providers 
was directions for use, withdrawal periods and correct dosing for animals (Figure 3.2). AHAs and 
agrovets usually gave this information by consulting antimicrobial packaging or recalling from 
their knowledge and experience. Overall, agrovets were more likely to provide information 
regarding use to farmers, than AHAs; half of AHAs stated that they gave no information to 
farmers when they purchased antimicrobials.  
 
 
Both AHAs and agrovets considered several factors when deciding which antimicrobial 
treatment to prescribe or sell. Both groups indicated that the cost of the antimicrobial 
(affordability to the farmer), customer preference and treatment effectiveness were major 
considerations. In agrovet shops, customer preference (65.3%) was the primary factor for sales. 
AHAs primary consideration was the effectiveness of the antimicrobial (57.9%) and then the 
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Figure 3.2 Information given to farmers at point-of-sale of antimicrobials by agrovets (n=49) and during 
recommendation or prescription by AHAs (n=28). 
Chapter Three  KAP Study 
 71 
affordability to the farmer (39.3%). Farmers were primarily concerned with the cost of 
antimicrobials (44.3%), followed by their effectiveness (40.0%). A small minority of farmers also 
considered antimicrobial availability and the distance they needed to travel to purchase specific 
types of antimicrobials as their main point of consideration (5.7%). 
 
3.3.5 Antimicrobial Prescription Patterns 
More than half (57.1%) of AHAs stated that they provided a prescription for farmers to fulfil at 
an agrovet shop, the rest routinely carried a selection of their own antimicrobials, and they 
treated animals at the time of consultation. Due to logistical issues (such as distance to travel to 
a farm), half of AHAs (50.0%) stated that they provided a farmer with a prescription over the 
phone, according to the described clinical signs. In these cases, once the prescription had been 
fulfilled by an agrovet, most AHAs (89.3%) would travel to the farm to treat the animal(s) 
themselves; the rest would give some instructions on how to treat the animal. Most AHAs 
followed up with the farmer to ensure that the designated treatment regime had been 
completed and was successful (85.7%). Approximately 60% of agrovets dispensed antimicrobials 
against a prescription from an AHA, leaving 40% who sold antimicrobials without a prescription. 
 
3.3.6 Antimicrobial Usage/Sale Patterns 
The most commonly purchased/prescribed/used antimicrobials were oxytetracycline, penicillin-
streptomycin and sulfa-drugs (Table 3.4). The question asked was “What are the five most 
common antimicrobials you sell/prescribe/use” – as between 1-5 antimicrobials were 
volunteered as answers, each time the antimicrobial was mentioned, it was counted. Therefore, 
percentages do not equal 100%. Oxytetracycline was indicated as the most common 
antimicrobial to be used by farmers and AHAs, followed by penicillin-streptomycin. 
Antimicrobials were used therapeutically by farmers (85.7%) and AHAs (100.0%) and sold for 
therapeutic purposes by agrovets (98.0%). However, some farmers (37.1%) and AHAs (28.6%) 
also used antimicrobials prophylactically; numerous agrovets (38.8%) said that they sold 
antimicrobials to be used prophylactically. Antimicrobials were also used relatively frequently 
as growth promoters by farmers (37.1%), but only one agrovet shop stated that they explicitly 
sold antimicrobials to be used as a growth promoter.  
 
Reported use of HPCIAs was extremely limited. There was no reported use or sale of 3rd-5th 
generation cephalosporins or fluoroquinolones, and there was only a single occasion 
volunteered by a farmer (1.4%) who reportedly treated animals using polymyxins (colistin). No 
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agrovets and only a single AHA (3.6%) were aware of what HPCIAs are, but this information was 
provided to all participants after the end of the questionnaire, to reinforce their importance. 
The majority of AHAs and agrovets were not aware of any specific guidelines which should be 
consulted regarding the prescription or sale of antimicrobials. Some AHAs cited guidelines from 
the Kenya Veterinary Board (n=6) or instructions from the County Veterinary Officer (n=3). 
Agrovets cited pharmaceutical guidelines (n=3) or Kenya Veterinary Board guidelines (n=7). One 
agrovet knew of the existence of some guidelines but was unable to recall which body issued 
them.  
 
Table 3.4 List of the most commonly used/purchased/prescribed antimicrobials according to farmers, 
agrovets and AHAs, to treat livestock. Up to 5 answers most common antimicrobials were volunteered as 
answers, therefore each antimicrobial was counted as the percentage of time it was volunteered as a most 
common antimicrobial. 
Antimicrobial 
AHAs (n=28) Agrovets (n=49) Farmers (n=70) 
n % n % n % 
Oxytetracycline 26 92.9 46 93.9 55 78.6 
Penicillin-streptomycin 27 96.4 39 79.6 33 47.1 
Sulfachloropyrazine 9 32.1 27 55.1 - - 
Sulfadimidine 9 32.1 13 26.5 2 2.9 
Trimethoprim & Sulfadiazine 9 32.1 8 16.3 4 5.7 
Tylosin & Doxycycline - - 18 36.7 2 2.9 
Sulfamethoxazole 3 10.7 8 16.3 - - 
Gentamicin 6 21.4 - - 1 1.4 
Tylosin 4 14.3 - - - - 
Tetracycline 1 3.6 3 6.1 - - 
Fosfomycin & Tylosin - - 4 8.2 - - 
Sulfamethoxazole & 
Trimethoprim - - 4 8.2 - - 
Erythromycin 2 7.1 - - 1 1.4 
Gentamicin & Doxycycline - - 3 6.1 - - 
Neomycin - - 3 6.1 - - 
Cefalexin 1 3.6 - - 1 1.4 
Metronidazole 1 3.6 - - 1 1.4 
Ampicillin 1 3.6 - - - - 
Streptomycin 1 3.6 - - - - 
Amoxicillin - - 1 2.0 - - 
Dexamethasone** - - 1 2.0 - - 
Erythromycin & Oxytetracycline - - 1 2.0 - - 
Colistin* - - - - 1 1.4 
*Highest Priority Critically Important Antimicrobials **not an antimicrobial but described by the respondent as one. 
 
All farmers stated that one or more of their animals had required some antimicrobial treatment 
during the previous 12 months. More than half of farmers treated their animals at regular 
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intervals: every 3-months (28.6%), every 4-months (24.3%) and every 6-months (20.0%). To 
assess the correct antimicrobial dose for animals, farmers determined the weight of animals by 
eye (88.6%), or by using a weighing band (8.6%). Others did not consider weight but gave a dose 
as instructed by agrovet staff or AHAs (24.3%). The majority of farmers administered 
antimicrobials by intramuscular injection (66.9%) except for poultry, where the preferred 
method of dispensing antimicrobials was in water (43.5%). Farmers stated that they gave the 
same dose (mg/kg) of antimicrobial to each of their animals, irrespective of their weight or 
species e.g. imported dairy cows were given the same dosage as indigenous Zebu cattle. 
 
3.3.7 Most common diseases treated with antimicrobials 
A large variety of diseases were reported during the questionnaire as affecting all farm animals. 
Treatment was almost always syndromic due to lack of available diagnostic facilities; diseases 
were usually diagnosed by AHAs or by agrovets according to visual examination of an animal or 
from the described clinical signs. More than half of AHAs said that they regularly perform blood 
smears (53.6%) to look for parasitic infections, but there was no report of culture and AMR 
testing. All participants were asked to describe the five main diseases affecting animals, for 
which antimicrobial treatment was given – usually, three or four diseases were given and each 
of these was counted as the number of times they were mentioned, thus percentages do not 
add up to 100%.  Across all interviews, agrovets reported 39 different diseases, AHAs reported 
29 different diseases and farmers reported 19 different diseases. There was some overlap 
between the reported diseases, though the most common diseases did not differ significantly 
by group (Figure 3.3), except for the reporting of anaplasmosis, east coast fever and dysentery. 
The most common diseases according to AHAs and farmers was East Coast fever, and according 
to agrovets was dysentery. Combined, the most common diseases were East Coast fever, 
anaplasmosis, trypanosomiasis, diarrhoea, and general respiratory diseases.  
 
3.3.8 Record Keeping 
A large majority of participants kept some form of records regarding antimicrobial purchase or 
use - AHAs (64.3%), agrovet shops (71.4%) and farmers (48.6%). Agrovet shops usually 
maintained a sales book to track sales and purchases. All sales books (where present) were 
inspected, and the agrovet-volunteered ‘top five most commonly sold antimicrobials’ were 
cross-referenced against these books. There was good concordance with those antimicrobials 
recorded in the record books and the volunteered responses. Half of farmers (50.0%) had some 
records of antimicrobials they administered to their animals; however, the records did not often  
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Figure 3.3 The most common conditions or infections cited requiring antimicrobial treatment by farmers, 
agrovets, and AHAs. Bars are 95% CI. 
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 contain specific antimicrobial names or dosages. When questioned, farmers were often unable 
to name the antimicrobials used as an AHA had provided and administered the treatment, and 
not recorded it for them (corroborating the previous point that AHAs do not provide detailed 
information regarding antimicrobials to farmers). Of those farmers that self-treated animals, 
some kept the discarded packaging, which were examined. Almost all the interviewed AHAs 
stated that they recorded treatments they gave in books owned by the farmer, however, almost 
all the farmers reported that the AHA maintained and kept the record book for their farm.  
 
3.3.9 Understanding and Management of AMR 
A large proportion of agrovets, AHAs and farmers were unable to give an accurate definition of 
‘AMR’ or ‘antibiotic resistance’. A large proportion of agrovet staff (69.2%), AHAs (39.7%) and 
farmers (29.0%) stated that they had never heard the terms before. Of those farmers, agrovets 
and AHAs who had heard of AMR, volunteered explanations for the cause of AMR included 
“underdosing”, “prolonged use” and “not following agrovet or AHA instructions” (Figure 3.4). 
Farmers also attributed resistance to “bacterial mutation” (2.9%), misdiagnosis by an 
agrovet/AHA (15.9%) and using “counterfeit antimicrobials” (1.4%). Some participants who 
were unsure about AMR still guessed at what it is, and what causes it. Some answers included: 
“when you treat an animal and it doesn’t respond”, “when the animal is tired, the antibiotic will 
not work” and “cheap drugs no longer work, but the more expensive ones do”. An accurate 
definition of AMR was given to all participants after they had answered, to ensure correct 
understanding in the future. 
Figure 3.4 Most common responses given by participants indicating what they thought were the main 
causes of antimicrobial resistance. Bars are 95% CI. 
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Farmers and AHAs were asked if there had been cases of AMR on farms. Agrovets were also 
asked if AMR had been reported to them when farmers purchase antimicrobials. The majority 
of agrovets indicated that they “[did] not know” or there was “no reported” resistance to 
antimicrobials (61.2%). Some stated that there was AMR, but they did not know to which 
antimicrobial (16.3%). A small minority of agrovets reported resistance to oxytetracyclines 
(10.2%), penicillin-streptomycin (4.1%) and sulfa-drugs (8.1%). AHAs reported higher rates of 
resistance to oxytetracycline (41.4%) and penicillin-streptomycin (27.6%), but no resistance to 
sulfa-drugs. Farmers suggested that they had not encountered resistance in more than half of 
treatments given to their animals (58.7%) (though this could mean that treatment was simply 
successful in these cases). Oxytetracycline resistance was the most commonly reported (20.6%), 
and a small minority also reported penicillin-streptomycin (7.9%) and sulfa-drug (1.6%) 
resistance. A small subgroup of farmers suggested that there had been resistance but were 
unsure to which antimicrobial (11.1%). 
 
AHAs and agrovets were asked, “If you recommend or prescribe an antimicrobial and the farmer 
returns to you and complains that it hasn't treated the disease, what do you do?”. AHAs stated 
that they would undertake a blood smear (53.6%) or perform a bacterial culture (7.1%), or PCR 
(3.6%), the rest would give an alternative antimicrobial. A quarter of agrovets involved a more 
experienced agrovet, an AHA or the owner of an agrovet shop (28.6%) where they suspected or 
had reported AMR. A similar proportion of agrovets would suggest an alternative antimicrobial 
without gaining more information regarding the animal (26.5%) and a small number of agrovets 
said that they had not encountered the issue before (22.4%). The rest of agrovets would first try 
to obtain more information i.e. ask about more clinical signs, and then recommend an 
alternative antimicrobial.  
 
Withdrawal periods are important to observe, to avoid consumption of antimicrobial residues 
through meat and milk products. Farmers had different levels of knowledge regarding these:  
“no understanding” (12.9%), whereby the farmer had no knowledge of withdrawal periods, 
“minor understanding” (34.3%) whereby the farmer had heard of withdrawal periods, but 
quoted incorrect withdrawal periods for milk, meat and eggs, and “good understanding” 
(27.1%), whereby the farmer had good knowledge of withdrawal periods and was easily able to 
quote the correct lengths of time for each antimicrobial they regularly treated animals with. 
These responses were cross-checked with antimicrobial packaging to ensure accuracy. The 
remainder of farmers were aware that withdrawal period information is printed on packaging, 
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and they sometimes referred to this (18.6%) to ascertain the correct length of time for 
withdrawal prior to consuming products or selling animals for slaughter.  
 
There were also some misconceptions regarding withdrawal periods - some farmers thought 
that they only applied to milk (12.9%), or meat (1.4%). The majority of farmers did not sell or 
consume animals or products during withdrawal periods (75.7%). However, some farmers said 
that they ignored withdrawal period recommendations (17.1%) as it wouldn’t harm them; 
commonly farmers would give antimicrobial residue-containing animal products (usually milk) 
to their dogs (14.3%), or still allowed a calf to suckle (44.3%). One farmer stated that he regularly 
gave contaminated milk to his animals, despite understanding residues: “[I] give to the calves 
and the dog. [I] understand that resistance may develop in these animals, but [I] choose to 
ignore it”.  
 
Finally, a number of farmers (20.0%, n=14) stated that they either had themselves given or had 
heard of other farmers dispensing human-intended antimicrobials to various animals (pigs and 
poultry, mainly). These included treating poultry with and pigs with metronidazole for diarrhoea 
and tetracycline and amoxicillin capsules being split open, mixed with water, and given orally to 
poultry and pigs. 
 
3.3.10 Observations made during interviews 
In instances where interviews were being conducted in Kiswahili by the translator, there was 
opportunity to observe farms and the way that business ran in agrovet shop (as we allowed 
paying customers priority when they arrived at agrovet shops).  
 
Whilst on farms, photographs were taken of a number of different antimicrobials used in 
treatment of animals,  as antimicrobial packaging is commonly disposed of in waste pile (Figure 
3.5), for burning, in Busia. Despite the most commonly used antimicrobials being volunteered 
to the interviewer, as part of the questionnaire study, packaging found on farms suggests some 
discordance to what is actually be used.   
 
At agrovet shops, illegal practices were witnessed, such as selling single syringes of 
antimicrobials from an opened bottle of penicillin-streptomycin (Figure 3.6). This practice is 
contravened by Kenyan Law (National Council for Law Reporting, 2012a), but is a common 
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practice owing to the reduced cost of purchasing a single syringe, opposed to a whole vial of 
antimicrobials. 
 
 
Figure 3.6 Image of a single syringe of penicillin-streptomycin being sold at an 
agrovet shop. This practice is contraindicated by Kenyan Law (National Council 
for Law Reporting, 2012a). 
Figure 3.5 Image of discarded packaging of antimicrobials on a farm. 
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3.4 Discussion 
This study investigated the common knowledge, attitudes, and practices towards AMU and AMR 
of both antimibocirbial users and prescribers. A questionnaire was used as a framework to 
interview farmers, agrovets and AHAs across 7 sub-counties in Busia, western Kenya. Questions 
were designed to specifically assess how antimicrobials are accessed, prescription patterns and 
knowledge of AMR and withdrawal periods. The findings from this study suggest that there is 
widespread access to antimicrobials, with and without prescriptions, and that knowledge 
regarding AMR is generally superficial. This is the first study to collect information regarding 
access to and understanding of antimicrobials and AMR in western Kenya, and the data 
presented here are an important set of results which help to address the paucity of data 
regarding AMU and AMR in this region.  
 
Previous studies conducted in sub-Saharan African countries have identified that one of the 
main factors causing increasing prevalence of AMR is the indiscriminate use of antimicrobials 
(Robinson et al., 2017). This is exacerbated by unregulated access to wide varieties of 
antimicrobials, which do not require prescriptions to be purchased (Kalungia et al., 2016).  The 
patterns of antimicrobial use and the general understanding of them at the community level 
remains largely unknown, though there is evidence to indicate that the high prevalence of AMR 
in animals is contributed to by overreliance of antimicrobials in agricultural practices (Marshall 
and Levy, 2011; Chang et al., 2015b; Hoelzer et al., 2017). In Kenya, people can access human 
antimicrobials at retail pharmacies without a prescription. Similar practices are common in the 
livestock sector, in the form of agrovet shops, due to poor regulation (Higham et al., 2016). All 
participants in Busia county accessed antimicrobials via their local agrovet shops or through 
AHAs who travelled to farms to treat animals. All the agrovet shops visited in this study (except 
for two large agrovets which supplied agrovet within Busia) were small privately-owned 
businesses; there was an absence of larger businesses or chains, suggesting that there is limited 
opportunity for scalability.  
 
There are many agrovet shops in each sub-County (average: 7) though it is unclear how many 
farms that these shops cover. Almost half of the visited agrovet shops (several may have not 
been located or were closed during repeat visits) did not have a license to operate. To legally 
open an agrovet shop, a license is to be issued by the county government, and to issue a license, 
a person must present a valid college diploma in a course related to antimicrobial prescription 
and/or animal health and disease. According to an official investigation, fewer than half of 
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agrovet staff did not have the required college diploma to legally sell veterinary antimicrobials 
(National Council for Law Reporting, 2012b) and this agrees with our findings in this study. By 
law, class 1 poisons (including vaccines and antimicrobials) should only be dispensed against a 
valid prescription and findings from this study indicate that approximately 40% of antimicrobials 
were not dispensed against a valid prescription, having been sold by specific request of a farmer. 
Non-prescription use of antimicrobials is worrying, as farmers may tend to select their favoured 
products by recognising packaging of previously used antimicrobials. In these instances, the 
disease being treated may not be susceptible or the drug may be inappropriate for the type of 
infection. All antimicrobial use creates selective pressures for AMR to develop, thus there is a 
need for better regulation, in order to reduce inappropriate use. One of the primary 
considerations for farmers purchasing antimicrobials was cost - as farmers may have limited 
income, they may wish to only purchase part of an entire course of antimicrobials for animals. 
Few studies have examined dosing regimens in livestock production in Kenya, though there has 
been evidence in the past of consistent underdosing in Narok county farmers (Irungu et al., 
2007) which is thought to be increasing the prevalence of AMR. Under-dosing is a known 
contributor of AMR development, as the selective pressures destroy sensitive bacteria, allowing 
those with higher minimum inhibitory concentrations i.e. more resistant strains, to outcompete 
others (Roberts et al., 2008).  
 
It has been shown that antimicrobial dispensers play an important role in providing information 
to the public about human and veterinary antimicrobials, and this has been shown in various 
sub-Saharan African countries (Kehinde and Ogunnowo, 2013; Kheder and Ayed, 2013; Higham 
et al., 2016). As agrovets do not usually offer clinical services, they have little actual involvement 
in the diagnostic process, and may not have any practical experience in livestock health and 
disease. As this study noted, less than half of agrovet staff had not completed any formal 
training in livestock health and disease or completed their college diploma. A third of agrovet 
staff suggested that their main training came from pharmaceutical companies – it is likely that 
these informal trainings are not impartial and are specific to the antimicrobials being provided 
by that company. This reveals a significant and concerning gap in impartial training provision for 
agrovet staff, on the informed and responsible dispensing of veterinary drugs to customers. A 
number of agrovet staff also suggested that they gave advice regarding antimicrobials from their 
own experience or from memory; it is possible that due to gaps in their knowledge, they could 
be spreading inaccurate information to farmers. This can be easily rectified with additional 
training and implementation of government-regulated antimicrobial prescribing guidelines – 
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these would mean that all agrovets are confident in suggesting appropriate antimicrobial 
treatments for farmers. Efforts are ongoing to ensure this happens, but limited resources and 
lack of personnel to ensure regulations are maintained mean that there has been some issue in 
targeting those who would benefit most from these suggestions, as well as discussing who could 
deliver educational programs and who will bear the cost (Government of Kenya, 2017).  
 
In cases where farmers purchase antimicrobials without consultation or with a valid 
prescription, they make the primary decision when choosing and administering antimicrobials 
to livestock. The findings in this study echo previous observations regarding the discordance 
between point-of-sale of veterinary antimicrobials and the advice given during the sale. Two 
previous studies also demonstrated the lack of diagnostic skill and knowledge of livestock 
diseases and treatment options amongst farmers and pastoralists (Grace et al., 2009; Jandreau 
and Berkes, 2016). As this study noted, the majority of farmers estimated animal weight by eye 
– all antimicrobials should be dosed according to weight, therefore it is important to accurately 
estimate this. A study examining smallholder farmers and AHAs ability to estimate the weight 
of animals found that inaccurate estimations were leading to chronic underdosing of 
antimicrobials (Machila et al., 2008). In that study, 85.7% of cattle were estimated to have their 
weights underestimated by an average of 46.9% of their true weight. Only 19.0% of cattle had 
their weights estimated accurately to within ±20% of their true weight by farmers. AHAs in the 
same study were better at estimating cattle weights – they accurately estimated 76.6% of cattle 
to within ±20% of their true weight (Machila et al., 2008). This suggests that AHAs are 
significantly better at estimating the weight of animals, and it is therefore important that they 
are consulted when treating animals, to ensure the correct dosages are being given to animals. 
Chronic underdosing can also place enhanced selective pressures on bacteria, enabling 
resistance to develop more rapidly, however, it is possible to mitigate this issue. By training 
farmers and AHAs, evidence suggested that both groups estimates of animal weights improved 
over time, as they received feedback of the true weights of different sizes of cattle (Machila et 
al., 2008). Similarly, an alternative to estimation, such as using weight tapes for larger animals, 
may significantly improve the issue with chronic underdosing. 
 
This study (Chapter 3) compiled commonly used antimicrobials from a mixture of participant 
recollection and records kept by farmers, agrovets and AHAs. The most commonly used 
antimicrobials in livestock treatment included oxytetracyclines, penicillin-streptomycin and 
sulfa-drugs. According to the literature review (Chapter 1) there are around 24 African countries 
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which do not have antimicrobial use data; indeed, the majority of use in animal production 
systems in LMICs is largely undocumented (Schar et al., 2018). The use of antibiotics classed as 
HPCIAs (EMA, 2015; WHO, 2019b) was extremely limited which is positive to note. This KAP 
study found no reported use of fluoroquinolones, 3rd+ generation cephalosporins, and only one 
reported use of colistin. Few people had heard of or recognised any examples of critically 
important antimicrobials; this is likely due to lack of awareness and available information, given 
that these drugs are available for purchase in more urbanised areas (Muloi et al., 2019b). 
 
There was a high prevalence of antimicrobial resistance detected amongst faecal E. coli; these 
findings differed from previously published studies, however, suggesting that there is a much 
lower carriage of tetracycline and sulfa-drug resistant E. coli in Kenyan goats (Njoroge et al., 
2013) and poultry (Langata et al., 2019), and animals in other African countries such as Zambia 
(Mainda et al., 2015). Resistance to ampicillin and trimethoprim are also commonly reported in 
E. coli isolated from food-producing animals in sub-Saharan African countries (Kikuvi et al., 2006; 
Ojo et al., 2010; Donkor et al., 2012). Some AHAs reported that some certificate and diploma 
courses did not have specific training in prescribing or recommending antimicrobials for specific 
diseases, beyond broad-spectrum tetracyclines and penicillin-streptomycin. The Kenyan NAP 
(Fleming Fund, 2019) aims to increase education regarding AMR, as well as reducing 
inappropriate sale and use of antimicrobials. There has been a correlation between AMU in 
animals and the occurrence of AMR, and several studies suggest that reducing the use of 
antimicrobials in animals, was effective at reducing AMR in animals (Dorado-García et al., 2016; 
McDonnell et al., 2017). However, it remains to be seen if there are direct benefits to reduction 
of AMU in animals on AMR in humans, though it stands to reason that reducing any reservoirs 
of AMR bacteria amongst animals (food-producing, and companion animals) may prevent 
opportunistic colonisation of humans (van Alen et al., 2017).    
 
Many different diseases affecting livestock were reported by all groups. In the majority of cases, 
treatment was syndromic, without diagnostic support. Three main diagnostic laboratories exist 
to cover western Kenya – the Busia/ILRI diagnostic laboratory, Kericho regional laboratory and 
Eldoret regional laboratory. Outside of these three laboratories, there is a lack of well-funded 
and well-equipped diagnostic services. Due to logistical issues with transporting samples (lack 
of cold-chain, and distance to these laboratories) as well as long turnaround time and cost 
involved, this has made farmers and field veterinarians reluctant to submit samples for 
culture/sensitivity testing to confirm diagnoses, before beginning treatment (Global Antibiotic 
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Resistance Partnership, 2011). AHAs usually rely on their clinical experience for disease 
identification, and agrovets typically rely on farmers or more experienced agrovets to report 
clinical signs. This can lead to misdiagnosis, and lack of confidence in diagnosis can drive the use 
of empirical, broad-spectrum antimicrobials (which is common practice in Kenya). In a follow-
up study, it may provide useful insight to include specific questions into why there is high use of 
empirical therapies and compare these with the results in this KAP study. Because AMR 
surveillance has not been previously systematically conducted in Kenya, for many AHAs and 
agrovets, there is no indication as to why commonly used antimicrobial regimens are becoming 
less effective against many infections, and this is a concern. 
 
The general knowledge of AMR varied according to farmers, agrovets and AHAs. Initially, few 
agrovets, AHAs and farmers had a good understanding of what AMR was, but after a definition 
was provided, many were able to give examples of factors which they thought may contribute 
to the emergence of AMR. However, this study has indicated that general knowledge regarding 
AMR is superficial. As noted above, there is insufficient finance and capacity in place to ensure 
that public health education materials are delivered to antimicrobial prescribers and providers. 
One major issue around lack of understanding ABR is that participants were unable to 
distinguish between AMR and treatment failure. For example, AMR could be due to chronic 
underdosing such is the case where doses incorrect to inaccurate estimation of animal weight  
(Machila et al., 2008), whereas treatment failure could be due to incorrect diagnosis and 
provision of an inappropriate (antimicrobial) treatment. Similarly, the disease may not be 
bacterial in origin. Where treatment failure has occurred, farmers often switch to another class 
of antimicrobial.  This is endorsed by World Organisation for Animal Health (OIE) guidelines for 
responsible use (OIE, 2017), but as no diagnostics procedures (bacterial culture and 
antimicrobial sensitivity) are performed, there is often a switch between two classes of broad-
spectrum antimicrobials (penicillin-streptomycin and oxytetracyclines), which may not be the 
most appropriate or effective treatment. There is a high proportion of AHAs and agrovets who 
provided an alternative antimicrobial to a farmer without obtaining further clinical information 
regarding the animals, and a quarter of farmers suggested that they requested a different 
antimicrobial without first consulting an agrovet or AHA. This self-prescription or uninformed 
prescription could be addressed through reforms of regulation controlling the sales of 
antimicrobials and introducing dispensing audits (Tangcharoensathien et al., 2018). These audits 
could potentially feed into the new surveillance systems being implemented as part of the 
national AMR Action Plan. 
Chapter Three  KAP Study 
 84 
Withdrawal periods were also generally not well understood or abided by in some cases. A study 
conducted in Tanzania also found that depending on the tribe, people were more or less likely 
to observe withdrawal periods (Caudell et al., 2017). In Kenya, there are regulatory frameworks 
for residue surveillance in animal products in parts of Kenya, though this is primarily directed 
towards milk sale (Kosgey et al., 2018). According to this study, some farmers with good 
knowledge of withdrawal periods still allowed calves and dogs to drink residue-containing milk, 
believing that this was safe for animals. Evidence investigating the impact of allowing calves to 
suckle residue-containing milk suggests the changes in faecal microbiota may alter the relative 
abundance of microbial cell functions (affecting cell signalling and stress responses), which can 
impact on the selection and dissemination of virulence genes and antimicrobial resistance 
(Pereira et al., 2018). Other farmers suggested that withdrawal periods only applied to milk or 
eggs and were unaware that residues may also exist in meat. There may be socio-economic 
factors e.g. not selling animal products may mean that farmers have no money to feed their 
families or pay for school fees. Recent studies of the dairy value chain concluded that 
antimicrobial residues detected in animal products were predominantly due to ignoring 
withdrawal periods (Orwa et al., 2017).  
 
A limitation of this study was the requirement for travel to farms alongside government 
representatives and a member of the Busia diagnostic laboratory during this study. It is likely 
that there was bias in the way that questions were answered by respondents, due to presence 
of government representatives. For example, farmers would not want to disclose poor or illegal 
practices, and may have answered the questions differently than if government representatives 
were not present. Another limitation of this study was language barrier – as more than half of 
the interviews were conducted in Kiswahili, by a translator, some questions may not have direct 
equivalence when asked in English. An example of this is the word dawa which is a Kiswahili 
word for ‘medicine’ – this is commonly used to denote antibiotics, as well as non-antimicrobials 
such as paracetamol in western Kenya. However, answers provided by participants to many 
questions were mostly consistent across each sub-county, particularly for antimicrobial 
purchase, which suggests that accurate insights of KAPs from a variety of antimicrobial users, 
providers and prescribers from larger and small farms, as well as a wide variety of agrovets shops 
was gained. Finally, interviews were conducted across Busia, using a stratified approach. This 
was done as a logistical consideration, as vehicular access was shared between other members 
of the laboratory group. Stratification assumes that there is homogeneity within each subgroup, 
however, this was not investigated prior to conducting the study. As several priors which formed 
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the sample size calculation were unknown, it may be possible that our analyses of the dataset 
has a higher standard error than if a different sampling strategy (such as optimum allocation) 
was used. Furthermore, after completing the interviews, no survey weighting was used. As the 
proportion of participants sampled did not consider the population density within strata, data 
may need to be weighted sothat downstream analyses have tighterh confidence intervals, and 
more accurately represent the population. Data weights are also usually used to compensate 
for non-responses, though there were no instances of questions that had non-responses during 
interviews. Due to the stratified approach in selecting farms, and lack of weighting given to 
questionnaire responses, no formal comparison has been made between sub-counties using the 
interview data. This may have provided additional insight into knowledge, attitudes and 
practices towards antimicrobials, in different geographical locations and will be considered in 
future analysis. 
 
There are several matters surrounding the understanding of, and consequences of, the use of 
antimicrobials in farm animals. Foremost, we determined that a key area to address is to 
encourage additional training regarding AMU and AMR, to fill in gaps in knowledge of 
antimicrobial users and providers who prescribe and sell antimicrobials. Training could be 
reasonably addressed in the short-term, through interactive courses or the introduction of a set 
of detailed guidelines on antimicrobial prescription and usage. Next, efforts could be increased 
to reform regulation surrounding antimicrobial use. There are good records in place of 
antimicrobials sold at agrovet shops and improving this by standardising record-keeping into a 
computerised system at agrovet or county-government level, would allow for accurate tracking 
of prescribed and sold antimicrobials and minimise over- and non-prudent use of antimicrobials. 
A widely accessible treatment plan could be made available as guidelines for treatments of 
animals; existing projects in western Kenya are seeking to survey the area for several diseases 
and this will be important in the future for advising policies.  With the new National Action plan 
for AMR, a country-wide surveillance system will help to identify the aetiological basis for many 
diseases and following this introduction of better diagnostic facilities would allow for 
microbiological support where first-line treatments are ineffective. This will allow antimicrobial 
providers and prescribers to initiate more narrow-spectrum therapies, relieving the 
overreliance on broad-spectrum antimicrobials. In the long term, additional ideas may be 
implemented to optimise livestock production and better control diseases in rural Kenya, as well 
as mitigating AMR in both animals and humans. It is vital that the One Health approach is 
accepted along with the investment of research into the still unknown contribution that 
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agriculture plays in AMR, to generate a synergistic educational, communication and clinical 
effort between human and veterinary medicine. If properly implemented, it is expected that the 
Kenyan National AMR action plan (Fleming Fund, 2019) will do all of these things. 
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4.1 Introduction 
AMR is having a negative impact on human and veterinary health (Cassini et al., 2019), by 
increasing treatment failures, morbidity and mortality and increasing the financial burden on 
healthcare services (O’Neill, 2016). As there is overlap in the antimicrobial classes used in both 
human and veterinary medicine, it is probable that AMU in animals exacerbates the 
development of AMR in bacteria acquired by humans, and vice-versa (Woolhouse et al., 2015), 
though a direct link between AMR in humans as a result of animal exposure is difficult to 
determine (Muloi et al., 2018). Adjacent to human and veterinary medicine is the selective 
pressures being placed upon environmental bacteria to develop or acquire AMR genes; this is 
occurring through leakage of antimicrobial residues and other co-selecting agents such as heavy 
metals, into the environment. As such, recent research has turned to a ‘One Health’ approach, 
to determine the degree to which antibiotic usage in human and veterinary medicine is 
exacerbating the selection and dissemination of bacterial resistance between humans, animals 
(Angulo et al., 2004; Carlet, 2012) and the environment (Chang et al., 2015b; Founou et al., 
2016). 
 
AMR in humans is thought to have increased rapidly due to widespread and indiscriminate AMU 
(World Health Organization, 2014). This is having an effect not only specialist pathogens, such 
as S. pneumoniae and M. tuberculosis, but also on commensal bacteria including E. coli and K. 
pneumoniae, which are increasingly becoming resistant to carbapenems and fluoroquinolones 
(World Health Organization, 2017). AMR in animals is also rising rapidly due to the reliance on 
antimicrobials for promotion of animal health, welfare and increased productivity in 
commercial systems (Hockenhull et al., 2017); there has been recent research to suggest that 
food-producing animals are an important reservoir of AMR bacteria (Aarestrup, 2015). In the 
environment, there is a reservoir of AMR in soil bacteria; this is unsurprising as bacteria have 
been producing natural antibiotics to eliminate competition for more than 30,000 years, and 
perhaps longer (D'Costa et al., 2011; Perron et al., 2015).  
 
Commensal bacteria such as E. coli can cause diarrhoeal disease, and other extraintestinal 
infections in humans and animals; whilst the diarrhoea is usually self-limiting, the emergence of 
MDR and ESBL-E. coli have led to increased mortality and morbidity in humans and animals 
(Colomb-Cotinat et al., 2016; van Duin and Paterson, 2016). As E. coli is readily isolated from the 
gastrointestinal tract of different animal species (including cattle, pigs, poultry, small 
ruminants), humans, and the environment (to a lesser extent), it is a good indicator species for 
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investigating AMR (van den Bogaard and Stobberingh, 2000; Sanderson et al., 2018). Due to E. 
coli’s ecological niche in the gut, the frequent exposure it receives to various antibiotics puts 
increased selection pressure on them to acquire antimicrobial resistance (Mubita et al., 2008; 
Wooldridge, 2012).  
 
Antimicrobial resistance genes are transferred between bacteria by horizontal transfer on 
mobile genetic elements such as plasmids (Chang et al., 2015a; Ter Kuile et al., 2016). These 
genes may then integrate into host E. coli chromosomes or spread to other commensal or 
pathogenic bacterial species (El Salabi et al., 2013). Plasmid-meditated ESBL-resistance is of 
particular concern, as plasmids carrying ESBL genes such as blaCTX-M and blaSHV, also frequently 
carry genes conferring resistance to aminoglycosides, quinolones and other antibiotics (Nilsen 
et al., 2013).  
 
A number of studies suggest that AMR bacteria and resistance genes of farm-animal-origin 
bacteria can be transferred to humans. There are thought to be three major routes of zoonotic 
transmission of AMR (though there is little empirical evidence for these) - contamination within 
the food chain (improper handling, inadequate cooking or storage), through direct contact with 
animals or their products, including meat and milk, or through contamination of the 
environment; use of animal faeces as fertiliser and subsequent leaching into water sources may 
also be a potential pathway for spread (Carattoli, 2008; Wooldridge, 2012; Woolhouse et al., 
2015; Muloi et al., 2019b). This is likely to contribute to the emergence of antibiotic resistance 
among human pathogens (Voets et al., 2013; de Been et al., 2014; Berg et al., 2017; Castellanos 
et al., 2017). However, the exact role of farm animals in the emergence and dissemination of 
AMR to humans is still contested (Marshall and Levy, 2011; Woolhouse et al., 2015) and Muloi 
from above. Many studies have relied on traditional methods such as MLST and macro-
restriction pulsed-field gel electrophoresis (which is only useful in indicating clonal 
dissemination of antimicrobial resistance, rather than the transfer of resistance genes between 
bacteria). These techniques may or may not have sufficient discriminatory power to infer 
directionality or provide evidence of transmission (Woolhouse et al., 2015; Muloi et al., 2018).  
 
The dynamics of AMR in developing countries are poorly understood, especially in 
community settings, due to a sparsity of data on AMR prevalence. Several studies involving 
pathogenic E. coli from sub-Sharan African countries have been conducted, and these report 
increased isolation of ESBL-producing E. coli  (Bercion et al., 2009; Sangare et al., 2016; 
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Musicha et al., 2017) and MDR E. coli from various human clinical cases, as well as from 
animal sources (Ibrahim et al., 2012; Manyahi et al., 2014; Adenipekun et al., 2015; Hassell 
et al., 2019). However, the reported data is limited to very few countries, due to the absence 
of surveillance systems (World Health Organization, 2017). Some transmission dynamics 
studies conducted in SSA countries have shown evidence to indicate the transfer of bacteria 
between humans, animals and the environment (Rwego et al., 2008; Lupindu et al., 2015), 
and this study will aim to build on those foundations. The issue with many previous studies 
investigating transmission is that simply demonstrating similarity of AMR bacteria and/or 
resistance determinants in humans, animals and the environment does not allow inference 
on the directionality of transfer. WGS is advantageous when compared to previously used 
methods as it can provide increased resolution for the study of genetic similarity of bacteria 
e.g. resistance can be identified on individual plasmids. WGS was not previously widely 
accessible, due to its high cost; as the technology and methods improve over time, it is 
becoming a more affordable, and accessible, method. By combining WGS analysis with 
epidemiological information, such as the prevalence of AMR genotypes and phenotypes, as 
well as antimicrobial usage statistics, it may be possible to reconstruct the complex 
transmission dynamics of resistant bacteria and their AMR determinants between human 
and food animal populations (De Maio et al., 2015; Woolhouse et al., 2015). 
 
The purpose of this study was to assess the carriage of AMR faecal E. coli of farmers, livestock 
and the farmers’ living environment by classical microbiological methods; assess the carriage of 
resistance and virulence genes of faecal E. coli isolated from farmers, livestock and the 
environment; determine relatedness of E. coli by constructing phylogenies using WGS, and; to 
determine risk factors for the carriage of AMR, MDR and ESBL-producing E. coli. 
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4.2 Methods 
4.2.1 Study Population and sample size determination 
The aim was to sample the faeces of the most commonly owned livestock species on smallholder 
farms; the animal population consisted of pigs, poultry, sheep and goats, and cattle from small-
holder farms in Busia county, western Kenya. The sample size was calculated according to a 
modified Cochran formula. As little previous work of this nature had been undertaken in the 
study area, a conservative estimate of the prevalence (p) of AMR E. coli of 35% was suggested 
by ILRI scientist Jane Poole, informed by the previously unpublished Urban Zoo project (Muloi 
et al., 2019b). Using a precision (d) of 5% and 95% confidence (standard two-sided 5% 
significance levels), an estimated 350 animals (N) needed to be recruited; this would be the 
optimal size for the study to assure an adequate power to detect statistical significance or 
differences in AMR E. coli carriage between human, livestock and envrionemtnal populations:  
 ! = #!$(1 − $))!  
 
The number of farms was predetermined from our previous questionnaire study (Chapter 3) to 
be 70 farms (10 farms in each of the seven sub-counties in Busia as the same farms were to be 
re-visited). The intra-cluster correlation coefficient (ICC) was estimated based on the same 
previous study (Urban Zoo) to be approximately 0.15 (p). The average cluster size was estimated 
to be approximately 10 (n). Thus, the adjusted sample size was 822.5 animals. This would 
average to approximately 12 samples per each of the 70 farms.  
 *+ = 1 + (- − 1)$ 
 
To achieve 12 samples per farm an equal number from each species present on that farm were 
collected such that the number from each species differed between farms depending on the 
composition of the species present. e.g. a farm containing cattle and goats only, had 6 samples 
collected from each of those species. Human participants were selected according to the 
expectance that 1-3 members of the household engaged with farming would be present on each 
farm (according to our questionnaire study) – this meant that between 70-210 human samples 
could be collected.  
  
As most smallholder farms in this area were thought to have a single source of water, 1 water 
sample per farm was collected from each farm. Similarly, one environmental (boot swab) 
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sample was collected from each household. A prior control study was performed at the 
University of Liverpool alongside Professor Nicola Williams. This was used to develop a protocol 
for use of boot swabs, and methods of growing and isolating bacteria from boot swabs (SK and 
NJW, unpublished data, 2016). This control study suggested that a diverse array of bacteria 
could be collected and successfully cultured from a single bootswab following overnight 
enrichment in buffered peptone water. As such only one boot swab sample per farm was 
collected.  
 
4.2.2 Data & Sample Collection 
Participants were recruited up to three days before the farm visit using GPS coordinates 
captured during the KAP study (Chapter 3) to locate farms. 27 farms declined to participate in 
this study, and so 27 new farms were recruited using the previously defined random method. A 
telephone number was collected at the time of recruitment to give warning the day before 
arrival at the farm. Immediately prior to sample collection, a questionnaire-based interview was 
used to obtain data from farmers (Appendix II, Figure II-iii); information collected included 
slaughter practices, personal protection equipment, human and animal illness, antimicrobial 
usage, and purchase. Samples were collected continuously between 25th April and 7th May 2017. 
Ethical approval was obtained from the University of Liverpool and ILRI prior to collection of 
data and samples; all samples were collected after obtaining signed and informed consent from 
participants. 
 
4.2.2.1 Human Faeces Collection 
Human participants were visited up to three days prior to sample collection to explain our 
intentions and what was required from them. A faecal pot and protective gloves were provided 
to each participant at the time of recruitment along with instructions on how to collect a non-
urine-contaminated sample; participants typically defecated onto a sheet of newspaper and 
then scooped up a faecal sample (5-40g) with the provided faecal pot (spoon attached to the 
lid). Participants were informed the night before they were due to be sampled so that they could 
provide a fresh faecal sample on the same morning the interview and animal samples were 
collected. 
 
4.2.2.2 Animal Faeces Collection 
Up to 12 lots of deposited faeces (i.e. from the ground) from around each farm were collected 
using a non-random (haphazard) method; faecal deposits were identified according to species 
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and an equal number of faeces were selected according to the type of species kept on the farm, 
if they were further than 1m apart from each other.  If there were 4 different species, 3 samples 
from were collected each type of animal. A faecal pot (with spoon attached to the lid) was used 
to collect between 20-35g of faeces. Poultry faeces were collected by placing a chicken onto 
newspaper/paper bag and then collecting deposited faeces, or from sampling a chicken house 
directly.  
 
4.2.2.3 Water and Environmental Samples 
The main water source was identified via a questionnaire. 15ml of water was collected in sterile 
universal tubes from various water sources, including boreholes, wells, rivers, and lakes where 
there was common grazing ground, collected rainwater and taps.  
 
For environmental sampling, sterile shoe covers (boot swabs) were used to collect bacteria from 
the floor of participant’s homes, where animals were allowed access. Boot swabs were pre-
moistened with 100µl of sterile water (to enhance the collection of bacteria from the ground) 
and then placed over blue overshoes, to prevent contamination of the boot swabs by the 
investigator’s shoes. Investigators then walked along the floor of participant’s living spaces, 
including cooking areas, covering as much floor area as available. Boot swabs were then 
transferred to sterile ziplock bags and sealed.  
 
4.2.3 E. coli Isolation 
After faecal, water and environmental sample collection was completed, samples were 
immediately placed into a cool box for transport back to the lab and processed on the same day. 
At the lab, initial culture and isolation of bacteria was performed at the Busia/ILRI laboratory 
(latitude/longitude 0.46416, 34.10670). Approximately 1g of faeces was homogenised 
separately in 5ml tryptone soy broth (Oxoid, Hampshire, UK). 10ml of each water sample was 
mixed with 10ml of double concentration (40g/l) buffered peptone water (Oxoid, Hampshire, 
UK) in a universal tube. 100ml of buffered peptone water was added to a ziplock bag containing 
boot swabs, shaken vigorously and then 20ml was collcted into a sterile universal tube. All 
samples were incubated aerobically overnight at 37°C. Following incubation, all samples were 
streaked onto plain eosin-methylene-blue agar (EMBA) (Oxoid, Hampshire, UK) with a sterile 
10µl plastic loop and again incubated overnight under the same conditions. Where E. coli was 
evident morphologically (shiny, metallic green colonies), a full-plate streak was taken with a 
sterile 10µl plastic loop and transferred to MicroBank™ tubes (Pro Lab diagnostics, Ontario, CA) 
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and inverted several times to equally cover the beads. Where there was no growth consistent 
with E. coli, the sample was discarded. After several minutes, excess supernatant was removed 
using a sterile pipette tip and discarded. All tubes were then frozen at -40°C prior to being 
shipped to the University of Liverpool, on ice packs. All original faecal samples were kept for 
long-term storage at -40°C.  Samples were shipped with appropriate export and import permits. 
 
At the University of Liverpool, samples were resuscitated by streaking one MicroBank™ bead 
onto a plain EMBA plate and incubating aerobically overnight at 37°C. From this, bacteria were 
sub-cultured for single colonies onto three EMBA plates, one containing cefotaxime (1μg/ml), 
one containing ceftazidime (1μg/ml) and one containing no antimicrobials. From the plain EMBA 
plate, five random picks of colonies that were morphologically consistent with E. coli (metallic 
green, shiny) were selected and sub-cultured onto nutrient agar. From the EMBA plates 
containing cefotaxime and ceftazidime, one pick was randomly selected for sub-culture. 
 
4.2.4 Antibiotic susceptibility testing 
All isolates were sub-cultured onto nutrient agar and subject to antibiotic disc diffusion testing, 
using a panel of seven antibiotics determined to be common to the study-site, informed by the 
questionnaire study (Chapter 3). Suspensions were made according to the EUCAST guidelines 
(EUCAST, 2017). MHA plates were inoculated with each isolate and seven antimicrobial discs 
applied: ampicillin (10µg), chloramphenicol (30µg), ciprofloxacin (5µg), gentamicin (10µg), 
sulfathiazole (1000µg), tetracycline (30µg) and trimethoprim (5µg). Isolates selected from EMBA 
plates containing ceftazidime or cefotaxime were subject to double-disc diffusion testing, using 
three pairs of antibiotic discs containing ceftazidime (30μg), cefotaxime (30μg) and cefpodoxime 
(30μg) with and without clavulanic acid (10μg). All plates were incubated aerobically overnight 
at 37°C and zones of inhibition were measured in mm, using a photograph of each plate and FIJI 
to digitally measure zones of inhibition; all but sulfathiazole and tetracycline zones of inhibition 
were interpreted according to EUCAST human clinical breakpoints (EUCAST, 2017). Tetracycline 
was interpreted according to BSAC human clinical breakpoints (BSAC, 2015). Sulfathiazole was 
interpreted according to a generated TECOFF (Chapter 2.5.1), according to the bimodal 
distribution of zones of inhibition. Suspected ESBL production was confirmed if the zone of 
inhibition for the cephalosporin with clavulanic acid disc was more than 5mm greater than the 
zone of its counterpart without clavulanic acid (M'Zali et al., 2000). 
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4.2.5 PCR Assays 
PCR assays targeting the uidA gene (McDaniels et al., 1996) were performed as previously 
described (Chapter 2.5.3) on all isolates to confirm if isolates were E. coli. Isolates which were 
confirmed as ESBL-producing by double-disc diffusion test were further analysed for the 
presence of blaCTX-M, blaSHV, blaOXA and blaTEM genes (Boyd et al., 2004; Dallenne et al., 2010). 
Isolates with the blaCTX-M gene were then further analysed to determine the specific CTX-M 
cluster (group 1, 2 or 9) (Batchelor et al., 2005; Hopkins et al., 2006; Carattoli et al., 2008). PCR-
confirmed ESBL-E. coli were also tested for the presence of trpa and pabB genes (Clermont et 
al., 2009), indicating if they belonged to the ST131 pandemic clone.  
 
4.2.6 Whole Genome Sequencing 
Due to funding limitations, only 166 isolates could be selected for WGS, out of a total of 729 
cultures. Farms were selected if there were isolates of at least two or more species of animal, 
one human and (where possible) one environmental sample. Once a list had been compiled 
fulfilling this criterion, a random selection of antimicrobial-resistant, antimicrobial-sensitive, 
MDR and ESBL-producing properties were chosen according to a random number generator. 
This selection was made to ensure comparisons of resistance genes between livestock, humans 
and the environment could be made.   
 
4.2.6.1 DNA Extraction 
DNA was extracted from 24-hour cultures using the QIAamp® DNA Mini Kit (Qiagen, 
Manchester, UK) according to the manufacturer’s instructions. To quantify the concentration 
and purity of DNA, two methods were used: a) Nanodrop spectrophotometer (Thermo Fisher 
Scientific, Cheshire, UK) was used to analyse the purity of the DNA extraction by assessing the 
260/230 and 260/280 wavelength ratios and, b) Qubit Fluorometer (Thermo Fisher Scientific, 
Cheshire, UK) to analyse the concentration of dsDNA in each sample. All extracts were stored at 
-20°C before being transferred to Liverpool Centre for Genomic Research for sequencing. 
 
4.2.6.2 DNA Sequencing 
The following protocol is provided as is, from the University of Liverpool CGR: 
 
One hundred and sixty DNA samples were submitted for Illumina TruSeq nano libraries 
preparation. Briefly, 200ng DNA of each sample was sheared with the Picoruptor to generate 
fragments approx. 550bp. After shearing the samples were cleaned-up with a 1.6x Ampure XP 
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beads and end-repaired. Following the end repair reaction, the samples were size selected with 
the sample prep beads and then A-tailed followed by the ligation of Truseq DNA UDI adaptors.  
These samples were Ampure cleaned twice to remove excess adapter and amplified with 7 
cycles of PCR. The libraries were cleaned with equal volume of Ampure XP beads. The quantity 
and quality of the pools were assessed by Qubit and Bioanalyzer and subsequently by qPCR 
using the Illumina Library Quantification Kit from Kapa (KK4854) on a Roche Light Cycler LC480II 
according to manufacturer's instructions. Briefly, a 20 µl PCR reaction (performed in triplicate 
for each pooled library) was prepared on ice with 12 µl SYBR Green I Master Mix and 4 µl diluted 
pooled DNA (1:1000 to 1:100,000 depending on the initial concentration determined by the 
Qubit dsDNA HS Assay Kit). PCR thermal cycling conditions consisted of initial denaturation at 
95°C for 5 minutes, 35 cycles of 95°C for 30 seconds (denaturation) and 60°C for 45 seconds 
(annealing and extension), melt curve analysis to 95°C (continuous) and cooling at 37°. 
and checked with Qubit assay and Bioanalyser chip.  
 
Following calculation of the molarity using qPCR data, template DNA was diluted to 3nM and 
5ul of each final pool were denatured for 8 minutes at room temperature using 5µl freshly 
diluted 0.1 N sodium hydroxide (NaOH) and the reaction was subsequently terminated by the 
addition of 5ul 0.1M TrisCl pH=8. The final loading concentration of 300pM was reached by 
adding 35µl exclusion amplification enzyme mix. The libraries were sequenced on 2 lanes of an 
Illumina HiSeq 4000 platform using sequencing by synthesis (SBS) technology to generate 2 x 
150 bp paired-end reads. 
 
4.2.6.3 WGS Workflow 
The standard workflow as described in (Chapter 2.6.1) was run on all sequences. Briefly, raw 
paired-end reads were quality controlled using FastQC v0.11.7 (Andrews, 2010) Poor quality 
reads (score <20) and any detected primers or adapters were removed using Trimmomatic v0.36 
(Bolger et al., 2014). Forward and reverse reads were then mapped to a reference E. coli genome 
(E. coli K12 MG1655; NCBI Reference Sequence: NC_000913.3 (Blattner et al., 1997), using the 
Burrow-Wheeler Alignment (bwa mem v0.7.17) (Li, 2013). Once BAM files had been made, a 
further QC step to check the mean mapping quality scores and coverage in relation to the 
reference genome was performed with QualiMap2 (Okonechnikov et al., 2015). Any reads which 
did not map to the reference genome were assembled de novo into contigs, using  SPADES 
v3.12.0 (Bankevich et al., 2012). Speciation analysis of those contigs was then performed using 
Kraken v2.0.7 (Wood and Salzberg, 2014) and an in-house database downloaded from the NCBI 
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sequence read archive (https://www.ncbi.nlm.nih.gov/sra/). Non-E. coli contigs were excluded 
from analysis.  Phylogenetic trees were constructed using IQ-Tree (Nguyen et al., 2015), using 
1000 bootstrap replicates and the GTR model Tree topology was checked using Figtree v1.4.4 
(Rambaut, 2012) and then annotated using the interactive tree of life (iTOL) v5.0 (Letunic and 
Bork, 2016). MLST was determined using a batch script which blasted each contig against the E. 
coli #1 schema (https://pubmlst.org/escherichia/) (Jolley and Maiden, 2014) – from this a 
sequence type (ST) was assigned according to the adk, fumC, gyrB, icd, mdh, purA and recA loci. 
In silico phylotyping was serotyping were formed using the Clermont Typing tool (Beghain et al., 
2018) and SerotypeFinder (Joensen et al., 2015) respectively. As of 2019, the Clement 
phylotyping tool also identifies the new phylogroup, G (Clermont et al., 2019). Plasmid replicon 
typing was performed using the PlasmidFinder database using the batch uploading platform 
(identity ≥90%, coverage ≥60%) (Carattoli et al., 2014).   
 
A brief comparison of methods was made regarding resistance and virulence gene data. Rather 
than relying on online tools, the most up to date resistance and virulence gene sequences from 
several different databases were downloaded, and the frequency of detection of common 
resistance and virulence genes was assessed. Databases were manually compiled on 18th 
October 2018 and used to screen all reads mapped to the E. coli reference strain (U00096.3). 
Databases downloaded included ResFinder (Zankari et al., 2012), CARD (McArthur et al., 2013), 
NCBI Antibacterial Resistance Reference gene database (NCBI A Accession: PRJNA313047, ID: 
313047), EcOH (Ingle et al., 2015), PlasmidFinder (Carattoli et al., 2014) and VDFB (Chen et al., 
2016). 
 
4.2.7 Antimicrobial Resistance Data Analysis 
Both questionnaire and microbiological data were entered in a spreadsheet initially (Microsoft 
Excel 2019, Microsoft Corporation) and reviewed to ensure accurate input. A binary coding 
system was implemented such that data was either susceptible (0) or resistant (1), using EUCAST 
human clinical breakpoints (EUCAST, 2017), BSAC human clinical breakpoints (BSAC, 2015) for 
tetracycline and the previously defined TECOFF value for sulfathiazole (Chapter 2.5.1). 
Descriptive statistics and Chi-squared tests for association were conducted in SPSS v25 (IBM 
Corp, Armonk, NY). 
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4.2.8 Questionnaire Data Analysis 
Responses given by participants during questionnaire-guided interviews were stored within the 
AppSheet application until an internet connection was available. Data were then uploaded to a 
secure server in XLS format for later analysis. Data were imported from the XLS file into 
Microsoft Excel 2016 (Microsoft Corporation, Redmond, USA) and descriptive analysis 
(frequency tables of participant demographics), was conducted using SPSS Statistics 25.0 (IBM 
SPSS Statistics for Windows Version 25.0, (New York: IBM Corp).  
 
Open-ended questions were analysed on a question-per-question basis using a thematic 
approach (Nowell et al., 2017). Briefly, text responses were read twice to ascertain a general 
comprehension of the responses. A large number of themes were identified and input into an 
Excel spreadsheet. Once all responses had been categorised, similar themes were condensed 
together. To ensure reproducibility, these themes were cross-checked by Dr Gina Pinchbeck 
(University of Liverpool). All data was then imported into SPSS Statistics 25.0 (IBM SPSS Statistics 
Version 25.0, New York: IBM Corp). 
 
4.2.9 Risk Factor Analysis 
Data for risk factor analysis comprised only of sample-level data; risk factor analysis used data 
from all isolates and the outcome variable was phenotypic resistance to antibiotics following 
AST testing.  From each set of 5 isolates belonging to a primary sample (of which there were 
n=X), if one isolate carried a specific resistance phenotype, then the sample was classed as 
having antibiotic resistant E. coli. Antibiotic resistance outcomes included: resistance to any of 
the seven antibiotics tested, MDR (resistance to three or more classes of antimicrobial) and 
ESBL-producing E. coli. Potential risk factors were identified from the questionnaire data 
obtained concurrently with biological sampling. All but one explanatory variable (see section 
4.3.6.2) derived from the questionnaire were binary (yes/no). One explanatory variable (farm 
size) was included as a continuous variable for analysis. Species was kept in all models as a fixed 
effect. 
 
As data were clustered within farms and within regions, each outcome was examined with a 
separate multilevel logistic regression model with binomial distribution and logit link function. 
Each model included region and farm as random effects at level 3 and 2 respectively, to account 
for clustering. Samples were considered the level one unit of interest. Univariable analysis was 
conducted on all explanatory variables using individual models for each outcome. All variables 
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which showed association with the presence of resistant E. coli from individual univariable 
analyses (with a P-value <0.25) were considered for incorporation into a final multivariable 
model for each outcome. Final models were checked for farms which may have had an increased 
influence upon the mixed effects models. Farm level (2) residuals were plotted against the 
overall means; where there was any significant difference detected, all data from those farms 
were meticulously rechecked (and verified by Gina Pinchbeck) for any errors. 
 
Multilevel, multivariable models were constructed using manual backward variable selection; 
only variables with a Wald P-value <0.05, after adjusting for other variables, were retained in 
the final model. First order interaction terms were tested for biologically plausible variables 
remaining in the final models. All analyses were conducted in MlWin v3.02 (Centre for Multilevel 
Modelling, University of Bristol). 
 
As data obtained within this study were clustered within farms, to accurately approximate the 
prevalence (and confidence intervals) of resistance within this population, the prevalence of 
each outcome was estimated using separate logistic regression models including farm as a 
random effect to account for clustering at this level. The adjusted prevalence was calculated 
using the beta coefficient (β0) from intercept-only, random effects models constructed for each 
outcome using the following formula: 
 ." =	 0#$1 +	0#$ 
 
In the case of prevalence estimates, 95% confidence intervals were calculated as a function of 
the calculated standard error of the beta coefficient from the intercept-only logistic regression 
model for each outcome.  
 
4.2.10 Maps and Georeferenced Data 
Maps were constructed using QGis v3.2 (QGIS Development Team, http://qgis.osgeo.org/). The 
latitude and longitude of each farm were captured using a mobile phone and Google Maps 
(Google Map Data 2019, California, USA). All co-ordinates for each farm were then imported 
into QGIS for mapping. A base layer of Busia county was taken from Google Maps – upon this, 
Kenya administrative levels 0-2 boundary polygons and line shapefiles were layered, having 
been acquired from an open-source database hosted by the Humanitarian Data Exchange 
(https://data.humdata.org/). Map data is updated annually and as such, the borders of sub-
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counties have moved slightly since the start of this study. Ten farms per sub-county were 
sampled, but according to generated maps e.g. Figure 4.1, some sub-counties appear to be over 
or underrepresented. This is due to map boundaries changing over time. For all resistance 
analysis, farms were considered to be part of the same sub-county as when first recorded. 
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4.3 Results 
4.3.1 Samples Collected 
In total 840 faecal samples from pigs, poultry, sheep, goats and cattle, from 70 farms were 
collected for this study, as well as 130 faecal samples from human participants, 1 water sample, 
and 1 environmental boot swab (70, each) were collected from each household. The total 
number of animals representing each sample was: cattle, n=208; pig, n=58; poultry, n=199; 
sheep and goats, n=96.  
 
4.3.2 Prevalence of Antibiotic-Resistant E. coli 
E. coli was successfully cultured from 726 human, animal, and environmental samples and E. 
coli with resistance to at least once class of antibiotic was isolated from 692 (95.3%) samples. 
The sample prevalence of resistance to each of the tested antibiotics, as well as MDR and ESBL-
producing E. coli are detailed in (Table 4.1). The total prevalence of resistance was adjusted for 
clustering, using intercept-only models.  
 
MDR was isolated from 53.9% of samples with the largest proportion from sheep and goats and 
environmental sources. The largest proportion of ESBL E. coli was isolated from water samples, 
though this was a small sample size of water (n=15) and environment (n=20). Tetracycline and 
trimethoprim were the two most common antimicrobial resistance phenotypes detected in all 
sample groups. Fluoroquinolone and aminoglycoside resistance were the least prevalent 
amongst all sample groups.  
 
All farms contained E. coli with resistance to at least one antimicrobial. The locations of farms 
with E. coli containing MDR and ESBL-producing E. coli are shown in (Figure 4.1). Twenty-nine 
samples (4.0%) had E. coli which were sensitive to all tested antibiotics. MDR E. coli was found 
in at least one sample on all visited farms; 320 samples (44.1%) had E. coli which were resistant 
to 3 classes, 60 samples (8.3%) to 4 classes, 9 samples (1.2%) to 5 classes and 3 samples (0.4%) 
were resistant to 6 classes of antibiotic. No samples were resistant to all 7 classes of antibiotic 
tested. ESBL-producing E. coli was found across Busia county, though there were two sub-
counties with a higher prevalence - Nambale (central) and Butula (south-east). Chi-squared tests 
showed a significant association between region and prevalence of MDR (p=0.006), and 
prevalence of ESBL-producing E. coli (p=0.01).  
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Table 4.1 The proportion of human, animal and environmental-origin E. coli with resistance to at least one 
antibiotic, MDR resistance and ESBL-production. Proportions are of E. coli were successfully cultured, i.e. 
726 samples. Below each proportion are 95% CIs. Total column was adjusted for clustering. Numbers 
indicate prevalence and 95% CIs in brackets. Prevalence are colour coded from green (low) to red (high).  
Antimicrobial Cattle Pigs Poultry 
Sheep/Go
ats 
Humans Water 
Environme
nt 
Total 
Resistance n=208 n=58 n=199 n=96 n=130 n=15 n=20 n=726 
Ciprofloxacin 
4.3% 1.7% 3.5% 5.2% 2.3% 0.0% 0.0% 3.70% 
(1.6 – 
7.1) 
(0.0 – 
5.0) 
(0.9 – 
6.1) 
(0.8 – 
9.6) 
(0.0 – 
4.9) 
(0.0 – 
20.0) 
(0.0 – 
20.0) 
(2.2 – 
6.3) 
Chloramphen
icol 
4.3% 8.6% 4.5% 11.5% 9.2% 0.0% 25.0% 6.8% 
(1.6 – 
7.1) 
(1.4 – 
15.8) 
(1.6 – 
7.4) 
(5.1 – 
17.9) 
(4.2 – 
14.2) 
(0.0 – 
20.0) 
(6.0 – 
44.0) 
(4.9 – 
9.5) 
Gentamicin 
2.9% 1.7% 2.0% 4.2% 7.7% 0.0% 0.00% 3.6% 
(0.6 – 
5.2) 
(0.0 – 
5.0) 
(0.1 – 
4.0) 
(0.2 – 
8.2) 
(3.1 – 
12.3) 
(0.0 – 
20.0) 
(0.0 – 
20.0) (2.5 - 5.3) 
Tetracycline 
88.5% 93.1% 82.4% 93.8% 93.1% 100% 100% 89.2% 
(84.2 – 
92.3) 
(86.6 – 
99.6) 
(77.1 – 
87.7) 
(89.0 – 
98.6) 
(88.7 – 
97.5) 
(80.0 – 
100) 
(80.0 – 
100.0) 
(83.0 - 
93.4) 
Sulfathiazole 
59.8% 69.0% 65.3% 71.9% 84.6% 66.7% 90.0% 69.4% 
(53.1 – 
66.5) 
(57.1 – 
80.9) 
(58.7 – 
71.9) 
(62.9 – 
80.9) 
(78.4 – 
90.8) 
(42.9 – 
90.6) 
(76.9 – 
99.9) 
(60.6 – 
76.9) 
Ampicillin 
57.9% 55.2% 58.3% 67.7% 66.2% 73.3% 65.0% 60.9% 
(51.2 – 
64.6) 
(42.4 – 
68.0) 
(51.5 – 
65.2) 
(58.4 – 
77.1) 
(58.1 – 
74.3) 
(50.9 – 
95.7) 
(44.1 – 
85.9) 
(56.0 – 
65.6) 
Trimethoprim 
62.7% 69.0% 67.8% 74.0% 79.2% 66.7% 85.0% 71.0% 
(56.1 – 
69.3) 
(57.1 – 
80.9) 
(61.3 – 
74.3) 
(65.2 – 
82.8) 
(7.9 – 
19.7) 
(42.9 – 
90.6) 
(69.4 – 
99.9) 
(62.4 – 
78.3) 
MDR (n=371) 
52.2% 51.7% 53.8% 65.6% 58.5% 46.7% 60.0% 53.9% 
(45.4 – 
59.0) 
(38.8 – 
64.6) 
(46.9 – 
60.7) 
(56.1 – 
75.1) 
(50.0 – 
67.0) 
(21.5 – 
72.0) 
(38.5 – 
81.5) 
(48.7 – 
59.1) 
ESBL (n=103) 
14.4% 15.5% 13.6% 18.8% 14.6% 46.7% 10.0% 14.8% 
(9.6 – 
19.2) 
(6.2 – 
24.8) 
(8.8 – 
18.4) 
(11.0 – 
26.6) 
(8.5 – 
20.7) 
(21.5 – 
72.0)   
(0.0 – 
23.2) 
(11.1 – 
19.5) 
 
 
When divided according to individual sources, different patterns of resistance were observed 
(Figure 4.2). Overall, the most common resistance phenotype among E. coli was tetracycline-
sulfathiazole-ampicillin-trimethoprim, which was found in 38.6% of all the samples.  Tetracycline 
resistance was found in all five of the most common resistance phenotypes. Tetracycline only 
resistance was the most common resistance pattern in cattle. Three of the four most common 
resistance phenotypes were MDR. 
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4.3.3 Whole Genome Sequence Analysis 
Following mapping of reads to the reference genome, a further QC step was undertaken to 
assess the mapping quality and depth/coverage of genomes. Of the 166 sequenced samples, 
150 mapped genomes  (representing 150 original samples) were considered for downstream 
analysis, as 16 samples were disregarded due to poor coverage across sites indicating resistance 
determinants (0-10x). Of those 150 genomes, 24 belonged to human-derived E. coli isolates, 118 
from animal and 8 from the environment. 						
0 40km 
Figure 4.1 Geographical distribution of a) all farms (n=70, green diamonds) and b) farms with ESBL-producing E. 
coli (n=18, red diamonds).    
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TET = Tetracycline, SULFA = Sulfathiazole, TRIM = Trimethoprim, AMP = Ampicillin, CHLOR = Chloramphenicol, 3GCP 
= 3rd Gen Cephalosporin. 3GCF non-specific, as determined by double-disc diffusion test. 
 
4.3.3.1 Comparison of Resistance Gene Methods 
A comparison of the most prevalent resistance genes from each database was compiled (Table 
4.2). There were differences in the number of results returned by each method tested; 
ResFinder v2.2 returned 55 unique genes, ResFinder custom-database 18th October 2018 
(termed version ‘S’) returned 58 genes, NCBI AMR database returned 73 unique genes, and the 
CARD database, which reports each constituent of a gene family separately (e.g. one entry for 
each of the four str fimbriae) returned over 1600 unique resistance-associated genes. However, 
for the most commonly identifiable and reported resistance genes in the literature, there was 
good similarity of fosfomycin, macrolides, phenicols, quinolones and sulfonamides resistance 
genes between each ResFinder iteration and the NCBI database. Where there were any 
differences in the frequency of genes reported by each database, the average difference 
between databases was 0.85% (i.e. one count of a gene). 
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Figure 4.2 The four most commonly identified antimicrobial resistance phenotypes, divided by individual 
animal, human and environmental origin. The figure reflects the overall proportion of isolates displaying a 
specific antimicrobial resistance phenotype; 726 unique E. coli isolates were examined. Bars indicate 95% 
CIs. 
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There were some small discrepancies found between databases with regards to 
aminoglycosides, tetracyclines, trimethoprim and β-lactams and the MDR gene mdf(A). The 
ResFinder vS database underreported the presence of aminoglycoside aadA1 compared to all 
other databases. The NCBI AMR gene database did not record any instance of the MDR gene 
mdf(A), despite the other databases finding a high proportion of this gene. Only the NCBI AMR 
gene database identified the qacEΔ1 gene, conferring resistance to ethidium bromide, 
antiseptics and disinfectants (Kazama et al., 1998) as an AMR gene. The prevalence of the 
tetracycline resistance tet(A) gene was reported differently by all databases, notably most 
frequently in the v2.2 database, but less frequently in the ResFinder vS database. In the CARD 
database, tet(A) was reported in only 12.7% of genomes, compared to an average of 68.5% in 
the other databases. Similarly, tet(B) was not reported at all in CARD, despite being reported in 
all other databases. The trimethoprim resistance gene dfrA1 was also not reported in the CARD 
database, despite being recorded in all others. Finally, the NCBI AMR gene database recorded a 
family of chromosomally encoded, class C β-lactamases, which were not found in the other 
comparison databases.  
 
From this comparison, there was close similarity between both iterations of ResFinder, with 
some minor differences in aminoglycosides and mdf(A) gene reporting. The NCBI database 
detected on average more β-lactamase genes and was the only database to contain the qacEΔ1 
resistance gene. The CARD database was the most divergent - it underreported or omitted 
fosfomycin, all phenicol, quinolone, tetracycline and trimethoprim genes, despite a manual 
check of the database showing that it contained these genes. Despite underreporting numerous 
major genes, the CARD database identified the most resistance determinants, though many of 
these included gene regulators, activators, and sensors, making it difficult to compare to 
ResFinder and NCBI. It is possible there was some alternative naming used in the CARD 
database. As such, minor discrepancies between reporting of genes between each database can 
alter the presented results. As much of the existing literature uses ResFinder preferentially, the 
work presented here is based on those databases.  
 
Initial analysis was performed with the most up-to-date version of the ResFinder database 
(generated on 18th October 2018). To date (April 2020), there have been numerous updates to 
the ResFinder programme, which have included updates of blaCARB and blaFRI genes, updates to 
the fusidic acid, tetracycline, beta-lactamase and quinolone databases. These updates have not 
largely altered the results published in this thesis.  
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Table 4.2 Most commonly identified resistance genes from whole genome sequencing of 150 E. coli isolates from animal, human and environmental samples from 42 farms. 
Five different databases were used to screen sequences for resistance genes – the prevalence in the dataset, according to each of the databases is shown here. Resistance 
genes are shown on the same row, with the associated prevalence of that gene according to that database. 
ResFinder v2.2 (Sept16) ResFinder vS (Oct18) NCBI AMR Genes CARD Database 
Gene Ab 
Class 
% Gene Ab 
Class 
% Gene Ab 
Class 
% Gene Ab 
Class 
% 
aph(6)-Id aminoglycoside 82.2 aph(6)-Id aminoglycoside 79.3 aph(6)-Id aminoglycoside 79.3 aph(6)-Id aminoglycoside 79.3 
aph(3'')-Ib aminoglycoside 80.9 aph(3'')-Ib aminoglycoside 69.3 aph(3'')-Ib aminoglycoside 68.7 aph(3'')-Ib aminoglycoside 69.3 
aadA1 aminoglycoside 34.2 aadA1 aminoglycoside 14.0 aadA1 aminoglycoside 34.0 aadA1 aminoglycoside 34.0 
fosA fosfomycin 7.2 fosA fosfomycin 7.3 fosA fosfomycin 6.7 - - - 
fosA7 fosfomycin 2.0 fosA7 fosfomycin 2.0 fosA7 fosfomycin 2.0 fosA7 fosfomycin 2.0 
fosA3 fosfomycin 1.3 fosA3 fosfomycin 1.3 fosA3 fosfomycin 1.3 fosA3 fosfomycin 1.3 
mph(A) macrolides 6.6  mph(A) macrolides 6.7 mph(A) macrolides 6.7  mph(A) macrolides 6.7 
mdf(A) MDR 94.7  mdf(A) MDR 80.7 - - - mdf(A) MDR 80.7 
catA1 phenicols 7.2 catA1 phenicols 7.3 catA1 phenicols 7.3 - - - 
catA2 phenicols 2.0 catA2 phenicols 2.0 catA2 phenicols 2.0 - - - 
cmlA1 phenicols 0.7 cmlA1 phenicols 1.3 cmlA1 phenicols 1.3 - - - 
qnrS1 quinolones 19.1 qnrS1 quinolones 19.3 qnrS1 quinolones 19.3 qnrS1 quinolones 19.3 
qnrB19 quinolones 2.6 qnrB19 quinolones 2.7 qnrB19 quinolones 2.7 - - - 
oqxA quinolones 1.3 oqxA quinolones 1.3 oqxA quinolones 0 oqxA quinolones 1.3 
- - - - - - qacEΔ1 
ethidium 
bromide 44.7 - - - 
sul2 sulfonamides 82.2 sul2 sulfonamides 82.7 sul2 sulfonamides 82.7 sul2 sulfonamides 82.7 
sul1 sulfonamides 41.4 sul1 sulfonamides 41.3 sul1 sulfonamides 40.0 sul1 sulfonamides 40.0 
sul3 sulfonamides 3.3 sul3 sulfonamides 3.3 sul3 sulfonamides 3.3 sul3 sulfonamides 3.3 
tet(A) tetracycline 71.1 tet(A) tetracyclines 66 tet(A) tetracyclines 66.0 tet(A) tetracyclines 12.7 
tet(B) tetracycline 13.2 tet(B) tetracyclines 12.7 tet(B) tetracyclines 12.7 - - - 
tet(D) tetracycline 2.0 tet(D) tetracyclines 2.0 tet(D) tetracyclines 2.0 tet(D) tetracyclines 10.0 
dfrA14 trimethoprim 44.1 dfrA14 trimethoprim 44.7 dfrA14 trimethoprim 44.7 dfrA14 trimethoprim 44.7 
dfrA1 trimethoprim 33.6 dfrA10 trimethoprim 29.3 dfrA1 trimethoprim 34.0 - - - 
dfrA7 trimethoprim 11.8 dfrA7 trimethoprim 12.7 dfrA7 trimethoprim 12.0 dfrA7 trimethoprim 12.0 
blaTEM-1B β-lactams 67.8 blaTEM-1B β-lactams 68.7 blaTEM-1B β-lactams 68.7 blaTEM-1B β-lactams 70.7 
blaCTX-M-15 ESBL 21.7 blaCTX-M-15 ESBL 22.0 blaCTX-M-15 ESBL 22.0 blaCTX-M-15 ESBL 22.0 
blaACT-4 β-lactams 2.0 blaACT-4 β-lactams 1.3 blaACT-4 β-lactams 1.3 blaACT-4 β-lactams 1.3 
- - - - - - blaEC-18 β-lactams 41.3 - - - 
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4.3.3.2 Genetic Background of Isolates 
To determine the genetic background of the E. coli, all 150 isolates were assigned a Multilocus 
Sequence Type (MLST) and Clermont phylogroup. Molecular serotyping was also performed. A 
comprehensive list of all isolates and the data discussed in the following sections can be found 
in [Appendix II, Table II-iv]. 
 
A maximum-likelihood phylogenetic tree (constructed with 832038 SNPs) (Figure 4.3) of all 
isolates shows the distribution of human, animal, and environmental E. coli. There were no 
apparent clustering by species or location for most of the sampled animal species, human and 
environmental E. coli, suggesting a high diversity of E. coli across the entire county. Of note were 
two clades which indicated an extremely high degree of genetic similarity, suggesting two 
separate clonal groups, belonging to ST2852 and ST196. This is discussed further in section 
4.3.3.6. 
 
The results of  MLST assignment indicated that the 150 human, animal and environmental 
genomes belonged to 44 different STs. 25 STs were represented by a single sequence only, and 
49 genomes could not be assigned a ST as they carried at least one novel allele, not included in 
the database. The most commonly identified STs included ST196 (8.9%, n=13), ST2852 (6.8%, 
n=10), ST10 (4.8%, n=7) and ST155 (3.4%, n=5). The distribution of these STs between groups 
can be seen below in (Figure 4.4). 32 STs were only found in livestock and 7 STs were only found 
in humans. There was only one ST common to all three sample groups (humans, livestock, and 
environment): ST196, the other most common STs were only found in individual groups (not all 
three). Of note, two clades of extremely low genetic variation (fewer than 300SNPs) discovered 
during phylogenetic tree construction belonged to two STs – the first low genetic variation group 
(comprised of animal and environmental isolates only) belonged to ST2852; the second low 
genetic variation group (comprised of human, animal and environmental isolates) belonged to 
ST196. Two further small clades were identified with the same degree of low genetic varitions, 
and these each had three genomes in their clades. These belonged to ST46 and ST1421.      
 
All sequences were phylotyped in silico, according to Clermont’s phylogrouping (Beghain et al., 
2018; Clermont et al., 2019). Several isolates could not be phylotyped in silico and were reported 
as ‘unknown’ (Figure 4.5). Phylogroup B1 was the overall most common in livestock (49.2%,  
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Figure 4.4. Distribution of multilocus sequence types by host group. Error bars are 95% CI. 
 
n=61), human (44.0%, n=9) and environmental (75.0%, n=5) isolates. There was some variation 
in the detected phylogroups; environmental isolates consisted of phylogroups B1 and A (with 
one unknown). Human isolates consisted primarily of B1, with a secondary majority of A (32.0%, 
n=8), one (4.0%, n=1) (each) of phylogroups B2, C, D and E (and 16.7%, n=4) and unknown. 
Isolates from livestock also were primarily phylogroup B1 (49.2%, n=58) and A (16.9%, n=20). 
Livestock isolates also had 5.9% (n=6) phylogroup D and 9.3% (n=10) phylogroup E. Surprisingly, 
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one livestock isolate was also classified as the newly discovered phylogroup G (1.7%, n=1) which 
is associated with high virulence and AMR potential (Clermont et al., 2019). Surprisingly, this 
isolate only (F41G4A) only carried two AMR genes and 5 virulence factors. This was rechecked 
using a lower threshold for % identity (≥75%, instead of ≥90%) which revealed that this isolate 
actually carried 10 resistance genes (potentially across multiple reads, hence the lower identity).   
 
Figure 4.5 Distribution of phylogroups of E. coli isolated from humans, livestock and the environment on 
70 different farms in western Kenya. Error bars are 95% CI.  
 
All isolates were serotyped in silico to assign lipopolysaccharide (O) and flagellar (H) surface 
antigen groups (Joensen et al., 2015). Of the 150 samples, 3 isolates were not assigned either 
an O or H grouping, and 8 isolates were only assigned an H grouping. There were 107 uniquely 
characterised O:H groupings across all three groups of humans, animals, and environmental 
isolates. The most prevalent O antigens were O8 (21.7%), O9 (7.2%) and O21 (3.6%). The most 
prevalent H antigens were H7 (20.5%), H10 (8.2%) and H4 (6.2%). The most prevalent 
combination serotype was O8:H7 (14.6%, n=22). All O8:H7 isolates were all MDR, carrying 
combinations of β-lactamase, fluoroquinolone, sulfonamide, tetracycline, aminoglycoside, and 
trimethoprim resistance genes. All isolates in the two clades (marked 1 and 2) (Figure 4.3) 
belonging to ST196 and ST2852, were also serotype O8:H7.   
 
4.3.3.3 Resistance Genes 
Using the most up to date ResFinder database (compiled in October 2018), all detected 
resistance genes were tabulated, and the prevalence of each gene determined according to 
group (human, individual animal species and environment). The most commonly identified 
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resistance genes which covered two or more of the host groups were plotted on (Figure 4.6) 
and compared.  
 
A total of 60 unique resistance genes were detected in 149 of the sequenced genomes. All 
genomes carried more than one resistance gene. The most commonly identified resistance 
genes overall included to aminoglycosides, the blaTEM beta-lactamase (ampicillin), multi-drug 
transporters (macrolides-lincosamides-streptogramin), sulfonamides and tetracyclines. There 
was no statistically significant difference (p>0.05, Kruskal Wallis) in the carriage of 12 of the 18 
most prevalent resistance gene between host groups i.e. genes which were carried by each of 
the four animal species, environment, and humans. There were some genes which were absent 
or differed signifincatly in their carriage, and these are highlighted in the text below. 
 
There were two common β-lactamase resistance genes carried amongst the sequenced isolates. 
The more common of the two was blaTEM-1B. This  is extremely common in Gram-negative bacteria 
and confers up to 90% of reported ampicillin resistance in E. coli; the gene was highly prevalent 
in all 6 groups. The other commonly carried resistance gene was blaCTX-M-15, an important 
extended-spectrum β-lactamase, associated with multi-drug-resistance. This gene was carried 
by all animal species except for pigs, as well as in humans and environmental sources.  
 
Relatively few isolates were found to carry a chloramphenicol resistance gene.  
 
Three trimethoprim resistance genes were prevalent amongst all isolates – dfrA7, dfrA10 and 
dfrA14. The dfrA7 resistance gene was carried by isolates in all groups, except for humans. The 
other two genes were carried by isolates in all groups. The dfreA14 gene was the most prevalent, 
followed by dfrA10 and dfrA7. 
 
The multi-drug efflux gene, mdf(A) was isolated in a large proportion of all human, animal, and 
environmental-origin E. coli. The pattern observed is similar to the tetracycline resistance genes, 
tet(a) and tet(b), as the mdf(A) gene is part of the same major facilitator superfamily (MFS). The 
higher prevalence of tet(A) suggests that this is the dominant tetracycline resistance gene, 
conferring much of the tetracycline resistance in all groups. 
 
There was a low prevalence of resistance genes for quinolones and fluoroquinolones. The three 
most prevalent resistance genes are all plasmid-mediated resistance genes which provide low-
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Resistance genes: aminoglycoside: ant(3'')-Ia, aph(3'')-Ib, aph(6)-Id;  ESBL: blaCTX-M-15; non-ESBL: blaTEM-1B; phenicol: catA1; trimethoprim: dfrA10, dfrA14, dfrA7; multi-drug 
exporter: mdf(A); macrolide: mph(A); fluoroquinolone: oqxA, oqxB, qnrS1; sulfonamide: sul1, sul2; tetracycline: tet(A), tet(B). 
Figure 4.6 The proportion of isolates carrying a selection of the 18 most common resistance genes, divided according to source/species. Error bars indicate 95%CI. Resistance 
genes with less than 5% prevalence or found in single groups/species only, were excluded from this figure. 
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level resistance but may integrate with the host chromosome which results in mutations than 
can confer higher-level resistance. The two resistance genes oqxA and oqxB are part of the 
oqxAB gene complex, which encodes for the OqxAB pump; this confers low-level resistance to 
ciprofloxacin and cross-resistance to trimethoprim.   
 
Neither of these resistance genes were found in any environmental isolates but were found in 
low numbers in both human and animal bacteria. The qnrS1 gene is also plasmid-mediated and 
confers low-level resistance to quinolones such as nalidixic acid. No qnrS1 was carried by pig 
isolates, but this gene was more prevalent than oqxAB in all groups. 
 
There was a high prevalence of two sulfonamide resistance genes in all groups. In poultry, 
sheep/goats, humans and the environment, significantly more sul2 (Mann-Whitney U, p<0.01) 
was carried compared with sul1, and there was only a single (pig) isolate which was found to 
carry the sul3 gene (not shown on graph). In all groups, the patterns of sul resistance gene 
prevalence in the respective groups was identical, albeit sul2 having a higher prevalence.  
 
Finally, the mph(A) gene which inactivates macrolides (preferentially inactivating erythromycin, 
telithromycin and roxithromycin) was found in a low proportion of isolates. No mph(A) was 
carried by pig or environmental isolates; the largest proportion was carried by human isolates. 
 
As the ResFinder database only contains a curated list of acquired AMR genes, a search for point 
mutations was made using the PointFinder tool (Zankari et al., 2017). In total, only 11 genomes 
were found to have point mutations which conferred resistance to one or more of nalidixic acid, 
ciprofloxacin and streptomycin. Eight of the point mutations were found in genomes of E. coli 
from livestock and three were from humans. No point mutations were found in environmental 
E. coli genomes. In all three humans, a mutation in gyrA (all S83L) was present, in one human 
there was also two parC mutations (S57T and S80I). In livestock, two genomes had point 
mutations parC gene and four had mutations in the parE gene (I355T), and three genomes also 
had gyrA mutations (S83L and D87N). Additionally (not seen in human isolates), there was a 
single livestock genome which had a mutation in the 16S ribosomal RNA gene (rrnaB) which 
conferred resistance to streptomycin.   
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 4.3.3.4 Virulence Genes 
A total of 49 unique virulence genes were identified in all sequenced genomes. Four isolates 
carried no virulence genes. A brief description of the function of the most common virulence 
genes is described in (Table 4.3). As with the resistance genes, the most commonly identified 
virulence genes which spanned at least two groups were assessed for comparison of prevalence 
(Figure 4.7) using the Kruskal Wallis test.  
 
Table 4.3 Brief description of the function of the most commonly carried virulence genes from a population 
of 145 animal, human and environment-derived E. coli isolates. Original references documented in (Table 
1.1). 
Virulence 
Gene 
Role Function 
gad 
Glutamate 
decarboxylase 
Converts glutamate to GABA; maintains intracellular pH when cells when 
traversing stomach acid – aids in colonisation. 
iss Protectin 
Associated with exPEC strains; increased serum survival associated with serum 
resistance. 
lpfA Adhesin Encodes for chaperone-usher fimbriae used in adhering to gut wall. 
mchF 
Antibacterial 
Peptide 
Produces bacteriocin peptide, microcin. Compete with enteric pathogens by 
mimicking siderophores 
iroN Siderophore 
Scavenges iron from mineral phases of soluble iron complexes for growth and 
maintenance. 
cma Toxin 
Toxin active against various Enterobacteriaceae – causes lysis of cells and 
murein degradation. 
astA Toxin Produces EAST1 toxin resulting in diarrhoea in host organisms. 
eilA Regulator 
Transcription regulator of pathogenicity island SPI1. Activates expression of 
invasin genes. 
 
 
The most commonly identified virulence genes overall included gad, iss, IpfA, air and mchF. In 
addition to these five, only one other virulence gene was carried by all groups of isolates – eilA. 
Most other virulence genes identified in the genomes were limited to two or three groups of 
isolates, with no apparent pattern – e.g. pic and hylE were only found at low prevalence in 
poultry and shoat isolates, whilst K88ab was only found in human and environmental isolates. 
Pig isolates seemed to have the lowest virulence gene diversity compared to other groups. 
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Figure 4.7 The most prevalent virulence genes carried by E. coli from all groups and species. Error bars indicate 95%CI. There was no significant difference between the carriage 
of virulence genes between any source. The 20 most prevalent virulence genes were tabulated and those which covered at least two groups or species were plotted in this 
figure. A short explanation of virulence genes can be seen in (Table 1.1 and Table 4.3). 
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There were some common virulence gene patterns amongst the genomes – the most frequently 
occurring combinations of genes included gad-iss-IpfA (23.5%, n=35), gad-IpfA (12.1%, n=18) 
and cma-gad-iroN-iss-IpfA-mchF (10.7%, n=16).  
 
Overall, three isolates carried more than ten virulence genes: two human isolates: F4H2A (21 
genes), F33H2A (17 genes) and one cattle isolate: F35C3E (18 genes); these isolates carried the 
largest number of virulence genes and were each MDR, however, there was no discernible 
pattern between the number of resistance and number of virulence genes carried. Despite 
carrying the highest number of virulence genes, these isolates carried ten, four and four 
resistance genes respectively; many other isolates carrying fewer virulence genes (e.g. 2) carried 
up to and including 5 or more resistance genes.  
 
4.3.3.5 Plasmids 
Mobile genetic elements such as plasmids are known to carry both resistance and virulence 
genes. These plasmids can disseminate through E. coli populations by horizontal transfer, 
conferring AMR to previously antimicrobial sensitive bacteria. Considering the high prevalence 
of MDR E. coli amongst these isolates (Chapter 4), this could be due to the co-transfer of 
multiple AMR genes on plasmids.  
 
14 different plasmid replicon types were detected in all three groups (livestock, humans and 
environment, Figure 4.8). When combined by replicon type, the most prevalent plasmid 
replicons were IncFIB, followed by IncFII and then IncQ; these three types collectively accounted 
for approximately 66% of the plasmid replicon types detected across all genomes. All the other 
replicon types were found at a low prevalence in human and environmental isolates. In animal 
isolates, replicon type IncY was found in 11.3% (n=33) of isolates, but the remainder of replicon 
types were also found at low prevalence.  
 
Of note was the p0111 plasmid replicon, which was found in the genomes of all three groups. 
Humans carried significantly more of this plasmid (p<0.01, Mann-Whitney U test), compared to 
livestock and the environment. There was only one other significant difference in the carriage 
of plasmids between groups: humans also carried significantly more (p<0.01) IncFII (pRSB107) 
than livestock. There was no other significant difference in the carriage of plasmids in instances 
where one plasmid was found in all three groups.   
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Figure 4.8 Distribution of different plasmid replicon types according to host. Bars are 95% CI. 
 
Analysis of the distribution of AMR genes carried in relation to plasmid replicons types showed 
that most resistance genes co-occurred with ColRNAI, IncFII, IncFIB, IncQ1 and p0111 plasmids. 
IncFII and IncFIB replicons were also often co-carried, suggesting that both replicons may have 
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been be carried on a single plasmid. There was a significant association between the presence 
of ColRNAI and p0111 plasmids, and carriage of mdf(A), sul2, tet(A), aph(3’’)-Ib, aph(6)-Id and 
dfrA1 (χ2 = 8.5, p0.002, Chi-squared test).   
 
To further imply co-carriage of multiple AMR genes, several isolates carrying the same plasmid 
replicon profiles (Table 4.4) showed similarities in the virulence and resistance genes carried by 
the bacterium. For isolates found on the same farm (Table 4.5), there was a higher likelihood of  
observing similarities between resistance and virulence genes, then there was on isolates 
between farms. 
 
Table 4.4 Corresponding virulence and resistance genes carried by three groups of isolates with the same 
plasmid replicon profiles. 
Isolate Species Resistance Genes Virulence Plasmids 
F41G3E Sheep/Goat aadA1  aph(3'')-Ib  aph(6)-Id  blaTEM-1B  dfrA1  dfrA14  mdf(A)  qnrS1  sul1  sul2  sul3  tet(A) 
capU  iss  
lpfA IncFII IncFIB
 
F37P3B Poultry aadA1  aph(3'')-Ib  aph(6)-Id  blaTEM-1B  dfrA1  mdf(A)  sul1  sul2  tet(A) gad  lpfA IncFII IncFIB 
F41P1E Poultry fosA7  mdf(A) 
cma  gad  
iroN  iss  lpfA  
mchF 
IncFII IncFIB 
F32P1A Poultry aadA1 aph(3'')-Ib  aph(6)-Id  dfrA1  dfrA14  mdf(A)  sul2  tet(A) gad  lpfA
 IncHI1B 
F32C1A Cattle aph(3'')-Ib  aph(6)-Id  blaTEM-1B  dfrA7  mdf(A)  sul1  sul2  tet(A) gad  lpfA
 IncHI1B 
F28P2A Poultry aph(3'')-Ib  aph(6)-Id  dfrA14  mdf(A)  sul2 gad  iss  lpfA IncHI1B 
F38C3A Cattle aph(3'')-Ib  aph(6)-Id  blaTEM-1B  dfrA7  mdf(A)  sul1  sul2 
air  eilA  f17A  
f17G  gad  iss IncI1
 
F32C5A Cattle aph(3'')-Ib  aph(6)-Id  blaTEM-1B  dfrA7  mdf(A)  sul1  sul2  tet(A) gad  iss  lpfA
 IncI1 
F32P3A Poultry aph(3'')-Ib  aph(6)-Id  dfrA14  mdf(A)  sul2  tet(A) gad  iss  lpfA IncI1 
  
Table 4.5 Two examples of virulence and resistance genes carried by E. coli isolates from humans and 
animals and the environment, on the same farm ((F)arm 11 and (F)arm 12). 
Isolate Host Resistance Genes Virulence Genes Plasmids 
F11C4E Cattle 
aadA1 aph(3'')-Ib aph(6)-Id blaCTX-M-
15 blaTEM-1B dfrA1 dfrA14 mdf(A) 
qnrS1 sul1 sul2 tet(A) tet(B) 
air celb cma eilA 
gad iha iroN iss 
lpfA mchF 
IncFIA  IncFIB  IncFII 
IncFIB  IncY 
IncB/O/K/Z 
F11P3E Poultry aph(3'')-Ib aph(6)-Id blaTEM-1B dfrA8 mdf(A) sul2 tet(A) tet(B) 
air astA eilA gad 
ireA iroN iss lpfA 
mchF 
IncFII IncFIB 
F11H3CZ Human 
aadA1 aph(3'')-Ib aph(6)-Id blaCTX-M-
15 blaTEM-1B dfrA1 mdf(A) sul1 sul2 
tet(A) 
cma gad iroN iss 
lpfA mchF IncFII IncFIB  IncQ1 
F11H3A Human 
aph(3'')-Ib aph(6)-Id blaCTX-M-15 
blaOXY-2-1 blaTEM-1B dfrA14 fosA7 
mdf(A) qnrS1 sul1 sul2 tet(A) 
astA capU eilA gad 
iss K88ab lpfA 
IncFII IncI1 IncFIB  
IncFII  IncX1 IncY 
F11C4CZ Cattle 
aph(3'')-Ib aph(6)-Id blaCTX-M-15 
blaTEM-1B dfrA14 mdf(A) qnrS1 sul2 
tet(A) 
gad lpfA IncY 
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Isolate Host Resistance Genes Virulence Genes Plasmids 
F11C3CZ Cattle 
aph(3'')-Ib aph(6)-Id blaCTX-M-15 
blaTEM-1B dfrA14 mdf(A) qnrS1 sul2 
tet(A) 
gad lpfA IncY 
F12S2C Sheep/Goat 
aph(3'')-Ib aph(6)-Id blaTEM-1B dfrA1 
dfrA14 dfrA7 mdf(A) sul1 sul2 tet(A) 
tet(B) 
air astA capU eilA 
iss lpfA nfaE IncFIB  IncFII 
F12HOUSE
A Environment 
aph(3'')-Ib aph(6)-Id blaTEM-1B dfrA1 
mdf(A) sul2 tet(B) 
capU gad iss lpfA 
nfaE IncFII  IncFIB 
F12S2B Sheep/Goat aph(3'')-Ib aph(6)-Id blaACT-4 dfrA14 fosA mdf(A) qnrE1 sul2 gad iss lpfA 
IncFII  IncFIB  IncFII  
IncFIB  IncFIA  IncFIB 
F12P3CZ Poultry 
aadA1 aph(3'')-Ib aph(6)-Id blaCTX-M-
15 blaTEM-1B dfrA1 mdf(A) sul1 sul2 
tet(A) 
cma gad iroN iss 
lpfA mchF IncFII IncFIB 
F12S1CX Sheep/Goat 
aph(3'')-Ib aph(6)-Id blaCTX-M-15 
blaTEM-1B dfrA14 mdf(A) qnrS1 sul2 
tet(A) 
gad lpfA IncY 
 
4.3.3.6 Extended-Spectrum Beta Lactamases 
ESBLs are usually associated with MDR bacteria and as such their proliferation within 
communities (and hospitals) is as an important threat to global health. To highlight the potential 
clonal nature of specific clusters of isolates carrying AMR genes conferring the ESBL phenotype, 
a separate phylogenetic tree was constructed (Figure 4.9) and isolates were tabulated to assess 
their resistance profiles (Table 4.6). Due to funding limitations, only a subset of isolates could 
be sequenced, thus, a number of additional analyses of non-sequenced ESBL isolates were 
undertaken by PCR (section 4.3.3.7). 
 
Phylogenetic analysis indicates four distinct clades (marked 1-4 on Figure 4.9) which are very 
closely related (based on 238092 SNP with an average branch length of <0.0007, this suggest 
that they are fewer than 167 SNPs different). Interestingly, one isolate from clade one 
(F18HouseCX) and two (F32C3A) do not share the same serotype, despite having identical MLST 
and plasmids carried.  
 
Clade two primarily consisted of livestock-associated E. coli genomes and a single environmental 
genome. Clade one was much more diverse, with ESBL-producing E. coli being isolated from all 
three host groups (human, livestock and environment), on multiple farms across multiple sub-
counties. Whilst blaCTX-M-15 was the major ESBL gene carried within all of these genomes, there 
was also detection of a two blaCTX-M-14 (one human isolate and one cattle, which were co-carried 
alongside blaCTX-M-15)  and a single blaSHV-41 (isolate from a sheep/goat E. coli) from separate farms.  
 
Whilst not an ESBL, of note was that none of the genomes was found to carry blaCMY AmpC β-
lactamase resistance gene, but a single isolate carried a blaDHA-1.   
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Alongside genes conferring the ESBL phenotype, mobile genetic elements typically carry 
aminoglycoside and quinolone resistance genes also. Interestingly, a number of isolates carrying 
blaCTX-m-15 in conjunction with an IncY plasmid (13 isolates) carried quinolone resistance genes 
(QnrS/B) but did not carry any aminoglycoside resistance genes. Those isolates carrying blaCTX-
M-15 in association with an IncFII plasmid (16 isolates) almost always (14 isolates) carried an 
aminoglycoside resistance gene (aadA1), but only 5 of those isolates also carried any quinolone 
resistance genes. Also interesting was the number and diversity of virulence genes carried by 
ESBL isolates – those with the IncY replicon type carried 3 or fewer virulence genes, whilst those 
with the IncFII replicon type always carried 5 or more. Several unschemed plasmid replicons 
were also detected, including IncX and IncQ. One ESBL isolate was not found to carry any 
plasmids, despite being MDR, this was rechecked using a lower threshold for identification of 
plasmids (of ≥75%). After using a lower threshold for detection, plasmids were discovered. 
Irrespective of the plasmid replicon type, all but a single isolate carrying an ESBL gene were 
MDR. The majority of those MDR phenotypes were similar and reflected the overall most 
common resistance phenotype (TET-SULFA-AMP-TRIM) and the most common 3GC phenotype 
(TET-SULFA-AMP-TRIM-3GC).     
 
Twenty of the O8:H7 isolates also carried the blaCTX-M-15 gene. The majority of these were isolated 
from animal-origin E. coli. There was a significant association (p=0.003, Chi-squared test) with 
carriage of both blaCTX-M-15 and serotype O8:H7 - 13/20 isolates with this combination of genes 
were found in the same sub-county. The most commonly associated STs associated with ESBL-
producing E. coli were ST196 and ST2852. When examine alongside the phylogenetic tree, due 
to the high degree of similarity in carriage of plasmids, resistance genes, and low genetic 
diversity between each genome, there is strong evidence to suggest that the dissemination of 
these four groups of E. coli carrying blaCTX-M-15 may be clonal. Each of the suggested clonal groups 
were isolated predominantly from Nambale and Busia sub-counties (Figure 4.9). Besides ST196 
and ST2852, there were 4 other STs (ST36, ST1421, ST3036 and ST38) associated with carriage 
of blaCTX-M-15, though these were proportionately less representative of this population sample. 
There were some differences in the resistance genes carried by isolates within each ST, though 
the virulence genes in both groups were identical. One isolate carrying blaSHV-41 also had an 
unknown ST but carried many resistance and virulence genes. 
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Figure 4.9 Maximum likelihood tree (1000 bootstraps (black text)) of genomes carrying AMR genes blaSHV-41, blaCTX-M-14 and blaCTX-M-15, which confer the ESBL genotype (n=35). 
Based on 238092 SNPs compared to reference strain E. coli K12 MG1655. All E. coli was isolated on MHA containing ceftazidime (CZ) or ceftriaxone (CX). Four distinct genetically 
non-diverse clades are indicated with bracketed numbers 1-4. These all have branch lengths of lengths of <0.002 (green text). Root is the reference strain (U00096.3). 
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Table 4.6 Details of WGS-only E. coli isolates carrying the blaCTX-M-14, blaCTX-M-15 and blaSHV-41 ESBL resistance genes. Results are clustered by ST, then plasmid replicon type and 
resistance genes. 
Sample ID Host Location ST Resistance Genes Virulence Genes 
Plasmid Replicon 
Type 
F19H3CX Human Nambale 38 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA14 mdf(A)  qnrB19 qnrS1 sul2 tet(A) eilA gad iss IncY 
F18C6CX Cattle Nambale 38 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA14 mdf(A)  qnrS1 sul2 tet(A) eilA gad iss IncY 
F15P5CX Poultry Nambale 46 aadA5 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B catA1  dfrA17 mdf(A)  mph(A) qnrS1 sul1 sul2 tet(A) tet(B) cba cma gad mchF 
IncFIA  IncFIB  
IncFII  IncN  IncQ1 
F18P2CX Poultry Nambale 46 aadA5 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B catA1  dfrA17 mdf(A)  mph(A) qnrS1 sul1 sul2 tet(A) tet(B) cba cma gad mchF 
IncFIA  IncFIB  
IncFII  IncN  IncQ1 
F24H2CX Human Busia 46 aadA5 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B catA1  dfrA17 mdf(A) mph(A) sul1 sul2 tet(B) cba cma gad mchF 
IncFIA  IncFIB  
IncFII  IncN  IncQ1 
F27G2CX Shoat Busia 196 aadA1 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA1  mdf(A)  qnrS1  sul1 sul2 tet(A) cma gad iroN iss lpfA mchF IncFII  IncFIB  IncQ1 
F12P3CZ Poultry Nambale 196 aadA1 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA1  mdf(A)  sul1 sul2 tet(A) cma gad iroN iss lpfA mchF IncFII  IncFIB  IncQ1 
F13HOUSECZ Environment Nambale 196 aadA1 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA1  mdf(A)  sul1 sul2 tet(A) cma gad iroN iss lpfA mchF IncFII  IncFIB  IncQ1 
F13P3CX Poultry Nambale 196 aadA1 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA1  mdf(A)  sul1 sul2 tet(A) cma gad iroN iss lpfA mchF IncFII  IncFIB  IncQ1 
F13WATERCZ Environment Nambale 196 aadA1 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA1  mdf(A)  sul1 sul2 tet(A) cma gad iroN iss lpfA mchF IncFII  IncFIB  IncQ1 
F14C3CZ Cattle Nambale 196 aadA1 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA1  mdf(A)  sul1 sul2 tet(A) cma gad iroN iss lpfA mchF IncFII  IncFIB  IncQ1 
F20P5CZ Poultry Nambale 196 aadA1 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA1  mdf(A)  sul1 sul2 tet(A) cma gad iroN iss lpfA mchF IncFII  IncFIB  IncQ1 
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Sample ID Host Location ST Resistance Genes Virulence Genes 
Plasmid Replicon 
Type 
F30H2CZ Human Busia 196 aadA1 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA1  mdf(A)  sul1 sul2 tet(A) cma gad iroN iss lpfA mchF IncFII  IncFIB  IncQ1 
F18HOUSECX Environment Nambale 196 aadA1 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA1  mdf(A)  qnrS1 sul1 sul2  tet(A) cma gad iroN iss lpfA mchF IncFII  IncFIB  IncQ1 
F11H3CZ Human Bumala 196 aadA1 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA1  mdf(A)  sul1 sul2 tet(A) cma gad iroN iss lpfA mchF IncFII  IncFIB  IncQ1 
F18C1CX Cattle Nambale 196 aadA1 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA1  mdf(A)  sul1 sul2 tet(A) astA cma gad iroN iss lpfA mchF IncFII  IncFIB  IncQ1 
F26P2CZ Poultry Busia 1421 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA14 mdf(A)  qnrB19 qnrS1 sul2 tet(A) gad - 
F29H2CZ Human Busia 1421 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA14 mdf(A)  qnrS1 sul2 tet(A) gad - 
F22G1CZ Shoat Busia 1421 
aadA1 aadA2  aph(3'')-Ib  aph(6)-Id bla CTX-M-14 bla CTX-M-15 
blaTEM-1B cmlA1  dfrA14 fosA3 mdf(A)  qnrB19 qnrS1 sul2 
sul3 tet(A) 
gad IncHI2A  IncHI2 
F11C3CZ Cattle Bumala 2852 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA14 mdf(A)  qnrS1 sul2 tet(A) gad lpfA IncY 
F11C4CZ Cattle Bumala 2852 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA14 mdf(A)  qnrS1 sul2 tet(A) gad lpfA IncY 
F12G2CX Shoat Nambale 2852 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA14 mdf(A)  qnrS1 sul2 tet(A) gad lpfA IncY 
F12S1CX Shoat Nambale 2852 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA14 mdf(A)  qnrS1 sul2 tet(A) gad lpfA IncY 
F15S2CX Shoat Nambale 2852 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA14 mdf(A)  qnrS1 sul2 tet(A) gad lpfA IncY 
F22G1CX 
Shoat Busia 2852 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA14 mdf(A)  qnrS1 sul2 tet(A) gad lpfA IncY 
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Sample ID Host Location ST Resistance Genes Virulence Genes 
Plasmid Replicon 
Type 
F27C1CX Cattle Busia 2852 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA14 mdf(A)  qnrS1 sul2 tet(A) gad lpfA IncY 
F27P7CX Poultry Busia 2852 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA14 mdf(A)  qnrS1 sul2 tet(A) gad lpfA IncY 
F32C3A Cattle Budalangi 2852 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA14 mdf(A)  qnrS1 sul2 tet(A) gad iss lpfA IncY 
F9WATER Environment Bumala 2852 aph(3'')-Ib aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA14 mdf(A)  qnrS1 sul2 tet(A) gad lpfA IncY 
F23H3CZ Human Busia 3036 aph(3'')-Ib aph(6)-Id blaCTX-M-82  blaDHA-1 dfrA17 mdf(A)  mph(A) qnrB4 sul1 sul2 tet(A) gad iha mchB mchC mchF IncFII IncY 
F4H2C Human Bumala Unknown aadA1  aph(3'')-Ib  aph(6)-Id blaSHV-41 dfrA15 fosA  mdf(A)  oqxA  oqxB  sul1 tet(A) 
aaiC aap aar aatA agg3B agg3C agg3D 
agg5A aggR astA gad lpfA mchB mchC 
mchF mcmA ORF3 ORF4 pic sat sepA 
IncFII  IncFIB   IncR 
F11C4E Cattle Bumala Unknown aadA1 aph(3'')-Ib  aph(6)-Id bla CTX-M-15 blaTEM-1B dfrA1  dfrA14 mdf(A)  qnrS1 sul1 sul2 tet(A) tet(B) air celb cma eilA gad iha iroN iss lpfA mchF 
IncFIA IncFIB IncFII 
IncY 
F11H3A Human Bumala Unknown aph(3'')-Ib  aph(6)-Id bla CTX-M-15 blaOXY-2 blaTEM-1B dfrA14 fosA7  mdf(A)  qnrS1 sul1  sul2 tet(A) astA capU eilA gad iss K88ab lpfA 
IncI1 IncFIB IncFII 
IncX1 IncY 
F52H3C Human Teso North Unknown aadA5 aph(3'')-Ib  aph(6)-Id bla CTX-M-15 blaTEM-33  dfrA14  dfrA17 sul2 tet(A) gad iss lpfA IncX1 
F9C4CX Cattle Bumala Unknown aph(3'')-Ib  aph(6)-Id blaACT-7  bla CTX-M-14 bla CTX-M-15 blaTEM-1B dfrA14 fosA3 mdf(A)  qnrB19 qnrS1 sul2 tet(A) 
gad lpfA IncY 
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4.3.3.7 PCR characterisation of ESBL Isolates  
In addition to those isolates which were sequenced, 88 additional isolates (confirmed by ESBL 
double-disc diffusion) were also examined by PCR. All isolates were tested for the carriage of 
blaCTX-M, blaSHV and blaOXA and blaTEM. No isolates carried blaSHV genes, but 26 isolates (29.5%) 
carried blaOXA. All 88 isolates carried a blaCTX-M gene. All 88 isolates also carried blaTEM-1B. A further 
PCR confirmed that 7 isolates (10.2%) belonged to group CTX-M-2 and 81 isolates (89.8%) 
belonged to group CTX-M-1 (the most common of which could have been blaCTX-M-1 or blaCTX-M-
15). Due to the high prevalence of carriage of blaCTX-M, all isolates were subject to another PCR 
assay to determine if they were the pandemic clone, ST131. Five isolates were found to carry 
both the trpa and pabA genes, confirming them as belonging to the pandemic clone ST131. 
These isolates were carried by animals and humans on four different farms across the region. 
Two isolates were found on the same farm (belonging to a human and a goat) and the other 
three isolates were carried by one human, one pig and one cattle on different farms, but 
clustered in one sub-county. No isolates belonging to the ST131 clone were isolated from the 
environment. 
 
4.3.4 Questionnaire Data 
4.3.4.1 Slaughter Practices and Personal Protection Equipment (PPE) 
On-farm slaughter of animals was common in small-holders within Busia county. At the time of 
the questionnaire, 90.0% (n=63) of farmers reported slaughter of one or more animals in the 
previous twelve months. Of these, the majority were poultry (87.1%), all of which were for home 
consumption (100.0%).  During the slaughter process, almost none of the farmers (97.1%) 
indicated they wore any kind of PPE. 
 
4.3.4.2 Animal Sales 
Animal sales were conducted by more than half of the interviewed farmers (57.1%, n=40). 
During the twelve months prior to the questionnaire, the most common animals to be sold or 
traded were cattle (65.0%) and poultry (40.0%). Most commonly, potential buyers or other 
farmers looking to trade would purchase directly from the farm (72.5%), or farmers would sell 
animals at a farmer’s market (15.0%) or, very uncommonly, directly to a butcher (2.5%). 
 
4.3.4.3 Understanding of Antimicrobials, Resistance & Withdrawal Periods 
Participants were asked numerous questions regarding what they understood by the terms 
‘antimicrobial’, ‘withdrawal periods’ and ‘antimicrobial resistance’. In contrast with the previous 
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questionnaire, these terms were generally not well understood (Table 4.7). Several farmers 
confused antimicrobials with a type of disease. The majority of farmers did not understand or 
recognise the term ‘antibiotic or antimicrobial resistance’ and only a small minority understood 
or recognised that antibiotic treatment in animals required them to adhere to a withdrawal 
period.    
 
When the question was rephrased as “How did you know how long to wait after treating with 
antibiotics, before consuming, slaughtering or selling animal products?” more than one-third of 
farmers (35.7%, n=25) informed us that a doctor had told them how long to wait before they 
could safely sell animal products or consume them. 
 
4.3.4.4 Disease Profiles and Disposal of Infected Animals 
Animal deaths in the twelve months preceding the follow-up questionnaire were quite common, 
61.4% of farmers (n=43) reported no deaths in their animals, meaning that animals had died on 
27 farms. A total of twelve diseases were reported, each affecting less than 5 animals, including 
fowlpox (8.6%, n=6), infected wounds (4.3%, n=3) and foot and mouth disease (2.9%, n=2). The 
questionnaire did not contain a question to quantify the diseases associated with animal deaths. 
Of those animals that died, many farmers chose to bury the animal (47.1%, n=33) on their 
property, however, some farmers opted to consume the deceased animal (12.9%, n=9). The 
remaining farmers buried animals some distance from their farm. A large majority of animals 
had developed some clinical signs of gastrointestinal disease within 3 months of the 
questionnaire. Common clinical signs reported in animals included diarrhoea (78.6%), bloody 
diarrhoea (38.6%), weight loss (55.7%) and general weakness.  
 
4.3.4.5 Animal Treatments   
In the prior three months, approximately half of farmers said they had purchased antibiotics 
(52.9%, n=37) for the specific treatment of animals. Many farmers reported they had not used 
antibiotics (42.9%, n=29) in the 3 months prior to the questionnaire. The majority of farmers 
purchased antimicrobials directly from AHAs (81.4%, n=57) or from agrovets (52.9%, n=37), or 
a combination of the two.  
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Table 4.7 Volunteered responses to questions asked regarding understanding of antimicrobials during the 
pre-sampling questionnaire 
 
The most common antimicrobials used in treating animals included oxytetracycline (62.2%, 
n=23) and penicillin-streptomycin (29.7%, n=11) and sulfonamides (5.4%, n=2). When using 
injectable antibiotics (including penicillin-streptomycin and oxytetracycline), more than half of 
farmers used the same needle/syringe for all animals and all antimicrobials (55.7%, n=39). About 
two-thirds washed the needle and syringe between animals and when changing antimicrobials 
(65.0%, n=26).  
 
Farmers often opted to treat single animals when they became ill (57.1%, n=40), opposed to the 
entire herd, however, less than half of farmers decided to separate the ill animal (42.9%, n=40) 
from the rest during treatment. Vaccinations were given to animals shortly after birth or 
purchase (60.0%, n=42) in more than half of cases, though usually only to poultry and cattle. 
 
Question Responses 
Farmer 
Number 
(n) 
Percentage 
(%) 
In your own words, can you 
describe what an antibiotic is? 
A disease 29 41.4% 
A drug 10 14.3% 
Don't Know 10 14.3% 
Treatment for bacterial infection 10 14.3% 
Treat (nonspecific) disease 6 8.6% 
Prophylactic drug 2 2.9% 
A Painkiller 1 1.4% 
Treatment for viral infection 1 1.4% 
In your own words, can you 
describe what you understand 
by ‘antibiotic resistance’? 
Don't Know 57 81.4% 
The antibiotic has no effect - treatment failure 5 7.1% 
Due to noncompliance with dosage 3 4.3% 
Confusion with "tolerance" 1 1.4% 
Due to extended use 1 1.4% 
Short reoccurrence period 1 1.4% 
The antibiotic has no effect - confused with 
antimalarial 1 1.4% 
The antibiotic has no effect - requires vaccination 1 1.4% 
In your own words, can you 
describe what an ‘antibiotic 
withdrawal period’ is? 
Don't Know 50 71.4% 
Time to wait after treatment before consuming milk 
only - unknown time 5 7.1% 
Time to wait after treatment before consuming any 
products - incorrect time 4 5.7% 
Time to wait after treatment before consuming meat 
or milk only 3 4.3% 
Knows, but ignores withdrawal period 2 2.9% 
Time to wait after treatment before consuming any 
animal products - correct time 2 2.9% 
Time to wait after treatment before consuming milk 
only 1 1.4% 
Time to wait before consuming milk - gives to 
animals during withdrawal period 1 1.4% 
Time to wait until last dose given 1 1.4% 
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4.3.4.6 Human Health & Hygiene Practices 
No large livestock were allowed access to the inside of the housing (living spaces/kitchen etc.) 
however, all farmers noted that poultry had access, and regularly did enter the households. 
 
Almost all farmers indicated that their toilet facilities were deep pits, located outside of the 
house, on the farm (97.1%, n=68). Defecation almost always occurred in the latrine, except in 
some cases where defecation would occur whilst attending to crops on the farm (5.7%, n=4), 
due to the distance from the household. The interviewer noted that in most cases, the latrine 
was in close proximity to animal shelters, or in areas where animals could wander freely (97.1%, 
n=68). 
 
Most farmers indicated that they have almost daily contact i.e. 6-7 days per week, with any sort 
of animal on their farms (92.8%, n=65). However, hygiene practices reported were good, 71.4% 
of farmers (n=50) stated that they washed their hands after touching animals; 90.0% of farmers 
washed their hands with soap and water before eating and/or cooking meals (n=63), and 88.6% 
of farmers washed their hands after using the latrine (n=62). Wastewater, used for 
handwashing, cooking and feeding animals was not routinely treated (14.3%, n=10) before 
discarding onto the farm. 
 
Farmers also reported various gastrointestinal illnesses within the previous 3 months. These 
included diarrhoea (54.3%, n=38), abdominal pain (22.9%, n=16), typhoid (14.3%, n=10) and 
general nausea (10.0%, n=7). Of these people, 91.5% (n=43) opted to purchase some treatment, 
mainly from a doctor (67.4%) or from a hospital (23.3%). Of those who sought treatment, 30 
farmers received antibiotics and 1 received proton-pump inhibitors. Antibiotics reported 
included metronidazole (41.9%, n=13), ciprofloxacin and amoxicillin (both 16.1%, n=5), 
Augmentin (amoxicillin + clavulanic acid) (6.5%, n=2) and ceftriaxone, cephalexin, and 
erythromycin (all 3.2%, n=1). Ten farmers (32.3%) did not recall what they were prescribed.  
 
4.3.5 Risk Factor Analysis 
4.3.5.1 Univariable Analysis 
Initial univariable analysis revealed 22 potential explanatory variables for inclusion in multilevel, 
multivariable models (p<0.25) of the 6 resistance outcomes - multi-drug resistance (MDR), 
extended-spectrum β-lactamases (ESBL), tetracycline (TET), sulfathiazole (SULFA), ampicillin 
(AMP) and trimethoprim (TRIM) resistance. However, only a small number of significant 
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(P<0.05) variables were identified (Table 4.8). There were no variables that were consistently 
significant across all resistance outcomes, though several explanatory variables were associated 
with more than one outcome. As the prevalence of resistance to 3 of the resistance outcomes 
(chloramphenicol, gentamicin, and ciprofloxacin) was less than 10% of tested samples these 
were not included in these analyses.   
 
To avoid multicollinearity, tests for correlation (Pearson’s correlation coefficient, correlation 
matrices) between explanatory variables were examined. There were no highly correlated 
variables (<-0.3 or >0.3) detected which were used in any models.  
 
4.3.5.2 Multivariable Analysis 
Mixed effect logistic regression models were undertaken with each of the 6 resistance 
outcomes.  Individual sample level outcomes were clustered within farms and the region (sub-
county). Species was included in each model as a fixed effect. The MDR and AMP outcomes each 
had two significant explanatory variables (p<0.05) which were the farm also having a positive 
environmental ESBL sample and use of penicillin-streptomycin in the previous 3 months. The 
SULFA, TET and TRIM outcomes each had a single explanatory variable: farm size for SULFA and 
animals vaccinated for TET and TRIM (Tables 4.9 and 4.10). The ESBL outcome had no 
statistically significant explanatory variables. For those models which had multiple explanatory 
variables, there were no significant interactions identified.  
 
Antibiotic use in the last 3 months was associated with two outcomes.   
 
Animals being vaccinated when born or acquired was also associated with two outcomes – with 
increased risk of tetracycline resistance and trimethoprim resistance.  
 
After allowing for clustering within farms there were few significant differences between 
species; humans were significantly at higher risk of MDR compared to cattle and humans and 
sheep and goats were at higher risk of sulphonamide and trimethoprim resistance.  
 
From the mixed effects models, the variances at the sub-county level were generally small, apart 
from tetracycline. There was greater evidence of within-farm clustering, particularly with 
respect to ESBL and tetracycline outcomes. Farm level residual plots for all resistance outcomes 
(Appendix II, Figure II-iii) showed that 7 and 2 farms, respectively, were significantly different 
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from the overall mean. Secondary examination of the data from those outlying farms showed 
that they all contained at least one sample which was positive for ESBL and tetracycline 
resistance. There was a low prevalence of ESBL resistance, so it is plausible that some farms with 
positive ESBL samples may be outliers. However, there was a high prevalence of tetracycline 
resistance, and so it is unclear why the variance at farm level was found to be disproportionately 
high. All data from all farms was rechecked before accepting the model and validated 
independently by Gina Pinchbeck.  
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Table 4.8 Univariable analysis of explanatory variables, for inclusion in multivariate models of risk factors 
for carriage of AMR or ESBL-producing E. coli in human, animal and environmental populations. 
Explanatory Variables MDR ESBL TET SULFA AMP  TRIM 
Species 
Cattle             
Human             
Poultry             
Pig             
Sheep/Goats             
Environmental Sample MDR 
No             
Yes             
Environmental Sample ESBL 
No             
Yes             
Gender 
Female             
Male             
Age 
18-24             
25-44             
45-64             
<65             
Farm Size Mean             
Knowledge of Antibiotics 
Don't Know             
Good             
Bad             
Knowledge of Antibiotic 
Resistance 
Don't Know             
Good             
Knowledge of Antibiotic 
Withdrawal Periods 
Don't Know             
Some             
Good             
Actively Ignores             
Animal had Mastitis Last 12 
months? 
No             
Yes             
Animal had Diarrhoea in the last 
12 months? 
No             
Yes             
Animal had diarrhoea in the last 3 
months? 
No             
Yes             
Animal had Bloody diarrhoea in 
the last 3 months? 
No             
Yes             
Animals Vaccinated (when 
acquired/born)? 
No             
Yes             
When ill, treat all animals or 
single? 
Single Animal             
Whole Group             
Separate Ill animals? 
No             
Yes             
Bought Tetracycline in the last 3 
Months? 
No             
Yes             
Bought Penicillin-streptomycin in 
the last 3 months? 
No             
Yes             
Used Tetracycline in the last 3 
months? 
No             
Yes             
Used Penicillin-streptomycin in 
the last 3 months? 
No             
Yes             
Use the same needle/syringe for 
all antibiotics/animals? 
No             
Yes             
Main water source 
Taps             
Borehole/Well             
River/Lake             
Rainwater             
MDR = multi-drug resistance, ESBL = extended-spectrum β-lactamases, TET = tetracycline, AMP = ampicillin, TRIM = 
trimethoprim, SULFA – sulfathiazole, CHLOR = chloramphenicol. Grey shading: p<0.25, Black shading: p<0.05. 
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Table 4.9 Mixed effect logistic regression models of risk factors associated with multi-drug resistance, ESBL production and ampicillin resistance in E. coli isolated from faeces 
of animals and humans, and E. coli isolated from water and environmental sources in Busia, Kenya. 
 MDR ESBL AMP 
Variable Category β SE OR 95%CI p β SE OR 95%CI p β SE OR 95%CI p 
Species 
Cattle (ref) - - - - (ref) - - - - (ref) - - - - 
Human 0.699 0.239 2.011 1.258-3.215 0.003 0.076 0.359 1.079 0.534-2.18 0.832 0.343 0.239 1.409 0.882-2.251 0.151 
Poultry 0.191 0.207 1.21 0.806-1.817 0.357 -0.13 0.324 0.878 0.465-1.658 0.689 0.059 0.207 1.061 0.707-1.593 0.774 
Pig -0.108 0.315 0.898 0.484-1.665 0.732 0.24 0.476 1.271 0.501-3.23 0.614 -0.074 0.309 0.928 0.506-1.702 0.81 
Sheep/go
ats 
0.463 0.262 1.589 0.951-2.654 0.077 0.484 0.379 1.622 0.772-3.409 0.202 0.467 0.268 1.595 0.943-2.697 0.081 
Environment ESBL 
No (ref) - - - - - - - - - (ref) - - - - 
Yes 3.139 1.102 23.084 2.664-200.01 0.004 - - - - - 0.343 0.239 17.35 
2.127-
141.562 
0.008 
Used Penicillin-
streptomycin in the 
last 3 months? 
No - - - - - - - - - - (ref) - - - - 
Yes 0.561 0.195 1.753 1.197-2.567 0.004 - - - - - 0.536 0.187 1.71 1.184-2.468 0.004 
Variance Estimate 
Region 0.015(0.036) 0.035(0.158) 0.023(0.041) 
Farm 0.150(0.104) 1.207(0.427) 0.068(0.090) 
P-values in bold are statistically significant (p<0.05) values from the Wald Chi squared test; OR = Odds Ratio; SE = Standard Error; 95%CI = 95% Confidence Intervals. Variance Estimate = 
Variance (Standard Error). 
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Table 4.10 Mixed effect logistic regression models of risk factors associated with sulfathiazole, tetracycline and trimethoprim resistance in E. coli isolated from faeces of animals 
and humans, and E. coli isolated from water and environmental sources in Busia, Kenya. 
  
  
SULFA TET TRIM 
Variable  Category β SE OR 95%CI p β SE OR 95%CI p β SE OR 95%CI p 
Species 
Cattle (ref) - - - - (ref) - - - - (ref) - - - - 
Human 1.47 0.308 4.351 2.379-7.958 <0.001 0.541 0.491 1.718 0.656-4.5 0.271 1.178 0.300 3.247 1.803-5.846 <0.001 
Poultry 0.341 0.225 1.406 0.905-2.184 0.13 -0.521 0.346 0.594 0.302-1.17 0.132 0.327 0.229 1.387 0.886-2.171 0.153 
Pig 0.447 0.356 1.564 0.779-3.14 0.209 0.682 0.683 1.978 0.519-7.539 0.317 0.311 0.357 1.365 0.677-2.751 0.384 
Sheep/go
ats 
0.712 0.298 2.038 1.135-3.658 0.017 0.871 0.581 2.389 0.764-7.467 0.134 0.668 0.304 1.95 1.074-3.539 0.028 
Farm Size Mean 0.012 0.006 1.012 1.001-1.023 0.033      - - - - - 
Animals 
Vaccinated 
No - - - - - - - - - - (ref) - - - - 
Yes - - - - - 0.9 0.452 2.46 1.014-5.97 0.047 0.015 0.006 1.016 1.003-1.028 0.012 
Variance 
Estimate 
Region 0.259(0.198) 0.688(0.572) 0.266(0.203) 
Farm 0.469(0.186) 1.187(0.524) 0.471(0.189) 
P-values in bold are statistically significant (p<0.05) values from the Wald Chi squared test; OR = Odds Ratio; SE = Standard Error; 95%CI = 95% Confidence Intervals. Variance Estimate = 
Variance (Standard Error). 
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4.4 Discussion 
This study investigated the carriage and prevalence of AMR E. coli associated with humans, 
animals, and their shared environments in a smallholder crop-livestock system in western 
Kenya, part of the wider Lake Victoria crescent ecosystem. E. coli was isolated from the faeces 
of farmers and four species of farm animal commonly kept in the region, as well as from the 
living and cooking areas of farmers’ houses, and the main water source at each farm. The 
potential risk for the transmission of antimicrobial-resistant bacteria between animals, or 
animal food products and humans in sub-Saharan Africa has been highlighted before, however, 
from this region, no data on the spread of AMR determinants between human and animal 
reservoirs have been published (Alonso et al., 2017). The results of this study indicate a high 
prevalence of AMR, as well as a high level of diversity in the E. coli isolated, within and between 
hosts, according to their genetic makeup and carriage of virulence and resistance genes. This 
the first study investigating the prevalence of faecal-carriage of antibiotic-resistant E. coli in 
farm animals, farmers, and their associated environments, in western Kenya. Busia is a relatively 
poor county which borders Uganda to the west. A large proportion of people were traditional 
subsistence, small-holder farmers, but there has been a recent shift towards business-oriented 
farming. As such, more farmers are increasing the number of livestock they own. 
 
There was a high prevalence of AMR E. coli isolated from the faeces of humans and animals, as 
well as from the environment. More than half of all isolates were MDR (53.6%, 95% CI 50.0% – 
57.2%) which is a higher prevalence that is reported in studies in other Kenyan sub-counties. In 
Kitale sub-country, AMR E. coli in human clinical gastroenteritis cases showed a lower 
prevalence of MDR E. coli (42.2%) (Kipkorir et al., 2016) than our human population estimate of 
58.5% (95% CI 54.9% - 62.1%). Conversely, another study examining E. coli in the gut of Ugandan 
pastoralists, showing that approximately 57.0% of isolates were MDR  (Stanley et al., 2018), 
similar to our estimate. Human isolates in this study were also found to carry a high proportion 
of trimethoprim and sulfathiazole-resistant E. coli, with a prevalence of 84.6%, which is higher 
than in a parallel study conducted in Nairobi, who reported a rate of 46.7% MDR amongst 
humans (Muloi et al., 2019b). Use of trimethoprim and sulfa drugs as prophylaxis in persons 
infected with HIV (approximately 32% according to Kwena et al) may account for a proportion 
of the described resistance, as Busia county and other coastal areas are considered to be a high-
risk area for HIV transmission (Kwena et al., 2019).    
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There was also a high prevalence of AMR-E. coli found in food-producing animals. There was 
moderate to high prevalence of resistance to tetracycline, sulfathiazole, ampicillin, and 
trimethoprim, in all animals however as with the human population, there was a lower 
prevalence to ciprofloxacin, chloramphenicol and gentamicin. Sheep and goats in this study had 
higher carriage of MDR compared to non-human species (though this was not significantly 
different). The high prevalence of MDR and AMR-E. coli in goats and sheep is difficult to explain; 
deposited faeces from cattle and poultry were typically collected from across the entire farms, 
however, in the case of goats and sheep and pigs, faeces were usually limited to enclosures or 
pens. Goats and sheep are not always limited to pens though, and during the day may migrate 
across shared grasslands or within the farm to graze. Other studies suggest that animals raised 
in poor hygienic conditions (e.g. cramped in small areas) were more likely to carry AMR E. coli 
(Rehman et al., 2014; Islam et al., 2016), and pens on some of the visited farms were heavily 
littered with shoat faeces. A similar pattern was found in Ugandan livestock – E. coli from goat 
faeces showed a higher proportion of sulfa-drug resistance (87.5%) than in cattle, pigs or poultry 
(Okubo et al., 2019).  
 
In groundwater and surface water sources (including boreholes, wells and rainwater) in Isiolo 
county in Kenya, E. coli was isolated from 22.9% and 36.8% of sources, respectively (Onyango et 
al., 2008). This rate of isolation of E. coli (21.4%), in our study was similar, even though most of 
the E. coli was isolated from wells and boreholes. No phenotypic resistance was identified to 
ciprofloxacin or gentamicin in water or environmental boot swab isolates, although sample sizes 
were small; in other studies, boot swabs are routinely taken from animal enclosures when 
sampling (Nilsson et al., 2014; Gundran et al., 2019), however, our study opted to take swabs 
from the inside of houses, to specifically asses if bacteria were being brought in via humans or 
animals entering households. Resistance to chloramphenicol was the most prevalent in 
environmental samples (25.0%), though due to the low number of samples cultured confidence 
interval are wides. Although humans and poultry were the only two populations to have access 
to the insides of houses, there was no inflated prevelance of chloramphenicol resistacne in 
humans or poultry, compared to other hosts. There was a similar proportion of AMR E. coli in 
water isolates as there was in humans and animals, however isolation of E. coli from water (and 
the environment) was relatively low. These findings do still suggest that contamination of water 
in boreholes and wells may be occurring and that environmental sources present a risk of 
exposure. This is documented in the literature and is usually attributed to organic and faecal 
pollution of water sources; antimicrobial residues in faeces may be leaching into the soil, which 
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in turn leach into boreholes (Chen et al., 2017; Manyi-Loh et al., 2018; Cycoń et al., 2019); during 
the wet season in western Kenya, the water table may be close to the surface (Ogege. J, 2001).  
 
There were 43 different resistance phenotype patterns identified from all groups. The most 
common phenotype (TET-SULFA-AMP-TRIM) represented approximately one-third (32.4%) of 
all isolates (20.4% in humans, 15.0% to 30.0% in animal species, and 3.4% in environmental). 
Differing farm management practices and geographical locations have been shown to influence 
genetic diversity and the presence of AMR genes in commensal E. coli in pigs  (Leistner et al., 
2013), thus it is likely that this occurs in other animal populations too. High frequencies of 
tetracycline, streptomycin and trimethoprim/sulfamethoxazole resistance have been 
increasingly described in E. coli of animal origin, especially from poultry and pigs (Badi et al., 
2018), but there is less chloramphenicol resistance being reported. Environmental factors such 
as selection pressure caused by administration of antimicrobials may lead to upregulation of 
previously silenced genes, which results in phenotypic resistance to these antimicrobials (Card 
et al., 2013). Use of chloramphenicol in food-producing animals was banned in Kenya in 1994, 
according to the European Decision 2003/181/EC) (Wesongah et al., 2012), though it is possible 
that they are still being used privately, or the genes are remnants of high fitness-cost 
effectiveness. Indeed, from (Chapter 3) there were no reported sale or by proxy, use, of 
chloramphenicol to treat animals, neither were there any packaging observed in waste piles. 
Despite this, it is still avaial for purchase in some LMICs, without prescription, for use in animals. 
It has been shown that chloramphenicol resistance genes are transmissible on plasmids 
between E. coli in Kenyan farm animals (Kikuvi et al., 2007).  
 
As part of this study, several major databases were compared to determine the concordance of 
detected resistance and virulence genes in E. coli genomes. There was some concordance in 
commonly identified resistance genes between three different databases – ResFinder, NCBI and 
CARD, but there were also genes reported at vastly different frequencies, e.g. no detected 
chloramphenicol genes when using the CARD database, and no multi-drug efflux exporters 
(mdf(A)) reported by the NCBI database. One possible explanation for the discordance found 
between the investigated methods is that despite downloading the most recent databases for 
each method, those databases may not have contained identical genes. This may have led to 
false-negative WGS predictions. The need to continuously update curated resistance genes 
databases is a difficult challenge for bioinformaticians; indeed, as WGS and NGS become more 
common, it is likely that many novel mutations will be identified within resistance genes. 
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Alternatively, some discordance could be attributed to the specific methods used by each piece 
of software. Programs such as ResFinder use a method based on assembling WGS reads and 
then using BLAST to identify resistance genes (Zankari et al., 2012). By using this approach, it is 
possible that the prevalence of genes can be underreported where they are split across multiple 
assembled contigs, or in some cases, Blast may have a higher chance of detecting one of multiple 
closely related genes. The takeaway message from this comparison was that there is a trade-off 
between the required sensitivity and specificity to accurately detect genes and their variants. 
For instances where there was large discordance (such as detection of the mdf(A) gene), it may 
be appropriate in future studies to combine the curated databases used in each of the described 
methods, and then screen assemblies or mapped reads to this database. 
 
Phylogenetic reconstruction of genomes showed that a diverse array of STs and serotypes was 
dispersed amongst the isolates. The most prevalent ST was ST196 which has been linked to E. 
coli isolated from human faeces, livestock and food, which carry blaCTX-M-15, in studies in Germany 
and Cambodia (Fischer et al., 2014; Stoesser et al., 2015). Isolates belonging to ST196 showed 
highly similar resistance patterns and formed their own clade with almost no genetic distance 
(less than 150 SNPs) between them on a phylogenetic tree (Figure 4.6). Due to their low genetic 
variation and close distance on phylogenetic trees, it is likely that some of these have since 
acquired additional resistance or virulence genes, explaining their slight variation. This shows 
evidence of sharing of bacteria between hosts but does not help to infer directionality. The 
second most common ST was ST2852 (10 isolates), and these isolates also formed a distinct 
clade on a phylogenetic tree (Figure 4.6), with low genetic difference. All ST2852 isolates carried 
identical virulence and resistance genes, as well as the same plasmid replicon type (IncY), 
indicating these isolates may be clonal in nature, and are being disseminated amongst humans, 
cattle, sheep, goats, poultry, and their shared environments. As with isolates reported in various 
farm animals in Tanzania (Seni et al., 2016b), these clones all carried the blaCTX-M-15 resistance 
genes, as well as those encoding aminoglycoside, sulfa-drugs, trimethoprim, fosfomycin and 
tetracycline resistance.  
 
These findings suggest that multiple clones (or extremely closely related  bacteria) of ST196 and 
ST2852 may be circulating in the community, likely as intestinal commensals. Due to the carriage 
of blaCTX-M-15 and numerous resistance genes, they warrant further investigation to determine 
their origin. By merging the WGS data collected as part of this study (Chapter 4) and using 
additional WGS from other studies (if available) within western Kenya, it may be possible to try 
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to map the evolution of the resistance genes over time using Bayesian analysis of molecular 
sequences, with a relaxed clock model. 
 
Three additional STs were also found, including ST10, ST155 and ST38. ST10 is found in a broad 
range of hosts and has been described as a pandemic ExPEC lineage (Manges et al., 2019) being 
recorded most third-most frequently (after ST131 and ST69) in human clinical isolates, as well 
as meat products and food animals (Oteo et al., 2009; Cortes et al., 2010; Cohen Stuart et al., 
2012; Peirano et al., 2012). The ST10 E. coli isolated from animals were all (but one) MDR; these 
isolates carried large numbers of resistance genes (up to 12), but none carried an ESBL 
resistance gene. Isolates also carried many virulence genes (up to 21). ST155 has also been 
associated with human (ExPEC infections) and animals worldwide (Maluta et al., 2014; 
Matamoros et al., 2017). Isolates belonging to this ST were isolated from both environmental 
and animal sources, and were all (but one) MDR, carrying up to 13 resistance genes. None of 
these isolates carried an ESBL resistance gene. Finally, ST38, a successful enteroaggregative E. 
coli associated with urinary tract infections (Chattaway et al., 2014), was found in cattle, goats, 
poultry and humans. Two of these isolated also carried blaCTX-M-15 gene, but very few EAEC-
associated virulence genes, suggesting that these isolates were not EAEC.  
 
The majority of E. coli isolates belonged to phylogroups A, B1, B2 and D; these strains vary in 
their phenotypic and genotypic characteristics, ecological niche, and propensity to cause 
disease (Tenaillon et al., 2010). The majority of isolates which could be phylotyped, belonged to 
groups A and B1; in tropical climates and LMICs, human commensals are predominantly A and 
B1 (Escobar-Paramo et al., 2004) whereas animal commensals are usually B1 (Carlos et al., 
2010). This fits with our findings and indicates that there may be some association between 
phylogenetic groups and host species. It has been suggested in the literature that extraintestinal 
pathogenic strains of E. coli mainly belong to phylogroups B2 and to a lesser extent, D (Mora et 
al., 2009; Shaer et al., 2018). As relatively few of the isolates were found to be non-A or B1, it 
can be assumed that the sample consisted largely of commensal and non-pathogenic E. coli. 
Phylogroup E was detected in livesotkc isolates only, though there appears to be little literature 
which describes the association between phylogroup E and potential pathogenic or non-
pathogenic strains, thus there is uncertainty as to whether there is any relevance in this finding. 
One isolate of the newly discovered phylogroup G was also found during re-scanning of all reads 
using a newer ClermonTypying database (February 2020). Phylogroup G are isolates with high 
resistance and virulence potential (Clermont et al., 2019), and indeed this isolate carried a large 
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number of resistance (10) and virulence (8) genes. As this re-analysis was performed some time 
(almost two years) after the original results were compiled, this highlights the need to re-
evaluate historic data, to assess if existing epidemiological assumptions are still correct. The 
presence of a new phylogroup G isolate could be worrisome for public health if it is able to 
spread, or indeed acquire additional AMR genes, such as multiple ESBL genes.       
 
All isolates were also serotyped – there was a wide diversity of serogroups represented in this 
dataset, with 111 unique O:H groups reported. By itself, the most common O antigen was  O8; 
O8 antigens are commonly associated with ETEC, which causes serious foodborne infections in 
humans (Kaper et al., 2004). The most common H antigen was H7, which is famous for its 
association with O157:H7, a foodborne STEC strain which causes severe bloody diarrhoea and 
kidney failure (Lim et al., 2010).  The most commonly occurring serotype was O8:H7 and this 
was found predominantly in animal isolates. All O8:H7 isolates were MDR, carrying 
combinations of β-lactamase, fluoroquinolone, sulfonamide, tetracycline, aminoglycoside, and 
trimethoprim resistance genes. Most isolates identified in the large ST2962 and ST196 clades 
were also serotype O8:H7. Isolates carrying blaCTX-M genes, in association with serotype O8:H7 
have also been described in low prevalence on Japanese Dairy farms (Ohnishi et al., 2013). The 
number of resistance genes carried by these bacteria is worrying, as there is potential for these 
to rapidly disseminate to other animals, humans, and parts of the country.  
 
Isolates to be sequenced were pseudo-randomly selected as previously described. Analysis of 
resistance genes carried by all isolates showed a high diversity carried by E. coli. It was typical 
for several resistance genes to be found together – usually, aph(6)-1d/aph(3”)-1b were found 
together with sulfonamide, tetracycline and trimethoprim resistance genes, sul2/sul1, 
tet(A)/tet(B) and dfrA, respectively. It is likely that many of these resistance genes are carried 
on the same or similar plasmids, as many of the isolates carried IncFII or IncFIB plasmids. Low 
carriage of mph(A) (6.6%) is representative of the relatively low use of macrolides, but appears 
to be lower than the average carriage found by Nguyen et al, in five sub-Saharan African 
countries including Niger and Senegal (Phuc Nguyen et al., 2009). The proportion of dfrA genes 
also appeared to be dissimilar from the rates in neighbouring Tanzania, where significantly 
higher proportions (73.7%) of dfrA genes encoding trimethoprim resistance in commensal E. coli 
isolated from cattle and humans were reported (Galdiero et al., 2016), compared to our study 
(<50%). Fosfomycin resistance genes, fosA were discovered in only 7.2% of isolates – this is likely 
because antimicrobials containing fosfomycin were the most expensive type of product, 
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according to our prior questionnaire data (Chapter 3); and only approximately 8% of agrovets 
stated that they regularly sold fosfomycin-containing products. The low prevalence of 
fosfomycin resistance gene detection is in line with published figures for E. coli genomes (4.6%) 
(Ito et al., 2017). Where resistance genes were carried by all groups of isolates, there were 
almost no significant differences between their carriage. This suggests that patterns of AMR 
genes are similar between humans, animals, and the shared environment in this population.  
 
Alongside resistance genes, 49 unique virulence genes were carried by E. coli. There were no 
discernible patterns between the number of virulence genes carried, between animal species, 
humans, and the environment either between farms or within farms. Interestingly, even animals 
which were kept in the same housing or enclosures were found to carry different virulence 
genes. On one farm an E. coli isolated from a cow carried 18 virulence genes (F35C3E), and a 
human isolate and a poultry isolate carried only three and six virulence genes, respectively. 
Another isolate carried 21 virulence genes (F4H2C), as well a large number of resistance genes, 
including blaSHV-41. To our knowledge, this genotype, in association with a large number of 
virulence genes has not previously been reported in the literature, and may be of importance if 
it continues to spread. The three most commonly carried virulence genes carried by all groups 
include gad, iss and IpfA. The gad gene (encoding glutamate dehydrogenase) was the most 
prevalent virulence gene identified, with 92.8% of isolates carrying it. Gad is highly prevalent in 
both pathogenic and non-pathogenic E. coli isolated from both humans and animals; it is the 
most efficient acid resistance system in E. coli (Large et al., 2005) and is vital in maintaining 
physiological pH when passing through highly acidic environments, such as the stomach. The iss 
gene encodes proteins which are involved in increasing serum survivability and resistance to 
serum complement. They were first described in the ColV plasmid and are typically associated 
with APEC and UPEC (Nolan et al., 2003; Askari Badouei et al., 2015). Whilst particularly 
prevalent amongst our poultry samples (71.4% carriage), iss was also commonly detected in all 
other animal species, as well as in humans. Interestingly, 25.9% of isolates carrying iss also 
carried iroN which is a siderophore, important for scavenging iron from host tissues. This is also 
associated with ExPEC (including APEC), NMEC and UPEC from numerous species (Ewers et al., 
2007; Najafi et al., 2019). Finally, the IpfA gene, carried by 68.4% of isolates, encodes for long 
polar fimbriae which are involved in increased adhesion to epithelial cells (Toma et al., 2006) 
and resulting diarrhoea caused by EHEC and EPEC (Afset et al., 2006; Dogan et al., 2012).  
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IncF plasmids routinely carry both virulence and resistance genes, and a number of E. coli 
pathotypes are characterised by the carriage of toxins, adhesins and siderophores that are 
encoded by IncF plasmids (Johnson and Nolan, 2009). The most commonly identified plasmid 
and replicon type was IncFIB, which is sporadically reported in the literature, and is thought to 
have resulted from recombination events between other IncFII plasmids (Coque et al., 2008b; 
Partridge et al., 2011). IncFII plasmids were the second most commonly carried plasmid, 
followed by IncQ. Plasmids belonging to the IncQ incompatibility group are able to replicate in 
a broad range of bacterial hosts (Rawlings and Tietze, 2001), but are not widely reported in the 
literature in association with E. coli. IncF plasmids have previously been identified as carrying 
virulence genes and they have also been associated with carriage of blaCTX-M-15 that is often 
associated with blaTEM-1, blaOXA-1, and aac(6ʹ)-Ib-cr resistance genes (Carattoli, 2009). Indeed, 
the results from analysis of plasmids found circulating amonst E. coli from humans, livestock and 
the nvnonrment fit these findingds. 17 isolates from human, cattle, poultry, sheep, goats and 
the environment carried a combination of IncFIA, IncFIB and IncFII plasmids, as well as blaCTX-M-
15 and blaTEM-1B, but aph(3'')-Ib and aph(6)-Id instead of aac(6ʹ)-Ib-cr. In northern Tanzania, AMR 
E. coli carrying IncF plasmids was also isolated from drinking water sources  (Lyimo et al., 2016) 
with the same resistance profile as in our study, at similar rates (16% vs our study 18.1%), as 
well as in faecal samples collected from healthy people in Nigeria (14.0%) (Inwezerua et al., 
2014). 
 
For more than 10 years, CTX-M-producing E. coli have been spread all over the world as 
colonisers of the gut in livestock and wildlife animals as well as in humans or as a causative agent 
of various infections. Within the sample population, plasmid-associated resistance to 
cephalosporins was mediated primarily by the production of an ESBL (CTX-M), rather than 
pAmpC enzymes. This is in line with prevalence data from a number of Tanzanian, Kenyan and 
Ugandan studies examining predominant ESBL-encoding genes (CTX-M, TEM and SHV), albeit in 
clinical settings (Sonda et al., 2016). In non-African studies, there is also clear evidence to show 
that there is a predominance of ESBL-mediated resistance overproduction of pAmpC enzymes 
(Potz et al., 2006; del Castillo et al., 2013; van Hoek et al., 2015). The results presented in our 
study are also comparable to studies investigating faecal carriage of ESBL-producing 
Enterobacteriaceae in healthy individuals and community patients in the UK and Northern 
Europe, as well as animals in China, which identify blaCTX-M as the most prevalent ESBL variant in 
these populations (Rao et al., 2014; Valenza et al., 2014; Reuland et al., 2016). Globally, blaCTX-
M-15 has been linked to the dissemination of the pandemic E. coli ST131 clone, named as it has 
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spread to many different countries, particularly amongst humans, but also increasingly reported 
in animals, worldwide (Ewers et al., 2010; Schembri et al., 2015; Chiluisa-Guacho et al., 2018). 
However, we did not detect any ST131 isolates in our sequenced genomes. Due to the 
limitations in the number of isolates that could be sequenced, all non-sequenced ESBL isolates 
(confirmed with double-disc diffusion) were also assessed for trpa and pabA genes via PCR, 
indicating if they were ST131.  Five isolates were identified as being ST131:O25b:FimH30 – the 
pandemic clone. Two of these came from a single farm, from a human and goat, and three 
others were found in humans and animals across three other farms; all isolates had the same 
resistance phenotype (TET-SULFA-AMP-TRIM). This is a serious publich health threat, as the 
ST131:O25b:FimH30 clone carries a large numer of AMR genes and has high virulence potential. 
 
A large number of other STs are associated with the transmission of blaCTX-M e.g. ST10, ST38, 
ST46, ST196, ST131, ST405 etc. (Canton and Coque, 2006; Hernandez and Gonzalez-Acuna, 
2016). As well as ST196, and ST2852, 4 additional STs were associated with carriage of blaCTX-M 
genes; these were ST38, ST46, ST1421 and ST3036. Whilst ST3036 appears to be a novel ST, 
ST1421 has been associated with another CTX-M, blaCTX-M-64, in a German patient with a UTI 
(Pfeifer et al., 2018). The isolate associated with ST1421 (F22G1CZ) carried by a goat, carried 
both blaCTX-M-14, blaCTX-M-15 and 14 additional resistance genes, suggesting that this may be a 
particularly resistant strain. Whilst there was no documented use of cephalosporins, they may 
have been administered prior to our study, or without the knowledge of those interviewed 
farmers, as a concurrent study conducted in Nairobi appears to suggest a somewhat higher use 
of cephalosporins (Muloi et al., 2019a).   
 
By collectively assessing the resistance genes, virulence genes, plasmids and MLST of the 
sequenced isolates, there is evidence of potential transmission of AMR E. coli between humans, 
animals, and the environment. There were many similarities in AMR genes between humans, 
livestock and the environment, and comparison of these demonstrated that those three groups 
have overlapping AMR gene communities. There are complex interactions between humans, 
livestock and the environment which could help to explain this. In rural areas such as Busia, 
there is a high proportion of direct contact with livestock, consumption of livestock products, 
and a shared environment which receives both human sewage and manure from livestock. It is 
therefore possible that acquisition of AMR from a common source (the environment) could be 
playing some role in the similarities between AMR gene profile in all groups. Indeed, the 
presence of two different (large) highly similar (potentially clonal) groups (and two smaller ones) 
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dispersed throughout the population do suggest that there is transmission of AMR E. coli 
occurring between hosts.  
 
Questionnaire results were in-line with previous findings (Chapter 3), specifically, the majority 
of farmers slaughtered animals on their premises for familial consumption, sale to neighbours 
or to butchers. Most commonly traded animals were cattle and poultry, which coincides with 
the most commonly kept animals on the visited smallholder farms. During slaughter, almost no 
farmers wore PPE, which may contribute to the spread of AMR-bacteria via interaction with 
contaminated blood, bodily fluids, and viscera. It has been seen in an examination of 
slaughterhouse conditions in Busia and neighbouring counties that the combination of poor 
knowledge of zoonotic transmission of disease, lack of PPE and the slaughter of sick animals 
may all contribute to the spread of AMR between humans and animals (Cook et al., 2017).  
 
Relatively few participants of this questionnaire had a good understanding of AMR and 
withdrawal periods; approximately 40% of participants thought that antimicrobials were a 
disease, 82% did not know what antibiotic resistance was and 70% did not know what an 
antibiotic withdrawal period was. We suggest that the reason for this difference in knowledge 
between the two time points is attributable to the lack of sub-county veterinary officer present 
in follow-up visits. Speculation suggests that when these questions were first asked (Chapter 3), 
veterinary officers may have over-explained the concept to farmers when translating into 
Kiswahili due to differences in language equivalency. Alternatively, the presence of government 
officials could have biased recruits responses as they would not wish to divulge incorrect or 
illegal practices for fear of punishment. This highlights the difficulties of conducting KAP studies 
in multiple languages and reinforces the idea that all interviewers must be briefed appropriately, 
and be intimately familiar with the study and its outcomes. This will prevent the asking of leading 
questions to participants, and ensure there is continuity between interviews conducted in 
English and Kiswahili.  
 
Farmers reported several gastrointestinal illnesses which may have had a bacterial cause, 
including diarrhoea and abdominal pain. Farmers also specified that typhoid was a clinical sign. 
Relatively few farmers treated their gastrointestinal diseases with antimicrobials, but of those 
who did, common treatments included antiprotozoals, metronidazole, 3rd generation 
cephalosporins, fluoroquinolones and penicillins. Many of these were obtained from a doctor 
or hospital. There was little reported use of cephalosporins and fluoroquinolone for human 
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therpaies, which is in-line with the observed prevalence of resistance to these antimicrobials;  
human isolates were found to have a low prevalence of ESBL and ciprofloxacin resistance. 
Hygiene practices were generally good. Only a small proportion of farmers did not wash their 
hands prior to cooking and eating, and the majority washed their hands after using the latrine, 
thus limiting the risk of ingesting zoonotic bacteria. The high prevalence of AMR observed in 
human isolates highlights the need for continued monitoring, and may be explained by (i) the 
high antibiotic usage in humans (Kariuki and Dougan, 2014) though there is little correlation 
between AMU and AMR; or ii) frequent contact between humans and livestock. However, as 
suggested by the mixed effects modelling, AMU was seen as a significant (p>0.005) factor for 
AMR in some cases. This suggests the need to reduce the number of antimicrobials used or 
prescribed by hospitals or doctors in the area.  
 
Mixed effects regression models identified several factors associated with the investigated 
resistance outcomes. Use of penicillin-streptomycin was a significant risk factor; as previously 
explored, there is chronic underdosing, overdosing and potentially inappropriate use of 
antimicrobials in LMICs, as well as Kenya. Numerous studies have highlighted that when 
antimicrobials are purchased without a prescription, variable concentrations of antibiotics are 
given to animals (Mitema et al., 2001b; Irungu et al., 2007; Global Antibiotic Resistance 
Partnership, 2011) which increases selection pressure for AMR. Whilst there appears to be a 
preference for oxytetracycline use, there is also high use of penicillin-streptomycin. Where an 
environmental sample was also an ESBL-producer, this was also a risk factor for MDR bacteria 
in humans and animals. Surprisingly, the ESBL outcome did not have any significant variables 
implicating its risk.  A study conducted by Dohman et al also suggests that current or recent 
AMU was not significantly associated with isolation of ESBL-E. coli on pig farms, but use of 
cephalosporins sometime in the past increased the risk of sampling ESBL-producing E. coli from 
pigs (Dohmen et al., 2017). As there was no documented usage of 3rd generation cephalosporins 
on farms in this study, it is possible that the same phenomenon is occurring in this setting. 
However, the number of ESBL-producing E. coli in this study was low compared to others, and 
so low power may have had some impact on the ability to detect risk factors. 
 
For the ampicillin resistance outcome, use of penicillin-streptomycin was also a risk factor. There 
are numerous described examples in the literature of one antimicrobial potentially driving cross-
resistance to another (Langsrud et al., 2004; Horinouchi et al., 2017; Adamus-Bialek et al., 2019) 
due to carriage of multiple AMR genes on plasmids. Within this study (Chapter 4)  a number of 
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resistance genes were found to be carried by each isolate, and blaTEM-1B was highly prevalent in 
the study population. This gene was suggested to have originated in food-producing animals 
and transmitted to other E. coli by HGT of virulence and antibiotic resistance genes – more 
importantly, this gene confers resistance to ampicillin (Johnson and Nolan, 2009; Rebbah et al., 
2018). Increasing farm size was associated with increased sulfathiazole resistance. This may be 
due to larger farms using greater quantities of antimicrobials to treat infections, thus 
transmission is enhanced in larger farm sizes. In poultry, sulfa-drugs are routinely used for 
treatment, as well as for growth promotion in the form of sulfadiazine and sulfadimidine 
(Sasanya et al., 2005; Mubito et al., 2014). As the preferred mode of delivery of antimicrobials 
for poultry is in communal water sources, the dosing may be incorrect and lead to a higher 
concentration of circulating sulfonamides in both the water and animals. It would therefore be 
difficult to ascertain the true dose of the antibiotic ingested by each animal. For tetracycline and 
trimethoprim resistance, animals being vaccinated was a significant risk factor. It is unclear what 
vaccinations were used or whether antibiotic use is lower or higher in vaccinated animals in 
Kenya, as in other populations. Future studies should also look at the vaccination status of 
animals and the understanding that people have regarding vaccination; according to the 
questionnaire study (Chapter 3) there was confusion between vaccinations and injectable 
antibiotics. This could mean that there is a higher use of antibiotics than is reported with some 
confusion between vaccines and antibiotic therapies.  
 
Within this population, the proportion of variance attributed to region (sub-counties) ranged 
from 0.015 to 0.688. This is expected, as the animals, humans and environments encountered 
within each sub-county were likely to be more similar than in other sub-counties (the size of 
sub-counties ranges from approximately 10-20km across). This could be due to clustering of 
farm management practices, which may be marginally different, according to the dominant 
tribe in the sub-counties e.g. Teso (in Teso North and South) or Luhya (In the other 5 sub-
counties). However, despite stratifying farms by sub-county, no formal weighting was used to 
correct the responses to questionnaire data. As such tribe could not be used as a factor in any 
formal comparisons, and only speculation can be made on whether that contributed to variance. 
Similarly, as no other studies have been conducted in this area examining differences in farm 
management practices by tribe, there is no data to compare to. The variance attributed to farms 
varied for different model outcomes, there were two large (and two smaller) identified clonal 
groups associated with ESBL carriage, though unlike non-clonal groups of isolates, the spread of 
these isolates was often within an entire sub-county, not limited to individual farms.    
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There were several limitations to this study; the questionnaire focused primarily on current 
practices, though a number of questions also asked about historical exposure and use of 
antimicrobials i.e. last 3 or last 12 months. Validation of the information provided was often not 
possible as record-keeping was found to be largely incomplete, and there was no corroboration 
from treating AHAs or veterinary officers. Furthermore, when constructing the multivariable 
models, there was a low prevalence of AMR for some outcomes, so these were omitted. This 
study shows that the scale of sampling should be increased in order to identify a larger number 
of AMR isolates so that risk factor analysis can be undertaken for all outcomes. In future studies, 
the estimated prevalence of carriage of AMR E. coli from this study can be used in future sample 
size calculations.  
 
Regarding the use of WGS to infer sharing of AMR genes, all reads were mapped directly to a 
single reference genome, which despite being a common practice in viral genomics, will likely 
have caused us to miss a significant proportion of diversity by forcing alignment to a single E. 
coli genome. In future studies, rather than using a reference genome to map all reads to, it 
would be more appropriate (and yield additional relevant variant data) if all contigs were 
constructed de novo, and then scaffolds are used as a backbone to which reads could be 
mapped. Furthermore, as samples were only collected at a single time point, and in the case of 
animals, from deposited faeces, the true diversity of all animal E. coli was not sampled. 
Longitudinal sampling of the study site may allow for the construction of time-dependent 
Bayesian phylogenies (using relaxed clock models) which could allow for inference of 
directionality between humans, livestock and the environment (by measuring the variation in 
SNPS over time), opposed to only observing AMR gene similarities. Despite collecting many 
environmental samples using boot swabs, rather than limiting the study to human living areas, 
future studies should also examine the E. coli found on farms (not just human living areas), as 
only a relatively small proportion of E. coli were cultured from these boot swabs.  Despite these 
limitations, the data presented here is an important set of results in an otherwise data-poor 
research landscape, and they will help guide future surveillance activities in this region.  
 
Within this study, the prevalence of AMR in commensal enteric E. coli in humans and animals 
was investigated, as well as the E. coli isolated from environmental and water sources. The 
genetic make-up for a subset of these isolates was assessed and two major genetically similalr 
(potentially clonal) groups (and two smaller genetically similar groups) associated with carriage 
of ESBL resistance genes (blaCTX-M-15) were found. This has implications for public and animal 
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health, and efforts should be directed to determining the origin and transmission of these genes. 
These data clearly show that in this complex ecology, sharing of bacteria is occurring and there 
is potential for the emergence of AMR strains of both human and animal health relevance. 
Several risk factors for the carriage of AMR and ESBL E. coli have been identified in human, 
animal and environmental populations in western Kenya, and these indicate that there is 
increased risk of AMR owing to AMU. Limitations on the access to antimicrobials for animals, 
and increased diagnostic capabilities could help to determine resistance patterns prior to 
treatment, and guide appropriate therapies, reducing reliance on empirical broad-spectrum 
therapies. The high prevalence of AMR, MDR and ESBL-producing E. coli reported in this study 
is of great concern; the high diversity of resistance and virulence genes found in commensal E. 
coli could potentially be disseminated to other commensal and pathogenic bacteria such as 
Salmonella spp. which may spread through the food chain. We suggest that there is urgent need 
to monitor AMR bacteria such as E. coli in all sectors, notably in food-producing animals, in 
humans and the environment they share, in order to better understand the evolution and 
transmission dynamics of resistant bacteria in this area.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter Four  Farm Study 
 148 
 
Chapter Five  Slaughterhouse Study 
 149 
 
 
 
 
 
 
Chapter 5  
Antibiotic Resistance Patterns and Characterisation of 
faecal E. coli Isolated from Slaughterhouse Workers in 
Western Kenya 
 
 
 
 
 
 
 
 
  
Chapter Five  Slaughterhouse Study 
 150 
5.1 Introduction 
E. coli is a commensal bacterium found amongst the intestinal microflora of humans and 
a wide variety of animals. It is a zoonotic bacterium which is important in both human and 
veterinary health, due to the risk of transmission between the two host groups. Whilst 
many E. coli are benign, there are highly virulent and enteropathogenic livestock-
associated strains, such as O157:H7, which can be transmitted to humans (Belanger et al., 
2011; Carrie-Ann et al., 2017; Sarowska et al., 2019). Slaughterhouse workers have 
extremely close contact with animals, specifically faeces and internal organs, during the 
slaughter process, and as such, they may represent key contact points for bacterial 
transmission. Previous studies have identified links with the zoonotic spread of livestock-
associated bacteria during the slaughter process (Mulders et al., 2010; Gilbert et al., 
2012), indicating that workers may be at higher risk of occupational acquisition of 
pathogenic E. coli. Of the Enterobacteriaceae, E. coli is extremely common, and 
pathogenic strains associated with MDR and ESBL-producing resistance genes are 
considered to be highly infectious, with the potential for rapid transmission, particularly 
between humans (Pitout and Laupland, 2008). As such E. coli (specifically carbapenem 
and 3rd-generation cephalosporin-resistant) is recognised by the WHO as a bacterium to 
guide research, discovery, and development of new antibiotics (WHO, 2017a) to attempt 
to limit some of the dangers of acquiring AMR E. coli.  
 
E. coli ST131 is associated with the worldwide spread of the blaCTX-M-15 ESBL resistance 
gene, and has a strong association with MDR, including to fluoroquinolones (Johnson et 
al., 2010) and more recently, strains have been identified which are resistant to 
carbapenems (Peirano et al., 2014). The presence of ST131 is considered to be a public 
health threat, and indeed, there is potential for the spread of ESBL-producing E. coli from 
animal carcasses to slaughterhouse workers from animal carcasses (Bardon et al., 2013) 
to humans during the slaughter process.  
 
Foodborne E. coli is one subset of bacteria highlighted by the WHO Foodborne Disease 
Burden Epidemiology Reference Group as being a global public health concern due to 
their role in meat contamination and food-borne disease transmission (Hoffmann et al., 
2017), particularly amongst beef (cattle) and other small ruminants. Several public health 
concerns are linked to slaughter processes in sub-Saharan African countries. Inadequate 
infrastructure, poor hygiene, lack of ante- and post-mortem inspection, and inadequate 
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training can result in meat contamination, allowing for the transmission of pathogens 
along the supply chain (Herenda et al., 1994; Heinz, 2008; Mekonnen Haileselassie et al., 
2013; Basulira et al., 2019). In Ethiopia and Uganda, bovine tuberculosis, toxoplasmosis 
and porcine cysticercosis have all been detected post-inspection, corroborating that the 
meat inspection process may be inadequate (Muwonge et al., 2012; Gebremedhin et al., 
2014; Thomas et al., 2016). Indeed in a study examining the working conditions and 
practices of slaughterhouses in Kenya, some workers (9%) admitted to slaughtering sick 
animals, exposing both themselves and potential consumers to zoonotic diseases (Cook 
et al., 2017) and indicating that inspection was inadequate. This may also be due to lack 
of regulation enforcement as approximately 93% of slaughter slabs were inspected daily 
by meat inspectors, but only 7% performed an antemortem examination of animals (Cook 
et al., 2017).   
 
In western Kenya, Cook et al (2017) conducted a thorough investigation of the working 
conditions and practices of slaughterhouses. A number of potential risk factors for the 
spread of zoonotic disease were identified, for example, few slaughterhouses (3%) had 
access to running water and many did not have appropriate sanitation facilities such as 
toilets (12%) or soap (64%) for handwashing. Few workers wore personal protective 
equipment (PPE), such as aprons or gloves (32%), important for preventing interaction 
with blood and viscera during the cleaning and splitting of carcasses. In almost all 
slaughterhouses, a practice of ‘batch slaughtering’ was followed, slaughtering, bleeding, 
skinning, and evisceration were all performed in the same area, on the ground (Cook et 
al., 2017). This practice is also reported in other EU countries, such as southern Ireland 
(Wheatley et al., 2014). Furthermore, 25% of workers had reported being injured at work 
and 8% had an open wound during the study. Open wounds, linked with the lack of PPE is 
a significant risk for bacterial transmission (Cook et al., 2017). 
 
The situation described is generally indicative of a low level of hygiene in these key nodes 
of the food chain. Inadequate training in food safety and slaughter practices resulted in 
higher bacterial loads of E. coli, S. aureus and B. cereus on slaughterhouse meat in Ethiopia 
(Mekonnen Haileselassie et al., 2013). Similarly, poor training and education of meat 
inspectors have been associated with an increased risk of foodborne pathogens in Kenya 
(Kariuki et al., 2013). Finally, there has been a clear link to the lack of PPE worn by 
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slaughterhouse workers and the contraction of brucellosis in Uganda and Tanzania (Swai 
and Schoonman, 2009; Nabukenya et al., 2013).  
 
There are three classes of slaughterhouses (A, B and C) in Kenya, according to the size and 
whether meat is intended for local consumption or transport out of the community (Cook 
et al., 2017). Slaughterhouses are sub-divided into ruminant (cattle, sheep/goats) or pig-
only slaughterhouses, to respect the Muslim community. Many slaughterhouses in rural 
areas are informal, unregulated and commonly referred to as ‘slaughter slabs’. These 
facilities are usually privately owned and rented to butchers who employ their own team 
of slaughter workers (Kagira and Kanyari, 2010; Roesel and Grace, 2014). It is plausible 
that slaughterhouse workers can act as ‘sentinels’ for emerging zoonotic diseases (Abu-
Elyazeed et al., 1996; Rabinowitz et al., 2009; Nguku et al., 2010; Cook, 2015). 
 
Three main types of slaughterhouse were considered in this study, those which 
slaughtered cattle only, cattle and sheep and goats, and pigs only. The purpose of this 
study was to assess the carriage of AMR E. coli in the faeces of slaughterhouse workers 
from 93 slaughterhouses in Busia county and to assess the carriage of resistance and 
virulence genes of E. coli by WGS, with a specific focus on the carriage of MDR and ESBL-
producing E. coli.    
Chapter Five  Slaughterhouse Study 
 153 
5.2 Methods 
All methods in this chapter prior to bacterial culture of E. coli and WGS were conducted 
by Elizabeth Cook and colleagues (ILRI, Nairobi) during the collection of the original 
samples; slaughterhouse locations and details of recruitment and questionnaire results 
are published in the manuscript ‘Working conditions and public health risks in 
slaughterhouses in western Kenya’ (Cook et al., 2017) and described in brief here. Further 
information was obtained directly by personal communication. Informed consent 
collected by Cook et al. at the time of the study, allowed subsequent re-use of archived 
specimens for further research. This chapter makes use of those original samples. 
 
5.2.1 Study Population and Recruitment 
A census of slaughterhouses was undertaken in Busia and three other surrounding 
counties (Bungoma, Kakamega and Siaya) to quantify the total number of official 
slaughterhouses in each county. Data were provided by county directors of veterinary 
services, who were responsible for delegating meat inspections. All consenting 
slaughterhouses were recruited for the study (n=142). In slaughterhouses with 12 workers 
or less, all consenting participants were recruited. In slaughterhouses with more than 12 
workers, a random selection of 12 consenting participants from the workers present on 
the day were sampled. 
 
5.2.2 Sample Collection 
Samples and questionnaire data were collected between February and October 2012. 
Participants were asked if they were willing to provide a stool sample and informed 
consent was obtained from all participants individually; those who were amenable were 
provided with a stool pot with an integrated spoon in the lid. Participants were instructed 
on how to collect a large teaspoon of a sample, which was not contaminated with urine 
or had been in contact with the ground. After receiving stool samples, two cotton swabs 
were inserted into the stool, removed, and examined to ensure they had come into 
contact with stool. Swabs were then immediately inserted into a tube of Cary Blair 
transport medium (Transwab®, Medical Wire, Wiltshire). Samples were placed in a cool 
box and transported back to the lab for initial processing.  The original study was 
undertaken with full informed consent and ethical approval from the Kenya Medical 
Research Institute (SCC Protocol 2086).  
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5.2.3 Faecal Culture   
Faecal samples were processed at the time of collection before they were provided for 
use in this study. Briefly, a swab was removed from Cary Blair transport medium and 
incubated overnight in selenite F broth (Oxoid, Hampshire, UK), at 37°C. The following 
day, a sterile loopful of broth was inoculated onto one MacConkey agar plate and one 
Xylose lysine deoxycholate (XLD) agar plate; these were then incubated overnight at 37°C. 
Following incubation, plates were assessed for fermentation and hydrogen sulphide 
production. A nutrient agar plate was used to sub-culture colonies from both the XLD and 
MacConkey plates. E. coli was identified according to morphology. Colonies were then 
frozen at -40°C in tryptone soya broth (TSB) broth containing 20% glycerol in Busia, before 
being shipped to Nairobi for long-term storage at -80°C. 
 
5.2.4 Sample Acquisition and Shipping 
A 1ml aliquot was taken from each of the located samples from a -80°C long-term storage 
freezer in Nairobi, transferred to labelled cryovials, and shipped on ice back to the 
University of Liverpool for culture, antibiotic resistance testing and WGS (on a subset). All 
samples from Busia sub-county were located, but those from surrounding sub-counties 
(Bungoma, Siaya and Kakamega) were not all located in freezers. As such, comprehensive 
resistance analysis (as performed in (Chapter 4) were performed on E. coli isolated from 
Busia slaughterhouse workers, only. 
 
5.2.5 E. coli Culture at Liverpool University 
At the University of Liverpool, samples were resuscitated by streaking one 5µl loopful of 
the aliquot onto a plain EMBA plate and incubating aerobically overnight at 37°C. From 
this, bacteria were sub-cultured for single colonies onto three EMBA plates, one 
containing cefotaxime (1μg/ml), one containing ceftazidime (1μg/ml) and one containing 
no antimicrobials. From the plain EMBA plate, five random picks of bacterium that were 
morphologically-consistent with E. coli (green metallic, shiny) were selected and sub-
cultured onto nutrient agar. From the EMBA plates containing cefotaxime and 
ceftazidime, one pick was randomly selected for sub-culture. 
 
5.2.6 Antibiotic Resistance Testing  
1247 isolates from 447 slaughterhouse workers were sub-cultured onto nutrient agar and 
subject to disc diffusion testing, using a panel of seven antibiotics. Suspensions were 
made according to EUCAST guidelines (EUCAST, 2018). MHA plates were inoculated with 
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each isolate and seven antimicrobial discs applied: ampicillin (10µg), chloramphenicol 
(30µg), ciprofloxacin (5µg), gentamicin (10µg), sulfathiazole (1000µg), tetracycline (30µg) 
and trimethoprim (5µg). Isolates selected from EMBA plates containing ceftazidime or 
cefotaxime were subject to double-disc diffusion testing (M'Zali et al., 2000), using three 
pairs of antibiotic discs containing ceftazidime (30μg), cefotaxime (30μg) and 
cefpodoxime (30μg) with and without clavulanic acid (10μg). All plates were incubated 
aerobically overnight at 37°C and zones of inhibition were measured in mm. Suspected 
ESBL production was confirmed if the zone of inhibition for the cephalosporin with 
clavulanic acid disc was more than 5mm greater than the zone of its counterpart without 
clavulanic acid (Giske CG, 2013).  
 
5.2.7 PCR Assays 
PCR assays targeting the uidA gene (McDaniels et al., 1996) were performed as previously 
described (Chapter 2.5.3) on all isolates to confirm that they were E. coli.  
 
5.2.8 Whole Genome Sequencing 
Whole Genome sequencing service was provided by MicrobesNG 
(http://www.microbesng.uk). All isolates representing E. coli with unique MDR or ESBL 
phenotypes were selected for sequencing. In total, 188 isolates were selected for 
sequencing and this subset was chosen primarily due to funding limitations, and the desire 
to investigate only isolates which were MDR or ESBL-producing E. coli.  
 
5.2.8.1 DNA Extraction 
All frozen isolates were resuscitated from -80°C using the previously described methods. 
Isolates were provided to MicrobesNG in barcoded MicroBank™ tubes for sequencing. 
Briefly, isolates were cultured on nutrient agar and incubated overnight at 37°C. The 
following day, one 5µl loopful of each culture was added to each tube and sent to 
MicrobesNG.  
 
5.2.8.2 DNA Sequencing 
The MicrobesNG laboratory performed the following steps and provided this protocol as-
is: 
 
Three beads were washed with extraction buffer containing lysozyme and RNase A, 
incubated for 25 min at 37oC. Proteinase K and RNaseA were added and incubated for 5 
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min at 65oC. Genomic DNA was purified using an equal volume of SPRI beads and 
resuspended in EB buffer.  
 
DNA was quantified in triplicates with the Quantit dsDNA HS assay in an Ependorff AF2200 
plate reader. Genomic DNA libraries were prepared using Nextera XT Library Prep Kit 
(Illumina, San Diego, USA) following the manufacturer’s protocol with the following 
modifications: 2ng of DNA instead of 1ng were used as input, and PCR elongation time 
was increased to 1 min from 30 seconds. DNA quantification and library preparation were 
carried out on a Hamilton Microlab STAR automated liquid handling system. Pooled 
libraries were quantified using the Kapa Biosystems Library Quantification Kit for Illumina 
on a Roche light cycler 96 qPCR machine. Libraries were sequenced on the Illumina HiSeq 
using a 250bp paired end protocol.  
 
Reads were then downloaded from the MicrobesNG server, and the same WGS workflow 
as previously defined (and briefly redefined below 5.2.9.2) was performed. 
 
5.2.9 Data Analysis 
5.2.9.1  Antibiotic Resistance Data 
Microbiological data were entered in a spreadsheet initially (Microsoft Excel 2016, 
Microsoft Corporation) and reviewed to ensure accurate input. A binary coding system 
was implemented such that data indicated an isolate that was either susceptible (0) or 
resistant (1), using EUCAST human clinical breakpoints  (EUCAST, 2018) for all 
antimicrobials, except for tetracycline and sulfathiazole. Tetracycline was based upon 
BSAC human clinical breakpoints (BSAC, 2015) and sulfathiazole was based on the 
distribution of zones of inhibition, as described in (Chapter 2.5.1). Descriptive statistics 
and Chi-squared tests for association were conducted in SPSS v25 (IBM Corp, Armonk, 
NY). 
 
5.2.9.2  WGS Workflow 
The standard workflow as described in (Chapter 2.6.1) was run on all sequences. Briefly, 
raw paired-end reads were quality controlled using FastQC v0.11.7 (Andrews, 2010) Poor 
quality reads (score <20) and any detected primers or adapters were removed using 
Trimmomatic v0.36 (Bolger et al., 2014). Forward and reverse reads were then mapped 
to a reference E. coli genome (E. coli K12 MG1655; NCBI Reference Sequence: 
NC_000913.3 (Blattner et al., 1997), using the Burrow-Wheeler Alignment (bwa mem 
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v0.7.17) (Li, 2013). Once BAM files had been made, a further QC step to check the mean 
mapping quality scores and coverage in relation to the reference genome was performed 
with QualiMap2 (Okonechnikov et al., 2015). Any reads which did not map to the 
reference genome were assembled de novo into contigs, using  SPADES v3.12.0 
(Bankevich et al., 2012). Speciation analysis of those contigs was then performed using 
Kraken v2.0.7 (Wood and Salzberg, 2014) and an in-house database downloaded from 
NCBI sequence read archive (https://www.ncbi.nlm.nih.gov/sra/). Non-E. coli contigs 
were excluded from analysis. Phylogenetic trees were constructed using IQ-Tree (Nguyen 
et al., 2015), using 1000 bootstrap replicates and the GTR model Tree topology was 
checked using Figtree v1.4.4 (Rambaut, 2012) and then annotated using the interactive 
tree of life (iTOL) v5.0 (Letunic and Bork, 2016). MLST was determined using a batch script 
which scanned each contig against the E. coli #1 schema 
(https://pubmlst.org/escherichia/) (Jolley and Maiden, 2014) – from this a sequence type 
(ST) was assigned according to the adk, fumC, gyrB, icd, mdh, purA and recA loci. In silico 
phylotyping was serotyping were formed using the Clermont Typing tool (Beghain et al., 
2018) and SerotypeFinder (Joensen et al., 2015) respectively. Plasmid replicon typing was 
performed using the PlasmidFinder database using the batch uploading platform (identity 
≥90%, coverage ≥60%) (Carattoli et al., 2014).  For detected ST131 isolates, fim typing was 
undertaken using a custom script to blast genomes for fimA and fimH genes. Literature 
was then searched to match the fimtype to known ST131 isolates.   
 
5.2.10 Maps and Georeferenced Data 
Maps were constructed using QGIS v3.2 (QGIS Development Team, 
http://qgis.osgeo.org/). Geographic co-ordinates of each slaughterhouse had been 
captured with a portable GPS device (Garmin eTrex®) during the original study. A base 
layer of Busia county was taken from Google Maps – upon this, major western Kenyan 
towns, and cities (boundary polygons and line shapefiles) were layered. These were 
acquired from an open-source database hosted by the Humanitarian Data Exchange 
(https://data.humdata.org/). Latitude and longitude co-ordinates for each 
slaughterhouse were imported into QGIS and maps generated.  
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5.3 Results 
5.3.1 Samples Collected 
In total, 1245 E. coli isolates were cultured from the faeces of 447 slaughterhouse 
workers, from 93 different slaughterhouses in Busia, (and neighbouring) Bungoma, Siaya 
and Kakamega counties (Figure 5.1). The original study collected information and samples 
from 738 slaughterhouse workers from 142 slaughterhouses, our sample size only 
contains samples from Busia county, however.    
 
 
 
 
Figure 5.1 Geographical distribution of all slaughterhouses where samples were collected, and 
questionnaires given in the original study conducted by Cook et al (2017). Each individual slaughterhouse 
is identified with a red circle. Samples which contributed to this study are indicated with a yellow cattle 
icon (all slaughterhouses in Busia country, n=93)). Counties are (clockwise from most westerly) Busia, 
Bungoma, Kakemega and Siaya. Map base layer from Google Maps (2017). 
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5.3.2 Types and Spread of Slaughterhouses 
Slaughterhouses were spread across 15 different townships, within 4 main sub-counties. 
Slaughterhouses were divided according to the type of animals that were slaughtered 
there: only pigs, only cattle or cattle, sheep, and goats. The largest number of 
slaughterhouses were in Bumala, Teso and Busia township, all within Busia county. There 
were variations in the types of slaughterhouse found in each township, in Busia there was 
predominantly slaughter of pigs only; this was the only township where the number of pig 
slaughterhouses outnumbered ruminant slaughterhouses. In many townships (7/15), 
cattle-only were the most common type of slaughterhouse, followed by cattle and shoat 
slaughterhouses (6/15). 
 
5.3.3 Prevalence of AMR E. coli 
E. coli was successfully cultured from 447 human faecal samples; 38.0% (n=170) from 
workers in cattle only slaughterhouses, 32.4% (n=145) from workers from cattle and shoat 
slaughterhouses and 29.5% (n=132) from workers from pig-only slaughterhouses. 
Twenty-two samples (4.9%) had completely sensitive E. coli isolates. Four hundred and 
twenty-five samples had isolates which were resistant to at least one class of 
antimicrobial. The sample prevalence of resistance to each of the tested antibiotics, as 
well as MDR and ESBL-producing E. coli are detailed in (Table 5.1). There were 205 (61.5%) 
MDR E. coli isolate-containing samples. Of these 80 MDR samples (17.9%) had E. coli which 
were resistant to 3 classes of antibiotic, 140 (31.3%) to 4 classes, 40 (8.9%) to 5 classes, 
12 (2.7%) to 6 classes, and 3 (0.7%, extensively drug resistant (XDR) had isolates resistant 
to all 7 tested antimicrobials. The largest proportion of MDR E. coli (3 or more classes) 
were isolated from humans working in mixed ruminant slaughterhouses (cattle, sheep 
and goats). ESBL-E. coli was found in 46 samples (10.3%), the largest proportion of which 
were isolated from humans working in pig-only slaughterhouses. Isolates resistant to 
between 5 and 7 classes of antimicrobial were evenly spread across humans working in 
cattle and shoat, and cattle-only slaughterhouses. All three XDR isolates were isolated 
from humans working in pig only slaughterhouses. Additionally, two of the XDR Isolates 
were also ESBL producers.  
 
The 7 most common phenotypic resistance patterns were similar between workers 
working at each of the three types of slaughterhouse (Figure 5.2). Overall, the most 
common resistance phenotype was tetracycline (TET) only, which was observed in 
approximately a quarter of all samples. Tetracycline resistance featured in nine of the ten 
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most common resistance phenotypes. Many of the most common phenotypes were MDR, 
the TET-AMP-SULFA-TRIM phenotype was the most common for MDR isolates. All 46 ESBL 
isolates were also MDR and were also commonly associated with TET-SULFA-AMP-TRIM 
phenotypes. Cattle and shoat workers had the highest proportion of MDR isolates, but 
pig-only workers had the highest proportion of ESBL isolates. Relatively few phenotypes 
contained ciprofloxacin resistance, but these were generally associated with an MDR 
phenotype. 
 
Table 5.1 Proportion of AMR, MDR and ESBL-E.coli found in 447 samples. All isolates cultured from 
human faeces from slaughterhouses slaughtering cattle and sheep/goats, cattle only or pigs only. 
Brackets beneath each proportion indicate 95% CI. 
Antimicrobial 
Resistance 
Cattle and Sheep 
and goats  
(n=145) 
Cattle Only  
(n=170) 
Pigs Only  
(n=132) 
Total 
(n=447) 
Tetracycline 
99.3% 90.6% 85.6% 86.2% 
(97.9 - 100.7) (85.8 - 95.3) (79.9 - 91.3) (80.6 - 91.8) 
Trimethoprim 
69.0% 60.6% 60.6% 59.3% 
(61.4 - 76.5) (52.6 - 68.5) (52.7 - 68.6) (51.3 - 67.3) 
Sulfathiazole 
64.8% 59.4% 59.9% 57.4% 
(57.1 - 72.6) (51.4 - 67.4) (51.9 - 67.8) (49.4 - 65.4) 
Ampicillin 
45.5% 38.2% 47.7% 40.7% 
(37.4 - 53.6) (30.3 - 46.2) (39.6 - 55.9) (32.7 - 48.7) 
Chloramphenicol 
11.7% 10.6% 9.1% 9.9% 
(6.5 - 17) (5.6 - 15.6) (4.4 - 13.8) (5 - 14.8) 
Ciprofloxacin 
10.3% 7.7% 6.8% 7.8% 
(5.4 - 15.3) (3.3 - 12) (2.7 - 10.9) (3.4 - 12.2) 
Gentamicin 
4.8% 3.5% 6.1% 4.4% 
(1.3 - 8.3) (0.5 - 6.5) (2.2 - 9.9) (1.1 - 7.7) 
MDR (n=275) 
63.5% 42.0% 49.2% 61.5% 
(55.6 - 71.3) (34.6 - 49.4) (41.1 - 57.4) (57.0 - 66.0) 
ESBL (n=46) 
11.8% 6.5% 13.6% 10.3% 
(6.6 - 17.1) (2.8 - 10.2) (7.8 - 19.5) (7.5 - 13.1) 
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Figure 5.2 The most commonly identified antimicrobial resistance phenotypes, divided by 
slaughterhouse type. The figure reflects the overall proportion of isolates displaying a specific 
antimicrobial resistance phenotype; 477 unique E. coli isolates (from 477 samples) were examined. 
Phenotypes with a proportion of <5% were excluded from this figure. Error bars are 95% CI. 
 
TET = Tetracycline, SULFA = Sulfathiazole, AMP = Ampicillin, TRIM = Trimethoprim, GENT = Gentamicin, 3GC = 
3rd Generation Cephalosporin 
 
5.3.2 Whole Genome Sequencing 
The rationale for this study was to investigate carriage of MDR and ESBL-producing E. coli 
from the slaughterhouse study, to assess if there was specific sharing of multiple 
resistance genes between slaughterhouse workers. Due to financial restrictions, 188 
isolates were randomly selected (using random number generation) selected for 
sequencing. Of those, 187 isolates were successfully sequenced and passed QC.  
 
Following a comparison of resistance gene methodologies outlined in (Chapter 4), the 
same databases were used to assess carriage of resistance (ResFinder, October 2018) 
(Zankari et al., 2012) and virulence (VirulenceFinder, October 2018) (Joensen et al., 2014). 
In total, the following number of isolates from humans working in different 
slaughterhouses were sequenced: mixed ruminant (cattle, sheep and goats) n=74, cattle 
only, n=64 and pigs only, n=49.  
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5.3.2.1 Genetic Background of Isolates 
Following the initial QC of reads, mapping to the reference genome (U00096.3) and 
subsequent QC of the BAM files (assessing mapping quality scores and mean coverage 
across the genome), 187 genomes (of 188) were included in the construction of a 
maximum-likelihood phylogenetic tree (Figure 5.3) based on 832038 SNPs. Onto this, 
results of MLST assignment and serogrouping was layered, to assess similarities and 
genetic variance between isolates.   
 
As with the sequences in (Chapter 4) there was a wide distribution of interspersed E. coli 
from workers at different types of slaughterhouse, with no specific clustering by type of 
slaughterhouse. This suggests a high degree of diversity of E. coli amongst slaughterhouse 
workers across Busia county. Several distinct clades associated with specific multi-locus 
sequence types can be seen on the phylogenetic tree. 
 
A ST was successfully assigned to 135 DNA sequences; 52 sequences could not be assigned 
an ST, as one or more loci did not match perfectly to previously registered MLST alleles. 
These could be a novel arrangement which are not yet in the database, as for each 
sequence, alleles of each of the seven housekeeping genes searched for during mlst 
assignment were found. There were 37 unique ST assigned from the sequences (Figure 
5.4); 19 of these STs were associated with single isolates only, and 22 STs were carried by 
a single type of slaughterhouse worker only. Overall, the most common STs found among 
E. coli were ST10 (21.2%, n=25), ST617 (8.5%, n=10), ST361 (7.6%, n=9), ST48 and ST361 
(6.8%, n=8 each). STs were distributed across all three groups of slaughterhouse worker, 
and this is evident particularly across the more common STs. Where workers from 
different types of slaughterhouse shared an ST, there was no significant difference (Mann-
Whitney U, p>0.05) between the prevalence of that ST. The largest number of unique STs 
were isolated from E. coli from pig-only slaughterhouse workers (n=20). In total, eight 
isolates were found to belong to ST131; the highest proportion of these were also from 
pig-only slaughterhouse workers, though there was no significant difference between the 
proportion carried between different workers working at different types of 
slaughterhouse. Several distinct clades with low genetic variability (<500SNPs) can be 
seen, associated with ST131, ST361, ST10, ST43 and ST617.   
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Figure 5.4 Distribution of multilocus sequence types, differentiated by the type of slaughterhouse. 
 
All isolates were serotyped in silico to assign lipopolysaccharide (O) and flagellar (H) 
surface antigen groups. Of these, 8 were not assigned either an O or H group, 4 were only 
assigned an H group and 1 isolate was only assigned an O group. Overall, there were 86 
unique O:H serotype assigned. Most of these groups were assigned to only one or two 
isolates. The two most common serotypes were O9:H30 (7.1%) and O25:H4 (6.5%). 
Individually, the most common O groups were O8 (13.7%), O9 (11.3%) and O25 (10.7%). 
Individually, the most common H groups were H10 (20.1%), H4 (10.7%) and H30 (8.9%). 
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When divided according to slaughterhouse type, the most common serogroups shared 
overlap between isolates from workers in cattle-only and cattle and shoat 
slaughterhouses, but not to isolates from pig-only slaughterhouse workers. In isolates 
from cattle and shoat workers, the most common serotypes were O95:H10 (7.7%), 
O25:H4 (7.7%) and O9:H30 (6.4%). For isolates from cattle only workers, the most 
common serotypes were O9:H30 (8.5%), O89:H10 (7.0%) and O25:H4 (7.0%). Isolates 
from pig only workers had no clear serotype association with each isolate had a different 
serotype. Those O25:H4 isolates were especially significant as these were mainly 
associated with ST131. 
 
Finally, all isolates were phylotyped in silico. Thirty-eight isolates could not be phylotyped 
due to incomplete coverage of one or more of the genes (Figure 5.5). The largest 
proportion of the isolates were phylogroup A (38.5%), followed by B1 (13.9%) and E 
(13.4%). Phylogroups A and B1 (generally considered to be commensal, non-pathogenic 
strains) were approximately evenly distributed across all three types of slaughterhouse 
worker. Phylogroups B2 and D (generally considered to be more pathogenic) appeared to 
be most prevalent amongst pigs-only and cattle-only workers, respectively. Phylogroup E 
was least prevalent in pig-only workers. Finally, a single phylogroup F strain was isolated 
from a mixed ruminant slaughterhouse. There was a significant association between the 
type of slaughterhouse workers and phylogroup (χ2 = 9.2, p<0.001, Chi-squared test), but 
no significant difference between the proportions of E. coli with specific phylogroups 
between types of slaughterhouse (Kruskal-Wallis, p>0.05). 
Figure 5.5 Distribution of phylogroups between slaughterhouse workers. Error bars are 95% CI. 
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5.3.2.2 Resistance Genes 
Using the same ResFinder database as in Chapter 4 (October 2018), all detected resistance genes 
were tabulated, and the prevalence of each gene determined according to slaughterhouse type 
(mixed ruminants, cattle-only and pig-only). The most commonly identified resistance genes 
which encompassed two or more of the groups were examined for similarities (Figure 5.6). 
 
A total of 53 unique resistance genes were detected in 187 of the sequenced genomes. Using 
the previously defined thresholds for detection of genes (≥90% identity and ≥60% coverage), 
one genome was found to have no resistance genes. As such, analysis of resistance genes was 
rerun with a more modest threshold of ≥75% identity and ≥60% coverage. With these 
thresholds, all genomes were found to carry more than one resistance gene.  
 
The most commonly identified resistance genes included to sulfonamides, aminoglycosides, the 
blaTEM-1B beta-lactamase (ampicillin), multi-drug transporters (macrolides-lincosamides-
streptogramin) and chloramphenicol. There was no statistically significant difference between 
the carriage of 20 out of 22 of the most prevalent resistance genes i.e. those carried by human 
isolates from all three types of slaughterhouse. Carriage of chloramphenicol resistance gene, 
catA2, was not identified in humans working in pig-only slaughterhouses. There was a high 
prevalence of the multi-drug exporter gene mdf(A). In pig-only workers, the carriage of mdf(A) 
was 100%, and significantly (Mann-Whitney, p=0.003) more prevalent amongst pig-only 
workers than in cattle-only and mixed ruminant workers. There was a high carriage of 
sulfonamide resistance genes, particularly sul2, in all groups, with an average carriage rate of 
>90%. There was similarly high carriage of tet genes, specifically tet(A), tet(B) and tet(J) amongst 
all groups. 
 
Two common aminoglycoside resistance genes were prevalent in all three groups: aph(3”)-1b 
(also called strA) and aph(6)-1d (also called strB). A third aminoglycoside resistance gene 
(aadA5) was common to all three groups but significantly less prevalent (Mann-Whitney, 
p<0.001) than the other two.  
 
Three common β-lactamase resistance gene were identified in the sequenced isolates. The most 
prevalent was blaTEM-1B which confers ampicillin resistance in E. coli. The second most prevalent 
was blaOXA-1 which confer resistance to ampicillin, cephalothin, oxacillin and cloxacillin. The final 
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Figure 5.6 The proportion of isolates carrying a selection of 22 of the most common resistance genes, divided according to slaughterhouse type. Error bars indicate 95%CI. 
Resistance genes with less than 5% prevalence or found in single groups/species only, were excluded from this figure. 
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common gene was blaCTX-M-15 which confers an ESBL phenotype; isolates carrying this gene also 
frequently co-carried quinolone (qnr) and aminoglycoside (aph) resistance genes. All the isolates 
carrying the blaCTX-M gene had an MDR genotype and phenotype. Whilst blaCTX-M-15 was the most 
prevalent blaCTX gene carried, three other ESBL resistance genes were also carried amongst E. 
coli, including blaCTX-M-3, blaCTX-M-27 and blaSHV-12.  
 
There was also a high proportion of slaughterhouse workers harbouring E. coli with point 
mutations conferring resistance to both nalidixic acid and ciprofloxacin. The most common of 
these was in gyrA (D87N, 22.5%, n=42) and parC (S80I, 18.7%, n=35). In addition to these, there 
were also numerous point mutations found in the 16S and 23S ribosomal RNA (rRNA) genes; in 
16S there were several mutations in both rrsB and rrsC. In 3.2% (n=1) genome each, there was 
r.1192A>G, r.1192T>G, r.1066C>T and r.1192T>A which confer resistance to spectinomycin and 
also 3.2% (n=1) with r.1058T>C, which confers resistance to tetracycline, doxycycline, 
minocycline and tigecycline. In rrsC, 6.4% (n=2) genomes contained the r.1519C>G mutation, 
conferring resistance to kasugamycin. In the 23S rRNA gene, 3.2% (n=1) genomes each also had 
the r.754T>A mutations conferring resistance to erythromycin and telithromycin and 
r.2032G>A, conferring resistance to linezolid. There was no significant difference (p>0.005, 
Kruskal Walis) between the presence of point mutations and the type of slaughterhouse which 
the workers worked at.  
 
There was a low prevalence of resistance genes for fosfomycin and macrolides (fosA and 
mph(A)), though rates of carriage were similar in all three groups.  
 
There was a low prevalence of quinolone and fluoroquinolone resistance genes in all 
slaughterhouse workers groups; three plasmid-mediated resistance genes, oqxA, oqxB and 
qnrS1 were carried by isolates from all three groups. Both oqxA and oqxB are part of the oqxAB 
gene complex which encode for the OqxAB pump which confers low-level resistance to 
ciprofloxacin, and cross-resistance to trimethoprim. The qnrS1 gene is also plasmid-mediated 
and confers low-level resistance to quinolones such as nalidixic acid.  
 
5.3.2.3 Virulence Genes 
A total of 36 unique virulence genes were identified in all sequenced genomes.  Six isolates 
carried no detectable virulence genes. Most isolates carried more than 3 unique virulence 
genes, with several isolates carrying more than 10 genes. Diversity of carried genes was similar 
in all three groups, 13 of the 15 most common genes were carried by isolates from all three 
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groups. A brief description of the most commonly identified virulence genes is described below 
(Table 5.2). Additional genes were also described in Chapter 4 and Chapter 1. As with the 
resistance genes, the most commonly identified virulence genes which spanned at least two 
groups were assessed for comparison of prevalence (Figure 5.7). 
 
Table 5.2 Brief description of the function of the most commonly carried  virulence genes from a population 
of 187 human-origin E. coli from workers slaughtering only pigs, only cattle, and cattle and sheep and goats. 
(References in Chapter 1, Table 1.1) 
Virulence 
Gene Role Function 
gad Glutamate decarboxylase 
Converts glutamate to GABA; maintains intracellular pH when cells when traversing stomach 
acid – aids in colonisation. 
iss Protectin Associated with exPEC strains; increased serum survival associated with serum resistance. 
iha Adhesin Associated with StxEAEC and UPEC, homologue of IrgA adhesin; confers adherence to nonadherent strains.   
lpfA Adhesin Encodes for chaperone-usher fimbriae used in adhering to gut wall. 
senB Toxin Toxin active against Enterobacteriaceae, increased retention of water and associated with watery diarrhoea.  
sat  Toxin Associated with UPEC and exPEC strains, a secreted autotransporter toxin, triggers destruction of the cell cytoskeleton, followed by autophagy.   
astA Toxin Produces EAST1 toxin resulting in diarrhoea in host organisms. 
iroN Siderophore Scavenges iron from mineral phases of soluble iron complexes for growth and maintenance. 
mchF Antibacterial Peptide 
Produces bacteriocin peptide, microcin. Compete with enteric pathogens by mimicking 
siderophores 
 
Figure 5.7 The most prevalent virulence genes carried by E. coli from three groups of slaughterhouse 
worker. Error bars indicate 95%CI. The 16 most prevalent virulence genes were tabulated and those which 
covered at least two groups were plotted in this figure. A short explanation of virulence genes can be seen 
in (Table 1.1 and Table 5.2). 
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The most commonly identified virulence genes in all groups were gad, iss, iha and capU. There 
were two virulence genes which were not carried in pig-only sequences, including eilA and air. 
The gad virulence gene was carried almost universally by isolates from cattle and cattle and 
shoat workers, and in almost all isolates from pig-only workers. Besides these differences, the 
majority of other virulence genes identified in the genomes had similar patterns of prevalence. 
 
There was low-level carriage of several genes relating to EAEC – the pathotype associated with 
diarrhoeal disease. These included aap (a dispersin, enhancing colonisation of the gut) and four 
different toxin-encoding genes: senB, sat, astA and cma. There was no difference between the 
carriage of these genes between any of the three groups, but they are important to note as they 
were associated with MDR and/or ESBL-producing isolates.  
 
There was no identifiable pattern between the carriage of resistance genes and the carriage of 
virulence genes. For example, isolates from pig-only workers carried a large number of 
resistance genes (between 7-21), but commonly only 4-6 virulence genes. Almost all the isolates 
belonging to the ST131 group carried a wide variety of resistance genes, as well as toxin-
producing virulence genes (sat and senB) but also only 3-4 other virulence genes. This suggests 
that whilst they have high AMR potential, they are not necessarily highly virulent.  
 
5.3.2.4 Plasmids 
Mobile genetic elements such as plasmids are known to carry both resistance and virulence 
genes and facilitate the spread of AMR genes between bacterial species via horizontal transfer, 
conferring antimicrobial resistance to previously antimicrobial-sensitive bacteria.  
 
As with the farm dataset (Chapter 4), there was a high prevalence of MDR E. coli found amongst 
slaughterhouse workers (Chapter 5) working in Busia county. This could indicate that numerous 
AMR genes are being transferred between bacteria on (multiple) plasmids.  
 
18 different plasmid replicon types were detected amongst humans working at three different 
types of slaughterhouse in Busia county (Figure 5.8). The most common plasmid replicon types 
found in E. coli genomes were IncFII (76.6%, n=141), IncFIB (65.1%, n=122), IncQ and IncQ1 
(65.0%, n=121, and IncFIA (28.8%, n=51). A moderate proportion of the sequenced genomes 
had co-carriage of IncFI, IncFII, IncQ and IncQ1 (42.7%, n=80), though there was no significant 
difference between the type of slaughterhouse and carriage of those plasmids  (Kruskal Wallis, 
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p>0.05). More than one replicon type was found in 94.7% (n=177) isolates, and in 60.9% of these 
isolates the most common plasmid replicon co-occurrence was IncFIB and IncFII (p<0.001). For 
plasmid replicons which were carried by workers from each of the three types of 
slaughterhouse, there was no significant difference between the proportion of the plasmids 
carried, and the type of slaughterhouse (p>0.05). This suggests that the type of slaughterhouse 
does not make a large difference to the diversity of plasmids acquired by E. coli of 
slaughterhouse workers. 
 
Due to the high prevalence of AMR genes carried within this population, an examination of the 
number and type of plasmids found in the isolates with the largest number of AMR genes was 
made. Of note, was a significant association between the carriage of ESBL genes (specifically 
blaCTX-M-15) and the presence of any IncF plasmid (IncFIA, IncFIB or IncFII). The combination of  
blaCTX-M-15 and IncFIA was found in 26 isolates (78.7%) (p<0.001, Fisher’s Exact Test). The 
combination of  blaCTX-M-15 and IncFIB was found in 28 isolates (72.7%) (p=0.01, Fisher’s Exact 
Test). The combination of blaCTX-M-15 and IncFII was found in 24 isolates (81.8%) (p=0.01, Fisher’s 
Exact Test). The occurrence of blaCTX-M-15 with all three of those plasmids was 45.4% (n=15) 
(p=0.04, Fisher’s Exact Test). The high association of blaCTX-M-15 with IncF plasmids, suggests that 
they have a significant role in the dispersal of ESBL genes amongst slaughterhouse workers in 
Busia county. 
 
Conversely, the other major ESBL genotype (attributed to blaSHV-12) was more likely to be 
associated with carriage of IncQ1 and IncX3 plasmids (p=0.02, Fisher’s Exact Test), opposed to 
IncF plasmids. 
 
Isolates which carried the same replicon types were likely to carry the majority of similar, but 
not identical resistance and virulence genes. Isolates carrying only IncFII and IncFIB were 
tabulated and the carriage of both resistance and virulence genes was noted (Table 5.3). Minor 
differences in the detected resistance and virulence genes may suggest that other methods of 
gene acquisition other than on mobile genetic elements may be occurring in this population. 
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Figure 5.8 Proportions of each of the plasmids carried within E. coli genomes, isolated from farmers 
working at three different types of slaughterhouse. Error bars are 95% CI. 
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Table 5.3 Heat-map showing the virulence and resistance genes carried by a group of isolates carrying the same two plasmid replicon types, IncFII and IncFIB to highlight 
variability in strains with the same plasmids. One random isolate was selected from 9 different STs to ensure adequate diversity was compared. 
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5.3.2.5 Extended-Spectrum Beta Lactamases  
Several clusters of ESBL-producing E. coli could be identified on the phylogenetic tree (Figure 
5.3). E. coli from the ST617 clade carried a blaCTX-M-15 resistance gene and were detected in pig-
only and cattle and mixed ruminant slaughterhouse workers. Isolates from the ST361 clade 
carried a blaSHV-12 resistance gene and were detected in all three types of slaughterhouse worker. 
All but one of the isolates from the ST131 clade also all carried a blaCTX-M-15 resistance gene; one 
ST131 isolate carried a blaCTX-M-27. ST131 isolates were also dispersed amongst all three types of 
slaughterhouse workers. 5 isolates belonging to the ST131 clade (which carried the blaCTX-M-15 
resistance gene) belonged to serogroup O25:H4. Interestingly, two of the ST131 isolates which 
were a part of the ST131 clade, carried numerous AMR genes, including to aminoglycosides, 
sulfonamides, tetracyclines and chloramphenicol, but they did not appear to carry an ESBL 
resistance gene, despite also being serogroup O25:H4. To confirm if this was accurate, 
resistance gene analysis was re-run using a lower threshold of detection (coverage remained at 
≥90%, but identity dropped to ≥75%) and the same results were found.  
 
One genome (58-596D) was found to carry a blaCMY-135 resistance gene, conferring resistance to 
a wide array of antimicrobials. This was co-carried alongside blaCTX-M-27 and belonged to the ST10 
cluster (isolated from one cattle-only slaughterhouse worker).  
 
The majority of isolates clustering within ST361 group belonged to serogroup O9:H30 (80.%, 
n=8); of these ST361:O9:H30 isolates, all carried the blaSHV-12 ESBL resistance gene, and two of 
those also carried co-carried blaCTX-M-15. Isolates were from geographically distinct areas and 
dispersed amongst each of the three types of slaughterhouse (mixed ruminants, cattle only and 
pigs only). A clade of 8 ST131 isolates was also dispersed amongst all three types of 
slaughterhouse worker. Of those, 6 isolates belong to serotype O25:H4, 4 carried the blaCTX-M-15 
ESBL resistance gene and 1 carried the blaCTX-M-27 gene  
 
The most commonly carried β-lactamase conferring the ESBL phenotype was blaCTX-M-15. The 
blaSHV-12 ESBL resistance gene was less common but was carried by several different E. coli from 
all three slaughterhouse types. There were three instances of co-carriage of blaSHV-12, with blaCTX-
M-15, in pig-only isolates (n=2) and mixed ruminant isolates (n=1). Isolates carrying the blaCTX-M 
resistance genes were more associated with IncFIB, IncFIA and IncFII plasmids (p<0.001, Fisher’s 
Exact Test), whereas those carrying a blaSHV resistance gene were more commonly associated 
with IncQ1 and IncX3 plasmids (p<0.001, Fisher’s Exact Test). However, several blaSHV-12 carrying 
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isolates also carried IncF plasmids which proves exception to this rule and suggests that ESBL 
genes may be carried on different plasmids, or in combinations. 
 
All isolates carried numerous resistance genes in association with different combinations of 
plasmids (Table 5.4). Despite the high degree of genetic similarity (<500 SNPs difference) shown 
on the phylogenetic tree, each group of STs contained isolates carrying non-identical plasmids 
and resistance genes. This is expected as there are numerous different plasmid replicons 
circulating in this population. This is true of ST131, four isolates carry identical resistance genes, 
but isolates 58-583CZ carries almost entirely different resistance genes, as well as a different 
blaCTX-M resistance gene (27, instead of 15). Similarly, with ST617 isolates, six are identical, and 
58-468CZ is almost identical, except for the additional carriage of a fosfomycin resistance gene 
(fosA). 
 
Some similarities within serogroups were evident (Table 5.5) - similar virulence genes were 
associated with isolates belonging to the same groups. There was a large number of toxin-
producing genes in serotypes within the O8 and O25 group, particularly of sat and senB; many 
of these isolates were found in cattle-only or cattle and mixed ruminant slaughterhouses. This 
could be of importance, as isolates belonging to phylogroup B2 have been associated with exPEC 
disease.  
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Table 5.4 A heatmap showing the details of E. coli isolates carrying blaCTX-M or blaSHV ESBL resistance genes. Results are sorted by the ESBL genes carried by the bacterium, then by ST and then 
plasmid replicon type. 
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IncQ1 
                                  blaCTX-M-
15 
58-454C 150 P 10 
SULFA TET AMP 
TRIM - 
                                  blaCTX-M-
15 
58-724A 5 P 43 CIP SULFA TET 
AMP GENT TRIM 
IncFIB IncFII 
IncFIA 
IncQ1 
                                  blaCTX-M-
15 
120347 124 C+S 101 CIP SULFA CHLOR 
TET AMP TRIM 
IncB/O/K/Z 
IncFII 
                                  blaCTX-M-
15 
58-454CZ 150 P 131 
CIP SULFA CHLOR 
TET AMP GENT 
TRIM 
IncFIB 
IncFIA 
                                  blaCTX-M-
15 
58-716CZ 5 P 131 
SULFA TET AMP 
TRIM 
IncFIB 
IncFIA 
                                  blaCTX-M-
15 
58-725CX 37 P 131 CIP SULFA TET 
AMP TRIM 
IncFIB 
IncFIA 
                                  blaCTX-M-
15 
58-740CZ 4 P 131 
SULFA TET AMP 
TRIM 
IncFIB 
IncFIA 
                                  blaCTX-M-
15 
120519 22 C 224 
SULFA TET AMP 
TRIM 
IncFII IncFIB 
IncFII IncR 
IncQ1 
                                  blaCTX-M-
15 
1 76  
 
 
Chapter Five                  Slaughterhouse Study 
 
 
Sa
m
pl
e 
ID
 
Sl
au
gh
te
rh
ou
se
 N
o.
 
Sl
au
gh
te
rh
ou
se
 T
yp
e 
ST
 
Re
si
st
an
ce
 P
he
no
ty
pe
 
 
Pl
as
m
id
 R
ep
lic
on
 T
yp
es
 
 
Resistance Genes 
ES
BL
 R
es
is
ta
nc
e 
G
en
es
 
aa
c(
3)
-II
a 
aa
c(
3)
-II
d 
aa
c(
6'
)Ib
-
cr
 
aa
dA
1  
aa
dA
2  
aa
dA
5  
bl
aA
CT
-
10
 
bl
aC
M
Y-
51
 
bl
aO
XA
-1
 
bl
aT
EM
-
1B
 
ca
tA
1  
ca
tB
3  
df
rA
1 
df
rA
7 
df
rA
8 
df
rA
12
 
df
rA
14
 
df
rA
15
 
df
rA
17
 
fo
sA
 
m
ph
(A
)  
oq
xA
 
oq
xB
 
qe
pA
 
Q
nr
S1
 
sp
h 
st
rA
 
st
rB
 
su
l1
 
su
l2
 
te
t(
A)
 
te
t(
B)
 
te
t(
c)
 
te
t(
j)  
58-704A 40 P 617 SULFA TET AMP 
TRIM 
IncFIA 
IncHI1B 
IncFIB IncFII 
                                  blaCTX-M-
15 
58-363CX 6 P 617 SULFA TET AMP TRIM 
IncFIB 
IncFIA IncFII                                   
blaCTX-M-
15 
58-464CZ 119 C+S 617 
CIP SULFA TET 
AMP GENT TRIM 
IncFIB 
IncFIA IncFII 
                                  blaCTX-M-
15 
58-468CX 119 C+S 617 SULFA TET AMP TRIM 
IncFIB 
IncFIA IncFII 
                                  blaCTX-M-
15 
58-468CZ 119 C+S 617 
SULFA TET AMP 
TRIM 
IncFIB 
IncFIA IncFII 
                                  blaCTX-M-
15 
58-725CZ 37 P 617 SULFA TET AMP TRIM 
IncFIB 
IncFIA IncFII 
                                  blaCTX-M-
15 
58-747CX 38 P 617 SULFA TET AMP 
TRIM 
IncFIB 
IncFIA IncFII 
                                  blaCTX-M-
15 
58-751CZ 38 P 617 SULFA TET AMP TRIM 
IncFIB 
IncFIA IncFII 
                                  blaCTX-M-
15 
58-751CX 38 P 617 SULFA TET AMP 
TRIM 
IncFIB 
IncFIA IncFII 
                                  blaCTX-M-
15 
120346 124 C+S 648 CIP SULFA TET 
AMP TRIM 
IncFIA IncFII 
IncFIB 
IncQ1 
                                  blaCTX-M-
15 
121930 1 C+S 5386 SULFA TET AMP 
TRIM 
IncFIB 
IncFIA IncFII 
IncQ1 
                                  blaCTX-M-
15 
58-570CX 9 C - SULFA TET AMP 
TRIM 
IncFIB 
IncFIA IncFII 
                                  blaCTX-M-
15 
58-747CZ 38 P - 
SULFA TET AMP 
TRIM 
IncFIB 
IncFIA IncFII 
                                  blaCTX-M-
15 
58-639CZ 34 P - SULFA TET AMP TRIM IncFIB IncFII 
                                  blaCTX-M-
15 
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58-467A 22 C - CIP SULFA TET 
AMP TRIM 
IncFIB IncFII 
IncFIA 
IncQ1 
                                  blaCTX-M-
15 
121766 79 C+S - SULFA TET AMP TRIM 
IncFII IncFIA 
IncR IncQ1 
                                  blaCTX-M-
15 
58-630CZ 153 P - 
SULFA TET AMP 
TRIM - 
                                  blaCTX-M-
15 
58-464CX 119 C+S - CIP SULFA TET 
AMP GENT TRIM 
IncFIA 
IncFIB IncFII 
IncX3 IncQ1 
                                  
blaCTX-M-
15, 
blaSHV-12 
58-454CX 150 P - 
CIP SULFA CHLOR 
TET AMP GENT 
TRIM 
IncFIB 
IncFIA 
IncX3 IncQ1 
                                  
blaCTX-M-
15, 
blaSHV-12 
58-477CX 169 P - 
SULFA TET AMP 
TRIM 
IncFII 
IncHI2A 
IncHI2 
IncFIB 
IncFIA 
IncX3 IncQ1 
                                  
blaCTX-M-
15, 
blaSHV-12 
58-596D 9 C 10 SULFA TET AMP 
TRIM 
IncFIB IncFII 
IncFIA 
IncFIB 
IncQ1 
                                  blaCTX-M-
27 
58-583CZ 9 C 131 SULFA TET AMP 
TRIM 
IncFIA IncFII 
IncFIB 
                                  blaCTX-M-
27 
120172 124 C+S - SULFA TET AMP 
TRIM 
IncFII IncFIC 
IncI1 IncFIB 
IncQ1 
                                  blaCTX-M-
3 
58-533CZ 26 C+S 361 SULFA TET AMP TRIM 
IncFII IncFIB 
IncX3 IncQ1 
                                  blaSHV-12 
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58-539CX 26 C+S 361 SULFA TET AMP TRIM IncQ1 IncX3 
                                  blaSHV-12 
58-539CZ 26 C+S 361 SULFA TET AMP 
TRIM 
IncQ1 IncX3                                   blaSHV-12 
58-560CX 3 C 361 SULFA TET AMP TRIM IncQ1 IncX3 
                                  blaSHV-12 
58-586CX 3 C 361 SULFA TET AMP 
TRIM 
IncQ1 IncX3                                   blaSHV-12 
58-588CX 3 C 361 SULFA TET AMP TRIM IncQ1 IncX3 
                                  blaSHV-12 
58-716CX 5 P 361 SULFA TET AMP 
TRIM 
IncQ1 IncX3                                   blaSHV-12 
58-546CX 110 C+S 361 
CIP SULFA CHLOR 
TET AMP TRIM - 
                                  blaSHV-12 
58-546CZ 110 C+S 361 CIP SULFA CHLOR 
TET AMP TRIM 
-                                   blaSHV-12 
58-464A 119 C+S - CIP SULFA TET AMP GENT TRIM 
IncFII IncFIB 
IncFIA 
IncX3 IncQ1 
                                  blaSHV-12 
58-562CZ 9 C - SULFA TET AMP TRIM 
IncFII IncFIB 
IncX3 IncQ1 
                                  blaSHV-12 
58-340C 148 C - SULFA TET AMP TRIM 
IncFII 
IncHI1B 
IncFIB IncR 
IncX3 IncQ1 
                                  blaSHV-12 
58-578CX 3 C - CIP SULFA TET 
AMP TRIM 
IncX3 IncFII 
IncQ1 
                                  blaSHV-12 
120516 119 C+S 10 SULFA TET AMP TRIM 
IncFIA IncFII 
IncFIB 
IncQ1 
                                  blaCTX-M-
15 
1 79 
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120504 108 C+S 10 SULFA TET AMP 
TRIM 
IncFIB IncFII 
IncB/O/K/Z 
IncQ1 
                                  blaCTX-M-
15 
58-454C 150 P 10 SULFA TET AMP TRIM - 
                                  blaCTX-M-
15 
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Table 5.5 Serogroups, phylogroups and virulence genes carried by 46 isolates of ESBL-producing E. coli. The four detected toxin-producing virulence genes are highlighted in four respective colours 
(astA = red, cma = blue, sat = yellow and senB = green). Data is sorted according to O group, then H group, then phylogroup. Slaughterhouse type key: C+S = cattle and sheep and goats, C = cattle-
only, P = pig-only. 
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120516 C+S E 1 6                        blaCTX-M-15 
120346 C+S F 1 6                        blaCTX-M-15 
58-596D C - 8 10                        blaCTX-M-27 
121930 C+S D 8 10                        blaCTX-M-15 
58-340C C E 8 11                        blaSHV-12 
58-464CZ C+S A 9 10                        blaCTX-M-15 
58-464CX C+S - 9 30                        blaCTX-M-15, blaSHV-12 
58-562CZ C - 9 30                        blaSHV-12 
58-477CX P A 9 30                        blaCTX-M-15, blaSHV-12 
58-533CZ C+S A 9 30                        blaSHV-12 
58-539CX C+S A 9 30                        blaSHV-12 
58-539CZ C+S A 9 30                        blaSHV-12 
58-546CZ C+S A 9 30                        blaSHV-12 
58-560CX C A 9 30                        blaSHV-12 
58-586CX C A 9 30                        blaSHV-12 
58-588CX C A 9 30                        blaSHV-12 
58-716CX P A 9 30                        blaSHV-12 
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120172 C+S D 22 2                        blaCTX-M-3 
58-724A P - 25 4                        blaCTX-M-15 
58-747CZ P - 25 4                        blaCTX-M-15 
58-454CZ P B2 25 4                        blaCTX-M-15 
58-464A C+S B2 25 4                        blaSHV-12 
58-570CX C B2 25 4                        blaCTX-M-15 
58-583CZ C B2 25 4                        blaCTX-M-27 
58-716CZ P B2 25 4                        blaCTX-M-15 
58-725CX P B2 25 4                        blaCTX-M-15 
58-740CZ P B2 25 4                        blaCTX-M-15 
58-630CZ P - 25 10                        blaCTX-M-15 
121766 C+S - 25 19                        blaCTX-M-15 
58-454CX P - 25 30                        blaCTX-M-15, blaSHV-12 
58-546CX C+S A 25 30                        blaSHV-12 
58-704A P A 88 16                        blaCTX-M-15 
58-363CX P A 89 10                        blaCTX-M-15 
58-468CX C+S A 89 10                        blaCTX-M-15 
58-468CZ C+S A 89 10                        blaCTX-M-15 
58-725CZ P A 89 10                        blaCTX-M-15 
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58-747CX P A 89 10                        blaCTX-M-15 
58-751CX P A 89 10                        blaCTX-M-15 
58-751CZ P A 89 10                        blaCTX-M-15 
58-467A C E 89 41                        blaCTX-M-15 
58-578CX C - 95 10                        blaSHV-12 
58-454C P A 107 36                        blaCTX-M-15 
120504 C+S - 160 9                        blaCTX-M-15 
120519 C B1 174 3                        blaCTX-M-15 
120347 C+S B1 174 28                        blaCTX-M-15 
58-639CZ P B2 - -                        blaCTX-M-15 
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5.4 Discussion 
This study examined the carriage and prevalence of AMR E. coli in the faeces of slaughterhouse 
workers, working in cattle only, mixed ruminant, and pig-only slaughterhouses across Busia 
county, in Western Kenya. Slaughterhouse workers are at high risk of coming into contact with 
livestock-associated E. coli during the slaughter process. Numerous shortcomings in the 
slaughter process may contribute to the increased risk for the transmission of AMR bacteria 
between livestock and humans in sub-Saharan Africa slaughterhouse environments however, in 
this region, there are no data investigating this. The results of this study indicate a high 
prevalence of AMR, MDR and ESBL-producing E. coli carriage amongst slaughterhouse workers, 
as well as a high level of diversity in the E. coli isolated. This is the first study investigating the 
prevalence of faecal carriage of AMR E. coli in slaughterhouse workers in western Kenya.   
 
There was a high prevalence of AMR E. coli isolated from the faeces of slaughterhouse workers 
across the four sampled western Kenyan counties. The majority of isolates (95.6%) were 
resistant to at least one antimicrobial class, with approximately half being MDR in all 
slaughterhouse types. There are relatively few studies assessing rates of MDR E. coli in humans 
outside of clinical context and a lack of data in African countries, thus this study provides the 
first data in this respect.  
 
There was a moderately high carriage of ESBL-E. coli amongst slaughterhouse workers. ESBL-
producing E. coli was isolated from 6.5% (95%CI 2.8 - 10.2%) of cattle-only slaughterhouse 
workers, 11.8% (95%CI 6.6 – 17.1%) of mixed ruminant slaughterhouse workers, and 13.6% 
(95%CI 7.8 – 19.5%) of pig-only slaughterhouse workers. This is in-line with a previous study 
investigating the ESBL carriage in Dutch pig slaughterhouse workers, who reported an overall 
prevalence of 4.9% (95%CI 1.57 - 12.62%) (Dohmen et al., 2017). However, it is impossible to 
conclude from this study if ESBL-producing E. coli was acquired from livestock in the 
slaughterhouse or from elsewhere. Indeed, a number of these isolates (e.g. those belonging to 
the ST131, ST361 and other clades) are also associated with clinical infection amongst humans, 
all over the world (Ahmed et al., 2015; Manges et al., 2019). It is difficult to speculate on the 
increased rates of carriage for ruminant-slaughterhouses, though this could be related to AMU. 
It has been described that ESBL carriage is considerably higher in slaughterhouse workers who 
eviscerate pig carcasses (specifically the lungs, heart, liver, tongue) and remove the heads and 
spinal cords of these animals (Lowe et al., 2011; Lăpușan et al., 2012) and our findings mirror 
this, as the highest proportion of ESBL-E.coli was found in pig slaughterhouse workers. 
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Furthermore, evisceration may be a risk factor for people slaughtering other animals including 
cattle, particularly as the majority of Kenyan workers participate in several aspects of animal 
slaughter (Cook et al., 2017). There is poor hygiene in slaughterhouses in this region (Cook et 
al., 2017), thus there is potential transmission of E. coli from animal carcasses to workers, and 
then from worker-to-worker. Phenotypic resistance to antimicrobials commonly used in animals 
was apparent in all human E. coli isolates, similar to those noted in humans and animals in our 
farm study (Chapter 4). As there is significant overlap in the antibiotics used in humans and 
animals in this study site (oxytetracyclines, penicillin-streptomycin etc.), the same selective 
pressures may be placed on E. coli to develop AMR in humans, as in animals. 
 
Tetracycline resistance was the most common amongst all workers (86.2%). This corresponds 
to the most commonly used antimicrobials in cattle and other farm animals, which is 
oxytetracycline (results from Chapter 3; (Founou et al., 2018). The most common phenotypes 
were similar in all groups, with no statistically significant differences found. More than half 
(61.3%) of the 31 detected phenotypic patterns were MDR. There was frequent co-carriage of 
resistance genes conferring resistance to sulfonamides, tetracycline, trimethoprim, and 
ampicillin. The high proportion of MDR E. coli isolated from slaughterhouse workers in this 
cohort, as well as the presence of numerous plasmid replicons found in E. coli genomes suggests 
that AMR genes are being mobilised between slaughterhouse workers on multiple mobile 
genetic elements, such as plasmids. This theory is consistent with the WGS results (Chapter 5) 
which showed a direct correlation between carriage of IncF plasmids and the presence of MDR 
(including tet, dfr and sul resistance genes) and ESBL-producing E. coli. Furthermore, the high 
degree of tetracycline resistance is fitting with the notion that humans have access to a wide 
variety of antimicrobials which can be purchased without a prescription (Muloi et al., 2019b). 
This finding is also consistent with commonly purchased antimicrobials according to the farm 
study (Chapter 4). Cook et al showed that 18% of slaughterhouse workers reported being unwell 
in the 3 months prior to sampling and that 18% of slaughterhouse workers also knowingly 
slaughtered sick animals (Cook et al., 2017). There is a significant risk of contracting AMR strains 
of E. coli during the slaughter process, particularly if workers have skin lacerations. As a number 
of these slaughterhouses did not also have ready access to running water and soap, and workers 
have to purchase their own PPE (Cook et al., 2017), there is adequate opportunity for 
colonisation of E. coli from animal carcasses to occur. As PPE was worn by only 27% of 
slaughterhouse workers and hand-washing facilities were only present at 20% of 
slaughterhouses (Cook et al., 2017), there is an opportunity for bacterial acquisition from animal 
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carcasses to humans via open wounds. Workers may contaminate their clothes with viscera and 
then spread bacteria to their homes and other people.  
 
In silico MLST analyses and serotyping also revealed a variety of STs and serotypes amongst E. 
coli isolated from slaughterhouse workers. The most prevalent STs were ST10, ST617 and ST48. 
ST10 strains are usually generalists and are frequently found as intestinal commensals 
particularly in pigs (Lugsomya et al., 2018), but also in many other animals (Abraham et al., 
2015), and also in humans (Fischer et al., 2017). The ST10 clonal complex (ST10 and closely 
related STs) have also been associated with human infections and ESBL production, being 
isolated from human clinical specimens, meat products, and food animals (Oteo et al., 2009; 
Cortes et al., 2010; Cohen Stuart et al., 2012; Peirano et al., 2012). ST10 E. coli was previously 
discovered in the farm study (Chapter 4) though none of these were found in human samples 
on farms. The second most common ST, ST617 is also part of the ST10 clonal complex and has 
recently been identified as a potential evolutionary descendant of ST10 and associated with 
carriage of ESBL genes (Zong et al., 2018). A study in rural farming communities in Mwanza, 
Tanzania showed that E. coli belonging to ST617 and carrying blaCTX-M-15 was isolated from 
various animals (Seni et al., 2016a). It is possible that the crossover of E. coli ST617 from animals 
to humans has occurred via clonal spread. E. coli belonging to ST48 (also part of the ST10 clonal 
complex) appears to be a common type in human and animal isolate origins, according to the 
PubMLST database. In Tunisia, ST48 E. coli has been associated with the production of ESBLs in 
healthy human volunteers (Ben Sallem et al., 2012). Despite being relatively common, no ST48 
isolates were reported to carry an ESBL gene in this study population.  
 
From the phylogenetic tree, three major clades of E. coli with a high degree of genetic similarity 
(<500 SNPs difference) were detected, belonging to ST361, ST617 and ST131. The presence of 
ST131 E. coli is particularly relevant, as four of these isolates were associated with serotype 
O25:H4. ST131 has been identified as a pandemic, MDR, community- and hospital-associated 
strain (Rogers et al., 2010) and has severe implication for public health, owing to its difficulty in 
treatment. Four isolates from pig-only slaughterhouse workers were identified as having a high 
degree of similarity (fewer than 150 SNPs difference), all belonging to ST131, and all carrying 
the blaCTX-M-15 resistance gene. Fimtyping showed that these all had the same Fim switch – H30. 
ST131:FimH30 have been described globally, and recently in Sweden (Ny et al., 2019). These 
four isolates do indeed belong to the ST131:O25/FimH30 pandemic strain (Pitout and DeVinney, 
2017; Kondratyeva et al., 2020). As discussed in Chapter 4, livestock may represent a major 
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reservoir of ESBL-producing E. coli and it is entirely possible that during the slaughter processes, 
there can be transmission from animal carcasses to humans which is then spread between 
workers. However, this strain could also be circulating specifically amongst slaughterhouse 
workers and spread from human-to-human due to poor hygiene practices, such as eating in the 
slaughterhouse or not having access to running water and soap (Cook et al., 2017) 
 
The most commonly occurring serotypes were O9:H30 and O25:H4. Serotype O25:H4 is of 
particular importance, as it associated with the intercontinental emergence of ST131-O25b E. 
coli (Nicolas-Chanoine et al., 2008; Rogers et al., 2010). Typically, this lineage carries numerous 
virulence genes and is associated with extraintestinal infections. Indeed, all the O25:H4 isolates 
(8 isolates) carried 5 or more virulence genes, and all of them also carried a combination of 
toxin-associated virulence factors (astA, sat and senB) as well as other genes encoding for 
adhesins and siderophores. The number and combination of virulence genes found here 
strongly imply a robust virulence capability (Johnson et al., 2002). Characteristically, human E. 
coli derived from phylogroup B2 are associated with the ExPEC pathotype, whilst phylogroups A 
and B1 are associated with commensal carriage (Micenkova et al., 2016). Half of the O25:H4 
isolates did belong to phylogroup B2 and two other isolates (which could not be phylotyped due 
to mismatches in the ClermontTyping database) each carried 16 virulence genes, alongside 
toxin-producing genes sat and senB. Whilst there is no certainty that these are also phylogroup 
B2 isolates, the virulence profile, in concordance with the serogrouping and carriage of blaCTX-M-
15 strongly indicates that these isolates carry a much more extensive array of virulence genes 
than a typical ESBL-producing B2 (Johnson et al., 2003). Other B2 isolates did not appear to carry 
specialised virulence factors to aid in colonisation (such as adhesins and siderophores) and thus, 
did not satisfy the criteria for ExPEC.  
 
The emergence and dissemination of the pandemic clone is particularly concerning. As these 
isolates were first collected in 2012, it is possible that there has been additional spread since 
then. It is important to determine the origins, reservoirs, and transmission pathways of these 
ST131 isolates, so that appropriate interventions can be implemented. Previous transmission-
based studies have been inconclusive in determining if bacteria is transmitted to or from 
livestock or indeed if bacterial populations are self-contained (Muloi et al., 2018), however 
specifically from these results it is possible that the ST131 pandemic strain may have been 
transferred to slaughterhouse workers from livestock, during the slaughter process. As the 
prevalence of ESBL-producing and MDR E. coli has not been previously investigated in western 
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Kenya, this finding highlights the need to increase AMR surveillance and better hygiene 
practices, in order to limit the spread or incidence of E. coli to/from carcasses intended for 
consumption. A better definition of the extent of this problem is needed, to clarify how great a 
public health threat these strains actually pose, so that resources can be allocated accordingly 
if necessary. Furthermore, it may be important to assess the carriage in other members of the 
community as this (whilst unlikely) may reflect normal carriage patterns. The other most 
common serogroup found in this population was O9:H30-ST361. These have been infrequently 
reported in the literature, though it has been reported that the ST131 pandemic evolved from 
an H30-ST131Rx subclone (Price et al., 2013; Nicolas-Chanoine et al., 2014). The ST131 has 
previously been reported in the faecal E. coli of malnourished children in Kenya (Mwangi, 2016) 
and so, by detecting it in another group of people, it is even more important to set up 
appropriate surveillance systems so that this can be tracked and prevented from spreading 
further. 
 
There was a statistically significant difference in the carriage of the mdf(a) gene between 
isolates from different slaughterhouse workers; in isolates taken from workers in pig-only 
slaughterhouses, the prevalence was 100%. The clinical relevance of mdf(a) has been addressed 
in some studies and examined in Chapter 4; particularly in MDR E. coli there appears to be high 
carriage of mdf(a), associated with IncX plasmids, especially in clinical patients (Wang et al., 
2013; Wang et al., 2014; Yardeni et al., 2018). There was also a similarly high prevalence of 
mdf(A) carriage amongst farmers in Busia (Chapter 4). As all the sequenced isolates were MDR 
and/or ESBL-producers, it makes sense that prevalence is relatively high, however, there is no 
explanation for why it is more prevalent in pig-only isolates.  
 
There was moderate carriage rate of a number of resistance genes, including mph(a), fosA, 
oqxA/B and qnrS1 genes, these act on macrolides, fosfomycin and fluoroquinolones, 
respectively. In Chapter 3, farmers indicated extremely low use of macrolides, fosfomycin and 
fluoroquinolones in animals and in Chapter 4, the supporting questionnaire given to human 
participants also suggested that there was low fluoroquinolone (16.1%), erythromycin (3.2%) 
and cephalosporin (3.2%) use in farmers (though data was only collected in relation to 
antimicrobial therapies for gastrointestinal issues). Human isolates from farmers in Chapter 4 
also showed a low-moderate prevalence of carriage of these resistance genes which was 
consistent with the low reported use. Patterns of carriage in livestock were also similar to both 
farmers and slaughterhouse workers. The high carriage of aminoglycoside resistance genes, 
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specifically aph(3’’)-Ib and aph(6)-Id are both highly prevalent in companion and domestic farm 
animals in neighbouring Tanzania and typically associated (or co-carried) on plasmids alongside 
blaCTX-M-15 (Seni et al., 2016a). This was also consistent with our findings amongst farmers 
(Chapter 4) and in slaughterhouse workers. As previously discussed in Chapter 3 and 4, there is 
particularly high usage of sulfonamides, tetracyclines and trimethoprim in farm animals, but 
despite there being little reported use in humans (results from questionnaires Chapters 3 and 
4), the prevalence of resistance to these antimicrobials was similar in livestock, farmers and 
slaughterhouse workers. These similarities in the prevalence of AMR genes could be reflective 
of overlapping usage patterns in both humans and livestock, or it could suggest that having close 
contact with animals may increase the risk of humans acquiring AMR E. coli from animals, or it 
could reflect other indirect transmission patterns e.g. via the shared environment. To better 
answer this question, additional work in the form of constructing logistic regression models with 
animal contact and/or working in a slaughterhouse as a factor could be constructed (though this 
is currently being undertaken by Dr Annie Cook, hence it was omitted from this thesis). 
Additionally, instead of testing only slaughterhouse workers for the presence of AMR E. coli, it 
would have been beneficial to also collect samples from animal carcasses.   
 
Despite being from different studies, with different selection criteria, there was an interesting 
difference between farmers and livestock, and slaughterhouse workers, which was the 
difference in the carriage of chloramphenicol resistance genes. E. coli from livestock and farmers 
had an extremely low carriage of catA1, whereas slaughterhouse workers had a high prevalence 
of catA1 and catA2. Despite chloramphenicol use for livestock production being banned in 
Kenya (Global Antibiotic Resistance Partnership, 2011), there was still significant resistance 
detected amongst animals. This could be explained by the use of florfenicol, a fluorinated 
derivative of chloramphenicol, which shows some cross-resistance with chloramphenicol 
(White et al., 2000). The higher prevalence of resistance genes in slaughterhouse workers may 
be due to of unreported self-use of chloramphenicol or derivatives amongst human workers, 
which is being compounded by interactions with animal faeces during the slaughter process. It 
is important to note that this could be due to the selection bias introduced when choosing 
samples for WGS, but it is interesting to note, nonetheless. Indeed, the amplification and 
persistence of AMR determinants in faeces has been described and this could be the pathway 
by which these determinants are disseminated to slaughterhouse workers (Pornsukarom and 
Thakur, 2017). There is further evidence in the literature to suggest that there is sharing of 
bacteria between animal carcases and humans (Muloi et al., 2018); the questionnaire 
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accompanying the original collection of these isolates (Cook et al., 2017) stated that on average, 
only 32% (as volunteered by interviewees) of workers (27%, observed by interviewers) wore 
some form of personal protective equipment (PPE). This highlights that through close contact 
with animal carcasses (meat, viscera, faeces), resistance genes may be acquired by human E. 
coli on MGEs or AMR E. coli colonising the slaughterhouse workers through skin lacerations or 
via the faecal-oral route. 
 
There was little significant difference in the carriage of the majority of virulence genes between 
the types of slaughterhouse workers. Two of the 16 most common virulence genes were not 
carried by E. coli isolated from humans working in pig-only slaughterhouses – eilA and air. As 
pig-only isolates made up a smaller proportion of the sequenced isolates compared to the other 
two groups, this may be reflective of the sample size.  A number of toxin-producing virulence 
genes were found in isolates from each of the three groups. Toxin-producing genes carried by 
ESBL isolates associated with serogroup O25:H4 were almost identical, strongly suggesting 
clonal transfer within humans working at slaughterhouses slaughtering cattle only and cattle 
and small ruminants, in distinct locations, particularly within Busia sub-counties (approximately 
40km apart). The most commonly carried toxin-producing virulence gene was senB, encoding 
ShET2 – this is commonly associated with EIEC/STEC diarrhoeal disease. As the investigation 
focused on enteric bacteria, this is an interesting finding as we previously observed extremely 
infrequent toxin gene carriage amongst livestock and human isolates in the farm study (Chapter 
4). Toxin-carrying E. coli strains are being more commonly associated with food-borne diseases 
worldwide (European Food Safety Authority and Control, 2018) and this study has shown that 
on average, those isolates carrying toxin-producing genes, also carried more virulence and 
resistance genes than non-toxin producing counterparts. The high levels of resistance to 
tetracyclines and sulfonamides, in association with toxin-production genes is also supported by 
the literature (Ojo et al., 2010; Carrie-Ann et al., 2017; Sethulekshmi et al., 2018). As toxigenic 
E. coli was not found amongst farm animals, this also suggests that slaughterhouse workers may 
be a reservoir of toxigenic E. coli and these are not necessarily being acquired from livestock.  
 
Four major plasmid replicons were carried by a high proportion of isolates from all three groups: 
IncFII, IncFIB, IncQ and IncQ1. The IncF plasmid is commonly associated with ESBL-producing 
Enterobacteriaceae (mostly blaCTX-M-1 and blaCTX-M-15) in the literature (Novais et al., 2007; 
Carattoli, 2011; Irrgang et al., 2017) and was also found to be significantly correlated with ESBL-
producing E. coli in our findings, specifically with the presence of blaCTX-M-15. Three isolates 
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carrying blaCTX-M-15 also carried the aac(6’)-Ib-cr variant gene which simultaneously induces 
resistance to aminoglycosides and ciprofloxacin. IncFII plasmids carrying blaCTX-M-15 are known to 
be highly transferable (Carattoli, 2009) and the dispersal of both IncF plasmids and blaCTX-M-15 
amongst a variety of slaughterhouse workers, working at different types and location of 
slaughterhouses in Busia, supports this. This presents a public health issue as there is evidence 
to suggest that IncF and IncQ plasmids carrying multiple AMR and ESBL genes are circulating 
amongst slaughterhouse workers in Busia. As such, there is potential for the spread of such 
genes along the food chain via human-contaminated meat products. The other major plasmid 
replicon type, IncFIB was found to be commonly carried in our human, animal, and 
environmental study (Chapter 4). IncFIB plasmids are reported in the literature and are thought 
to have resulted from recombinational events between other IncFII plasmids (Coque et al., 
2008b; Partridge et al., 2011). The majority of isolates carrying an IncFIB plasmid were 
genotypically drug-resistant, carrying between 6-15 different AMR genes. However, these 
isolates also carried other replicon types, which may indicate that multiple resistance genes 
were being carried on multiple plasmids. Indeed, approximately one in five isolates harbouring 
the IncFIB plasmids also carried the IncFIA plasmid (21.3%) – these two plasmids have been 
reported in the literature as being part of a complex, occurring together and carrying blaCTX-M 
genes (and blaCMY in USA studies) (Freitag et al., 2018; Touzain et al., 2018).   
 
There were limitations to this study; the collection of human faecal samples was conducted by 
Cook et al in 2012 and analysed retrospectively. Only samples from Busia county were located 
and analysed, thus a number of background samples from neighbouring sub-counties which 
could have been included in phylogenetic reconstruction have been missed. As multiple workers 
from each slaughterhouse were sampled and slaughterhouses were visited in the same sub-
county, there may have been a clustering effect which was not considered in this analysis. As 
with Chapter 4, raw reads were subject to QC and then mapped to a reference E. coli strain 
(U00096.3), this would have had some effect on calling SNPs for phylogenetic analysis. In future 
studies, using de novo assemblies and filtering of contaminating reads with custom Kraken 
databases may yield additional information; this is particularly relevant with the thresholds used 
for detection of resistance genes – it is possible that many genes could have crossed multiple 
reads and were therefore not detected. Patterns of resistance detected in E. coli in this cohort 
are interesting to compare to our more recent farm study, but due to the large time delay in 
collecting both sets of isolates, and the different subsampling criteria for WGS,  comparisons 
should be interpreted with caution. This study did not assess the clinical history of patients with 
infections potentially caused by E. coli or any compounding effects of immunocompetence due 
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to HIV or other conditions, although basic information on health was available as part of the 
questionnaire given at the time of the study. Akin to the various other studies examining the 
transmission of AMR bacteria between humans and animals, this study only focused on one 
bacterium. Realistically, there is rapid dissemination of AMR determinants between bacterial 
species, which makes it difficult to track infective sources (Sheppard et al., 2016). Furthermore, 
this study only considered E. coli isolated from slaughterhouse workers, and crucially, not from 
livestock or the slaughter environment. 
 
A number of sequences could not be assigned an MLST even though alleles of each of the seven 
housekeeping genes were detected. Those ST assigned as unknown were due to the particular 
combination of alleles not being present in the EnteroBase database. Furthermore, a number of 
interesting findings related to plasmid carriage within these genomes was found, however 
shortcomings in plasmid reconstruction meant that no deeper analysis could be performed. It 
may be beneficial to use alternate, next-generation sequencing platforms such as Oxford 
Nanopore (Jain et al., 2016). As Illumina fragments are approximately 150-250bp long, 
reconstruction into whole genomes can often lead to errors in genome construction. Using a 
method such as Nanopore may allow for the construction of DNA fragments which are kilobases 
long, which could reduce the errors in genome construction and allow better insight into 
plasmids and the genes they carry. 
 
It is difficult to distinguish if there has been molecular transmission of AMR E. coli between 
humans and animal carcasses, or if AMR has arisen from selection pressures due to antibiotic 
use (Muloi et al., 2018). There is a clear overlap in the farming and slaughterhouse 
environments, slaughterhouse workers, livestock carcasses and food supply chains in Busia, and 
all of these sectors are interconnected (Alarcon et al., 2017b). It can therefore be difficult to 
determine the relative contribution to AMR that each of these sectors play. Further studies 
investigating transmission of AMR determinants between humans and livestock need to 
consider indirect transmission, particularly from the wider environment (e.g. soil, hospital, and 
farm effluents), to complement direct animal to human and/or human to animal transmission.  
 
In conclusion, a high prevalence of MDR E. coli was isolated from faeces of slaughterhouse 
workers in Western Kenya. Three major clonal groups of ESBL-E. coli were detected in 
sequenced isolates found in geographically distinct areas and from different types of 
slaughterhouses which may indicate there is transmission occurring, but there is insufficient 
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evidence to infer in which direction this is spreading. One group of O25:H4 isolates were all 
associated with MDR, ESBL production and a high number of toxin-producing virulence genes 
and shown to belong to the ST131 global pandemic clone, which is a public health concern 
affecting both food safety and human health. It is difficult to conclude if there is a definitive 
transmission of resistance determinants from humans to animals or vice-versa, as further work 
including longitudinal sampling of both slaughterhouse workers, livestock carcasses and the 
slaughter environment would be required to reconstruct accurate transmission patterns.  
 
This work suggests that there is urgent need to monitor AMR amongst slaughterhouse workers 
and animal carcasses as well as better regulation of slaughterhouses, alongside targeted 
measures to improve biosecurity and hygiene to reduce the spread of AMR. These issues are 
likely to be addressed as part of the new Kenya NAP, which will place focus on increasing 
education of slaughterhouse workers, and meat inspectors and increasing hygiene practices 
within slaughterhouses.
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6.1 General Discussion 
The increasing levels of AMR in human and veterinary medicine represents one of the largest 
global public health threats (WHO, 2019a). The role that complex ecological niches (such as 
those at the animal-human-environment interface) play in the dissemination of AMR, is the 
subject of much scrutiny and speculation. There is significant overlap in the E. coli populations 
and transmission pathways between all members of this niche, including in humans, livestock, 
and their shared environment. This interplay is particularly evident in LMICs, where there is a 
significant overlap of humans and livestock, particularly as they exist in close proximity and have 
shared environments, which both receive human and animal waste. This means that human, 
livestock and environmental populations may act as distinct reservoirs of AMR bacteria, 
meaning that there is an opportunity for resistance determinants to be transmitted in various 
directions (Woolhouse et al., 2015). Recently, research has focused on AMR gene dissemination 
between natural ecosystems and humans or livestock (Nesme et al., 2014; Guo et al., 2017); 
whilst some studies have tried to suggest evidence that transmission of AMR from animals to 
humans may occur, no robust conclusions on the directionality of that transmission have been 
drawn, due to limitations in study methodologies (Muloi et al., 2018).  
 
Recent research investigating transmission of AMR bacteria and/or AMR determinants has 
relied on low-resolution typing tools and the majority of studies in the last 10 years have been 
based on opportunistic sampling with little spatiotemporal overlap between humans, livestock 
and their shared environment. In this thesis, I have used high-resolution analysis of bacterial 
genomes obtained from farmers, livestock, their shared environment and slaughterhouse 
workers and used a combination of phylogenetic and ecological methods to try and determine 
AMR transmission between humans, livestock, slaughterhouse workers, and their shared 
environment. I used E. coli as a sentinel organism to investigate the prevalence of AMR, MDR 
and ESBL-producing E. coli in a potentially high-risk rural interface for AMR transmission 
between humans and livestock in Busia, Kenya. The overarching hypothesis of this thesis is that 
there is an epidemiologically significant crossover of AMR bacteria and AMR determinants 
between livestock, humans and their shared environments.  
 
This is the first ever study of this nature to be conducted in western Kenya, and it highlights the 
major AMR phenotypes amongst humans, rural livestock, and the farming/living environment. 
Overall there was a high carriage of AMR E. coli found in all sectors.  
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6.1.1 Knowledge and Attitudes towards Antimicrobials and AMR 
In Chapter 3 this study collected data regarding knowledge and attitudes of antimicrobial users 
and prescribers as well as characterising patterns of AMR E. coli amongst farmers, livestock and 
farming environments. Collecting these data simultaneously in both animals and humans has 
provided novel insight which could help determine the drivers for the development and 
maintenance of AMR and is consistent with the One Health approach advocated by global 
authorities concerned with combatting AMR. With respect to the Kenyan National AMR action 
plan (NAP) (Fleming Fund, 2019), specific aims of this plan included strengthening the 
knowledge base and evidence of AMR, improving monitoring and regulation of antimicrobials 
and optimising the use of antimicrobials in human and veterinary medicine. The work presented 
in this study is directly relevant to informing the implementation of that plan, in order to combat 
the spread of AMR. It does this primarily by reducing the paucity of data regarding AMR amongst 
rural human and livestock populations in this region.   
 
As a result of the questionnaire-based interviews, it was shown that knowledge and 
understanding of antimicrobials and the dangers they pose in terms of the development of AMR 
was superficial. Questionnaire-based interviews were used to investigate the patterns of 
antibiotic purchase, as a proxy for antibiotic usage in farm animals. Broad-spectrum β-lactams, 
sulphonamides (penicillin-streptomycin) and oxytetracyclines were the most commonly 
purchased for animal treatments. Colistin – a drug considered as being of last resort in human 
medicine, was also used by one farmer (1.4%) to treat his animals. Analysis of attitudes and 
practices of agrovet staff and community animal healthcare workers shows a high level of 
knowledge amongst AHAs, but knowledge of good prescription practices and appropriate levels 
of qualifications for dispensing antibiotics is insufficient amongst approximately 50% of agrovet 
staff. Similarly, knowledge of AMR was found to be lacking amongst both AHAs and agrovet 
staff. Finally, the practice of selling antimicrobials without prescription was common to this 
study site and is also common elsewhere in Kenya and other sub-Saharan African countries, 
which also describe unrestricted access to veterinary antimicrobials in informal shops (Higham 
et al., 2016; Chem et al., 2018; Basulira et al., 2019; Muloi et al., 2019a).  
 
All antimicrobial users in the veterinary sector access antimicrobials through agrovet shops 
suggesting that agroveterinary suppliers are key nodes of antimicrobial distribution to end 
users. Both human and veterinary pharmacists play an important role in enhancing 
antimicrobial stewardship initiatives, not just by highlighting issues surrounding AMU and AMR, 
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but by influencing crucial prescribing decisions (Sakeena et al., 2018; Haddadin et al., 2019). 
However, there is the constant tension between priorities as a business owner and priorities 
which advocate public health. Pharmacists, agrovet staff, and AHAs can only provide accurate 
information regarding AMU and AMR, if sufficiently trained, and in line with economic drivers 
and pressures placed on them. The NAP can reduce the sale of inappropriate antimicrobials by 
ensuring that antimicrobial providers are appropriately trained. Furthermore, if a clear 
antimicrobial supply chain is set up, this can help to reduce the number of informal outlets 
selling antimicrobials, whilst allowing for better enforcement of legislation regarding prudent 
use of antimicrobials, as well as ensuring that all people have access to essential antimicrobials 
at all levels.  
 
6.1.2 Carriage of AMR bacteria amongst farmers, livestock and their shared environment 
In Chapter 4, by using a combination of AMR phenotyping and genotyping, I explored variation 
in the carriage of AMR determinants (such as virulence and resistance genes) of AMR E. coli 
between human, livestock and environmental populations. 596 livestock and 130 human E. coli 
isolates were tested for susceptibility to a panel of 7 different antimicrobials (chosen based on 
their commonality from the questionnaire-based study, Chapter 3). There was a high prevalence 
of resistance to tetracycline, sulfonamides, trimethoprim and β-lactams, but extremely low 
prevalence of resistance to fluoroquinolones, chloramphenicol and aminoglycosides. More than 
half of the isolates (53.9%) were MDR (to >3 classes of antibiotic). There is significant overlap in 
the patterns of AMR between farmers, livestock, slaughterhouse workers. Evidence of a 
common co-occurring phenotype (conferring resistance to tetracycline, sulfathiazole, ampicillin 
and trimethoprim antibiotic classes) was found amongst livestock, farmers and environmental 
isolates, suggesting that a conjugative plasmid was disseminating MDR genes within the E. coli 
populations in each group, and that there are similar selection pressures and co-selection of 
resistance determinants in all hosts. Phylogenetic analysis of a number of isolates showed a 
highly diverse population of E. coli which were dispersed amongst each of the three groups; this 
strongly suggests that the general E. coli population within the study site is largely shared and 
that there are numerous overlapping transmission pathways which are not necessarily 
differentiated by the human, livestock or the environment compartments sampled in this study.  
 
Using WGS I characterised the carriage of and diversity of AMR genes within commensal E. coli 
isolated from farmers, livestock and the environment. A total of 60 unique acquired resistance 
genes were found amongst human, livestock and environmental E. coli, and 6 point mutations 
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were found amongst human and livestock E. coli. sul2, blaTEM-1B, mdf(A), tet(A), aph(3”)-Ib and 
aph(6)-Id conferring resistance to sulfonamides, β-lactams, tetracycline and aminoglycosides, 
respectively were the most common AMR genes amongst all three groups of isolates. There was 
no significant difference between the carriage of any of the genes except for sul2, which was 
significantly more prevalent than sul1 amongst all groups (except for pigs). According to 
maximum-likelihood phylogenetics, two large groups of isolates with low genetic variation and 
common STs and serogroups were found to be circulating within the study populations. These 
were not isolated from the same farms, rather, they often circulated in the same sub-counties 
(region). Interestingly, there was a particularly high prevalence of ESBL-E. coli in water samples, 
which may indicate that shared human-animal water sources (such as boreholes, rivers and 
piping leading to taps) are reservoirs of ESBL-E. coli. The production of ESBL enzymes is 
particularly important for AMR in the general population, as ESBL genes were co-carried 
alongside other AMR genes (such as aminoglycoside and fluoroquinolone resistance) which can 
make them more difficult to treat. This can place undue strain on healthcare facilities and 
potentially increase AMU in efforts to treat resistant bacteria in the absence of effective 
diagnostics.  
 
The high prevalence of AMR E. coli in this population indicates that there is potential for further 
dissemination of AMR strains and their resistance determinants within the wider community 
(such as between livestock, when they are brought to farmers’ markets). I suggest that bacterial 
sharing is more dynamic than previously hypothesised; as part of the farm study (Chapter 4), I 
suggested that close proximity between livestock and animals may facilitate the transmission of 
bacteria. However, it may be more likely that there is a high proportion of indirect sharing of 
bacteria, via the shared environment, which encompasses both animals and livestock. There is 
a growing body of evidence which suggests that livestock play a minimal role in acquisition and 
infection of AMR bacteria in humans (Gouliouris et al., 2018; Ludden et al., 2019) and more 
attention needs to be directed towards the environment.   
 
The NAP suggests that the general population has a high risk of exposure to AMR bacteria. By 
constructing a baseline of carriage of AMR E. coli amongst this population, this study has 
reduced that paucity of data. Furthermore, the high rates of carriage of AMR E. coli suggest the 
potential for greater levels of resistance amongst bacterial populations, should other drugs 
(including HPCIAs) become more commonly used, in this setting. It should therefore be a priority 
for the NAP to also secure the long-term viability of 2nd and 3rd line drugs to ensure their 
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continued effectiveness. From this data, it is difficult to link specific patterns of AMR to specific 
hosts and this indicates a generalised risk of emergence of new strains and reaffirms the need 
to investigate AMR using a One Health approach. Expanded efforts on characterising all 
compartments of this complex ecosystem may allow for the interpretation of complex 
transmission pathways between all groups.  
 
6.1.4 Risk factor analysis of AMR outcomes amongst farmers, livestock and the environment 
In Chapter 4, risk factor analysis provided insight into AMR patterns amongst livestock, farmers, 
and the environment. Few risk factors were identified, indicating that resistance patterns were 
generalised across humans, livestock and the environment. This suggests that there may be 
other factors involved in the variability identified between strains found within these 
populations. Multivariable models showed that there was a low variance between sub-counties, 
indicative of local transmission of bacteria. There was greater variance attributed to farm level 
AMR, especially with respect to tetracycline resistance and ESBL-E. coli. A dairy farm in 
Madagascar noted that “livestock size” i.e. larger farms with >25 cattle and “disinfection” were 
associated with decreased risk of ESBL production (Gay et al., 2018). This suggests that by 
improving biosecurity measures and overall hygiene on farms, the risk of maintaining faecal 
carriage of ESBL-E. coli can be decreased. As such, improving hygiene practices on farms may 
help to reduce transmission of AMR.  
 
There were no significant risk factors associated with the ESBL-producing E. coli, despite a high 
proportion of tested water samples in this study being both MDR and ESBL-producing. As few 
water samples were collected, this could preclude further conclusions being drawn. MDR and 
ESBL-E. coli have previously been associated with irrigation water (Gekenidis et al., 2018), which 
lends credibility to the theory that common water sources are reservoirs of ESBL-producing E. 
coli, having become contaminated with both human and animal wastes. Additionally, there was 
risk associated with recent antimicrobial treatment (use of penicillin-streptomycin in the 3 
months prior to the study) for the MDR and ampicillin outcomes. This finding is consistent with 
AMU providing selection pressures for the development of AMR (Oz et al., 2014; Caudell et al., 
2017), though there are also additional environmental factors which must be important in 
indirect AMR transmission. 
 
Another point of the NAP is to reduce AMR by adopting preventative measures. Vaccination is 
an important strategy for reducing AMR as it aims to prevent disease outbreaks, reducing 
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reliance on antimicrobials. However, vaccination of animals was found to be a significant risk 
factor for tetracycline resistance. This was due to potential confusion between vaccinations and 
injectable treatments. As AHAs and agrovets are the main providers of vaccinations and 
antimicrobials, by adequately informing farmers and targeting educational programmes to 
antimicrobial and vaccine providers, it is possible to reduce the risk of a small proportion of AMR 
attributed to misuse.   
 
6.1.3 Carriage of AMR bacteria amongst slaughterhouse workers 
In Chapter 5, again, by using a combination of AMR phenotyping and genotyping, I explored 
variation in the carriage of AMR determinants of E. coli isolated from slaughterhouse workers, 
working at three different types of slaughterhouse. The three types included slaughterhouses 
which slaughtered i) mixed ruminants, ii) cattle only, and iii) pigs-only. 447 human faecal 
samples were tested for susceptibility to the same panel as for the farm study (Chapter 4). There 
was a high prevalence of resistance to the same antibiotics as in farm study, specifically to 
tetracycline, trimethoprim, sulfathiazole and (to a lesser degree) ampicillin.  There was a low 
prevalence of resistance to fluoroquinolones, chloramphenicol and aminoglycosides. Almost 
two-thirds of isolates (61.5%) were MDR (to >3 classes of antibiotic). There was no major 
difference in the overlap of AMR patterns amongst slaughterhouse workers suggesting that 
commonly co-occurring phenotypes (conferring resistance to tetracycline, sulfathiazole, 
ampicillin and trimethoprim antibiotic classes) were common to all types of slaughterhouse 
workers. This points to similar selection pressures and co-selection of resistance determinants 
in all slaughterhouse workers.  
 
A total of 53 unique acquired resistance genes were found amongst slaughterhouse workers, 
and 8 point mutations were found amongst E. coli isolated from slaughterhouse workers. sul2, 
blaTEM-1B, mdf(A), tet(A), catA1, aph(3”)-Ib and aph(6)-Id conferring resistance to sulfonamides, 
β-lactams, tetracycline, chloramphenicol and aminoglycosides, respectively were the most 
common AMR genes amongst all three groups of slaughterhouse worker. A higher proportion 
of point mutations were found amongst slaughterhouse workers than in farmers (Chapter 4), 
though the difference may be due to differences in subsampling strategies. There was no 
significant difference between the carriage of any AMR genes between groups, except in pig-
only slaughterhouse workers, where carriage of mdf(A) was significantly higher than in cattle 
only and mixed ruminant slaughterhouses. Phylogenetic analysis of a number of isolates showed 
a highly diverse population of E. coli which were dispersed amongst all slaughterhouse workers. 
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Numerous clades association with ST131, ST361, ST10, ST43 and ST617 were found with low 
genetic variation indicating that there is a high degree of bacterial sharing between 
slaughterhouse workers in this population.  
 
There was high carriage of toxin-producing virulence genes (astA, cma, sat and senB) amongst E. 
coli isolated from slaughterhouse workers, many of which were co-carried with ESBL genes 
(specifically blaCTX-M-15 and blaSHV-12). Toxin-producing strains of E. coli are particularly relevant for 
food production, and toxin-producing E. coli are increasingly becoming attributed to carriage 
amongst farm animals, food-borne infections, and subsequently diarrhoeal disease, all over the 
world (Veilleux and Dubreuil, 2006; Ochi et al., 2017; Dubreuil, 2019). The danger and relevance of 
these toxin-producing E. coli strains circulating amongst slaughterhouse workers, is the potential for 
transmission from the workers, to animal products and then wider distribution to consumers. These 
strains can cause diarrhoeal disease and may be difficult to treat if they persist, particularly in 
children, immunocompromised, pregnant and older people (GBD 2016 Diarrhoeal Disease 
Collaborators, 2018). Contaminating meat products during the slaughter process is therefore a public 
health risk. 
 
A startling finding was the presence of the ST131 global pandemic strain – four isolates were 
found to be ST131:O25b:FimH30. These isolates were MDR and highly virulent; further spread 
of these clones could be important for transmission prevention-based control strategies, which 
are to be implemented as part of the NAP, due to their resistance to effective antibiotics.  
 
Slaughterhouse workers were an important group to consider in assessing carriage of AMR E. 
coli, as they are responsible for slaughtering animals and preparing food-products destined for 
sale and consumption. As part of the slaughter, evisceration and butchering process, workers 
are exposed to a higher density of bacteria from animals, which may put them at high risk of 
colonisation with new bacterial strains from animal carcases. Due to their regular exposure to 
animals, slaughterhouse workers may be acting as a sink - acquiring diverse bacterial 
populations through occupational exposure, as well as their normal lives. Slaughterhouse 
workers could therefore be key populations of AMR E. coli emergence.  
 
There is a need to urgently address shortcoming during the slaughter process (such as 
inadequate hygiene practices and addressing biosecurity) to ensure that there is limited spread 
of highly successful AMR, MDR, ESBL- and toxin-producing strains amongst slaughterhouse 
workers and potentially to food-products. The importance of good hygiene practices in 
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slaughterhouses, access to running water and soap (to clean utensils, carcasses and hands), and 
use of PPE such as gloves and aprons (to prevent bacteria from colonising open wounds) are 
paramount to ensure that AMR bacteria does not spread to humans through contact with 
animals, to animals products through cross-contamination, and to the environment via disposed 
of carcasses.  The ZooLiNK project has undertaken several such activities, providing workers with 
new slaughter equipment, PPE, and training.  More needs to be done to continue to raise the 
standard in rural slaughterhouses in Kenya. 
 
6.1.5 Implications of this study for surveillance and public health 
Numerous initiatives have been taken by regulatory agencies and governments to combat AMR, 
but many of these have only been implemented in developed countries (Government of the 
United Kingdom, 2013; WHO, 2015). In Kenya, a GARP working group is established, but the lack 
of resources means that policies and the means to penalise those who do not follow policy, is 
limited (Global Antibiotic Resistance Partnership, 2011). With further support from the 
government, informed by data collected in this study, there are clear targets for optimising 
supply chain of antimicrobials and education of antimicrobial suppliers. 
 
The high prevalence of clinically relevant AMR phenotypes and genotypes described amongst 
farmers, livestock, the shared environment and slaughterhouse workers in this thesis support 
previous findings (Woolhouse et al., 2016; Caudell et al., 2018; Ingle et al., 2018) that AMR is 
becoming increasingly common in LMICs. Data collected as part of this thesis regarding the 
carriage of AMR E. coli in key populations in Western Kenya is a significant contribution to the 
paucity of data regarding AMR. These results reiterate the need for integrated surveillance of 
AMR, and an urgent need for public health policy to adopt effective strategies which will aim to 
reduce the emergence and spread of AMR determinants.  
 
The use of WGS in this thesis in a low-income setting is important, given the recent efforts to 
implement WGS in public health settings as the cost of sequencing and infrastructure becomes 
more accessible. In public health settings, genomics can help in characterising and tracking the 
spread of bacterial strains, as well as providing rich surveillance data regarding genomic 
mechanisms of resistance. Indeed, with the advent of NGS platforms such as Oxford Nanopore, 
sequencers are no larger than a matchbox and ‘real-time’ genomics can be performed in the 
field.  
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AMU use is likely one of the most important drivers of AMR in both humans and livestock 
(Holmes et al., 2016; Robinson et al., 2016). In LMICs, where resistance is beginning to emerge, 
there is a short window of opportunity to limit the spread of AMR, by encouraging the switch to 
sustainable farming practices and reducing the reliance on antimicrobials. This can be achieved 
through policy recommendations aimed at selectively reducing inappropriate use of antibiotics, 
increasing appropriate use of antibiotics to treat and prevent disease, and reducing the need 
for antibiotics (Van Boeckel et al., 2019). As described, the results of this study are directly useful 
in informing policies to be rolled out as part of the NAP. To summarise, the KAP study Chapter 
3 highlighted gaps in the knowledge of antimicrobial users and providers – these could be the 
targets for public communication campaigns, particularly the providers. Furthermore, practices 
such as over-the-counter sales of veterinary and human antimicrobials by informal sources, as 
well as unlicensed agroveterinary business may be targeted for government intervention, which 
can attempt to set up clearer antimicrobial supply chains, enforce prudent use of antimicrobials 
and allow the wider population to access essential antimicrobials. In Chapter 4 and 5, the high 
carriage of AMR, MDR and ESBL E. coli amongst all sampled populations highlights shortcomings 
in infectious diseases control practices – notably the lack of promotion of vaccination 
programmes as an alternative to prophylactic AMU, while better food and water safety may 
assist in preventing transmission of AMR bacteria. In order to track and report AMR, and AMU, 
a national database needs to be established and used, and the use of mobile phone-based 
technology to do this may be worth investigating. Clearly, the issues raised are complex and will 
require significant cross-sectorial collaboration but addressing these will be an important part 
of protecting human and animal health in Kenya in the future. 
 
6.2 Future Work 
In Chapter 3 and 4 I designed and implemented questionnaire-based interviews which were 
administered to antimicrobial users and providers. This showed superficial knowledge of the 
risks of AMR but also highlighted issues with translating questionnaires into the local dialect. In 
future studies, adequately briefing all staff on the perceived outcomes of the study will reduce 
the incidence of leading questions or over-explaining of questions to compensate for differences 
in language. This will allow for consistent data which are fully comparable between 
questionnaires.  
 
Whilst the largest number of locatable AHAs and agrovet shops in the county were interviewed, 
there are a number of informal sources of antimicrobial sale throughout the region which may 
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not have been interviewed. Similarly, only a relatively small subset of 70 farms were visited 
across the region, by expanding the number of participants and future studies to a longitudinal 
survey of AMR use, additional data could be captured, giving a more accurate portrayal of the 
drivers of AMR. As no weighting was given to questionnaire results, it is possible that results 
from the captured sample are not fully representative of the entire population. As the sample 
size was relatively small, by using post-analysis weighting, this may increase the 
representativeness of the sample.   
 
The basis of good surveillance systems for AMR and AMU, is accurate record-keeping of 
purchased and dispensed antimicrobials. A standardised reporting system can feed into a 
national surveillance system to provide targeted interventions and combat AMR. Whilst Kenya 
is an LMIC, approximately 93% of Kenyans (across the whole country) use mPesa, the largest 
mobile wallet in Kenya. This highlights the fact that when people are empowered, they can use 
digital technology to innovate. The possibility of using mobile phones and technology for such 
surveillance purposes is certainly realistic, and through education, people could be taught why 
surveillance to reduce AMR is of importance for their future. The NAP seeks to implement a 
national database in which antimicrobial use and AMR reporting is compulsory, and this may be 
done using existing technology. A surveillance system, using data directly from antimicrobial 
prescribers and users could be designed and implemented using the same software as was used 
for the KAP study (Chapter 3) which can be rolled out to users cheaply and using existing mobile 
phone capacity. 
 
In Chapters 4 and 5, I demonstrated an overlap of E. coli between and within human, livestock 
and environmental populations. However, a  number of isolates were not sequenced due to a 
cost-based trade-off. Also, a subset of E. coli isolates from each population was selected for 
sequencing using different selection criteria. In the farm study, only isolates from farms where 
E. coli was isolated from human, animal, and environmental samples were sequenced, and thus, 
a number of farms were not studied further. However, as a broad range of farms from across all 
sub-counties were included in the analysis, despite some selection bias, the results should be 
representative of the study site. In the slaughterhouse study, only MDR and ESBL-producing 
isolates were sequenced. This introduced selection bias, as also sequencing antimicrobial-
sensitive isolates would have provided an opportunity to also assess carriage of non-screened 
resistance phenotypes and resistance determinants. Regarding the phenotypic analysis of 
isolates, numerous samples were collected from animals and humans on each farm, but as 
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deposited faeces were collected in a non-random way, selection bias may have skewed the 
interpretation of the results, and samples may have belonged to the same animal which may 
have reduced the captured diversity (or conversely, increased it, as additional bacteria spread 
from walking across the ground could have been sampled). In future studies, use of additional 
methods such as rectal swabbing and additional sequencing of a wider variety of randomly 
selected isolates may yield different results relating to the gut microbiome and prevalence of 
AMR determinants amongst these populations.  
 
Despite characterising a number of plasmids circulating amongst AMR E. coli, shortcomings in 
plasmid reconstruction and other mobile genetic elements from short-read data meant that this 
study was unable to pinpoint an exact mechanism by which AMR determinants are acquired and 
dispersed. Additional studies may look to incorporating long-read sequencing techniques to 
accurately reconstruct plasmids to better determine if carriage of AMR genes is on single or 
multiple plasmids (Rozwandowicz et al., 2018).  
 
Risk factor analysis could not be completed for a number of low-prevalence outcomes and was 
not estimated as part of the slaughterhouse study. By increasing the sample size, additional data 
can be captured, allowing for more rigorous risk factor analyses for a larger number of outcomes 
to be determined. As the role that food-producing animals and the environment play in the 
transmission and maintenance of AMR bacteria is still being actively investigated, a longitudinal 
study which can highlight antimicrobial residues passing through the food chain may provide 
further insights.  
 
6.3 Concluding Remarks 
The findings presented in this study suggest that there are gaps in the knowledge of both 
antimicrobial users and prescribers, particularly in areas such as the risk of antimicrobial 
resistance and withdrawal periods. This has far-reaching implications and may lead to a situation 
where there is significantly reduced efficacy of antimicrobials in both humans and animals. This 
thesis has demonstrated how fine-scale analysis of bacterial genomes, which, if embedded in 
an epidemiologically structured sampling framework can be used to i) inform surveillance of the 
prevalence, emergence and spread of AMR, ii) identify risk factors for carriage of AMR strains 
and AMR determinants, and iii) track bacterial overlap in a rural LMIC setting. I have provided 
evidence of carriage and resistance to a number of antimicrobials including tetracyclines, 
trimethoprim, sulfonamides and ampicillin amongst farmers, animals, slaughterhouse workers 
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and the environment E. coli populations. At the SNP level, there was evidence of bacterial 
sharing between humans, livestock and the environment which indicates that transmission 
between groups is occurring. As there is a clear overlap between humans, animals, and the 
environment in rural settings, it is important to consider not only direct routes of transmission 
of bacteria between humans and animals, and humans and humans, but also indirect 
transmission via their shared environments. The use of WGS as a tool to investigate AMR 
determinants has been particularly useful in elucidating the molecular epidemiology of 
resistance amongst commensal E. coli, and risk factor analysis has highlighted the complex 
interactions involved in AMR. Overall, this study has highlighted the usefulness of an integrated 
One Health approach, as well as the need for surveillance systems to collect AMR data across 
countries, to allow for targeted interventions where required.
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Figure I-i Participant Information Sheet for KAP Study 
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Figure I-ii Informed consent form given to all participants before collecting data during the KAP 
Study 
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Figure I-iii Questionnaire framework for KAP Study
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Figure II-i Information sheet given to all participants regarding the Farm study 
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Figure II-ii Informed Consent Form completed by all participants prior to data and sample 
collection during the Farm Study 
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Figure II-iii Questionnaire framework used in  Farm Study 
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Results of Univariable Analysis 
Complete results of univariable analysis for all outcomes of interest are presented on pages 285 – 290. 
 
Table II-i Results of univariable analysis for risk factors associated with multi-drug resistance and ESBL-production in faecal E. coli samples from humans, livestock, and the 
environment. 
  MDR ESBL 
Variable  Category β SE z-ratio p-value L95%CI U95%CI 
odds 
ratio 
β SE z-ratio p-value L95%CI U95%CI 
odds 
ratio 
Species Cattle Ref       Ref       
 Human 0.704 0.24 2.941 0.003 1.265 3.234 2.023 0.076 0.359 0.212 0.832 0.534 2.18 1.079 
 Poultry 0.179 0.207 0.862 0.389 0.796 1.794 1.195 -0.13 0.324 -0.4 0.689 0.465 1.658 0.878 
 Pig -0.098 0.316 -0.31 0.757 0.488 1.684 0.907 0.24 0.476 0.505 0.614 0.501 3.23 1.271 
 Sheep/Goats 0.429 0.265 1.623 0.105 0.915 2.58 1.536 0.484 0.379 1.277 0.202 0.772 3.409 1.622 
EnvironmentMDR No Ref       Ref       
 Yes -0.408 0.283 -1.441 0.149 0.382 1.158 0.665 0.384 0.453 0.849 0.396 0.605 3.566 1.469 
EnvironmentESBL No Ref       Ref       
 Yes 3.115 1.131 2.753 0.006 2.452 206.886 22.523 1.248 0.916 1.363 0.173 0.579 20.992 3.485 
Gender Female Ref       Ref       
 Male 0.024 0.221 0.11 0.912 0.665 1.579 1.025 0.224 0.388 0.579 0.563 0.586 2.676 1.252 
Age 18-24 Ref       Ref       
 25-44 -0.191 0.522 -0.367 0.714 0.297 2.298 0.826 0.88 1.122 0.784 0.433 0.268 21.711 2.41 
 45-64 -0.078 0.554 -0.14 0.888 0.312 2.742 0.925 1.131 1.161 0.974 0.33 0.318 30.152 3.097 
 <65 0.171 0.567 0.302 0.763 0.39 3.608 1.187 1.055 1.18 0.894 0.371 0.284 29.011 2.871 
Farm Size GrandMean 0.006 0.004 1.42 0.156 0.998 1.014 1.006 0.004 0.007 0.552 0.581 0.991 1.017 1.004 
Knowledge of Abs Don't Know Ref       Ref       
 Good 0.376 0.298 1.264 0.206 0.813 2.61 1.457 0.315 0.446 0.706 0.48 0.572 3.282 1.37 
 Bad 0.143 0.285 0.502 0.616 0.66 2.017 1.154 -0.786 0.464 -1.694 0.09 0.183 1.131 0.456 
KnowledgeAbResistance Don't Know Ref       Ref       
 Good 0.109 0.311 0.349 0.727 0.606 2.05 1.115 0.637 0.493 1.293 0.196 0.72 4.972 1.892 
KnowledgeAbWithdrawal Don't Know Ref       Ref       
 Some 0.178 0.261 0.681 0.496 0.716 1.995 1.195 -0.371 0.472 -0.785 0.432 0.274 1.742 0.69 
 Good 0.557 0.527 1.057 0.291 0.621 4.906 1.746 1.892 0.708 2.672 0.008 1.656 26.585 6.635 
 Actively Ignores 1.103 0.678 1.628 0.104 0.798 11.384 3.015 0.463 0.989 0.468 0.64 0.228 11.045 1.589 
Mastitis Last 12 months? No Ref       Ref       
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  MDR ESBL 
Variable  Category β SE z-ratio p-value L95%CI U95%CI 
odds 
ratio 
β SE z-ratio p-value L95%CI U95%CI 
odds 
ratio 
 Yes 0.484 0.233 2.073 0.038 1.027 2.563 1.622 0.233 0.417 0.559 0.576 0.558 2.858 1.263 
Diarrhoea 12 months? No Ref       Ref       
 Yes -0.067 0.261 -0.255 0.798 0.561 1.56 0.936 -0.23 0.473 -0.486 0.627 0.315 2.007 0.795 
Diarrhoea 3 months? No Ref       Ref       
 Yes 0.024 0.265 0.091 0.928 0.61 1.721 1.024 -0.781 0.429 -1.819 0.069 0.198 1.062 0.458 
Bloody diarrhoea 3 months? No Ref       Ref       
 Yes -0.491 0.211 -2.33 0.02 0.405 0.925 0.612 -0.116 0.388 -0.3 0.764 0.416 1.904 0.89 
Animals Vaccinated? No Ref       Ref       
 Yes 0.22 0.217 1.014 0.311 0.814 1.908 1.246 0.062 0.383 0.161 0.872 0.502 2.252 1.064 
Treat whole group? Single Animal Ref       Ref       
 Whole Group -0.266 0.213 -1.245 0.213 0.505 1.165 0.767 -0.298 0.381 -0.784 0.433 0.352 1.565 0.742 
Separate Ill animals? No Ref       Ref       
 Yes -0.225 0.215 -1.047 0.295 0.524 1.217 0.799 0.012 0.378 0.031 0.975 0.483 2.121 1.012 
BoughtTetracyckine3Month
s? 
No Ref       Ref       
 Yes -0.017 0.23 -0.074 0.941 0.626 1.544 0.983 0.261 0.388 0.672 0.502 0.607 2.776 1.298 
BoughtPen-strep3months? No Ref       Ref       
 Yes 0.483 0.294 1.643 0.1 0.911 2.884 1.621 0.029 0.508 0.058 0.954 0.381 2.787 1.03 
UsedTetracycline3months? No Ref       Ref       
 Yes 0.221 0.214 1.029 0.303 0.819 1.898 1.247 0.49 0.373 1.311 0.19 0.785 3.393 1.632 
UsedPenstrep3months? No Ref       Ref       
 Yes 0.582 0.212 2.747 0.006 1.181 2.709 1.789 -0.035 0.394 -0.088 0.93 0.446 2.092 0.966 
Sameneedlesyringe? No Ref       Ref       
 Yes 0.24 0.216 1.115 0.265 0.833 1.941 1.272 0.19 0.378 0.503 0.615 0.576 2.54 1.21 
Mainwatersource Taps Ref       Ref       
 Borehole/Well -0.321 0.353 -0.91 0.363 0.363 1.449 0.725 1.009 0.764 1.322 0.186 0.614 12.25 2.743 
 River/Lake -0.779 0.401 -1.943 0.052 0.209 1.007 0.459 1.087 0.833 1.305 0.192 0.579 15.162 2.964 
 Rainwater -0.679 0.467 -1.455 0.146 0.203 1.266 0.507 1.145 0.93 1.232 0.218 0.508 19.43 3.142 
P-values highlighted in green are statistically significant (p<0.25) values from the Wald Chi squared test; OR = Odds Ration; SE = Standard Error; 95%CI = 95% Confidence Intervals. 
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Table II-ii Results of univariable analysis for risk factors associated with tetracycline and sulfathiazole resistance in faecal E. coli samples from humans, livestock, and the 
environment. 
  Tetracycline Sulfathiazole 
Variable Category β SE z-ratio p-value L95%CI U95%CI 
odds 
ratio 
β SE z-ratio p-value L95%CI U95%CI 
odds 
ratio 
Species Cattle Ref       Ref       
 Human 0.51 0.496 1.027 0.304 0.63 4.403 1.665 1.479 0.309 4.792 <0.001 2.396 8.033 4.387 
 Poultry -0.519 0.349 -1.487 0.137 0.3 1.18 0.595 0.334 0.225 1.488 0.137 0.899 2.169 1.397 
 Pig 0.693 0.687 1.01 0.313 0.521 7.681 2 0.503 0.355 1.419 0.156 0.825 3.314 1.654 
 Sheep/Goats 0.867 0.586 1.479 0.139 0.754 7.51 2.38 0.703 0.299 2.354 0.019 1.125 3.628 2.02 
EnvironmentMDR No Ref       Ref       
 Yes -0.957 0.61 -1.57 0.117 0.116 1.269 0.384 -0.069 0.353 -0.196 0.845 0.468 1.863 0.933 
EnvironmentESBL No Ref       Ref       
 Yes 35.51 0.907 39.145 <0.001 4.5E+14 1.5E+16 2.6E+15 36.243 0.481 75.324 <0.001 
2.1399E
+15 
1.411E+
16 
5.495E+
15 
Gender Female Ref       Ref       
 Male -0.019 0.408 -0.047 0.962 0.441 2.184 0.981 0.293 0.273 1.076 0.282 0.786 2.287 1.341 
Age 18-24 Ref       Ref       
 25-44 -0.967 1.441 -0.671 0.502 0.023 6.414 0.38 0.268 0.564 0.474 0.635 0.432 3.951 1.307 
 45-64 -0.128 1.513 -0.085 0.932 0.045 17.059 0.88 0.302 0.598 0.505 0.614 0.419 4.366 1.352 
 <65 -0.94 1.522 -0.617 0.537 0.02 7.724 0.391 1.285 0.642 2.001 0.045 1.027 12.736 3.616 
Farm Size GrandMean 0.017 0.014 1.171 0.242 0.989 1.045 1.017 0.012 0.005 2.186 0.029 1.001 1.023 1.012 
Knowledge of Abs Don't Know Ref       Ref       
 Good 0.382 0.712 0.536 0.592 0.363 5.917 1.465 0.311 0.357 0.871 0.384 0.678 2.749 1.365 
 Bad -0.521 0.611 -0.854 0.393 0.179 1.966 0.594 0.126 0.338 0.372 0.71 0.584 2.2 1.134 
KnowledgeAbResistance Don't Know Ref       Ref       
 Good 0.306 0.73 0.419 0.675 0.325 5.676 1.357 0.389 0.385 1.01 0.313 0.693 3.141 1.476 
KnowledgeAbWithdrawal Don't Know Ref       Ref       
 Some        0.277 0.341 0.812 0.417 0.676 2.571 1.319 
 Good  Error in convergence  -0.026 0.601 -0.044 0.965 0.3 3.16 0.974 
 Actively Ignores        1.286 1.016 1.266 0.206 0.494 26.5 3.618 
Mastitis Last 12 months? No Ref       Ref       
 Yes 0.629 0.599 1.05 0.293 0.58 6.068 1.876 0.279 0.306 0.915 0.36 0.727 2.407 1.322 
Diarrhoea 12 months? No Ref       Ref       
 Yes 0.056 0.614 0.091 0.927 0.318 3.523 1.058 -0.068 0.322 -0.211 0.833 0.497 1.756 0.934 
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  Tetracycline Sulfathiazole 
Variable Category β SE z-ratio p-value L95%CI U95%CI 
odds 
ratio 
β SE z-ratio p-value L95%CI U95%CI 
odds 
ratio 
Diarrhoea 3 months? No Ref       Ref       
 Yes 0.019 0.619 0.03 0.976 0.303 3.43 1.019 0.135 0.326 0.414 0.679 0.604 2.17 1.145 
Bloody diarrhoea 3 months? No Ref       Ref       
 Yes -0.058 0.528 -0.11 0.912 0.335 2.658 0.943 -0.359 0.275 -1.306 0.192 0.407 1.197 0.698 
Animals Vaccinated? No Ref       Ref       
 Yes 0.869 0.451 1.929 0.054 0.986 5.771 2.386 0.479 0.259 1.85 0.064 0.972 2.683 1.615 
Treat whole group? Single Animal Ref       Ref       
 Whole Group -0.711 0.477 -1.491 0.136 0.193 1.251 0.491 -0.105 0.262 -0.4 0.689 0.539 1.505 0.9 
Separate Ill animals? No Ref       Ref       
 Yes 0.043 0.475 0.09 0.929 0.411 2.65 1.044 -0.133 0.255 -0.521 0.602 0.53 1.444 0.875 
BoughtTetracyckine3Month
s? No Ref 
      Ref       
 Yes 0.062 0.552 0.112 0.911 0.361 3.137 1.064 -0.156 0.283 -0.55 0.582 0.491 1.491 0.856 
BoughtPen-strep3months? No Ref       Ref       
 Yes 0.744 0.763 0.975 0.329 0.472 9.389 2.105 0.568 0.356 1.594 0.111 0.878 3.55 1.765 
UsedTetracycline3months? No Ref       Ref       
 Yes -0.07 0.479 -0.146 0.884 0.364 2.386 0.932 0.154 0.26 0.591 0.555 0.7 1.942 1.166 
UsedPenstrep3months? No Ref       Ref       
 Yes 0.593 0.512 1.157 0.247 0.663 4.935 1.809 0.511 0.274 1.863 0.062 0.974 2.852 1.666 
Sameneedlesyringe? No Ref       Ref       
 Yes 0.354 0.495 0.716 0.474 0.541 3.757 1.425 0.084 0.267 0.315 0.753 0.645 1.835 1.088 
Mainwatersource Taps Ref       Ref       
 Borehole/Well 0.306 0.786 0.389 0.697 0.291 6.337 1.357 -0.295 0.445 -0.662 0.508 0.311 1.782 0.745 
 River/Lake 0.019 0.869 0.021 0.983 0.185 5.598 1.019 -0.635 0.495 -1.283 0.199 0.201 1.398 0.53 
 Rainwater -0.328 1.002 -0.328 0.743 0.101 5.131 0.72 -0.526 0.574 -0.918 0.359 0.192 1.818 0.591 
P-values highlighted in green are statistically significant (p<0.25) values from the Wald Chi squared test; OR = Odds Ration; SE = Standard Error; 95%CI = 95% Confidence Intervals. 
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Table II-iii Results of univariable analysis for risk factors associated with ampicillin and trimethoprim resistance in faecal E. coli samples from humans, livestock, and the 
environment. 
 
  Ampicillin Trimethoprim 
Variable Category β SE z-ratio p-value L95%CI U95%CI 
odds 
ratio 
β SE z-ratio p-value L95%CI U95%CI 
odds 
ratio 
Species Cattle Ref       Ref       
 Human 0.343 0.239 1.437 0.151 0.883 2.25 1.409 1.185 0.301 3.938 0 1.813 5.899 3.27 
 Poultry 0.042 0.207 0.203 0.839 0.695 1.565 1.043 0.318 0.229 1.389 0.165 0.878 2.151 1.374 
 Pig -0.057 0.311 -0.184 0.854 0.514 1.736 0.945 0.378 0.357 1.059 0.29 0.725 2.937 1.459 
 Sheep/Goats 0.436 0.271 1.609 0.108 0.909 2.629 1.546 0.655 0.305 2.145 0.032 1.058 3.503 1.925 
EnvironmentMDR No Ref       Ref       
 Yes -0.231 0.263 -0.88 0.379 0.474 1.328 0.794 -0.23 0.369 -0.623 0.533 0.386 1.638 0.795 
EnvironmentESBL No Ref       Ref       
 Yes 2.79 1.088 2.563 0.01 1.928 137.434 16.277 35.734 0.523 68.372 0 
1.1863E
+15 
9.2031E
+15 
3.3041E
+15 
Gender Female Ref       Ref       
 Male 0.101 0.206 0.489 0.625 0.738 1.658 1.106 0.408 0.286 1.427 0.154 0.859 2.634 1.504 
Age 18-24 Ref       Ref       
 25-44 -0.16 0.494 -0.324 0.746 0.324 2.243 0.852 -0.052 0.607 -0.086 0.932 0.289 3.117 0.949 
 45-64 -0.046 0.525 -0.088 0.93 0.341 2.671 0.955 0.034 0.641 0.053 0.958 0.294 3.637 1.035 
 <65 0.025 0.536 0.046 0.963 0.358 2.934 1.025 1.194 0.695 1.717 0.086 0.844 12.897 3.3 
Farm Size GrandMean 0.003 0.004 0.751 0.453 0.995 1.011 1.003 0.015 0.006 2.509 0.012 1.003 1.027 1.015 
Knowledge of Abs Don't Know Ref       Ref       
 Good 0.316 0.278 1.133 0.257 0.794 2.366 1.371 0.423 0.379 1.117 0.264 0.727 3.206 1.526 
 Bad 0.039 0.265 0.148 0.883 0.619 1.748 1.04 0.136 0.356 0.381 0.703 0.57 2.3 1.145 
KnowledgeAbResistance Don't Know Ref       Ref       
 Good 0.158 0.293 0.538 0.59 0.659 2.078 1.171 0.793 0.428 1.854 0.064 0.956 5.116 2.211 
KnowledgeAbWithdrawal Don't Know Ref       Ref       
 Some 0.271 0.243 1.118 0.264 0.815 2.112 1.312 0.602 0.361 1.668 0.095 0.9 3.701 1.825 
 Good 1.019 0.545 1.868 0.062 0.951 8.064 2.77 -0.121 0.621 -0.195 0.845 0.262 2.992 0.886 
 Actively Ignores 0.802 0.622 1.289 0.197 0.659 7.552 2.23 2.006 1.314 1.527 0.127 0.566 97.727 7.436 
Mastitis Last 12 months? No Ref       Ref       
 Yes 0.53 0.22 2.405 0.016 1.103 2.617 1.699 0.376 0.325 1.159 0.246 0.771 2.753 1.457 
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  Ampicillin Trimethoprim 
Variable Category β SE z-ratio p-value L95%CI U95%CI 
odds 
ratio 
β SE z-ratio p-value L95%CI U95%CI 
odds 
ratio 
Diarrhoea 12 months? No Ref       Ref       
 Yes 0.108 0.245 0.441 0.659 0.689 1.8 1.114 0.193 0.347 0.557 0.578 0.615 2.394 1.213 
Diarrhoea 3 months? No Ref       Ref       
 Yes 0.08 0.246 0.324 0.746 0.669 1.754 1.083 0.233 0.345 0.674 0.5 0.641 2.484 1.262 
Bloody diarrhoea 3 months? No Ref       Ref       
 Yes -0.421 0.198 -2.129 0.033 0.446 0.967 0.657 -0.429 0.288 -1.492 0.136 0.37 1.144 0.651 
Animals Vaccinated? No Ref       Ref       
 Yes 0.072 0.204 0.353 0.724 0.721 1.603 1.075 0.429 0.275 1.556 0.12 0.895 2.635 1.535 
Treat whole group? Single Animal Ref       Ref       
 Whole Group -0.187 0.201 -0.931 0.352 0.559 1.23 0.829 0.008 0.276 0.028 0.978 0.587 1.731 1.008 
Separate Ill animals? No Ref       Ref       
 Yes -0.146 0.202 -0.724 0.469 0.581 1.284 0.864 -0.176 0.27 -0.65 0.515 0.494 1.424 0.839 
BoughtTetracyckine3Months? No Ref       Ref       
 Yes 0.092 0.217 0.427 0.67 0.717 1.677 1.097 0.303 0.301 1.009 0.313 0.751 2.442 1.355 
BoughtPen-strep3months? No Ref       Ref       
 Yes 0.436 0.28 1.559 0.119 0.894 2.677 1.547 0.567 0.381 1.488 0.137 0.835 3.717 1.762 
UsedTetracycline3months? No Ref       Ref       
 Yes 0.28 0.199 1.411 0.158 0.897 1.954 1.324 0.271 0.273 0.993 0.321 0.768 2.241 1.312 
UsedPenstrep3months? No Ref       Ref       
 Yes 0.529 0.204 2.597 0.009 1.139 2.529 1.697 0.52 0.29 1.79 0.073 0.952 2.972 1.682 
Sameneedlesyringe? No Ref       Ref       
 Yes 0.307 0.201 1.528 0.127 0.917 2.014 1.359 0.269 0.28 0.961 0.337 0.756 2.265 1.309 
Mainwatersource Taps Ref       Ref       
 Borehole/Well -0.145 0.335 -0.432 0.666 0.449 1.669 0.865 0.199 0.199 1 0.318 0.826 1.804 1.221 
 River/Lake -0.561 0.379 -1.483 0.138 0.272 1.198 0.57 0.071 0.227 0.315 0.753 0.689 1.674 1.074 
 Rainwater -0.392 0.439 -0.893 0.372 0.285 1.598 0.675 0.071 0.272 0.262 0.793 0.63 1.831 1.074 
P-values highlighted in green are statistically significant (p<0.25) values from the Wald Chi squared test; OR = Odds Ration; SE = Standard Error; 95%CI = 95% Confidence Intervals. 
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Figure II-iii. Farm level residuals plotted against the overall mean for each mixed effect 
model (n=70 farms). X-axis is farm number in order from 1 at the left, to 70 at the right. 
Error bars are 95% CI. 
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Whole Genome Sequencing 
Table II-iv Standard metrics of 150 sequences obtained from whole genome sequencing of livestock, 
humans, and environmental isolates. Raw reads were QC and then mapped to reference genome K12 E. 
coli  
 
Isolate Bacterial Host 
Number of 
sequences 
Genome Size Mean Coverage 
F4H2C Human 7594049 5010573 48 
F6C3B Cattle 7409363 4669865 48 
F6C3C Cattle 6915014 4664779 43 
F9C1A Cattle 6349380 4721225 117 
F9C3A Cattle 6349380 4701158 86 
F9C4CX Cattle 6207820 4825261 86 
F9C5A Cattle 6207820 4695529 127 
F9C5B Cattle 6206940 4657781 128 
F9H2A Human 6051696 4665384 165 
F9WATER Environment 6029597 4709000 75 
F11C3CZ Cattle 6029597 4709006 97 
F11C4CZ Cattle 5967560 4709006 144 
F11C4E Cattle 5776919 4651216 144 
F11H3A Human 5699804 4651921 127 
F11H3CZ Human 5699804 4708245 127 
F11P3E Poultry 5637595 4650020 155 
F12G2CX Sheep/Goat 5622626 4709006 112 
F12HOUSEA Environment 5446127 4652044 112 
F12P3CZ Poultry 5378647 4708724 124 
F12S1CX Sheep/Goat 5307585 4709005 89 
F12S2B Sheep/Goat 5243568 4650859 89 
F12S2C Sheep/Goat 5243568 4643102 113 
F13HOUSECZ Environment 5185791 4708244 135 
F13P3CX Poultry 5174394 4708632 22 
F13WATERCZ Environment 5174394 4708025 141 
F14C3CZ Cattle 5160598 4708637 141 
F15P5CX Poultry 5157245 4663297 124 
F15S2CX Sheep/Goat 5157245 4709007 108 
F16C9B Cattle 5099785 4644768 108 
F16C10A Cattle 5078123 4709912 122 
F18C1CX Cattle 5056281 4708167 92 
F18C6CX Cattle 4990032 4679690 92 
F18HOUSECX Environment 4990032 4649517 27 
F18P2CX Poultry 4963740 4663611 139 
F19C4CZ Cattle 4940177 4709108 141 
F19H3CX Human 4940177 4679112 144 
F19HOUSEA Environment 4884411 4820056 121 
F20P5CZ Poultry 4864582 4708144 121 
F22G1CX Sheep/Goat 4862929 4709006 140 
F22G1CZ Sheep/Goat 4862929 4684077 140 
F23H3CZ Human 4815181 4645235 117 
F24H2CX Human 4802866 4760295 96 
F26P2CZ Poultry 4802866 4684195 156 
F27C1CX Cattle 4790867 4709005 101 
F27G2CX Sheep/Goat 4790867 4707945 101 
F27P7CX Poultry 4783647 4709005 24 
Chapter Eight   Appendix II  
 313 
Isolate Bacterial Host 
Number of 
sequences 
Genome Size Mean Coverage 
F28P1E Poultry 4783647 4672601 110 
F28P2A Poultry 4726257 4708300 110 
F28P3A Poultry 4712673 4655050 152 
F29C4A Cattle 4663312 4698851 138 
F29H2CZ Human 4647731 4684319 148 
F29P1A Poultry 4608338 4660184 148 
F30C2C Cattle 4589108 4711185 109 
F30H2CZ Human 4589108 4708143 119 
F30HOUSEA Environment 4577186 4710879 204 
F31G1B Sheep/Goat 4527916 4709099 150 
F31G2C Sheep/Goat 4456531 4675650 164 
F31G3B Sheep/Goat 4443808 5139067 103 
F31H2A Human 4410936 4708813 23 
F31H3D Human 4410936 4651169 118 
F31PI1E Pig 4406693 4643290 118 
F31PI2A Pig 4355539 4703054 90 
F32C1A Cattle 4355539 4670876 90 
F32C3A Cattle 4353151 4710507 146 
F32C4B Cattle 4307653 4643718 189 
F32C5A Cattle 4298492 4710991 189 
F32G1B Sheep/Goat 4289152 4701600 92 
F32H1A Human 4289152 4642900 92 
F32H2A Human 4269760 4710777 92 
F32P1A Poultry 4269760 4649764 117 
F32P3A Poultry 4260231 4708397 107 
F32P4B Poultry 4256438 4709527 112 
F33C4B Cattle 4240203 4642448 86 
F33G2B Sheep/Goat 4202885 4698326 86 
F33H2A Human 4177115 4772753 29 
F33PI1A Pig 4177115 4864770 98 
F33PI2A Pig 4128577 4708741 94 
F33PI4B Pig 4128399 4643172 129 
F33PI5A Pig 4128399 4645330 100 
F34G1A Sheep/Goat 4103397 4709726 98 
F34H2B Human 4094342 4697866 98 
F35C3E Cattle 4081643 4648923 187 
F35H1A Human 4076991 4642826 187 
F35P2C Poultry 4031911 4648021 178 
F35P3D Poultry 4009892 4675175 141 
F36G1E Sheep/Goat 4009892 4699816 82 
F36H2A Human 3998512 4644351 137 
F36H3B Human 3976247 4709878 130 
F37C1A Cattle 3964061 4709562 117 
F37C2A Cattle 3962990 4647542 144 
F37P1C Poultry 3962990 4900040 144 
F37P2A Poultry 3960940 4646114 126 
F37P3B Poultry 3960940 4708835 126 
F37PI1B Pig 3947606 4658093 78 
F37PI2A Pig 3916495 4699680 78 
F37PI3A Pig 3859723 4655711 68 
F38C3A Cattle 3848138 4699545 105 
F38P4A Poultry 3834335 4648288 106 
F40G2A Sheep/Goat 3783005 4691471 127 
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Isolate Bacterial Host 
Number of 
sequences 
Genome Size Mean Coverage 
F40P2A Poultry 3743488 4700698 127 
F41G1B Sheep/Goat 3743488 4645860 101 
F41G3E Sheep/Goat 3730659 4645625 116 
F41G4A Sheep/Goat 3692884 4645337 104 
F41H3A Human 3676919 4690463 104 
F41P1E Poultry 3676919 4708128 79 
F41P5A Poultry 3646594 4709156 79 
F42C1A Cattle 3612171 4709333 81 
F42HOUSEA Environment 3592044 4658099 81 
F42PI3D Pig 3592044 4646941 179 
F43G1A Sheep/Goat 3535438 4710040 179 
F43H1B Human 3535438 4656035 115 
F43P1A Poultry 3498326 4655524 124 
F43PI1D Pig 3464240 4657165 124 
F44C2B Cattle 3464240 4649352 154 
F44C4C Cattle 3424858 4657244 154 
F44C5A Cattle 3408439 4659978 130 
F44H2C Human 3404504 4645261 155 
F44P1A Poultry 3388692 4851928 155 
F44P3B Poultry 3361927 4642551 100 
F44P4A Poultry 3350862 4644377 151 
F44P5A Poultry 3335785 4644884 174 
F44PI1A Pig 3335785 4709883 128 
F45C2C Cattle 3320111 4665743 170 
F45G1A Sheep/Goat 3320111 4709100 170 
F45G2C Sheep/Goat 3258101 4659978 117 
F45P1A Poultry 3238373 4709020 117 
F45P2E Poultry 3231920 4644812 169 
F45P3B Poultry 3178216 4700566 92 
F46C1A Cattle 3127357 4656277 133 
F46G2B Sheep/Goat 3127357 4779860 118 
F46H1A Human 3082237 4665507 79 
F46P3A Poultry 3024047 4652783 185 
F47C1A Cattle 3019330 4709401 124 
F47P1E Poultry 3019330 4643357 124 
F48C1A Cattle 3005253 4709890 122 
F48G3A Sheep/Goat 3005253 4648107 106 
F48P3B Poultry 2940394 4651511 106 
F49C1A Cattle 2940394 4710009 223 
F49C3A Cattle 2930597 4644146 87 
F49P7A Poultry 2930597 4708679 87 
F51C2C Cattle 2902327 4656087 144 
F51P2A Poultry 2902327 4645120 144 
F52G1A Sheep/Goat 2898710 4709508 81 
F52G2B Sheep/Goat 2898710 4649446 78 
F52G3B Sheep/Goat 2867122 4708548 91 
F52H3C Human 2855451 4645950 183 
F52P2A Poultry 2855451 4709018 162 
F53H3A Human 2768818 4643605 80 
F53PI1A Pig 2768818 4643471 113 
F55G3A Sheep/Goat 2725448 4649339 152 
 Average 4276582.08 4691652 118 
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Figure II-iii Slanted maximum likelihood phylogenetic tree of all WGS isolates. Tree is slanted to indicate 
bootstrap support values clearly and is split across two pages. All nodes are in the same order as Figure 
4.3.  
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Table III-i Standard metrics of 187 sequences obtained from whole genome sequencing of faecal E. coli 
isolated from slaughterhouse workers. 
 
Isolate Type of Slaughterhouse 
Number of 
sequences 
Genome Size Mean coverage 
120336 Cattle and Sheep/Goats 280444 4647468 19 
120233 Cattle only 801789 4642033 28 
120375 Cattle only 818581 4887208 29 
120418 Cattle only 173901 4820417 26 
120431 Cattle and Sheep/Goats 792986 4820343 25 
120500 Cattle and Sheep/Goats 216922 4644879 29 
120504 Cattle and Sheep/Goats 510637 4712205 22 
120505 Cattle and Sheep/Goats 508273 4659989 22 
120510 Cattle and Sheep/Goats 418541 4764593 19 
120511 Cattle and Sheep/Goats 1180995 4660451 53 
120515 Cattle and Sheep/Goats 537141 4651390 23 
120516 Cattle and Sheep/Goats 344653 4697450 13 
120519 Cattle only 1164967 4647188 54 
120520 Cattle and Sheep/Goats 593661 4677960 25 
120531 Pigs only 690268 4657096 30 
120534 Pigs only 785925 4681720 32 
120540 Cattle only 894226 4645678 39 
120544 Cattle only 1042161 4647103 48 
120546 Cattle only 407029 4650145 16 
120547 Cattle only 5312475 4694562 243 
120548 Cattle only 1190524 5085209 55 
120550 Cattle only 422153 5083874 19 
120561 Cattle only 252654 4690411 29 
120564 Cattle only 1028585 4656472 30 
120595 Cattle and Sheep/Goats 2252194 4787402 89 
120596 Cattle and Sheep/Goats 368273 4787437 15 
120597 Cattle and Sheep/Goats 809933 4680078 36 
120633 Cattle only 1657061 4647460 77 
120637 Cattle only 736931 4692297 33 
120655 Cattle only 6921496 4657801 319 
120689 Pigs only 1617929 4658892 76 
120721 Cattle and Sheep/Goats 1357007 4677039 58 
120724 Cattle and Sheep/Goats 1279570 4650381 60 
120725 Cattle and Sheep/Goats 2671485 4715062 125 
120726 Cattle and Sheep/Goats 2456962 4779760 118 
120748 Cattle and Sheep/Goats 621427 4759651 28 
120798 Pigs only 1920259 4713344 86 
120802 Cattle only 523779 4645326 24 
120811 Pigs only 523779 4830662 24 
120819 Cattle only 815485 4657034 35 
121231 Cattle and Sheep/Goats 1476998 4658311 70 
121236 Cattle and Sheep/Goats 732522 4711302 35 
121250 Pigs only 2084868 4646355 91 
121317 Cattle and Sheep/Goats 1745880 4730711 84 
121340 Cattle only 2270720 4734044 104 
121368 Cattle only 767913 4661015 35 
121369 Cattle only 2276807 4692192 100 
121426 Cattle only 1131480 4706178 53 
121427 Cattle only 1485164 4645347 69 
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Isolate Type of Slaughterhouse 
Number of 
sequences 
Genome Size Mean coverage 
121428 Cattle only 831785 4659560 40 
121460 Cattle only 1216605 4686061 58 
121464 Cattle only 837529 4661237 41 
121466 Cattle only 779504 4643650 34 
121528 Pigs only 3222557 4687117 150 
121560 Cattle only 1027236 4655576 50 
121568 Cattle only 1431653 4650325 70 
121595 Cattle and Sheep/Goats 1864989 4647465 87 
121613 Cattle only 1532070 4650753 74 
121617 Pigs only 892608 4680259 42 
121644 Cattle only 875612 4679800 41 
121650 Cattle only 1276962 4646246 59 
121680 Cattle only 2189915 4646676 106 
121712 Cattle only 1899829 4656115 85 
121721 Cattle and Sheep/Goats 5065805 4646160 199 
121723 Cattle and Sheep/Goats 678257 4645923 20 
121736 Cattle and Sheep/Goats 787708 4688050 37 
121766 Cattle and Sheep/Goats 767120 4656603 33 
121772 Cattle and Sheep/Goats 1028589 4709581 50 
121921 Cattle and Sheep/Goats 648519 4669160 31 
121949 Pigs only 1126183 4661094 53 
121967 Pigs only 1859777 4712927 88 
123519 Cattle and Sheep/Goats 728122 4756079 34 
123549 Cattle and Sheep/Goats 1263567 4658544 57 
123559 Cattle and Sheep/Goats 642201 4713353 30 
120172a Cattle and Sheep/Goats 928172 4674699 45 
120172b Cattle and Sheep/Goats 1863447 4644767 88 
120346a Cattle and Sheep/Goats 1065411 4649141 51 
120346b Cattle and Sheep/Goats 2809256 4674378 121 
120347a Cattle and Sheep/Goats 1109773 4651050 48 
120347b Cattle and Sheep/Goats 1892940 4656820 92 
120347c Cattle and Sheep/Goats 878163 4691546 41 
120354a Cattle only 632581 4651001 29 
120354b Cattle only 1321223 4675349 62 
120360a Cattle only 2038289 4642708 99 
120360b Cattle only 872777 4645045 39 
120502a Cattle and Sheep/Goats 654552 4662467 31 
120502b Cattle and Sheep/Goats 1078722 4642064 51 
120506a Cattle and Sheep/Goats 1748033 4656303 83 
120506b Cattle and Sheep/Goats 1722343 4656505 81 
120690a Pigs only 1722343 4690405 81 
120690b Pigs only 1587380 4799692 76 
120741a Cattle and Sheep/Goats 1376318 4706221 64 
120741b Cattle and Sheep/Goats 1139716 4706311 55 
120741c Cattle and Sheep/Goats 1888328 4706333 90 
120749a Cattle and Sheep/Goats 1019141 4690637 46 
120749b Cattle and Sheep/Goats 2778074 4657171 132 
120750a Cattle and Sheep/Goats 1018063 4657089 43 
120750b Cattle and Sheep/Goats 4381797 4788506 191 
121608a Cattle only 1024489 4875078 50 
121608b Cattle only 1401990 4756010 59 
121615a Cattle only 1180697 4682967 57 
121615b Cattle only 1786210 4791783 86 
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Isolate Type of Slaughterhouse 
Number of 
sequences 
Genome Size Mean coverage 
121649a Cattle only 1106527 4649688 53 
121649b Cattle only 1517529 4662305 70 
121919a Cattle and Sheep/Goats 1741276 4714564 84 
121919b Cattle and Sheep/Goats 1254488 4644707 58 
121930a Cattle and Sheep/Goats 2918074 4644271 141 
121930b Cattle and Sheep/Goats 2326000 5083875 114 
121972a Pigs only 1564150 4646940 74 
121972b Pigs only 1693830 4639706 77 
58-263A Cattle and Sheep/Goats 1566089 4646537 71 
58-286C Cattle and Sheep/Goats 2144176 4684738 103 
58-294D Cattle and Sheep/Goats 2276536 4657564 102 
58-323C Cattle and Sheep/Goats 1889368 4645351 80 
58-337B Cattle and Sheep/Goats 2628689 4684732 109 
58-340C Cattle only 2100408 4656779 96 
58-363CX Pigs only 2100408 4887207 96 
58-367C Cattle only 2967843 4647573 124 
58-377C Cattle only 2415277 4684939 100 
58-454A Pigs only 280444 4887499 10 
58-454C Pigs only 801789 4656520 28 
58-454CX Pigs only 818581 4657251 29 
58-454CZ Pigs only 173901 4645897 26 
58-457CZ Pigs only 792986 4887206 25 
58-464A Cattle and Sheep/Goats 216922 4657075 29 
58-464CX Cattle and Sheep/Goats 510637 4644490 22 
58-464CZ Cattle and Sheep/Goats 508273 4666249 22 
58-465CX Cattle only 418541 4719106 19 
58-467A Cattle only 1180995 4656748 53 
58-468CX Cattle and Sheep/Goats 537141 4763529 23 
58-468CZ Cattle and Sheep/Goats 344653 4810327 13 
58-477CX Pigs only 1164967 4669584 54 
58-490B Pigs only 593661 4759767 25 
58-498CZ Cattle and Sheep/Goats 690268 4661468 30 
58-503A Pigs only 785925 4759726 32 
58-523C Pigs only 894226 4643670 39 
58-533A Cattle and Sheep/Goats 1042161 4667241 48 
58-533CZ Cattle and Sheep/Goats 407029 4767895 16 
58-539CX Cattle and Sheep/Goats 5312475 4645507 243 
58-539CZ Cattle and Sheep/Goats 1190524 4683177 55 
58-546A Pigs only 422153 4900032 19 
58-546CXa Pigs only 252654 4657077 29 
58-546CXb Pigs only 1028585 4657080 30 
58-546CZ Pigs only 2252194 4961227 89 
58-547CX Cattle only 368273 4666141 15 
58-549C Cattle and Sheep/Goats 809933 4642313 36 
58-554A Cattle only 1657061 4708600 77 
58-558CZ Cattle only 736931 4769144 33 
58-560CX Cattle only 6921496 4657075 319 
58-562CZ Cattle only 1617929 4669369 76 
58-570CX Cattle only 1357007 4659212 58 
58-578CX Cattle only 1279570 4853074 60 
58-579C Cattle only 2671485 4756270 125 
58-583CZ Cattle only 2456962 4657081 118 
58-586CX Cattle only 621427 4643601 28 
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Isolate Type of Slaughterhouse 
Number of 
sequences 
Genome Size Mean coverage 
58-588CX Cattle only 1920259 4657076 86 
58-596D Cattle only 523779 4687187 24 
58-606A Cattle and Sheep/Goats 523779 4655363 24 
58-630CZ Pigs only 815485 4657076 35 
58-639CZ Pigs only 1476998 4782516 70 
58-644B Pigs only 732522 4692279 35 
58-651C Cattle only 2084868 4648121 91 
58-663A Cattle only 1745880 4657018 84 
58-671A Cattle and Sheep/Goats 2270720 4919764 104 
58-672B Cattle and Sheep/Goats 767913 4656904 35 
58-676A Cattle only 2276807 4670850 100 
58-676CZ Cattle only 1131480 4657551 53 
58-687A Cattle and Sheep/Goats 1485164 4680830 69 
58-697D Cattle and Sheep/Goats 831785 4679672 40 
58-702CX Pigs only 1216605 4677663 58 
58-704A Pigs only 837529 4684738 41 
58-706E Pigs only 779504 4760361 34 
58-716CX Pigs only 3222557 4645200 150 
58-716CZ Pigs only 1027236 4656512 50 
58-718D Pigs only 1431653 4887210 70 
58-724A Pigs only 1864989 4657856 87 
58-724CX Pigs only 1532070 4645384 74 
58-725CX Pigs only 892608 4661280 42 
58-725CZ Pigs only 875612 4643117 41 
58-733D Pigs only 1276962 4657544 59 
58-740CZ Pigs only 2189915 4657563 106 
58-742CX Pigs only 1899829 4693275 85 
58-747CX Pigs only 5065805 4656512 199 
58-747CZ Pigs only 678257 4656510 29 
58-751CX Pigs only 787708 4656503 37 
58-751CZ Pigs only 767120 4657006 33 
58-754B Pigs only 1028589 4656793 50 
 Average 1398731 4698734 64 
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Figure II-i Slanted maximum likelihood phylogenetic tree of all WGS isolates. Tree is slanted to indicate 
bootstrap support values clearly and is split across two pages. All nodes are in the same order as Figure 
5.3.  
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